0001306830-23-000086 10-Q 109 20230331 20230510 20230510 Celanese Corp 0001306830 2820 980420726 DE 1231 10-Q 34 001-32410 23906874 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 972-443-4000 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 Celanese CORP 20041102 Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. 20041022 10-Q 1 ce-20230331.htm 10-Q ce-20230331
000130683012/312023Q1falsehttp://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#InterestExpensehttp://fasb.org/us-gaap/2022#InterestExpensehttp://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#OtherAssetsCurrent http://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsCurrent http://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsCurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsCurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent91100013068302023-01-012023-03-310001306830us-gaap:CommonStockMember2023-01-012023-03-310001306830ce:EURSeniorUnsecuredNotesDue2023Member2023-01-012023-03-310001306830ce:EURSeniorUnsecuredNotesDue2025Member2023-01-012023-03-310001306830ce:EURSeniorUnsecuredNotesDue2026Member2023-01-012023-03-310001306830ce:EURSeniorUnsecuredNotesDue2027Member2023-01-012023-03-310001306830ce:EURSeniorUnsecuredNotesDue2028Member2023-01-012023-03-310001306830ce:EURSeniorUnsecuredNotesDue2029Member2023-01-012023-03-3100013068302023-05-05xbrli:sharesiso4217:USD00013068302022-01-012022-03-31iso4217:USDxbrli:shares00013068302023-03-3100013068302022-12-310001306830us-gaap:CommonStockMember2022-12-310001306830us-gaap:CommonStockMember2021-12-310001306830us-gaap:CommonStockMember2023-01-012023-03-310001306830us-gaap:CommonStockMember2022-01-012022-03-310001306830us-gaap:CommonStockMember2023-03-310001306830us-gaap:CommonStockMember2022-03-310001306830us-gaap:TreasuryStockMember2022-12-310001306830us-gaap:TreasuryStockMember2021-12-310001306830us-gaap:TreasuryStockMember2023-01-012023-03-310001306830us-gaap:TreasuryStockMember2022-01-012022-03-310001306830us-gaap:TreasuryStockMember2023-03-310001306830us-gaap:TreasuryStockMember2022-03-310001306830us-gaap:AdditionalPaidInCapitalMember2022-12-310001306830us-gaap:AdditionalPaidInCapitalMember2021-12-310001306830us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001306830us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001306830us-gaap:AdditionalPaidInCapitalMember2023-03-310001306830us-gaap:AdditionalPaidInCapitalMember2022-03-310001306830us-gaap:RetainedEarningsMember2022-12-310001306830us-gaap:RetainedEarningsMember2021-12-310001306830us-gaap:RetainedEarningsMember2023-01-012023-03-310001306830us-gaap:RetainedEarningsMember2022-01-012022-03-310001306830us-gaap:RetainedEarningsMember2023-03-310001306830us-gaap:RetainedEarningsMember2022-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-3100013068302022-03-310001306830us-gaap:NoncontrollingInterestMember2022-12-310001306830us-gaap:NoncontrollingInterestMember2021-12-310001306830us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001306830us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001306830us-gaap:NoncontrollingInterestMember2023-03-310001306830us-gaap:NoncontrollingInterestMember2022-03-3100013068302021-12-310001306830ce:ConsolidatedVenturesMember2023-03-31xbrli:pure0001306830ce:MobilityMaterialsMember2022-11-010001306830ce:MobilityMaterialsMember2022-11-012022-11-01ce:facilityce:patentce:employees0001306830ce:MobilityMaterialsMember2022-01-012022-03-310001306830ce:CelaneseCorporationMemberce:KoreaEngineeringPlasticsCoLtdMember2022-04-010001306830ce:MitsubishiGasChemicalCompanyMemberce:KoreaEngineeringPlasticsCoLtdMember2022-04-010001306830ce:KoreaEngineeringPlasticsCoLtdMember2022-04-012022-04-010001306830ce:KoreaEngineeringPlasticsCoLtdMember2022-04-01ce:annualInstallmentiso4217:EUR0001306830ce:EngineeredMaterialsMember2022-12-310001306830ce:AcetylChainMember2022-12-310001306830ce:EngineeredMaterialsMember2023-01-012023-03-310001306830ce:AcetylChainMember2023-01-012023-03-310001306830ce:EngineeredMaterialsMember2023-03-310001306830ce:AcetylChainMember2023-03-310001306830us-gaap:LicensingAgreementsMember2022-12-310001306830us-gaap:CustomerRelationshipsMember2022-12-310001306830us-gaap:DevelopedTechnologyRightsMember2022-12-310001306830us-gaap:OtherIntangibleAssetsMember2022-12-310001306830us-gaap:LicensingAgreementsMember2023-01-012023-03-310001306830us-gaap:CustomerRelationshipsMember2023-01-012023-03-310001306830us-gaap:DevelopedTechnologyRightsMember2023-01-012023-03-310001306830us-gaap:OtherIntangibleAssetsMember2023-01-012023-03-310001306830us-gaap:LicensingAgreementsMember2023-03-310001306830us-gaap:CustomerRelationshipsMember2023-03-310001306830us-gaap:DevelopedTechnologyRightsMember2023-03-310001306830us-gaap:OtherIntangibleAssetsMember2023-03-310001306830us-gaap:TrademarksAndTradeNamesMember2022-12-310001306830us-gaap:TrademarksAndTradeNamesMember2023-01-012023-03-310001306830us-gaap:TrademarksAndTradeNamesMember2023-03-310001306830ce:MobilityMaterialsMember2023-03-310001306830ce:MobilityMaterialsMember2022-12-310001306830us-gaap:RevolvingCreditFacilityMember2023-03-310001306830us-gaap:RevolvingCreditFacilityMember2022-12-310001306830us-gaap:ShortTermDebtMember2023-03-310001306830us-gaap:ShortTermDebtMember2022-12-310001306830us-gaap:RevolvingCreditFacilityMember2023-03-310001306830us-gaap:RevolvingCreditFacilityMember2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2023Member2023-03-310001306830ce:EURSeniorUnsecuredNotesDue2023Member2022-12-310001306830ce:SeniorUnsecuredNotesDue2024Member2023-03-310001306830ce:SeniorUnsecuredNotesDue2024Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2024Member2023-03-310001306830ce:USDSeniorUnsecuredNotesDue2024Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2025Member2023-03-310001306830ce:EURSeniorUnsecuredNotesDue2025Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2025Member2023-03-310001306830ce:USDSeniorUnsecuredNotesDue2025Member2022-12-310001306830ce:SeniorUnsecuredTermLoanDue2025Member2023-03-310001306830ce:SeniorUnsecuredTermLoanDue2025Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2026Member2023-03-310001306830ce:USDSeniorUnsecuredNotesDue2026Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2026Member2023-03-310001306830ce:EURSeniorUnsecuredNotesDue2026Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2027Member2023-03-310001306830ce:EURSeniorUnsecuredNotesDue2027Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2027Member2023-03-310001306830ce:USDSeniorUnsecuredNotesDue2027Member2022-12-310001306830ce:SeniorUnsecuredTermLoanDue2027Member2023-03-310001306830ce:SeniorUnsecuredTermLoanDue2027Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2028Member2023-03-310001306830ce:EURSeniorUnsecuredNotesDue2028Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2029Member2023-03-310001306830ce:EURSeniorUnsecuredNotesDue2029Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2029Member2023-03-310001306830ce:USDSeniorUnsecuredNotesDue2029Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2032Member2023-03-310001306830ce:USDSeniorUnsecuredNotesDue2032Member2022-12-310001306830ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMembersrt:MinimumMember2023-03-310001306830srt:MaximumMemberce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2023-03-310001306830ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2023-03-310001306830ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2022-12-310001306830us-gaap:LoansPayableMember2023-03-310001306830us-gaap:LoansPayableMember2022-12-310001306830ce:A364DayDelayedDrawTermLoanMemberce:TermLoanFacilityMember2022-03-312022-03-310001306830ce:A364DayDelayedDrawTermLoanMemberce:TermLoanFacilityMember2022-03-310001306830ce:TermLoanFacilityMemberce:A5YearDelayedDrawTermLoanMember2022-03-312022-03-310001306830ce:TermLoanFacilityMemberce:A5YearDelayedDrawTermLoanMember2022-03-310001306830ce:A3YearDelayedDrawTermLoanMemberce:TermLoanFacilityMember2022-09-302022-09-300001306830ce:A3YearDelayedDrawTermLoanMemberce:TermLoanFacilityMember2022-09-300001306830us-gaap:RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2022-03-310001306830ce:ChinaRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-01-04iso4217:CNY0001306830ce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMember2023-01-060001306830ce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMember2023-01-062023-01-060001306830ce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMemberce:VariableInterbankInterestRateMember2023-01-062023-01-060001306830us-gaap:RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-03-310001306830ce:ChinaRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-03-310001306830ce:AcquisitionNotesMember2022-07-310001306830ce:AcquisitionNotesMember2022-07-312022-07-310001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2023-01-012023-03-310001306830us-gaap:SecuredDebtMemberce:AmendedRestatedReceivableSecuritizationFacilityMember2023-03-310001306830us-gaap:SecuredDebtMemberce:AmendedRestatedReceivableSecuritizationFacilityMember2022-12-310001306830us-gaap:SecuredDebtMemberce:AmendedRestatedReceivableSecuritizationFacilityMember2023-01-012023-03-310001306830us-gaap:SecuredDebtMemberce:AmendedRestatedReceivableSecuritizationFacilityMember2022-01-012022-12-310001306830ce:EuropeFactoringAgreementsMember2023-03-310001306830ce:SingaporeFactoringAgreementsMember2023-03-310001306830ce:EuropeAndSingaporeFactoringAgreementsMember2023-03-310001306830ce:EuropeAndSingaporeFactoringAgreementsMember2022-12-310001306830ce:EuropeAndSingaporeFactoringAgreementsMember2023-01-012023-03-310001306830ce:EuropeAndSingaporeFactoringAgreementsMember2022-01-012022-12-310001306830us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-03-310001306830us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-03-310001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-03-310001306830us-gaap:PensionPlansDefinedBenefitMember2023-03-310001306830us-gaap:OtherPensionPlansDefinedBenefitMember2023-01-012023-03-310001306830us-gaap:OtherPensionPlansDefinedBenefitMember2023-03-310001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-03-310001306830us-gaap:PensionPlansDefinedBenefitMember2022-12-310001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-310001306830ce:PassaicRiverNewJerseyMember2023-01-012023-03-310001306830ce:PassaicRiverNewJerseyMember2016-03-312016-03-310001306830ce:PassaicRiverNewJerseyMember2021-09-302021-09-300001306830ce:PassaicRiverNewJerseyMember2022-12-162022-12-160001306830ce:PassaicRiverNewJerseyMember2023-03-242023-03-240001306830ce:PassaicRiverNewJerseyMember2023-03-310001306830us-gaap:SubsequentEventMember2023-04-192023-04-1900013068302008-02-012023-03-310001306830us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001306830us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001306830us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310001306830us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310001306830us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001306830us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310001306830us-gaap:NetInvestmentHedgingMember2023-01-012023-03-310001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2023-03-312023-03-310001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-12-312022-12-310001306830ce:USDSeniorUnsecuredNotesDue2027Memberus-gaap:CurrencySwapMember2022-07-310001306830ce:USDSeniorUnsecuredNotesDue2032Memberus-gaap:CurrencySwapMember2022-07-310001306830us-gaap:NetInvestmentHedgingMemberce:AcquisitionNotesMember2022-07-312022-07-310001306830us-gaap:NondesignatedMember2023-01-012023-03-310001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-03-310001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-12-310001306830us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310001306830us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2022-01-012022-03-310001306830us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310001306830us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2022-01-012022-03-310001306830us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-01-012023-03-310001306830us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-03-310001306830us-gaap:CashFlowHedgingMember2023-01-012023-03-310001306830us-gaap:CashFlowHedgingMember2022-01-012022-03-310001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2023-01-012023-03-310001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-03-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2023-01-012023-03-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2022-01-012022-03-310001306830us-gaap:NetInvestmentHedgingMember2022-01-012022-03-310001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-01-012023-03-310001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-01-012022-03-310001306830us-gaap:NondesignatedMember2022-01-012022-03-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:CommodityContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel1Memberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:FairValueInputsLevel2Member2023-03-310001306830us-gaap:FairValueInputsLevel3Member2023-03-310001306830us-gaap:FairValueInputsLevel2Member2022-12-310001306830us-gaap:FairValueInputsLevel3Member2022-12-310001306830ce:IndemnificationAgreementsHoechstMember2023-03-310001306830ce:IndemnificationAgreementsHoechstMember1999-11-012023-03-310001306830ce:DivestitureAgreementsMember2023-03-310001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2023-01-012023-03-310001306830us-gaap:IntersegmentEliminationMember2023-01-012023-03-310001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2023-03-310001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2023-03-310001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2023-03-310001306830us-gaap:IntersegmentEliminationMember2023-03-310001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2022-01-012022-03-310001306830us-gaap:IntersegmentEliminationMember2022-01-012022-03-310001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2022-12-310001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2022-12-310001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2022-12-310001306830us-gaap:IntersegmentEliminationMember2022-12-3100013068302023-04-012023-03-3100013068302024-01-012023-03-3100013068302025-01-012023-03-310001306830ce:EngineeredMaterialsMembersrt:NorthAmericaMember2023-01-012023-03-310001306830ce:EngineeredMaterialsMembersrt:NorthAmericaMember2022-01-012022-03-310001306830us-gaap:EMEAMemberce:EngineeredMaterialsMember2023-01-012023-03-310001306830us-gaap:EMEAMemberce:EngineeredMaterialsMember2022-01-012022-03-310001306830ce:EngineeredMaterialsMembersrt:AsiaPacificMember2023-01-012023-03-310001306830ce:EngineeredMaterialsMembersrt:AsiaPacificMember2022-01-012022-03-310001306830srt:SouthAmericaMemberce:EngineeredMaterialsMember2023-01-012023-03-310001306830srt:SouthAmericaMemberce:EngineeredMaterialsMember2022-01-012022-03-310001306830ce:EngineeredMaterialsMember2022-01-012022-03-310001306830ce:AcetylChainMembersrt:NorthAmericaMember2023-01-012023-03-310001306830ce:AcetylChainMembersrt:NorthAmericaMember2022-01-012022-03-310001306830us-gaap:EMEAMemberce:AcetylChainMember2023-01-012023-03-310001306830us-gaap:EMEAMemberce:AcetylChainMember2022-01-012022-03-310001306830ce:AcetylChainMembersrt:AsiaPacificMember2023-01-012023-03-310001306830ce:AcetylChainMembersrt:AsiaPacificMember2022-01-012022-03-310001306830ce:AcetylChainMembersrt:SouthAmericaMember2023-01-012023-03-310001306830ce:AcetylChainMembersrt:SouthAmericaMember2022-01-012022-03-310001306830ce:AcetylChainMember2022-01-012022-03-310001306830ce:AcetylChainMemberus-gaap:IntersegmentEliminationMember2023-01-012023-03-310001306830ce:AcetylChainMemberus-gaap:IntersegmentEliminationMember2022-01-012022-03-310001306830us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001306830us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001306830us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001306830us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001306830us-gaap:EmployeeSeveranceMemberce:EngineeredMaterialsMember2022-12-310001306830ce:AcetylChainMemberus-gaap:EmployeeSeveranceMember2022-12-310001306830us-gaap:EmployeeSeveranceMemberus-gaap:CorporateAndOtherMember2022-12-310001306830us-gaap:EmployeeSeveranceMember2022-12-310001306830us-gaap:EmployeeSeveranceMemberce:EngineeredMaterialsMember2023-01-012023-03-310001306830ce:AcetylChainMemberus-gaap:EmployeeSeveranceMember2023-01-012023-03-310001306830us-gaap:EmployeeSeveranceMemberus-gaap:CorporateAndOtherMember2023-01-012023-03-310001306830us-gaap:EmployeeSeveranceMember2023-01-012023-03-310001306830us-gaap:EmployeeSeveranceMemberce:EngineeredMaterialsMember2023-03-310001306830ce:AcetylChainMemberus-gaap:EmployeeSeveranceMember2023-03-310001306830us-gaap:EmployeeSeveranceMemberus-gaap:CorporateAndOtherMember2023-03-310001306830us-gaap:EmployeeSeveranceMember2023-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________
Form 10-Q
☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
March 31, 2023
Or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-32410
CElogo.jpg
CELANESE CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware98-0420726
(State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification No.)

222 W. Las Colinas Blvd., Suite 900N
Irving, TX 75039-5421
(Address of Principal Executive Offices and zip code)

(972) 443-4000
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per shareCEThe New York Stock Exchange
1.125% Senior Notes due 2023CE /23The New York Stock Exchange
1.250% Senior Notes due 2025CE /25The New York Stock Exchange
4.777% Senior Notes due 2026CE /26AThe New York Stock Exchange
2.125% Senior Notes due 2027CE /27The New York Stock Exchange
0.625% Senior Notes due 2028CE /28The New York Stock Exchange
5.337% Senior Notes due 2029CE /29AThe New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑  No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑  No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  þ Accelerated filer  ☐ Non-accelerated filer  ☐ Smaller reporting company  ☐ Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☑
The number of outstanding shares of the registrant's Common Stock, $0.0001 par value, as of May 5, 2023 was 108,787,807.

CELANESE CORPORATION AND SUBSIDIARIES
Form 10-Q
For the Quarterly Period Ended March 31, 2023
TABLE OF CONTENTS
Page
2

Item 1. Financial Statements
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
March 31,
20232022
(In $ millions, except share and per share data)
Net sales2,853 2,538 
Cost of sales(2,222)(1,793)
Gross profit631 745 
Selling, general and administrative expenses(285)(174)
Amortization of intangible assets(41)(11)
Research and development expenses(42)(24)
Other (charges) gains, net(23)(1)
Foreign exchange gain (loss), net6 (1)
Gain (loss) on disposition of businesses and assets, net5 (3)
Operating profit (loss)251 531 
Equity in net earnings (loss) of affiliates15 56 
Non-operating pension and other postretirement employee benefit (expense) income1 24 
Interest expense(182)(35)
Interest income8 1 
Dividend income - equity investments34 37 
Other income (expense), net(6)2 
Earnings (loss) from continuing operations before tax121 616 
Income tax (provision) benefit(25)(112)
Earnings (loss) from continuing operations96 504 
Earnings (loss) from operation of discontinued operations(3)— 
Income tax (provision) benefit from discontinued operations— — 
Earnings (loss) from discontinued operations(3)— 
Net earnings (loss)93 504 
Net (earnings) loss attributable to noncontrolling interests(2)(2)
Net earnings (loss) attributable to Celanese Corporation91 502 
Amounts attributable to Celanese Corporation  
Earnings (loss) from continuing operations94 502 
Earnings (loss) from discontinued operations(3)— 
Net earnings (loss)91 502 
Earnings (loss) per common share - basic  
Continuing operations0.87 4.64 
Discontinued operations(0.03)— 
Net earnings (loss) - basic0.84 4.64 
Earnings (loss) per common share - diluted  
Continuing operations0.86 4.61 
Discontinued operations(0.03)— 
Net earnings (loss) - diluted0.83 4.61 
Weighted average shares - basic108,634,068 108,185,912 
Weighted average shares - diluted109,188,266 108,917,577 

See the accompanying notes to the unaudited interim consolidated financial statements.
3
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (LOSS)
Three Months Ended
March 31,
20232022
(In $ millions)
Net earnings (loss)93 504 
Other comprehensive income (loss), net of tax
Foreign currency translation gain (loss)13 (21)
Gain (loss) on cash flow hedges4 15 
Pension and postretirement benefits(1)2 
Total other comprehensive income (loss), net of tax16 (4)
Total comprehensive income (loss), net of tax109 500 
Comprehensive (income) loss attributable to noncontrolling interests
(2)(2)
Comprehensive income (loss) attributable to Celanese Corporation
107 498 

See the accompanying notes to the unaudited interim consolidated financial statements.
4
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETS
As of
March 31,
2023		As of
December 31,
2022
(In $ millions, except share data)
ASSETS
Current Assets  
Cash and cash equivalents1,167 1,508 
Trade receivables - third party and affiliates1,606 1,379 
Non-trade receivables, net707 675 
Inventories2,749 2,808 
Other assets219 241 
Total current assets6,448 6,611 
Investments in affiliates1,049 1,062 
Property, plant and equipment (net of accumulated depreciation - 2023: $3,791; 2022: $3,687)
5,588 5,584 
Operating lease right-of-use assets414 413 
Deferred income taxes813 808 
Other assets553 547 
Goodwill7,139 7,142 
Intangible assets, net4,086 4,105 
Total assets26,090 26,272 
LIABILITIES AND EQUITY
Current Liabilities  
Short-term borrowings and current installments of long-term debt - third party and affiliates
1,386 1,306 
Trade payables - third party and affiliates1,445 1,518 
Other liabilities1,014 1,201 
Income taxes payable6 43 
Total current liabilities3,851 4,068 
Long-term debt, net of unamortized deferred financing costs13,396 13,373 
Deferred income taxes1,223 1,242 
Uncertain tax positions295 322 
Benefit obligations411 411 
Operating lease liabilities359 364 
Other liabilities425 387 
Commitments and Contingencies
Shareholders' Equity  
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2023 and 2022: 0 issued and outstanding)
— — 
Common stock, $0.0001 par value, 400,000,000 shares authorized (2023: 170,448,231 issued and 108,786,738 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding)
— — 
Treasury stock, at cost (2023: 61,661,493 shares; 2022: 61,661,493 shares)
(5,491)(5,491)
Additional paid-in capital365 372 
Retained earnings11,289 11,274 
Accumulated other comprehensive income (loss), net(502)(518)
Total Celanese Corporation shareholders' equity5,661 5,637 
Noncontrolling interests469 468 
Total equity6,130 6,105 
Total liabilities and equity26,090 26,272 

See the accompanying notes to the unaudited interim consolidated financial statements.
5
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF EQUITY
Three Months Ended March 31,
20232022
SharesAmountSharesAmount
(In $ millions, except share data)
Common Stock
Balance as of the beginning of the period108,473,932 — 108,023,735 — 
Stock awards312,806 — 283,606 — 
Balance as of the end of the period108,786,738 — 108,307,341 — 
Treasury Stock
Balance as of the beginning of the period61,661,493 (5,491)61,736,289 (5,492)
Purchases of treasury stock, including related fees— — — — 
Balance as of the end of the period61,661,493 (5,491)61,736,289 (5,492)
Additional Paid-In Capital
Balance as of the beginning of the period372 333 
Stock-based compensation, net of tax(7)(7)
Balance as of the end of the period365 326 
Retained Earnings
Balance as of the beginning of the period11,274 9,677 
Net earnings (loss) attributable to Celanese Corporation91 502 
Common stock dividends(76)(73)
Balance as of the end of the period11,289 10,106 
Accumulated Other Comprehensive Income (Loss), Net
Balance as of the beginning of the period(518)(329)
Other comprehensive income (loss), net of tax16 (4)
Balance as of the end of the period(502)(333)
Total Celanese Corporation shareholders' equity5,661 4,607 
Noncontrolling Interests
Balance as of the beginning of the period468 348 
Net earnings (loss) attributable to noncontrolling interests2 2 
Dividends to noncontrolling interests(1)— 
Distributions to noncontrolling interests
— (4)
Balance as of the end of the period469 346 
Total equity6,130 4,953 

See the accompanying notes to the unaudited interim consolidated financial statements.
6
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended
March 31,
20232022
(In $ millions)
Operating Activities
Net earnings (loss)93 504 
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities
Depreciation, amortization and accretion178 106 
Pension and postretirement net periodic benefit cost3 (21)
Pension and postretirement contributions(12)(12)
Deferred income taxes, net1 4 
(Gain) loss on disposition of businesses and assets, net(6)3 
Stock-based compensation14 15 
Undistributed earnings in unconsolidated affiliates25 (30)
Other, net(1)3 
Operating cash provided by (used in) discontinued operations1 (4)
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net(216)(240)
Inventories45 (32)
Other assets99 — 
Trade payables - third party and affiliates(22)49 
Other liabilities(298)(29)
Net cash provided by (used in) operating activities(96)316 
Investing Activities
Capital expenditures on property, plant and equipment(164)(137)
Proceeds from sale of businesses and assets, net9 — 
Other, net(23)(12)
Net cash provided by (used in) investing activities(178)(149)
Financing Activities
Net change in short-term borrowings with maturities of 3 months or less(300)74 
Proceeds from short-term borrowings338 — 
Repayments of long-term debt(7)(7)
Purchases of treasury stock, including related fees— (17)
Common stock dividends(76)(73)
Distributions to noncontrolling interests(1)(4)
Issuance cost of bridge facility— (44)
Other, net(23)(24)
Net cash provided by (used in) financing activities(69)(95)
Exchange rate effects on cash and cash equivalents2 (3)
Net increase (decrease) in cash and cash equivalents(341)69 
Cash and cash equivalents as of beginning of period1,508 536 
Cash and cash equivalents as of end of period1,167 605 

See the accompanying notes to the unaudited interim consolidated financial statements.
7
CELANESE CORPORATION AND SUBSIDIARIES
NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
1. Description of the Company and Basis of Presentation
Description of the Company
Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals, for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles.
Definitions
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
Basis of Presentation
The unaudited interim consolidated financial statements for the three months ended March 31, 2023 and 2022 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.
In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with U.S. GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, 2022, filed on February 24, 2023 with the SEC as part of the Company's Annual Report on Form 10-K.
Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the entire year.
In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report.
For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as noncontrolling interests.
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension
8
and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.
2. Recent Accounting Pronouncements
There are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures.
3. Acquisitions, Dispositions and Plant Closures
Acquisitions
In November 2022, the Company acquired 100% ownership of entities and assets consisting of a majority of the Mobility & Materials business ("M&M") of DuPont de Nemours, Inc. ("DuPont") (the "M&M Acquisition") for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction. The Company acquired a global production network of 29 facilities, including compounding and polymerization, customer and supplier contracts and agreements, an intellectual property portfolio, including approximately 850 patents with associated technical and R&D assets, and approximately 5,000 employees across the manufacturing, technical, and commercial organizations. This acquisition of M&M enhances the engineered materials product portfolio by adding new polymers, brands, product technology, and backward integration in critical polymers, allowing the Company to accelerate growth in high-value applications including future mobility, connectivity and medical. The acquisition was accounted for as a business combination and the acquired operations are included in the Engineered Materials segment.
The Company preliminarily allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The purchase price allocation was based upon preliminary information and is subject to change if additional information about the facts and circumstances that existed at the acquisition date becomes available. The Company is in the ongoing process of conducting a valuation of the assets acquired and liabilities assumed related to the acquisition, including trade names and customer relationships, personal and real property, investment in equity affiliates and deferred taxes. The final fair value of the net assets acquired may result in adjustments to these assets and liabilities, including goodwill. During the measurement period to date, there were no adjustments that materially impacted the Company's goodwill initially recorded.
The following unaudited pro forma financial information presents the consolidated results of operations as if the M&M Acquisition had occurred at the beginning of 2022. M&M's pre-acquisition results have been added to the Company's historical results. The pro forma results contained in the table below include adjustments for (i) increased depreciation expense as a result of acquisition date fair value adjustments, (ii) amortization of acquired intangibles, (iii) interest expense and amortization of debt issuance costs of $172 million related to borrowings under the U.S Term Loan Facility (defined below) and the issuance of Acquisition Notes (defined below) as if these had taken place at the beginning of 2022 for the three months ended March 31, 2022 and (iv) net total inventory step up of inventory amortized to Cost of sales of $98 million for the three months ended March 31, 2022.
These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisitions occurred on the assumed dates, nor are they necessarily an indication of future operating results.
Three Months Ended
March 31, 2022
(In $ millions)
Unaudited Consolidated Pro Forma Results
Proforma Net sales
3,427 
Proforma Earnings (loss) from continuing operations before tax
312 
Korea Engineering Plastics Co. Restructuring
In April 2022, the Company completed the restructuring of Korea Engineering Plastics Co. ("KEPCO"), a joint venture owned 50% by the Company and 50% by Mitsubishi Gas Chemical Company, Inc. KEPCO was first formed in 1987 to manufacture and market polyoxymethylene ("POM") in Asia, with a particular focus on serving domestic demand in South Korea. KEPCO will now focus solely on manufacturing and supplying high quality products to its shareholders, who will independently market
9
them globally. As part of the restructuring of KEPCO, the Company paid KEPCO $5 million and will pay 5 equal annual installments of €24 million on October 1 of each year beginning in 2022. This resulted in an increase to the Company's investment in KEPCO of $134 million. The Company's joint venture partner will be making similar payments to KEPCO. The restructuring did not result in a change in ownership percentage of KEPCO, nor a change in control, and KEPCO will continue to be accounted for as an equity method investment.
4. Inventories
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Finished goods1,811 1,820 
Work-in-process210 202 
Raw materials and supplies728 786 
Total2,749 2,808 
5. Goodwill and Intangible Assets, Net
Goodwill
Engineered
Materials		Acetyl ChainTotal
(In $ millions)
As of December 31, 20226,775 367 7,142 
Acquisitions (Note 3)
(18)— (18)
Exchange rate changes11 4 15 
As of March 31, 2023(1)
6,768 371 7,139 
______________________________
(1)There were no accumulated impairment losses as of March 31, 2023.
Intangible Assets, Net
Finite-lived intangible assets are as follows:
LicensesCustomer-
Related
Intangible
Assets		Developed
Technology		Covenants
Not to
Compete
and Other		Total
(In $ millions)
Gross Asset Value
As of December 31, 202242 2,455 601 55 3,153 
Exchange rate changes— 22 — — 22 
As of March 31, 202342 2,477 601 55 3,175 
Accumulated Amortization
As of December 31, 2022(39)(567)(50)(40)(696)
Amortization— (30)(11)— (41)
Exchange rate changes— (8)— — (8)
As of March 31, 2023(39)(605)(61)(40)(745)
Net book value3 1,872 540 15 2,430 
10
Indefinite-lived intangible assets are as follows:
Trademarks
and Trade Names
(In $ millions)
As of December 31, 20221,648 
Exchange rate changes8 
As of March 31, 20231,656 
During the three months ended March 31, 2023, the Company did not renew or extend any intangible assets.
Estimated amortization expense for the succeeding five fiscal years is as follows:
(In $ millions)
2024160 
2025160 
2026160 
2027160 
2028160 
6. Current Other Liabilities
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Benefit obligations (Note 8)
25 25 
Customer rebates91 101 
Derivatives (Note 12)
39 63 
Interest (Note 7)
155 265 
Legal (Note 14)
22 21 
Operating leases88 83 
Restructuring (Note 18)
23 6 
Salaries and benefits123 151 
Sales and use tax/foreign withholding tax payable91 108 
Investment in affiliates94 79 
Other(1)
263 299 
Total1,014 1,201 
____________________________
(1)Includes $104 million and $166 million of liabilities related to the M&M Acquisition payable to DuPont as of March 31, 2023 and December 31, 2022, respectively.
11
7. Debt
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt551 506 
Short-term borrowings, including amounts due to affiliates(1)
617 500 
Revolving credit facilities(2)
218 300 
Total1,386 1,306 
______________________________
(1)The weighted average interest rate was 5.6% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.
(2)The weighted average interest rate was 3.4% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2023, interest rate of 1.125%
489 480 
Senior unsecured notes due 2024, interest rate of 3.500%
499 499 
Senior unsecured notes due 2024, interest rate of 5.900%
2,000 2,000 
Senior unsecured notes due 2025, interest rate of 1.250%
326 320 
Senior unsecured notes due 2025, interest rate of 6.050%
1,750 1,750 
Senior unsecured term loan due 2025, interest rate of 6.265%
750 750 
Senior unsecured notes due 2026, interest rate of 1.400%
400 400 
Senior unsecured notes due 2026, interest rate of 4.777%
1,088 1,067 
Senior unsecured notes due 2027, interest rate of 2.125%
542 531 
Senior unsecured notes due 2027, interest rate of 6.165%
2,000 2,000 
Senior unsecured term loan due 2027, interest rate of 6.265%
1,000 1,000 
Senior unsecured notes due 2028, interest rate of 0.625%
543 533 
Senior unsecured notes due 2029, interest rate of 5.337%
544 533 
Senior unsecured notes due 2029, interest rate of 6.330%
750 750 
Senior unsecured notes due 2032, interest rate of 6.379%
1,000 1,000 
Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%
163 164 
Bank loans due at various dates through 2026(1)
4 4 
Obligations under finance leases due at various dates through 2054
169 172 
Subtotal14,017 13,953 
Unamortized debt issuance costs(2)
(70)(74)
Current installments of long-term debt(551)(506)
Total13,396 13,373 
______________________________
(1)The weighted average interest rate was 1.3% and 1.3% as of March 31, 2023 and December 31, 2022, respectively.
(2)Related to the Company's long-term debt, excluding obligations under finance leases.
12
Senior Credit Facilities
In March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a term loan credit agreement (the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion. In September 2022, Celanese, Celanese U.S. and certain subsidiaries entered into an additional term loan credit agreement (the "September 2022 U.S. Term Loan Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Term Loan Credit Agreements"), pursuant to which lenders have provided delayed-draw term loans due 3 years from issuance in an amount equal to $750 million (the term loans represented by the U.S. Term Loan Credit Agreements collectively, the "U.S. Term Loan Facility"). The U.S. Term Loan Facility was fully drawn during the three months ended December 31, 2022.
Also in March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a new revolving credit agreement (the "U.S. Revolving Credit Agreement" and, together with the U.S. Term Loan Credit Agreements, the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027 (the "U.S. Revolving Credit Facility").
On February 21, 2023, the Company amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors"). The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.
On January 4, 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
Also on January 6, 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement," together with the China Revolving Credit Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn on January 10, 2023 and is supported by a letter of comfort from the Company. The Company expects that the China Credit Agreements will facilitate its efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of its U.S. debt to China at a lower average interest rate.
The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:
As of
March 31,
2023
(In $ millions)
U.S. Revolving Credit Facility
Borrowings outstanding— 
Available for borrowing1,750 
China Revolving Credit Facility
Borrowings outstanding218 
Available for borrowing37 
Senior Notes
The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date.
13
In July 2022, Celanese U.S. completed an offering of $7.5 billion aggregate principal amount of notes of various maturities in a public offering registered under the Securities Act (the "Acquisition USD Notes"). In July 2022, Celanese U.S. completed an offering of €1.5 billion in aggregate principal amount of euro-denominated senior unsecured notes due in 2026 and 2029 in a public offering registered under the Securities Act (collectively, the "Acquisition Euro Notes" and together with the Acquisition USD Notes, the "Acquisition Notes"). Certain of the Acquisition Notes were issued at a discount to par, which will be amortized to Interest expense in the consolidated statement of operations over the terms of the applicable Acquisition Notes. Fees and expenses of the offering of the Acquisition Notes, inclusive of underwriting discounts, were $65 million.
Accounts Receivable Purchasing Facility
In June 2021, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2024. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's unaudited consolidated balance sheet. The Company de-recognized $249 million and $1.1 billion of accounts receivable under this agreement for the three months ended March 31, 2023 and twelve months ended December 31, 2022, respectively, and collected $249 million and $1.1 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $109 million were pledged by the SPE as collateral to the Purchasers as of March 31, 2023.
Factoring and Discounting Agreements
The Company has factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $87 million and $320 million of accounts receivable under these factoring agreements for the three months ended March 31, 2023 and twelve months ended December 31, 2022, respectively, and collected $82 million and $325 million of accounts receivable sold under these factoring agreements during the same periods.
Covenants
The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. The Company is in compliance with the covenants in its material financing arrangements as of March 31, 2023.
14
8. Benefit Obligations
The components of net periodic benefit cost are as follows:
Three Months Ended March 31,
20232022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Service cost4 — 3 — 
Interest cost32 — 17 — 
Expected return on plan assets
(33)— (41)— 
Total3 — (21)— 
Benefit obligation funding is as follows:
As of
March 31,
2023
Total
Expected
2023
(In $ millions)
Cash contributions to defined benefit pension plans6 27 
Benefit payments to nonqualified pension plans5 18 
Benefit payments to other postretirement benefit plans1 4 
The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.
Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of:
As of March 31, 2023As of December 31, 2022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Noncurrent Other assets166 — 160 — 
Current Other liabilities(21)(3)(21)(3)
Benefit obligations(371)(35)(372)(35)
Net amount recognized(226)(38)(233)(38)
9. Environmental
The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.
15
The components of environmental remediation liabilities are as follows:
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Demerger obligations (Note 14)
19 20 
Divestiture obligations (Note 14)
14 14 
Active sites20 21 
U.S. Superfund sites9 10 
Other environmental remediation liabilities2 2 
Total64 67 
Remediation
Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (Note 14). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.
U.S. Superfund Sites
In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.
As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.
One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the Newark Bay Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the LPRSA and the Newark Bay Area.
16
In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. In September 2021, the EPA issued a Record of Decision selecting an interim remedial plan for the upper 9 miles of the Lower Passaic River ("Upper 9 Miles"). Pursuant to the EPA's Record of Decision, targeted dredging will be conducted in the Upper 9 Miles to address surface sediments with elevated contamination followed by the installation of an engineered cap at an EPA estimated cost of $441 million.
The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273 (MCA) (LDW) (U.S. District Court New Jersey) (the "2018 OCC Lawsuit"), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the 2018 OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs.
Separately, the United States lodged a Consent Decree in U.S. District Court for the District of New Jersey on December 16, 2022 that will resolve the Company's liability (and that of more than 80 other settling defendants) to the EPA for costs to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site in exchange for a collective payment of $150 million, United States v. Alden Leeds, Inc., No. 2:22-7326 (MCA) (LDW) (U.S. District Court New Jersey) ("Consent Decree Action"). The Consent Decree also will provide the Company protection from contribution claims by others for costs incurred to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site. The Company's proposed payment toward the $150 million collective settlement payment is not material to the Company's results of operations, cash flows or financial position. The Consent Decree is still subject to public comment and court approval.
On March 7, 2023, the U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit, pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. On March 24, 2023, OCC filed a new lawsuit against 40 parties, including a subsidiary of the Company, seeking to recover costs for remedial design work the EPA has ordered OCC to undertake for a portion of the LPRSA at an estimated cost of $71 million, Occidental Chemical Corporation v. Givaudan Fragrances Corporation, No. 2:23-cv-1699 (U.S. District Court New Jersey) (the "2023 OCC Lawsuit"). Like the earlier lawsuit, the 2023 OCC Lawsuit concerns the facility Essex County, New Jersey purchased and for which Essex County, New Jersey has agreed to defend and indemnify the Company. This new lawsuit does not change the Company's estimated liability for LPRSA cleanup costs.
The Company will continue to vigorously defend these matters and continues to believe that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, previously estimated at less than 1%, will not be material.
Other Environmental Matters
In April 2022, a methanol leak on a pipeline to our Bishop, Texas facility was discovered. The release has been contained, the leak has been repaired and the pipeline has resumed operation. The Company promptly disclosed the incident to state and federal authorities, including the Texas Commission on Environmental Quality and the EPA, and remediation activities are now completed. While the Company has not received a notice of violation nor been assessed any fines or penalties to date, the Company recorded a reserve in Other current liabilities based on anticipated clean-up costs and possible penalties to state or federal authorities. The Company does not believe that resolution of this matter will have a material impact on our financial condition or results of operations.
17
10. Shareholders' Equity
Common Stock
The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by its existing Global Credit Agreements and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant.
The Company declared a quarterly cash dividend of $0.70 per share on its Common Stock on April 19, 2023, amounting to $76 million. The cash dividend will be paid on May 15, 2023 to holders of record as of May 1, 2023.
Treasury Stock
The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.
Total From
February 2008
Through
March 31, 2023
Shares repurchased69,324,429 
Average purchase price per share$83.71 
Shares repurchased (in $ millions)$5,803 
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)
$6,866 
The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of shareholders' equity.
The Company did not repurchase any Common Stock during the three months ended March 31, 2023 and 2022.
Other Comprehensive Income (Loss), Net
Three Months Ended March 31,
20232022
Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount		Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(4)17 13 (15)(6)(21)
Gain (loss) on cash flow hedges4 — 4 19 (4)15 
Pension and postretirement benefits gain (loss)(1)— (1)2 — 2 
Total(1)17 16 6 (10)(4)
18
Adjustments to Accumulated other comprehensive income (loss), net, are as follows:
Foreign
Currency
Translation Gain (Loss)
Gain (Loss)
on Cash
Flow
Hedges
Pension and
Postretirement
Benefits Gain (Loss)
Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2022(488)(22)(8)(518)
Other comprehensive income (loss) before reclassifications(4)2 (1)(3)
Amounts reclassified from accumulated other comprehensive income (loss)
— 2 — 2 
Income tax (provision) benefit17 — — 17 
As of March 31, 2023(475)(18)(9)(502)
11. Income Taxes
Three Months Ended
March 31,
20232022
(In percentages)
Effective income tax rate21 18 
The effective income tax rate for the three months ended March 31, 2023, was higher compared to the same period in 2022, primarily due to increases in valuation allowances on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period, partially offset by increased earnings in low taxed jurisdictions during the three months ended March 31, 2023.
In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various final and proposed regulatory packages supplementing the TCJA provisions since 2018. There have been no material proposed or final regulatory packages during the three months ended March 31, 2023.
In August 2022, the Inflation Reduction Act (the "IRA") was enacted and included a 1% excise tax on share repurchases in excess of $1 million, and a corporate minimum tax of 15% on adjusted book earnings. The corporate minimum tax paid is creditable in future years to the extent that regular tax liability exceeds the minimum tax in any given year. The Company does not expect these provisions and any newly issued administrative guidance to have a material impact to future income tax expense. The IRA also provides various beneficial credits for energy efficient related manufacturing, transportation and fuels, hydrogen/carbon recapture and renewable energy, which the Company is evaluating in regard to planned projects.
The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense adjustments in the period the guidance is finalized or becomes effective.
Due to the TCJA and uncertainty as to future foreign source income, the Company previously recorded a valuation allowance on a substantial portion of its foreign tax credit carryforwards. The Company is currently evaluating tax planning strategies to enable the use of the Company's foreign tax credit carryforwards that may decrease the Company's effective tax rate in future periods as the valuation allowance is reversed.
The Company's tax returns have been under joint audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In September 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also proposed to apply these adjustments to open tax years through 2019. The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authorities. The Company is engaged in ongoing discussions with the other authorities regarding the ongoing examinations and will evaluate all additional potential remedies as the discussions progress.
In addition, the Company's income tax returns in Mexico are under audit for the years 2017 and 2018, and in Canada for the years 2016 through 2018. In January 2022, the Mexico tax authorities issued preliminary findings for disallowance of operating expenses on several of the applicable tax returns. The Company has analyzed the preliminary findings, engaged in preliminary
19
discussions with the Mexico tax authorities and has recorded the appropriate tax reserves as of March 31, 2023. The Company will continue discussions with the Mexico authorities in 2023. Related to Canada, the Company is discussing preliminary findings with the Canadian authorities and does not expect a material impact to income tax expense.
As of March 31, 2023, the Company believes that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised in the audits described above are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its positions, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded.
12. Derivative Financial Instruments
Derivatives Designated As Hedges
Net Investment Hedges
The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:
As of
March 31,
2023		As of
December 31,
2022
(In € millions)
Total5,652 5,639 
Concurrently with the offering of the Acquisition USD Notes in July 2022 (Note 7), the Company entered into cross-currency swaps to effectively convert $2.0 billion and $500 million of the Acquisition USD Notes into a euro-denominated borrowing at prevailing euro interest rates, maturing on July 15, 2027 and July 15, 2032, respectively. The swaps and €1.5 billion of the Acquisition Euro Notes qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investments of certain of its euro-denominated subsidiaries.
Derivatives Not Designated As Hedges
Foreign Currency Forwards and Swaps
Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Total1,892 1,314 
20
Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Three Months Ended March 31, Statement of Operations Classification
2023202220232022
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps— 17 1 — Cost of sales
Interest rate swaps— — (2)(2)Interest expense
Foreign currency forwards2 — (1)— Cost of sales
Total2 17 (2)(2)
Designated as Net Investment Hedges
Foreign currency denominated debt (Note 7)
(56)28 — — N/A
Cross-currency swaps(19)2 — — N/A
Total(75)30 — — 
Not Designated as Hedges
Foreign currency forwards and swaps
— — 2 (1)Foreign exchange gain (loss), net; Other income (expense), net
Total— — 2 (1)
See Note 13 for additional information regarding the fair value of the Company's derivative instruments.
Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement.
Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Derivative Assets
Gross amount recognized139 169 
Gross amount offset in the consolidated balance sheets1 — 
Net amount presented in the consolidated balance sheets138 169 
Gross amount not offset in the consolidated balance sheets26 16 
Net amount112 153 
21
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Derivative Liabilities
Gross amount recognized185 189 
Gross amount offset in the consolidated balance sheets1 — 
Net amount presented in the consolidated balance sheets184 189 
Gross amount not offset in the consolidated balance sheets26 16 
Net amount158 173 
13. Fair Value Measurements
The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:
Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.
Fair Value Measurement
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		TotalBalance Sheet Classification
(In $ millions)
As of March 31, 2023
Derivatives Designated as Cash Flow Hedges
Commodity swaps— 4 4 Current Other assets
Commodity swaps— 43 43 Noncurrent Other assets
Foreign currency forwards and swaps— 1 1 Current Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— 67 67 Current Other assets
Cross-currency swaps— 11 11 Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— 12 12 Current Other assets
Total assets— 138 138 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— (29)(29)Current Other liabilities
Cross-currency swaps— (145)(145)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— (10)(10)Current Other liabilities
Total liabilities— (184)(184)
22
Fair Value Measurement
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		TotalBalance Sheet Classification
(In $ millions)
As of December 31, 2022
Derivatives Designated as Cash Flow Hedges
Commodity swaps— 9 9 Current Other assets
Commodity swaps— 39 39 Noncurrent Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— 99 99 Current Other assets
Cross-currency swaps— 13 13 Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— 9 9 Current Other assets
Total assets— 169 169 
Derivatives Designated as Cash Flow Hedges
Commodity swaps— (2)(2)Current Other liabilities
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— (58)(58)Current Other liabilities
Cross-currency swaps— (126)(126)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— (3)(3)Current Other liabilities
Total liabilities— (189)(189)
Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
Fair Value Measurement
Carrying
Amount		Significant Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
(In $ millions)
As of March 31, 2023
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts21 21 — 21 
Long-term debt, including current installments of long-term debt
14,017 13,608 169 13,777 
As of December 31, 2022
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts22 23 — 23 
Long-term debt, including current installments of long-term debt
13,953 13,247 172 13,419 
In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement.
23
As of March 31, 2023, and December 31, 2022, the fair values of cash and cash equivalents, receivables, marketable securities, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.
14. Commitments and Contingencies
Commitments
Guarantees
The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.
The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following:
•Demerger Obligations
In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (Note 9).
The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of March 31, 2023 are $108 million. Though the Company is significantly under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.
The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.
Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued.
•Divestiture Obligations
The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk (Note 9).
The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $126 million as of March 31, 2023. Other agreements do not provide for any monetary or time limitations.
Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued.
24
Purchase Obligations
In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of March 31, 2023, the Company had unconditional purchase obligations of $4.2 billion, of which $532 million will be paid in 2023, $675 million in 2024, $549 million in 2025, $419 million in 2026, $341 million in 2027 and the balance thereafter through 2042.
Contingencies
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position.
15. Segment Information

Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended March 31, 2023
Net sales1,630 1,250 — (27)(1)2,853 
Other (charges) gains, net (Note 18)
(21)(1)(1)— (23)
Operating profit (loss)112 278 (139)— 251 
Equity in net earnings (loss) of affiliates
11 1 3 — 15 
Depreciation and amortization112 54 6 — 172 
Capital expenditures45 51 12 — 108 (2)
As of March 31, 2023
Goodwill and intangible assets, net
10,800 425 — — 11,225 
Total assets
18,522 5,730 1,838 — 26,090 
Three Months Ended March 31, 2022
Net sales
910 

1,652 

— (24)(1)2,538 
Other (charges) gains, net (Note 18)
(1)— — — (1)
Operating profit (loss)
124 503 (96)— 531 
Equity in net earnings (loss) of affiliates
49 4 3 — 56 
Depreciation and amortization
46 56 4 — 106 
Capital expenditures
30 70 14 — 114 (2)
As of December 31, 2022
Goodwill and intangible assets, net
10,826 421 — — 11,247 
Total assets
20,611 5,471 190 — 26,272 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $56 million and $23 million for the three months ended March 31, 2023 and 2022, respectively.
25
16. Revenue Recognition
The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of March 31, 2023, the Company had $1.4 billion of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $378 million of its remaining performance obligations as Net sales in 2023, $460 million in 2024, $319 million in 2025 and the balance thereafter.
Contract Balances
Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the unaudited consolidated balance sheets.
The Company does not have any material contract assets as of March 31, 2023.
Disaggregated Revenue
In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations.
The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects which are solutions-based and are tailored to each customer's unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment.
The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue.
Further disaggregation of Net sales by business segment and geographic destination is as follows:
Three Months Ended
March 31,
20232022
(In $ millions)
Engineered Materials
North America479 289 
Europe and Africa560 377 
Asia-Pacific548 221 
South America43 23 
Total1,630 910 
Acetyl Chain
North America365 425 
Europe and Africa460 592 
Asia-Pacific367 561 
South America31 50 
Total(1)
1,223 1,628 
______________________________
(1)Excludes intersegment sales of $27 million and $24 million for the three months ended March 31, 2023 and 2022, respectively.
26
17. Earnings (Loss) Per Share
Three Months Ended
March 31,
20232022
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations94 502 
Earnings (loss) from discontinued operations(3)— 
Net earnings (loss)91 502 
Weighted average shares - basic108,634,068 108,185,912 
Incremental shares attributable to equity awards(1)
554,198 731,665 
Weighted average shares - diluted109,188,266 108,917,577 
______________________________
(1)Excludes options to purchase 86,194 and 0 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively; and 72,574 and 61,297 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively, as their effect would have been antidilutive.
18. Other (Charges) Gains, Net
Three Months Ended
March 31,
20232022
(In $ millions)
Restructuring(23)(1)
Total(23)(1)
During the three months ended March 31, 2023, the Company recorded $23 million of employee termination benefits primarily related to Company-wide business optimization projects.
The changes in the restructuring liabilities by business segment are as follows:
Engineered
Materials		Acetyl
Chain		OtherTotal
(In $ millions)
Employee Termination Benefits
As of December 31, 20224 1 1 6 
Additions21 1 1 23 
Cash payments(4)(1)(1)(6)
As of March 31, 202321 1 1 23 
27
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms the "Company," "we," "our" and "us," refer to Celanese and its subsidiaries on a consolidated basis. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
The following discussion should be read in conjunction with the Celanese Corporation and Subsidiaries consolidated financial statements as of and for the year ended December 31, 2022 filed on February 24, 2023 with the Securities and Exchange Commission ("SEC") as part of the Company's Annual Report on Form 10-K ("2022 Form 10-K") and the unaudited interim consolidated financial statements and notes to the unaudited interim consolidated financial statements herein, which are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").
Investors are cautioned that the forward-looking statements contained in this section and other parts of this Quarterly Report involve both risk and uncertainty. Several important factors could cause actual results to differ materially from those anticipated by these statements. Many of these statements are macroeconomic in nature and are, therefore, beyond the control of management. See "Forward-Looking Statements" below and at the beginning of our 2022 Form 10-K.
Forward-Looking Statements
Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and other parts of this Quarterly Report contain certain forward-looking statements and information relating to us that are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. Generally, words such as "believe," "expect," "intend," "estimate," "anticipate," "project," "plan," "may," "can," "could," "might," and "will," and similar expressions, as they relate to us are intended to identify forward-looking statements. These statements reflect our current views and beliefs with respect to future events at the time that the statements are made, are not historical facts or guarantees of future performance and involve risks and uncertainties that are difficult to predict and many of which are outside of our control. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. All forward-looking statements made in this Quarterly Report are made as of the date hereof, and the risk that actual results will differ materially from expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation, and disclaim any duty, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in our expectations or otherwise.
Risk Factors
See Part I - Item 1A. Risk Factors of our 2022 Form 10-K for a description of certain risk factors that you should consider which could significantly affect our financial results. In addition, the following factors, among others, could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements:
•changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate;
•volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources;
•the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries;
•the ability to pass increases in raw material prices, logistics costs and other costs on to customers or otherwise improve margins through price increases;
•the accuracy or inaccuracy of our beliefs or assumptions regarding anticipated benefits of the acquisition (the "M&M Acquisition") by us of the majority of the Mobility & Materials business (the "M&M Business") of DuPont de Nemours, Inc. ("DuPont");
•the possibility that we will not be able to realize all of the anticipated improvements in the M&M Business's financial performance – including optimizing pricing, currency mix and inventory – or realize all of the anticipated benefits of the M&M Acquisition, including synergies and growth opportunities, within the anticipated timeframe or at all, whether as a
28
result of difficulties arising from the operation or integration of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities;
•increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies;
•risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all;
•diversion of management's attention from ongoing business operations and opportunities and other disruption caused by the M&M Acquisition and the integration processes and their impact on our existing business and relationships;
•risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility;
•the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance;
•the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants;
•increased price competition and the introduction of competing products by other companies;
•the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with our strategy;
•market acceptance of our products and technology;
•compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war (such as the Russia-Ukraine conflict) or terrorist incidents or as a result of weather, natural disasters, or other crises;
•the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to us;
•changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions;
•changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property;
•potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters;
•potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate;
•changes in currency exchange rates and interest rates; and
•various other factors, both referenced and not referenced in this Quarterly Report.
Many of these factors are macroeconomic in nature and are, therefore, beyond our control. Should one or more of these risks or uncertainties materialize, affect us in ways or to an extent that we currently do not expect or consider to be significant, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report as anticipated, believed, estimated, expected, intended, planned or projected. We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of their dates.
29
Overview
We are a global chemical and specialty materials company. We are a leading global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals, for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, medical, consumer electronics, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles. Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures.
Our large and diverse global customer base primarily consists of major companies across a broad array of industries. We hold geographically balanced global positions and participate in diversified end-use applications. We combine a demonstrated track record of execution, strong performance built on differentiated business models and a clear focus on growth and value creation. Known for operational excellence, reliability and execution of our business strategies, we partner with our customers around the globe to deliver best-in-class technologies and solutions.
Results of Operations
Financial Highlights
Three Months Ended March 31,
20232022Change
(unaudited)
(In $ millions, except percentages)
Statement of Operations Data
Net sales2,853 2,538 315 
Gross profit631 745 (114)
Selling, general and administrative ("SG&A") expenses(285)(174)(111)
Other (charges) gains, net(23)(1)(22)
Operating profit (loss)251 531 (280)
Equity in net earnings (loss) of affiliates15 56 (41)
Non-operating pension and other postretirement employee benefit (expense) income1 24 (23)
Interest expense(182)(35)(147)
Interest income8 1 7 
Dividend income - equity investments34 37 (3)
Earnings (loss) from continuing operations before tax121 616 (495)
Earnings (loss) from continuing operations96 504 (408)
Earnings (loss) from discontinued operations(3)— (3)
Net earnings (loss)93 504 (411)
Net earnings (loss) attributable to Celanese Corporation91 502 (411)
Other Data
Depreciation and amortization172 106 66 
SG&A expenses as a percentage of Net sales10.0 %6.9 %
Operating margin(1)
8.8 %20.9 %
Other (charges) gains, net
Restructuring
(23)(1)(22)
Total Other (charges) gains, net
(23)(1)(22)
______________________________
(1)Defined as Operating profit (loss) divided by Net sales.
30
As of
March 31,
2023		As of
December 31,
2022
(unaudited)
(In $ millions)
Balance Sheet Data
Cash and cash equivalents1,167 1,508 
Short-term borrowings and current installments of long-term debt - third party and affiliates1,386 1,306 
Long-term debt, net of unamortized deferred financing costs13,396 13,373 
Total debt14,782 14,679 
Factors Affecting Business Segment Net Sales
The percentage increase (decrease) in Net sales attributable to each of the factors indicated for each of our business segments is as follows:
Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022
VolumePriceCurrencyTotal
(unaudited)
(In percentages)
Engineered Materials80 2 (3)79 
Acetyl Chain(9)(13)(2)(24)
Total Company23 (8)(3)12 
Consolidated Results
Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022
Net sales increased $315 million, or 12%, for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•higher volume in our Engineered Materials segment, primarily related to our acquisition of the majority of the Mobility & Materials business (the "M&M Business") and the Korea Engineering Plastics Co., Ltd. ("KEPCO") restructuring (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information); and
•higher pricing in our Engineered Materials segment, due to product mix and pricing actions to address higher raw material costs;
partially offset by:
•lower pricing in our Acetyl Chain segment due to weaker economic conditions particularly in Asia;
•lower volume in our Acetyl Chain segment, primarily due to decreased demand, primarily in Europe; and
•an unfavorable currency impact resulting from a weaker euro relative to the U.S. dollar.
Selling, general and administrative expenses increased $111 million, or 64%, for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•an increase in spending of approximately $114 million in our Engineered Materials segment and Other Activities primarily related to our acquisition of the M&M Business.
31
Operating profit decreased $280 million, or 53%, for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•higher raw material costs and spending in our Engineered Materials segment as a result of our acquisition of the M&M Business; and
•lower Net sales in our Acetyl Chain segment;
partially offset by:
•higher Net sales in our Engineered Materials segment; and
•lower raw material and sourcing costs in our Acetyl Chain segment.
Equity in net earnings (loss) of affiliates decreased $41 million for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•a decrease in equity investment in earnings of $15 million as a result of our KEPCO strategic affiliate restructuring; and
•losses from our DuPont Teijin Films Luxembourg S.A., DuPont Teijin Films UK Ltd. and DuPont Teijin Films US Limited Partnership (collectively "DuPont Teijin Films") strategic affiliates due to restructuring.
Our effective income tax rate for the three months ended March 31, 2023 was 21% compared to 18% for the same period in 2022. The higher effective income tax rate was primarily due to increases in valuation allowances on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period, partially offset by increased earnings in low taxed jurisdictions during the three months ended March 31, 2023 (see Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information).
Business Segments
Engineered Materials
Three Months Ended March 31, Change%
Change
20232022
(unaudited)
(In $ millions, except percentages)
Net sales1,630 910 720 79.1 %
Net Sales Variance
Volume80 %
Price2 %
Currency(3)%
Other— %
Other (charges) gains, net(21)(1)(20)(2,000.0)%
Operating profit (loss)112 124 (12)(9.7)%
Operating margin6.9 %13.6 %
Equity in net earnings (loss) of affiliates
11 49 (38)(77.6)%
Depreciation and amortization
112 46 66 143.5 %
Our Engineered Materials segment includes our engineered materials business, our food ingredients business and certain strategic affiliates. Our engineered materials business develops, produces and supplies a broad portfolio of high performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. Together with our strategic affiliates, our engineered materials business is a leading participant in the global specialty polymers industry.
The pricing of products within the Engineered Materials segment is primarily based on the value of the material we produce and is generally independent of changes in the cost of raw materials, but may be impacted during periods of inflation and increased
32
costs. Therefore, in general, margins may expand or contract in response to changes in raw material costs. We attempt to address increases in raw material costs through appropriate pricing actions.
Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022
Net sales increased for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•higher volume, primarily related to our acquisition of the M&M Business and the KEPCO restructuring (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information); and
•higher pricing for most of our products, primarily due to product mix and pricing actions to address higher raw material costs;
partially offset by:
•an unfavorable currency impact resulting from a weaker euro relative to the U.S. dollar.
Operating profit decreased for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•higher raw material costs as a result of our acquisition of the M&M Business;
•higher spending of $187 million as a result of our acquisition of the M&M Business; and
•an unfavorable impact of $20 million to Other (charges) gains, net. During the three months ended March 31, 2023, we recorded $21 million of employee termination benefits primarily related to Company-wide business optimization projects in the current year (see Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);
largely offset by:
•higher Net sales.
Equity in net earnings (loss) of affiliates decreased for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•a decrease in equity investment in earnings of $15 million as a result of our KEPCO strategic affiliate restructuring; and
•losses from our DuPont Teijin Films strategic affiliates due to restructuring.
33
Acetyl Chain
Three Months Ended March 31, Change%
Change
20232022
(unaudited)
(In $ millions, except percentages)
Net sales1,250 1,652 (402)(24.3)%
Net Sales Variance
Volume(9)%
Price(13)%
Currency(2)%
Other— %
Operating profit (loss)278 503 (225)(44.7)%
Operating margin22.2 %30.4 % 
Dividend income - equity investments33 36 (3)(8.3)%
Depreciation and amortization
54 56 (2)(3.6)%
Our Acetyl Chain segment, which includes the integrated chain of our intermediate chemistry, emulsion polymers, ethylene vinyl acetate polymers, redispersible powders and acetate tow businesses, is active in every major global industrial sector and serves diverse consumer end-use applications. These include conventional uses, such as paints, coatings, adhesives, and filter products, as well as other unique, high-value end uses including flexible packaging, thermal laminations, pharmaceuticals, wire and cable, and compounds. Together with our strategic affiliates, our Acetyl Chain businesses are leading producers and suppliers in multiple global industrial sectors.
The pricing of products within the Acetyl Chain is influenced by industry utilization rates and changes in the cost of raw materials. Therefore, in general, there is a directional correlation between these factors and our Net sales for most Acetyl Chain products. This impact to pricing typically lags changes in raw material costs over months or quarters.
Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022
Net sales decreased for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•lower pricing for most of our products, primarily vinyl acetate monomer ("VAM") and acid due to weaker economic conditions particularly in Asia, partially offset by acetate tow;
•lower volume for most of our products due to decreased demand, primarily in Europe; and
•an unfavorable currency impact resulting from a weaker euro relative to the U.S. dollar.
Operating profit decreased for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•lower Net sales;
partially offset by:
•lower raw material and sourcing costs, primarily for ethylene, acid and VAM.
34
Other Activities
Three Months Ended March 31, Change%
Change
20232022
(unaudited)
(In $ millions, except percentages)
Operating profit (loss)(139)(96)(43)(44.8)%
Non-operating pension and other postretirement employee benefit (expense) income
1 24 (23)(95.8)%
Other Activities primarily consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expense associated with financing activities and results of our captive insurance companies. Other Activities also includes the components of net periodic benefit cost (interest cost, expected return on assets and net actuarial gains and losses) for our defined benefit pension plans and other postretirement plans not allocated to our business segments.
Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022
Operating loss increased for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•higher functional and project spending of $46 million, primarily related to our acquisition of the M&M Business.
Non-operating pension and other postretirement employee benefit income decreased for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•higher interest cost and lower expected return on plan assets.
35
Liquidity and Capital Resources
Our primary sources of liquidity are cash generated from operations, available cash and cash equivalents, dividends from our portfolio of strategic investments and available borrowings under our senior U.S. unsecured revolving credit facility. As of March 31, 2023, we have $1.75 billion available for borrowing under our senior U.S. unsecured revolving credit facility, and $37 million available for borrowing under our separate China Revolving Credit Facility (defined below), if required, in meeting our working capital needs and other contractual obligations. In addition, we held cash and cash equivalents of $1.2 billion as of March 31, 2023. We are actively managing our business to maintain and improve cash flow, and we believe that liquidity from the above-referenced sources will be sufficient to meet our operational and capital investment needs and financial obligations for the foreseeable future.
In November 2022, we acquired a majority of the M&M Business for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction. For further information regarding the acquisition, see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements.
Our incurrence of debt to finance the purchase price for the M&M Acquisition has increased our leverage and our ratio of indebtedness to consolidated EBITDA as set forth in our senior unsecured credit facilities. We believe that cash flows from our operations, together with cash generation, synergy opportunities from the M&M Acquisition and cost reduction initiatives, will support our deleveraging efforts over the next few years. In furtherance of these deleveraging efforts, we have paused our share repurchase program and are in the process of evaluating additional cash generation opportunities which may include the opportunistic disposition or monetization of product or business lines or other assets. We are committed to rapid deleveraging and to maintaining our investment grade debt rating.
While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next twelve months. If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital or seeking to restructure or refinance our indebtedness. There can be no assurance, however, that we will continue to generate cash flows at or above current levels.
We continue to prioritize those projects expected to drive productivity in the near term and expect capital expenditures to be approximately $500 million in 2023, primarily associated with certain investments in growth opportunities and productivity improvements. In Engineered Materials, at our Nanjing, China facility, our expansions of (1) the compounding plant is in construction and (2) the new liquid crystal polymer ("LCP") plant is in detailed engineering design. Our energy optimization productivity project at our polyoxymethylene ("POM") unit in Frankfurt, Germany is in front end engineering design. In the Acetyl Chain, our planned expansion of our acetic acid unit at Clear Lake, Texas is on track to be mechanically complete in the second quarter with start-up scheduled for the third quarter. The other major projects that support the Acetyl Chain are in various stages of construction and on schedule, which include our planned expansions of (1) our vinyl acetate ethylene ("VAE") emulsions units in Nanjing, China, (2) our VAE emulsion plant in Frankfurt, Germany, (3) our vinyl acetate monomer ("VAM") plant in Bay City, Texas, (4) the sustainable production of methanol ("MeOH") at our Fairway joint venture MeOH unit in Clear Lake, Texas using captured carbon dioxide as feedstock. We continue to see the incremental capacity from investments made in recent years strengthen our manufacturing network reliability to best serve our customers.
On a stand-alone basis, Celanese and its immediate 100% owned subsidiary, Celanese U.S., have no independent external operations of their own. Accordingly, they generally depend on the cash flow of their subsidiaries and their ability to pay dividends and make other distributions to Celanese and Celanese U.S. in order to meet their obligations, including their obligations under senior credit facilities and senior notes, and to pay dividends on our Common Stock.
We are subject to capital controls and exchange restrictions imposed by the local governments in certain jurisdictions where we operate, such as China, India and Indonesia. Capital controls impose limitations on our ability to exchange currencies, repatriate earnings or capital, lend via intercompany loans or create cross-border cash pooling arrangements. Our largest exposure to a country with capital controls is in China. Pursuant to applicable regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, the Chinese government imposes certain currency exchange controls on cash transfers out of China, puts certain limitations on duration, purpose and amount of intercompany loans, and restricts cross-border cash pooling. While it is possible that future tightening of these restrictions or application of new similar restrictions could impact us, these limitations do not currently restrict our operations.
36
We remain in compliance with the covenants in the Global Credit Agreements (defined below, and as amended to date) and expect to remain in compliance based on our current expectation of future results of operations. If our actual future results of operations differ materially from these expectations, we may be required to seek an amendment to or waiver of any impacted covenants, which may increase our borrowing costs under the Global Credit Agreements.
Cash Flows
Cash and cash equivalents decreased $341 million to $1.2 billion as of March 31, 2023 compared to December 31, 2022. As of March 31, 2023, $1.0 billion of the $1.2 billion of cash and cash equivalents was held by our foreign subsidiaries. Under the TCJA, we have incurred a prior year charge associated with the deemed repatriation of previously unremitted foreign earnings, including foreign held cash. These funds are largely accessible without additional material tax consequences, if needed in the U.S., to fund operations.
•Net Cash Provided by (Used in) Operating Activities
Net cash used in operating activities increased $412 million to $96 million for the three months ended March 31, 2023 compared to cash provided by operating activities of $316 million for the same period in 2022, primarily due to:
•a decrease in Net earnings; and
•an increase in cash interest paid of $243 million;
partially offset by:
•favorable trade working capital of $30 million, primarily due to the timing of collections of trade receivables, inventory builds and settlement of trade payables during the three months ended March 31, 2023.
•Net Cash Provided by (Used in) Investing Activities
Net cash used in investing activities increased $29 million to $178 million for the three months ended March 31, 2023 compared to the same period in 2022; primarily due to:
•an increase of $27 million in capital expenditures during the three months ended March 31, 2023.
•Net Cash Provided by (Used in) Financing Activities
Net cash used in financing activities decreased $26 million to $69 million for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to:
•a payment of $44 million during the three months ended March 31, 2022 for fees related to a bridge facility commitment letter with Bank of America, N.A. ("Bank of America") pursuant to which Bank of America has committed to provide, subject to the terms and conditions set therein, a 364-day $11.0 billion senior unsecured bridge term loan facility (the "Bridge Facility"), which did not recur in the current year;
partially offset by:
•a decrease in net borrowings on short-term debt of $36 million, primarily as a result of higher borrowings under our revolving credit facilities, which did not recur in the current year.
Debt and Other Obligations
In March 2022, we entered into a term loan credit agreement (the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders have committed to provide a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion. In September 2022, we entered into an additional term loan credit agreement (the "September 2022 U.S. Term Loan Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Term Loan Credit Agreements"), pursuant to which lenders have committed to provide delayed-draw term loans due 3 years from issuance in an amount equal to $750 million (the term loans represented by the U.S. Term Loan Credit Agreements collectively, the "U.S. Term Loan Facility").
37
Also in March 2022, we entered into a new revolving credit agreement (the "U.S. Revolving Credit Agreement" and, together with the U.S. Term Loan Credit Agreements the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027. The proceeds of a $365 million borrowing under the new senior unsecured revolving credit facility were used to repay and terminate our then-existing revolving credit facility.
On February 21, 2023, we amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations.
On January 4, 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed floating rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
Also on January 6, 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement", together with the China Revolving Credit Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn on January 10, 2023 and is supported by a letter of comfort from us. We expect the China Credit Agreements will facilitate our efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of our U.S. debt to China at a lower average interest rate.
There have been no material changes to our debt or other obligations described in our 2022 Form 10-K other than those disclosed above and in Note 7 - Debt in the accompanying unaudited interim consolidated financial statements.
Accounts Receivable Purchasing Facility
In June 2021, we entered into an amendment to the amended and restated receivables purchase agreement under our U.S. accounts receivable purchasing facility among certain of our subsidiaries, our wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). We de-recognized $249 million and $1.1 billion of accounts receivable under this agreement for the three months ended March 31, 2023 and twelve months ended December 31, 2022, respectively, and collected $249 million and $1.1 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $109 million were pledged by the SPE as collateral to the Purchasers as of March 31, 2023.
Factoring and Discounting Agreements
We have factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. We de-recognized $87 million and $320 million of accounts receivable under these factoring agreements for the three months ended March 31, 2023 and twelve months ended December 31, 2022, respectively, and collected $82 million and $325 million of accounts receivable sold under these factoring agreements during the same periods.
Covenants
We are in compliance with the covenants in our material financing arrangements as of March 31, 2023.
See Note 7 - Debt in the accompanying unaudited interim consolidated financial statements for further information.
Guarantor Financial Information
We have outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933, as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. ("Issuer") and are guaranteed by Celanese Corporation ("Parent Guarantor") and the Subsidiary Guarantors (collectively the "Obligor Group"). See Note 7 - Debt in the accompanying unaudited interim consolidated financial statements for further information. The Issuer and Subsidiary Guarantors are 100% owned subsidiaries of the Parent Guarantor. The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.
38
The Parent Guarantor and the Subsidiary Guarantors have guaranteed the Senior Notes on a full and unconditional, joint and several, senior unsecured basis. The guarantees are subject to certain customary release provisions, including that a Subsidiary Guarantor will be released from its respective guarantee in specified circumstances, including (i) the sale or transfer of all of its assets or capital stock; (ii) its merger or consolidation with, or transfer of all or substantially all of its assets to, another person; or (iii) its ceasing to be a majority-owned subsidiary of the Issuer in connection with any sale of its capital stock or other transaction. Additionally, a Subsidiary Guarantor will be released from its guarantee of the Senior Notes at such time that it ceases to guarantee the Issuer's obligations under the U.S Credit Agreements (subject to the satisfaction of customary document delivery requirements). The obligations of the Subsidiary Guarantors under their guarantees are limited as necessary to prevent such guarantees from constituting a fraudulent conveyance or fraudulent transfer under applicable law.
The Parent Guarantor and the Issuer are holding companies that conduct substantially all of their operations through their subsidiaries, which own substantially all of our consolidated assets. The Parent Guarantor has no material assets other than the stock of its immediate 100% owned subsidiary, the Issuer. The principal source of cash to pay the Parent Guarantor's and the Issuer's obligations, including obligations under the Senior Notes and the guarantee of the Issuer's obligations under the U.S Credit Agreements, is the cash that our subsidiaries generate from their operations. Each of the Subsidiary Guarantors and our non-guarantor subsidiaries is a distinct legal entity and, under certain circumstances, applicable country or state laws, regulatory limitations and terms of other debt instruments may limit our subsidiaries' ability to distribute cash to the Issuer and the Parent Guarantor.
For cash management purposes, we transfer cash among the Parent Guarantor, Issuer, Subsidiary Guarantors and non-guarantors through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. While the non-guarantor subsidiaries do not guarantee the Issuer's obligations under our outstanding debt, the transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Senior Notes, U.S. Credit Agreements, other outstanding debt, Common Stock dividends and Common Stock repurchases.
The summarized financial information of the Obligor Group is presented below on a combined basis after the elimination of: (i) intercompany transactions among such entities and (ii) equity in earnings from and investments in the non-guarantor subsidiaries. Transactions with, and amounts due to or from, non-guarantor subsidiaries and affiliates are separately disclosed.
Three Months Ended
March 31, 2023
(In $ millions)
(unaudited)
Net sales to third parties476 
Net sales to non-guarantor subsidiaries291 
Total net sales767 
Gross profit143 
Earnings (loss) from continuing operations(153)
Net earnings (loss)(155)
Net earnings (loss) attributable to the Obligor Group(155)
39
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
(unaudited)
Receivables from non-guarantor subsidiaries708 754 
Other current assets1,608 1,588 
Total current assets2,316 2,342 
Goodwill526 567 
Other noncurrent assets2,729 2,718 
Total noncurrent assets3,255 3,285 
Current liabilities due to non-guarantor subsidiaries2,772 2,100 
Current liabilities due to affiliates2 2 
Other current liabilities1,756 2,201 
Total current liabilities4,530 4,303 
Noncurrent liabilities due to non-guarantor subsidiaries3,391 3,400 
Other noncurrent liabilities13,860 13,842 
Total noncurrent liabilities17,251 17,242 
Share Capital
We declared a quarterly cash dividend of $0.70 per share on our Common Stock on April 19, 2023, amounting to $76 million.
There have been no material changes to our share capital described in our 2022 Form 10-K other than those disclosed above and in Note 10 - Shareholders' Equity in the accompanying unaudited interim consolidated financial statements.
Contractual Obligations
We have not entered into any material off-balance sheet arrangements.
Except as otherwise described in this report, there have been no material revisions outside the ordinary course of business to our contractual obligations as described in our 2022 Form 10-K.
Tax Return Audits
Our tax returns are under joint audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In addition, our income tax returns in Mexico are under audit for the years 2017 and 2018, and in Canada for the years 2016 through 2018. As of March 31, 2023, we believe that an adequate provision for income taxes has been made for all open tax years related to the examinations by the Authorities and Mexico tax authorities. We are discussing preliminary findings with the Canadian authorities and do not expect a material impact to income tax expense. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised by the government authorities are resolved in a manner inconsistent with our expectations or we are unsuccessful in defending its positions, we could be required to adjust our provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded. See Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.
Business Environment
We started to experience demand recovery, partially offset by normalized pricing across many products that exceeded a reduction in cost pressure on raw material inputs. We continue to closely monitor the impact of, and responses to, geopolitical effects on demand conditions and the supply chain. Demand conditions improved across certain regions in Europe and Asia, offset by continued destocking and decreased consumer activity in the Americas. Average prices of energy feedstocks, particularly natural gas, which are a significant input and source of energy for our manufacturing operations, have begun to normalize. We expect demand to continue to recover, reduction in our inventory levels and improvement in sourcing costs and inflationary pressures throughout the year.
40
Following Russia's invasion of Ukraine, we suspended sales into Russia, Belarus and the sanctioned regions of Ukraine. Revenue from these countries and regions constituted less than 0.1% of our consolidated Net sales in fiscal year 2022 and we have no manufacturing assets in these countries or regions. We do not currently expect the conflict to result in a material impact on our business or financial results, but the full impact of the conflict and international responses thereto remains uncertain and will depend on future geopolitical and economic developments that are impossible to predict. Potential risks we may face include increased volatility in capital and commodity markets, rapid changes to sanctions, supply chain and transportation disruptions, exacerbation of inflationary conditions, impacts to consumer or business sentiment and an increased risk of cyber security incidents.
Critical Accounting Policies and Estimates
Our unaudited interim consolidated financial statements are based on the selection and application of significant accounting policies. The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Actual results could differ from those estimates. However, we are not currently aware of any reasonably likely events or circumstances that would result in materially different results.
We describe our significant accounting policies in Note 2 - Summary of Accounting Policies, of the Notes to the Consolidated Financial Statements included in our 2022 Form 10-K. We discuss our critical accounting policies and estimates in MD&A in our 2022 Form 10-K.
Recent Accounting Pronouncements
See Note 2 - Recent Accounting Pronouncements in the accompanying unaudited interim consolidated financial statements included in this Quarterly Report for information regarding recent accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market risk for the Company has not changed materially from the foreign exchange, interest rate and commodity risks disclosed in Item 7A. Quantitative and Qualitative Disclosures about Market Risk in our 2022 Form 10-K. See also Note 12 - Derivative Financial Instruments in the accompanying unaudited interim consolidated financial statements for further discussion of our market risk management and the related impact on the Company's financial position and results of operations.
Item 4. Controls and Procedures
Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, as of March 31, 2023, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective.
Changes in Internal Control Over Financial Reporting
During the period covered by this report, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
41
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of its business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust and competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where it is named as a defendant. Due to the inherent subjectivity of assessments and unpredictability of outcomes of legal proceedings, the Company's litigation accruals and estimates of possible loss or range of possible loss may not represent the ultimate loss to the Company from legal proceedings. See Note 9 - Environmental and Note 14 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements for a discussion of material environmental matters and material commitments and contingencies related to legal and regulatory proceedings. There have been no significant developments in the "Legal Proceedings" described in our 2022 Form 10-K other than those disclosed in Note 9 - Environmental and Note 14 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements. See Part I - Item 1A. Risk Factors of our 2022 Form 10-K for certain risk factors relating to these legal proceedings.
Item 1A. Risk Factors
In addition to the information in this Quarterly Report, readers should carefully consider the information in Part I, Item 1A. Risk Factors of our 2022 Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
We did not repurchase any Common Stock during the three months ended March 31, 2023. As of March 31, 2023, our Board of Directors had authorized the repurchase of $6.9 billion of our Common Stock since February 2008, with approximately $1.1 billion value of shares remaining that may be purchased under the program. See Note 10 - Shareholders' Equity in the accompanying unaudited interim consolidated financial statements for further information.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
None.
42
Item 6. Exhibits(1)
Exhibit
Number
Description
2.1†
3.1
3.1(a)
3.1(b)
3.1(c)
3.2
10.1
10.2
10.3
10.4*‡
10.5*‡
10.6*‡
10.7*‡
22.1
31.1*
31.2*
32.1*
32.2*
101.INS*Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.
43
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 has been formatted in Inline XBRL.
*    Filed herewith.
‡    Indicates a management contract or compensatory plan or arrangement.
†    The Company has omitted certain schedules and similar attachments to such agreements pursuant to Item 601(a)(5) of Regulation S-K. The Company will furnish a copy of such omitted documents to the SEC upon request.
(1)The Company and its subsidiaries have in the past issued, and may in the future issue from time to time, long-term debt. The Company may not file with the applicable report copies of the instruments defining the rights of holders of long-term debt to the extent that the aggregate principal amount of the debt instruments of any one series of such debt instruments for which the instruments have not been filed has not exceeded or will not exceed 10% of the assets of the Company at any pertinent time. The Company hereby agrees to furnish a copy of any such instrument(s) to the SEC upon request.
44
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CELANESE CORPORATION
By: /s/ LORI J. RYERKERK
Lori J. Ryerkerk
Chair of the Board of Directors,
Chief Executive Officer and President
Date:May 10, 2023

By: /s/ SCOTT A. RICHARDSON
Scott A. Richardson
Executive Vice President and
Chief Financial Officer
Date:May 10, 2023
45
 EX-10.4 2 ex1043312310q.htm EX-10.4 Document

Exhibit 10.4
[Form of 2023 Performance-Based RSU Agreement]





celogo.jpg








CELANESE CORPORATION
2018 GLOBAL INCENTIVE PLAN

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
DATED [Grant Date]



Pursuant to the terms and conditions of the Celanese Corporation 2018 Global Incentive Plan, you have been awarded Performance-Based Restricted Stock Units, subject to the restrictions described in this Agreement. In addition to the information included in this Award Agreement, the Participant's name and the number of Restricted Stock Units awarded can be found in the Grant Summary located in the electronic stock plan award administration system maintained by the Company or its designee that contains a link to this Agreement (which summary information is set forth in the appropriate records of the Company authorizing such award).


2023 Performance RSU Award

Target Award: [Number of Shares Granted] Units


This grant is made pursuant to the Performance-Based Restricted Stock Unit Award Agreement dated as of [Grant Date], between Celanese and [Participant Name], covering a performance period from January 1, 2023 through December 31, 2025, which Agreement is attached hereto and made a part hereof.


Page 1 of 14
© 2023 Celanese Corporation

CELANESE CORPORATION
2018 GLOBAL INCENTIVE PLAN

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
This Performance-Based Restricted Stock Unit Award Agreement (the "Agreement") is made and entered into as of [Grant Date] (the "Grant Date"), by and between Celanese Corporation, a Delaware corporation ("Celanese" and together with the participating subsidiaries that are employers of the Participants, the "Company"), and [Participant Name] (the "Participant"). Capitalized terms used, but not otherwise defined, herein shall have the meanings ascribed to such terms in the Celanese Corporation 2018 Global Incentive Plan (as amended from time to time, the "2018 Plan").
1.Performance RSU Award: In order to encourage the Participant's contribution to the successful performance of the Company, Celanese hereby grants to the Participant as of the Grant Date, pursuant to the terms of the 2018 Plan and this Agreement, an award (the "Award") of [Number of Shares Granted] performance-based Restricted Stock Units ("Performance RSUs") representing the right to receive, subject to the attainment of the performance goals set forth in Appendix A, the number of Common Shares to be determined in accordance with the formula set forth in Appendix A. The Participant hereby acknowledges and accepts such Award upon the terms and subject to the performance requirements and other conditions, restrictions and limitations contained in this Agreement and the 2018 Plan.
2.Performance-Based Adjustment and Vesting:
(a)    Subject to Section 3 and Section 6 of this Agreement, the Performance RSUs are subject to adjustment for performance during the Performance Period in accordance with the performance measures, targets and methodology set forth in Appendix A. The number of Performance RSUs determined after the Performance Period based on such performance is referred to as the "Performance-Adjusted RSUs."
(b)    Subject to Section 3 and Section 6 of this Agreement, the Performance-Adjusted RSUs shall vest on February 15, 2026 (the "Vesting Date"). The period between the Grant Date and the Vesting Date shall be referred to as the "Vesting Period."
3.Effects of Certain Events:
(a)If the Participant's employment with the Company is terminated by the Company without Cause or due to the Participant's Retirement prior to the Vesting Date (other than as provided in Section 3(b)), then:
(i) in all such cases the Performance RSUs shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period; and
(ii) a prorated number of the Performance-Adjusted RSUs will vest on the Vesting Date in an amount equal to (x) the unvested Performance-Adjusted RSUs in the Vesting Period multiplied by (y) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination, and the denominator of which is the number of complete and partial calendar months in the Vesting Period, such product to be rounded up to the nearest whole number.
Page 2 of 14
© 2023 Celanese Corporation

Such prorated Performance-Adjusted RSUs will be settled following the Vesting Date in accordance with the provisions of Section 4, subject to any applicable taxes under Section 7 upon such vesting and settlement. The remaining portion of the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment. To the extent permitted by applicable country, state or province law, as consideration for the vesting provisions upon Retirement contained in this Section 3(a), upon Retirement, the Participant shall enter into a departure and general release of claims agreement with the Company that includes two-year noncompetition and non-solicitation covenants in a form acceptable to the Company.
(b)Notwithstanding any provision herein to the contrary, if the Participant's employment with the Company is terminated by the Company in connection with a Qualifying Disposition, as determined by the Company in its sole discretion, other than for Cause, and regardless of whether the Participant is then eligible for Retirement or is offered employment with the acquiror or successor, then:
(i) a prorated number of the unvested Performance RSUs determined in accordance with the provisions of Section 3(a) had those provisions applied shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period, and shall be settled in accordance with the provisions of Section 3(a); and
(ii) the remaining number of the unvested Performance RSUs that would have otherwise been forfeited had the provisions of Section 3(a) applied shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period, and any such Performance-Adjusted RSUs will vest and be settled in accordance with the provisions of Section 4, subject to any applicable taxes under Section 7 upon such vesting and settlement.
Notwithstanding the foregoing, in case of a termination of employment covered by this Section 3(b), if the Company determines that the Participant has been offered employment with the acquiror or successor and in connection with that employment will receive a substitute award from the acquiror or successor with an equivalent (or greater) economic value and no less favorable vesting conditions as this Award, the Company, in its sole discretion, may determine not to provide for the additional vesting under clause (ii) of this Section 3(b).
(c)If the Participant's employment with the Company is terminated due to the Participant's death or Disability prior to the Vesting Date, then a prorated number of Performance RSUs will vest in an amount equal to:
(i) the Target number of Performance RSUs granted hereby multiplied by
(ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination, and the denominator of which is the number of complete and partial calendar months in the Vesting Period, such product to be rounded up to the nearest whole number.
The prorated number of Performance RSUs shall immediately vest and a number of Common Shares equal to such prorated number of Performance RSUs described above shall be delivered to the Participant or beneficiary within thirty (30) days following the date of termination, subject to the provisions of Section 7. The remaining portion of the Award shall be immediately forfeited
Page 3 of 14
© 2023 Celanese Corporation

and cancelled without consideration as of the date of the Participant's termination of employment for death or Disability.
(d)Upon the termination of a Participant's employment with the Company for any other reason prior to the Vesting Date, the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment.
A Participant's employment will be considered to have been terminated for Cause, and the Award forfeited and cancelled without consideration, if the Company determines, in its sole discretion, that the Participant engaged in an act constituting Cause at any time prior to the Vesting Date, regardless of whether the Participant's termination initially was considered to have been without Cause. In such case, the provisions of Section 3(a), 3(b) or 3(c) are inapplicable.
4.Settlement of Performance RSUs: The Committee shall determine the Performance-Adjusted RSUs as soon as administratively practicable following the computation of the Company's performance for the Performance Period (but not later than 2 ½ months after the end of the Performance Period (i.e., March 15, 2026)). The date of such determination is referred to as the "Performance Certification Date." Subject to Sections 2, 3, 5, 6 and 7 of this Agreement, the Company shall deliver to the Participant (or to a Company-designated brokerage firm or plan administrator) as soon as administratively practicable after the Performance Certification Date (but not later than 2 ½ months after the end of the Performance Period (i.e., March 15, 2026)), in complete settlement of the Performance-Adjusted RSUs vesting on such Vesting Date, a number of Common Shares equal to the Performance-Adjusted RSUs determined in accordance with this Agreement.
5.Rights as a Stockholder: The Participant shall have no voting, dividend or other rights as a stockholder with respect to the Award until the Performance RSUs have vested and Common Shares have been delivered pursuant to this Agreement.
6.Change in Control; Dissolution:
(a)Notwithstanding any other provision of this Agreement to the contrary, in connection with the occurrence of a Change in Control, with respect to any unvested Performance RSUs granted pursuant to this Agreement that have not previously been forfeited:
(i)If (A) a Participant's rights to the unvested portion of the Award are not adversely affected in connection with the Change in Control, or, if adversely affected, a substitute award with an equivalent (or greater) economic value and no less favorable vesting conditions is granted to the Participant in connection with the occurrence of a Change in Control, and (B) the Participant's employment is terminated by the Company (or its successor) without Cause within two years following the Change in Control, then Performance RSUs in an amount equal to the higher of (x) the Target number of Performance RSUs granted hereby (or, as applicable, the substitute award) or (y) the number of Performance RSUs payable based on estimated Company performance during the Performance Period through the Change in Control as determined by the Committee in accordance with this Agreement, shall immediately vest and a number of Common Shares equal to the number of Performance RSUs so determined shall be delivered to the Participant within 30 days following the date of termination, subject to the provisions of Section 7.
(ii)If a Participant's right to the unvested portion of the Award is adversely affected in connection with the Change in Control and a substitute award is not made pursuant to Section 6(a)(i) above, then upon the occurrence of a Change in Control, a
Page 4 of 14
© 2023 Celanese Corporation

number of Performance RSUs equal to the higher of (A) the Target number of Performance RSUs granted hereby or (B) the number of Performance RSUs payable based on estimated Company performance during the Performance Period through the Change in Control as determined by the Committee in accordance with this Agreement, shall immediately vest and a number of Common Shares equal to the number of Performance RSUs so determined shall be delivered to the Participant within 30 days following the occurrence of the Change in Control, subject to the provisions of Section 7.
(b)Notwithstanding any other provision of this Agreement to the contrary, in the event of a corporate dissolution of the Company that is taxed under Section 331 of the Code, then in accordance with Treasury Regulation Section 1.409A-3(j)(4)(ix)(A), this Agreement shall terminate and any Performance RSUs granted pursuant to this Agreement that have not previously been forfeited shall immediately become Common Shares and shall be delivered to the Participant within 30 days following such dissolution.
7.Income and Other Taxes: The Company shall not deliver Common Shares in respect of any vested Performance RSUs unless and until the Participant has made arrangements satisfactory to the Company to satisfy applicable withholding tax obligations for U.S. federal, state, and local income taxes (or the foreign counterpart thereof) and applicable employment taxes. Unless otherwise permitted by the Committee, withholding shall be effectuated by withholding Common Shares in connection with the vesting and/or settlement of Performance-Adjusted RSUs. Withholding shall be effected using a rate or method chosen by the Company consistent with ASC Topic 718 (or any successor applicable equity accounting standard applicable to this Award) and the U.S. Internal Revenue Service withholding regulations or other applicable tax requirements, not to exceed maximum statutory rates. The Participant acknowledges that the Company shall have the right to deduct any taxes required to be withheld by law in connection with the vesting or settlement of Performance-Adjusted RSUs from any amounts payable by it to the Participant (including, without limitation, future cash wages). The Participant acknowledges and agrees that amounts withheld by the Company for taxes may be less than amounts actually owed for taxes by the Participant in respect of the Award. Any vested Performance-Adjusted RSUs shall be reflected in the Company's records as issued on the respective dates of issuance set forth in this Agreement, irrespective of whether delivery of such Common Shares is pending the Participant's satisfaction of his or her withholding tax obligations.
8.Securities Laws: The Company may impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common Shares issued as a result of the vesting or settlement of the Performance RSUs, including without limitation (a) restrictions under an insider trading policy, and (b) restrictions as to the use of a specified brokerage firm for such resales or other transfers. Upon the acquisition of any Common Shares pursuant to the vesting or settlement of the Performance-Adjusted RSUs, the Participant will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement and the 2018 Plan. All accounts in which such Common Shares are held or any certificates for Common Shares shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or quotation system upon which the Common Shares are then listed or quoted, and any applicable federal or state securities law, and the Company may cause a legend or legends to be put on any such certificates (or other appropriate restrictions and/or notations to be associated with any accounts in which such Common Shares are held) to make appropriate reference to such restrictions.
9.Non-Transferability of Award: The Performance RSUs may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by
Page 5 of 14
© 2023 Celanese Corporation

the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company; provided, that the Participant may designate a beneficiary, on a form provided by the Company, to receive any portion of the Award payable hereunder following the Participant's death.
10.Other Agreements; Release of Claims: Subject to Sections 10(a), 10(b) and 10(c) of this Agreement, this Agreement and the 2018 Plan constitute the entire understanding between the Participant and the Company regarding the Award, and any prior and/or contemporaneous agreements, understandings, representations, discussions, commitments or negotiations concerning the Award, whether written or oral, are superseded. No oral statements or other prior written material not specifically incorporated into this Agreement, other than the 2018 Plan, shall be of any force or effect.
(a)The Participant acknowledges that as a condition to the receipt of the Award, the Participant:
(1)    shall have delivered to the Company an executed copy of this Agreement;
(2)    shall be subject to the Company's stock ownership guidelines, to the extent applicable to the Participant;
(3)    shall be subject to policies and agreements adopted by the Company from time to time, and applicable laws and regulations, requiring the repayment by the Participant of incentive compensation under certain circumstances, including that certain Celanese Corporation Incentive Compensation Recoupment Policy adopted by the Committee on October 16, 2019 (collectively, "Clawback Policies"), without any further act or deed or consent of the Participant; and
(4)    shall have delivered to the Company an executed copy of the current form of Long-Term Incentive Claw-Back Agreement, as determined by the Company in its sole discretion. For purposes hereof, "Long-Term Incentive Claw-Back Agreement" means an agreement between the Company and the Participant associated with the grant of long-term incentives of the Company, which contains terms, conditions, restrictions and provisions regarding one or more of (i) noncompetition by the Participant with the Company, and its customers and clients; (ii) non-solicitation and non-hiring by the Participant of the Company's employees, former employees or consultants; (iii) maintenance of confidentiality of the Company's and/or clients' information, including intellectual property; (iv) nondisparagement of the Company; and (v) such other matters deemed necessary, desirable or appropriate by the Company for such an agreement in view of the rights and benefits conveyed in connection with an award.
(b)The Participant acknowledges that if the Participant violates any of the terms or provisions of the Clawback Policies or the Long-Term Incentive Claw-Back Agreement, whether before or after termination of employment, then the Company will, to the fullest extent permitted by applicable law, (i) terminate the Participant's rights in any unvested Performance RSUs under this Award, and (ii) claw back (i.e., recover) all Common Shares previously issued under this Award.
(c)If the Participant is a non-resident of the U.S., there may be an addendum containing special terms and conditions applicable to awards in the Participant's country. The issuance of the Award to any such Participant is contingent upon the Participant executing and returning any such addendum in the manner directed by the Company.
Page 6 of 14
© 2023 Celanese Corporation

11.Not a Contract for Employment; No Acquired Rights; Agreement Changes: This Agreement and the Award evidenced hereby are not an employment agreement, and nothing in this Agreement, the International Supplement, if applicable, or the 2018 Plan shall alter the Participant's status as an "at-will" employee of the Company or your employment status at the Company. None of this Agreement, the International Supplement, if applicable, or the 2018 Plan shall be construed as guaranteeing your employment by the Company, or as giving you any right to continue in the employ of the Company, during any period (including without limitation the period between the Date of the Agreement and the Vesting Date, or any portion of such period), nor shall they be construed as giving you any right to be reemployed by the Company following any termination of employment. This Agreement and the Award evidenced hereby, and all other long-term incentive awards and other equity-based awards, are discretionary. This Award does not confer on the Participant any right or entitlement to receive another Award or any other equity-based award at any time in the future or in respect of any future period. The Company has made this Award to you in its sole discretion. This Award does not confer on you any right or entitlement to receive compensation in any specific amount for any future year, and does not diminish in any way the Company's discretion to determine the amount, if any, of your compensation. This Award is not part of your base salary or wages and will not be taken into account in determining any other employment-related rights you may have, such as rights to pension or severance pay. The Company has the right, at any time and for any reason, to amend, suspend or terminate the 2018 Plan; provided, however, that no such amendment, suspension, or termination shall adversely affect the Participant's rights hereunder.
12.Severability: Should any provision of this Agreement be declared or held to be illegal, invalid or otherwise unenforceable, (a) such provision shall either be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise severed, (b) the remainder of this Agreement shall not be affected except to the extent necessary to reform or sever such illegal, invalid or unenforceable provision, and (c) in no event should such partial invalidity affect the remainder of this Agreement, which shall still be enforced.
13.Further Assurances: Each party shall cooperate and take such action as may be reasonably requested by either party hereto in order to carry out the provisions and purposes of this Agreement.
14.Binding Effect: The Award and this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns.
15.Electronic Delivery: By executing this Agreement, the Participant hereby consents to the delivery of any and all information (including, without limitation, information required to be delivered to the Participant pursuant to applicable securities laws), in whole or in part, regarding the Company and its subsidiaries, the 2018 Plan, and the Award via electronic mail, the Company's or a plan administrator's web site, or other means of electronic delivery.
16.Personal Data: By accepting the Award under this Agreement, the Participant hereby consents to the Company's use, dissemination and disclosure of any information pertaining to the Participant that the Company determines to be necessary or desirable for the implementation, administration and management of the 2018 Plan.
17.Miscellaneous:
(a)Governing Law. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be governed by, construed under and interpreted in accordance with the laws of the State of Delaware, without regard to its conflicts of laws rules.
Page 7 of 14
© 2023 Celanese Corporation

(b)Notice. The Participant is reminded to read the following carefully and after consulting with counsel of their choice:
The Participant agrees that the following provisions requiring arbitration, prohibiting recovery of attorneys' fees, waiving class actions and mass actions, waiving the right to a jury trial, waiving any right to seek punitive damages, limiting actual damages, and limiting remedies by waiving any right to injunctive or other equitable or legal relief are and were an important part of the Company's decision to adopt the Operative Documents and for Participant to be offered this Agreement. The Participant understands and agrees that absent the foregoing provisions, the Operative Documents would not have been offered or entered into or would have materially changed. The Participant acknowledges the benefits of receiving potential incentive awards. In reliance on the Participant's intent to abide by and enter into the following provisions, the parties have entered into the Operative Documents.
(c)MANDATORY ARBITRATION. All disputes arising out of or related in any manner to the Operative Documents shall be resolved exclusively by arbitration to be conducted only in the county and state of Dallas, Texas in accordance with the rules of the International Institute for Conflict Prevention and Resolution Rules for Non-Administered Arbitration ("CPR") applying the laws of Delaware and by a sole arbitrator. Within 45 days of the service of any demand for arbitration, the parties shall attempt to mutually agree on the appointment of an arbitrator and may seek names of potential arbitrators from CPR for their consideration. Failing agreement on selection of an agreed arbitrator, upon written request of either party, CPR shall appoint a single arbitrator in accordance with its rules, with the parties expressing a contractual preference for the selection of a retired judge with at least 10 years of judicial experience. Discovery shall be as provided by the CPR rules. The arbitration award shall be in writing and shall include a reasoned opinion by the Arbitrator. Consistent with the waiver of all claims to punitive or exemplary damages, the Arbitrator shall have no authority to award such damages. The parties understand that their right to appeal or to seek modification of any ruling or award of the arbitrator is severely limited, if any. Awards issued by the arbitrator shall be final and binding, and judgment may be entered on it in any court of competent jurisdiction. All parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrator. Any and all disputes regarding this arbitration provision and its enforceability shall be exclusively submitted to the United States District Court for the District of Delaware, if it has jurisdiction, and failing that, to the Delaware state court in Wilmington, Delaware.
(d)NO RECOVERY OF ATTORNEYS' FEES AND COSTS. Each party agrees that in any litigation or proceeding between the parties arising out of, connected with, related to, or incidental to the relationship between them in connection with the Operative Documents, each party shall bear all of its own attorneys' fees and costs regardless of which party prevails, except when prohibited by applicable law.
(e)CLASS ACTION AND MASS ACTION WAIVER. As part of this provision of arbitration as the contracted method of all dispute resolution under this Agreement, any claim, whether brought in a court of law or in arbitration, must be brought in the Participant's individual capacity, and not as a representative of any purported class or as a "mass action" (involving multiple plaintiffs) ("Class/Mass Action"). The parties expressly waive any ability to maintain any Class/Mass Action in any forum. The arbitrator shall not have authority to combine or aggregate similar claims or conduct any Class/Mass Action nor make an award to any person or entity not a party to the arbitration. Any claim that all or part of this Class/Mass Action waiver is unenforceable, unconscionable, void, or voidable may be determined only by a court of competent jurisdiction and not by an arbitrator. The Participant understands that but for this
Page 8 of 14
© 2023 Celanese Corporation

Agreement, he or she would have had a right to litigate through a court, to have a judge or jury decide the case and to be party to a Class/Mass Action. However, in exchange for the potential incentive awards provided herein and the receipt of the benefit of arbitration, the Participant understands and chooses to have only his or her individual claims decided, each in a separate case, by an arbitrator.
(f)WAIVER OF JURY TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW AND EXPRESSLY BECAUSE OF THE COMPLEXITY OF THE MATTERS IN THE OPERATIVE DOCUMENTS, EACH PARTY WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE ARISING OUT OF OR RELATING TO THE OPERATIVE DOCUMENTS.
(g)WAIVER OF PUNITIVE AND EXEMPLARY DAMAGE CLAIMS. The Participant waives, to the fullest extent allowed by law, any claims or rights to recover punitive, exemplary or similar damages.
(h)LIMIT ON ACTUAL DAMAGES. In no event may the actual damages awarded to the Participant in a dispute arising out of or relating to the Operative Documents exceed the Fair Market Value of the Performance RSU Target Award set forth on the first page of this Agreement as of the vesting date, reduced by the value of any shares or payments previously received under this Agreement (the "Damages Limit"). The Participant knowingly, voluntarily and irrevocably waives and releases any claim to damages in excess of this Damages Limit.
(i)LIMITATION OF REMEDIES. Except when prohibited by applicable law, the procedures and remedies set forth in this Agreement shall constitute the sole remedies available to the Participant. In no event shall the Participant seek equitable relief, injunctive relief, or otherwise bring claims directly or derivatively for ultra vires, corporate waste, breach of fiduciary duty, or any other claim or cause of action, whether legal or equitable, sounding in contract or tort. Nothing in this clause is intended to waive or limit any claim brought pursuant to any federal or state statute related to the protection of civil rights. Should any provision in this Agreement be found by a court of competent jurisdiction, after all appellate rights are exhausted, to be unenforceable or void, the Parties expressly agree to sever such provision and to otherwise proceed to dispute resolution with the remaining provisions in the Mandatory Arbitration provisions.
18.Performance RSUs Subject to Plan: By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the 2018 Plan and the 2018 Plan's prospectus. The Performance RSUs and the Common Shares issued upon settlement of such Performance RSUs are subject to the 2018 Plan, which is hereby incorporated by reference. In the event of any conflict between any term or provision of this Agreement and a term or provision of the 2018 Plan, the applicable terms and provisions of the 2018 Plan shall govern and prevail.
19.Validity of Agreement: This Agreement shall be valid, binding and effective upon the Company on the Grant Date. The Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within 90 days; otherwise the Company may, in its sole discretion, rescind the Award in its entirety.
20.Headings: The headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect.
Page 9 of 14
© 2023 Celanese Corporation

21.Compliance with Section 409A of the Internal Revenue Code: Notwithstanding any provision in this Agreement to the contrary, this Agreement will be interpreted and applied so that the Agreement does not fail to meet, and is operated in accordance with, the requirements of Section 409A of the Code. The Company reserves the right to change the terms of this Agreement and the 2018 Plan without the Participant's consent to the extent necessary or desirable to comply with the requirements of Code Section 409A. Further, in accordance with the restrictions provided by Treasury Regulation Section 1.409A-3(j)(2), any subsequent amendments to this Agreement or any other agreement, or the entering into or termination of any other agreement, affecting the Performance RSUs provided by this Agreement shall not modify the time or form of issuance of the Performance RSUs set forth in this Agreement. In addition, if the Participant is a "specified employee" within the meaning of Code Section 409A, as determined by the Company, any payment made in connection with the Participant's separation from service shall not be made earlier than six months and one day after the date of such separation from service to the extent required by Code Section 409A.
22.Definitions: The following terms shall have the following meanings for purposes of this Agreement, notwithstanding any contrary definition in the 2018 Plan:
(a)"Adjusted Earnings Per Share" or "Adjusted EPS" means a measure used by the Company's management to measure performance, defined as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, certain items, refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method and further adjusted for certain items as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
Note: The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities, where applicable, and specifically excludes changes in uncertain tax positions, discrete items and other material items adjusted out of our GAAP earnings for adjusted earnings per share purposes, and changes in management's assessments regarding the ability to realize deferred tax assets. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual GAAP tax rate in any given future period.
(b)"Adjusted EBIT" means net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, refinancing expense and taxes, and further adjusted for certain items attributable to Celanese Corporation as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
(c)"Cause" means, as determined by the Company in its sole discretion, (i) the Participant's willful failure to perform the Participant's duties to the Company (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days following written notice by the Company to the Participant of such failure, (ii) the Participant's conviction of, or a plea of nolo contendere to, (x) a felony under the laws of the United States or any state thereof or any similar criminal act in a jurisdiction outside the United States or (y) a crime involving moral turpitude, (iii) the Participant's willful malfeasance or willful misconduct
Page 10 of 14
© 2023 Celanese Corporation

which is demonstrably injurious to the Company or its affiliates, (iv) any act of fraud by the Participant, (v) any violation of the Company's business conduct policy, (vi) any violation of the Company's policies concerning harassment or discrimination by the Participant, (vii) the Participant's conduct that causes harm to the business reputation of the Company or its affiliates, or (viii) the Participant's breach of any confidentiality, intellectual property, noncompetition or non-solicitation provisions applicable to the Participant under the Long-Term Incentive Claw-Back Agreement or any other agreement between the Participant and the Company. "Cause" shall be determined by the Company in its sole discretion, and such determination shall be final, binding, and conclusive on the Participant.
(d)"Change in Control" means:
(i)    any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the then-outstanding shares of common stock of the Company (the "Outstanding Company Common Stock") or (B) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the "Outstanding Company Voting Securities"); provided, however, that, for purposes of this subparagraph, the following acquisitions shall not constitute a Change of Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Affiliate, or (iv) any acquisition pursuant to a transaction that complies with clauses (A), (B) or (C) in paragraph (iii) of this definition; or
(ii)    individuals who, as of the effective date of this Agreement, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this Agreement whose election, or nomination for election by the Company's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii)    consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving the Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any of its subsidiaries (each, a "Business Combination"), in each case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company's assets either directly or through one or more subsidiaries) in
Page 11 of 14
© 2023 Celanese Corporation

substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the Business Combination, and (C) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
(iv)    approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.
Notwithstanding the foregoing, if it is determined that an Award hereunder is subject to the requirements of Section 409A and the Change in Control is a "payment event" under Section 409A for such Award, the Company will not be deemed to have undergone a Change in Control unless the Company is deemed to have undergone a "change in control event" pursuant to the definition of such term in Section 409A.
(e)"Disability" has the same meaning as "Disability" in the Celanese Corporation 2008 Deferred Compensation Plan or such other meaning as determined by the Committee in its sole discretion, provided that in all events a "Disability" under this Agreement shall constitute a "disability" within the meaning of Treasury Regulation Section 1.409A-3(i)(4).
(f)"Operative Documents" means the 2018 Plan and this Agreement.
(g)"Peer Group" means, subject to the provisions below, entities included in the Dow Jones US Chemical Index as of December 31, 2022. This is a "closed group"; therefore, changes in the Peer Group during the period specified in the definition of Total Stockholder Return, shall be handled as follows:
(1)Closed Group: The composition of the Peer Group will be determined on the date specified above, and "frozen" as of that date; subsequent changes to the composition of the index will not change the Peer Group. Companies will not be market capitalization weighted.
(2)Multiple Class Companies: If a company in the Dow Jones US Chemical Index has more than one class of shares trading, only the "Class A" shares will be included in the Peer Group.
(3)    Acquisitions: If a company in the Peer Group is acquired during the Performance Period, such company is excluded from the Peer Group for purposes of the TSR calculation.
(4)    Spinoffs: The surviving parent entity will be retained in the Peer Group, by treating the value of the spinco as a reinvested dividend in parent stock.
Page 12 of 14
© 2023 Celanese Corporation

(5)    Bankruptcy: If a company in the Peer Group files for bankruptcy protection or is otherwise insolvent during the Performance Period, such company shall remain in the Peer Group but shall be assigned the lowest possible ranking for TSR.
(6)    No Trading: If a company is in the Dow Jones US Chemical Index but is not trading as of December 31, 2022, then it will be excluded from the Peer Group. If a company in the Peer Group is otherwise no longer publicly traded on the last day of the Performance Period (other than as a result of an acquisition as described in clause (3) above), such company shall remain in the Peer Group but shall be assigned the lowest possible ranking for TSR.
(h)"Performance Period" means the three-year period from January 1, 2023 through December 31, 2025.
(i)"Qualifying Disposition" means a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, and determined by the Committee to be a Qualifying Disposition.
(j)"Relative Total Stockholder Return" or "Relative TSR" is assessed in comparison of the percentile rank in TSR to the Peer Group. The lowest ranked company will be the 0% rank, the middle ranked company will be the 50th percentile rank and the top ranked company will be the 100th percentile rank.
(k)"Retirement" of the Participant shall mean a voluntary separation from service on or after the date when the Participant is both 55 years of age and has 10 years of service with the Company, as determined by the Company in its discretion based on payroll records. Retirement shall not include voluntary separation from service in which the Company could have terminated the Participant's employment for Cause.
(l)"Return on Capital Employed" or "ROCE" means a measure used by the Company's management to measure performance and is defined as Adjusted EBIT divided by capital employed, which is the beginning and end-of-year average of the sum of property, plant and equipment, net; trade working capital (calculated as trade receivables, net plus inventories less trade payables – third party and affiliates); goodwill; intangible assets, and investments in affiliates, adjusted to eliminate noncontrolling interests, and certain items as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
(m)"Settlement Date" means the date that Common Shares are delivered to the Participant following the Vesting Date.
(n)"Total Stockholder Return" or "TSR" measures the percent change in share price from the beginning of the Performance Period to the end of the Performance Period and assumes immediate reinvestment of dividends when declared at the closing share price on the date declared. The beginning share price will be calculated as an average of 60 data points: the closing share price on December 31, 2022 and the closing share price for each of the 59 trading days preceding December 31, 2022. The ending share price will be calculated as an average of 60 data points: the closing share price on December 31, 2025 and the closing share price for each of the 59 trading days preceding December 31, 2025.
[signatures appear on following page]
Page 13 of 14
© 2023 Celanese Corporation

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer.

CELANESE CORPORATION
By:
Lori J. Ryerkerk
Chair, Chief Executive Officer and President
Page 14 of 14
© 2023 Celanese Corporation

APPENDIX A
CALCULATION OF THE PERFORMANCE-BASED VESTING
Performance-Based Vesting Calculation
The Performance RSUs are subject to adjustment based on the achievement of specified levels of:
(i) the Company's Adjusted EPS during the Performance Period, weighted 70%; and
(ii) the Company's ROCE during the Performance Period, weighted 30%.
In addition, the Performance RSUs will be subject to further adjustment based on the Company's Relative TSR during the Performance Period.
Each metric will be calculated separately based on the targets set forth below. The results of each metric will determine the number of Performance RSUs earned for that metric. The total award will be the addition of the total number of Performance RSUs earned for each of the two performance metrics, with such result then subject to adjustment based on the Company's Relative TSR during the Performance Period. The number of Performance RSUs determined after such adjustments (and subject further to the additional vesting requirements of Section 2(b) of the Agreement) are referred to as the "Performance-Adjusted RSUs." Fractional shares remaining after such adjustments will be rounded up to the nearest whole share. No fractional shares will be issued.

Page A-1
© 2022 Celanese Corporation

A. Calculation of Performance Adjustment based on the Adjusted EPS Results
The following table outlines the percentage of the Performance RSUs that may become earned based on Adjusted EPS performance during the Performance Period.
Adjusted EPS
(70% weighting)
Result
Goal Achievement for Performance Period1
Performance Adjustment Percentage
Below ThresholdLess than $[●]0%
Threshold$[●]50%
Target$[●]100%
Superior$[●]or more200%
The Performance Adjustment Percentage for Adjusted EPS for the Performance Period shall be calculated by straight-line interpolation for results achieved between Threshold and Target, or for results achieved between Target and Superior. No Performance RSUs will be earned for the Adjusted EPS component for the Performance Period if Goal Achievement is Below Threshold.

1 To the extent not otherwise included as an adjustment to Adjusted EPS (as defined) or ROCE (as defined), if
(a) the historic financial statements of the Company for period(s) ending prior to the Performance Period are retrospectively recast in connection with a change in accounting principle or method adopted during the Performance Period,
(b) the Company effects a material acquisition, disposition, merger, spin-off or other similar transaction, or enters/exits a joint venture, affecting the Company or any subsidiary or any portion thereof, during the Performance Period,
(c) the Company suffers or incurs items of gain, loss or expense determined to be unusual in nature, or charges for restructurings, discontinued operations, or any other unusual or infrequent items, or any other event materially outside the scope of those anticipated in the Company's operating plans,
(d) there are changes in tax law or other such laws or provisions affecting reported results,
(e) the Company establishes accruals or reserves, or impairs assets, for reorganization or restructuring programs, and/or
(f) the Company incurs or is adversely affected by any other eventuality contemplated by the last sentence of Section 13(b) of the 2018 Plan,
then in each such case where the amount is significant to the Company, the Committee shall, as determined appropriate in its sole discretion, adjust the performance goals or level of assessed performance, as described in this Appendix A to ensure that the Participant is not unfairly advantaged or disadvantaged by any of the events described in items (a)-(f).
Page A-2
© 2022 Celanese Corporation

B. Calculation of Performance Adjustment based on the ROCE Results
The following table outlines the percentage of the Performance RSUs that may become earned based on ROCE performance during the Performance Period.
ROCE
(30% weighting)
Result
Goal Achievement for Performance Period1
Performance Adjustment Percentage
Below ThresholdLess than [●]%0%
Threshold[●]%50%
Target[●]% - [●]%100%
Superior[●]% or more200%
The Performance Adjustment Percentage for ROCE for the Performance Period shall be calculated by straight-line interpolation for results achieved between Threshold and the low end of the Target range, or for results achieved between the high end of the Target range and Superior. No Performance RSUs will be earned for the ROCE component for the Performance Period if Goal Achievement is Below Threshold.
C. Calculation of Relative TSR Modifier
The sum of the Performance RSUs earned for the Adjusted EPS component and the Performance RSUs earned for the ROCE component will be subject to further adjustment by multiplying such aggregate Performance RSUs earned by the "Modifier Percentage" determined based on the Company's Relative TSR percentile ranking during the Performance Period in accordance with the following table.
Relative TSR Modifier
Relative TSR Percentile AchievedModifier Percentage
< 25%
80%
25% to 75%100%
> 75%
120%

D. Adjustments In Case of Certain Dispositions and Acquisitions
In the event of a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, if such transaction is determined by the Committee to constitute a "change in ownership or control" within the meaning of Section 280G of the Code (and regardless of whether such transaction also constitutes a "Change in Control" as defined in this Agreement) (e.g., a sale or other disposition of assets of the Company that have a gross fair market value equal to or more than one-third of the total gross fair market value of all assets of the Company immediately before such transaction), the Committee may, in addition to or in lieu of any permitted adjustments to the performance goals or performance provided above, in its discretion take any action as determined to be equitable to reflect the closing of the transaction, including, but not limited to: (i) adjust the performance vesting conditions in any manner, including substituting new or additional performance goals, over the remaining Performance Period, (ii) cease the measurement of performance as of the closing of the transaction and adjust the Award to a time-vesting Award over the remainder of the Performance Period (at target, based on actual
Page A-3
© 2022 Celanese Corporation

or projected performance at the time of the transaction, or on any other basis as the Committee may determine), or (iii) accelerate the vesting of all or any portion of the Award.
In the event of an acquisition by the Company of one or more subsidiaries in a stock, asset, merger or other similar transaction or combination thereof (regardless of whether such transaction also constitutes a "Change in Control" as defined in this Agreement), the Committee may, in addition to or in lieu of any permitted or required adjustments to the performance goals or performance provided above, in its discretion take any action as determined to be equitable to reflect the closing of the transaction, including, but not limited to: (i) adjust the performance vesting conditions in any manner, including substituting new or additional performance goals, over the remaining Performance Period or (ii) cease the measurement of performance as of the closing of the transaction and adjust the Award to a time-vesting Award over the remainder of the Performance Period (at target, based on actual or projected performance at the time of the transaction, or on any other basis as the Committee may determine).
Page A-4
© 2022 Celanese Corporation
 EX-10.5 3 ex1053312310q.htm EX-10.5 Document

Exhibit 10.5
[Form of 2023 CEO Performance-Based RSU Agreement]





celogo2b.jpg








CELANESE CORPORATION
2018 GLOBAL INCENTIVE PLAN

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
DATED [Grant Date]



Pursuant to the terms and conditions of the Celanese Corporation 2018 Global Incentive Plan, you have been awarded Performance-Based Restricted Stock Units, subject to the restrictions described in this Agreement. In addition to the information included in this Award Agreement, the Participant's name and the number of Restricted Stock Units awarded can be found in the Grant Summary located in the electronic stock plan award administration system maintained by the Company or its designee that contains a link to this Agreement (which summary information is set forth in the appropriate records of the Company authorizing such award).


2023 Performance RSU Award

Target Award: [Number of Shares Granted] Units


This grant is made pursuant to the Performance-Based Restricted Stock Unit Award Agreement dated as of [Grant Date], between Celanese and [Participant Name], covering a performance period from January 1, 2023 through December 31, 2025, which Agreement is attached hereto and made a part hereof.


Page 1 of 15
© 2023 Celanese Corporation

CELANESE CORPORATION
2018 GLOBAL INCENTIVE PLAN

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
This Performance-Based Restricted Stock Unit Award Agreement (the "Agreement") is made and entered into as of [Grant Date] (the "Grant Date"), by and between Celanese Corporation, a Delaware corporation ("Celanese" and together with the participating subsidiaries that are employers of the Participants, the "Company"), and [Participant Name] (the "Participant"). Capitalized terms used, but not otherwise defined, herein shall have the meanings ascribed to such terms in the Celanese Corporation 2018 Global Incentive Plan (as amended from time to time, the "2018 Plan").
1.Performance RSU Award: In order to encourage the Participant's contribution to the successful performance of the Company, Celanese hereby grants to the Participant as of the Grant Date, pursuant to the terms of the 2018 Plan and this Agreement, an award (the "Award") of [Number of Shares Granted] performance-based Restricted Stock Units ("Performance RSUs") representing the right to receive, subject to the attainment of the performance goals set forth in Appendix A, the number of Common Shares to be determined in accordance with the formula set forth in Appendix A. The Participant hereby acknowledges and accepts such Award upon the terms and subject to the performance requirements and other conditions, restrictions and limitations contained in this Agreement and the 2018 Plan.
2.Performance-Based Adjustment and Vesting:
(a)    Subject to Section 3 and Section 6 of this Agreement, the Performance RSUs are subject to adjustment for performance during the Performance Period in accordance with the performance measures, targets and methodology set forth in Appendix A. The number of Performance RSUs determined after the Performance Period based on such performance is referred to as the "Performance-Adjusted RSUs."
(b)    Subject to Section 3 and Section 6 of this Agreement, the Performance-Adjusted RSUs shall vest on February 15, 2026 (the "Vesting Date"). The period between the Grant Date and the Vesting Date shall be referred to as the "Vesting Period."
3.Effects of Certain Events:
(a)If the Participant's service with the Company is terminated by the Company without Cause or due to the Participant's Retirement prior to the Vesting Date (other than as provided in Section 3(b)), then:
(i) in all such cases the Performance RSUs shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of service occurs during the Performance Period; and
(ii) a prorated number of the Performance-Adjusted RSUs will vest on the Vesting Date in an amount equal to (x) the unvested Performance-Adjusted RSUs in the Vesting Period multiplied by (y) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination, and the denominator of which is the number of complete and partial calendar months in the Vesting Period, such product to be rounded up to the nearest whole number.
Page 2 of 15
© 2023 Celanese Corporation

Such prorated Performance-Adjusted RSUs will be settled following the Vesting Date in accordance with the provisions of Section 4, subject to any applicable taxes under Section 7 upon such vesting and settlement. The remaining portion of the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service. To the extent permitted by applicable country, state or province law, as consideration for the vesting provisions upon Retirement contained in this Section 3(a), upon Retirement, the Participant shall enter into a departure and general release of claims agreement with the Company that includes a general release of claims, covenants relating to the provision of transition assistance and cooperation (including reasonable transition support to any successor CEO and cooperation in litigation related to the time period of Participant's service) and two-year noncompetition and non-solicitation covenants in a form acceptable to the Company.
(b)Notwithstanding any provision herein to the contrary, if the Participant's employment with the Company is terminated by the Company in connection with a Qualifying Disposition, as determined by the Company in its sole discretion, other than for Cause, and regardless of whether the Participant is then eligible for Retirement or is offered employment with the acquiror or successor, then:
(i) a prorated number of the unvested Performance RSUs determined in accordance with the provisions of Section 3(a) had those provisions applied shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period, and shall be settled in accordance with the provisions of Section 3(a); and
(ii) the remaining number of the unvested Performance RSUs that would have otherwise been forfeited had the provisions of Section 3(a) applied shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period, and any such Performance-Adjusted RSUs will vest and be settled in accordance with the provisions of Section 4, subject to any applicable taxes under Section 7 upon such vesting and settlement.
Notwithstanding the foregoing, in case of a termination of employment covered by this Section 3(b), if the Company determines that the Participant has been offered employment with the acquiror or successor and in connection with that employment will receive a substitute award from the acquiror or successor with an equivalent (or greater) economic value and no less favorable vesting conditions as this Award, the Company, in its sole discretion, may determine not to provide for the additional vesting under clause (ii) of this Section 3(b).
(c)If the Participant's service with the Company is terminated due to the Participant's death or Disability prior to the Vesting Date, then a prorated number of Performance RSUs will vest in an amount equal to:
(i) the Target number of Performance RSUs granted hereby multiplied by
(ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination, and the denominator of which is the number of complete and partial calendar months in the Vesting Period, such product to be rounded up to the nearest whole number.
The prorated number of Performance RSUs shall immediately vest and a number of Common Shares equal to such prorated number of Performance RSUs described above shall be delivered to
Page 3 of 15
© 2023 Celanese Corporation

the Participant or beneficiary within thirty (30) days following the date of termination, subject to the provisions of Section 7. The remaining portion of the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service for death or Disability.
(d)Upon the termination of a Participant's service with the Company for any other reason prior to the Vesting Date, the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service.
A Participant's service will be considered to have been terminated for Cause, and the Award forfeited and cancelled without consideration, if the Company determines, in its sole discretion, that the Participant engaged in an act constituting Cause at any time prior to the Vesting Date, regardless of whether the Participant's termination initially was considered to have been without Cause. In such case, the provisions of Section 3(a), 3(b) or 3(c) are inapplicable.
4.Settlement of Performance RSUs: The Committee shall determine the Performance-Adjusted RSUs as soon as administratively practicable following the computation of the Company's performance for the Performance Period (but not later than 2 ½ months after the end of the Performance Period (i.e., March 15, 2026)). The date of such determination is referred to as the "Performance Certification Date." Subject to Sections 2, 3, 5, 6 and 7 of this Agreement, the Company shall deliver to the Participant (or to a Company-designated brokerage firm or plan administrator) as soon as administratively practicable after the Performance Certification Date (but not later than 2 ½ months after the end of the Performance Period (i.e., March 15, 2026)), in complete settlement of the Performance-Adjusted RSUs vesting on such Vesting Date, a number of Common Shares equal to the Performance-Adjusted RSUs determined in accordance with this Agreement.
5.Rights as a Stockholder: The Participant shall have no voting, dividend or other rights as a stockholder with respect to the Award until the Performance RSUs have vested and Common Shares have been delivered pursuant to this Agreement.
6.Change in Control; Dissolution:
(a)Notwithstanding any other provision of this Agreement to the contrary, in connection with the occurrence of a Change in Control, with respect to any unvested Performance RSUs granted pursuant to this Agreement that have not previously been forfeited:
(i)If (A) a Participant's rights to the unvested portion of the Award are not adversely affected in connection with the Change in Control, or, if adversely affected, a substitute award with an equivalent (or greater) economic value and no less favorable vesting conditions is granted to the Participant in connection with the occurrence of a Change in Control, and (B) the Participant's service is terminated by the Company (or its successor) without Cause within two years following the Change in Control, then Performance RSUs in an amount equal to the higher of (x) the Target number of Performance RSUs granted hereby (or, as applicable, the substitute award) or (y) the number of Performance RSUs payable based on estimated Company performance during the Performance Period through the Change in Control as determined by the Committee in accordance with this Agreement, shall immediately vest and a number of Common Shares equal to the number of Performance RSUs so determined shall be delivered to the Participant within 30 days following the date of termination, subject to the provisions of Section 7.
Page 4 of 15
© 2023 Celanese Corporation

(ii)If a Participant's right to the unvested portion of the Award is adversely affected in connection with the Change in Control and a substitute award is not made pursuant to Section 6(a)(i) above, then upon the occurrence of a Change in Control, a number of Performance RSUs equal to the higher of (A) the Target number of Performance RSUs granted hereby or (B) the number of Performance RSUs payable based on estimated Company performance during the Performance Period through the Change in Control as determined by the Committee in accordance with this Agreement, shall immediately vest and a number of Common Shares equal to the number of Performance RSUs so determined shall be delivered to the Participant within 30 days following the occurrence of the Change in Control, subject to the provisions of Section 7.
(b)Notwithstanding any other provision of this Agreement to the contrary, in the event of a corporate dissolution of the Company that is taxed under Section 331 of the Code, then in accordance with Treasury Regulation Section 1.409A-3(j)(4)(ix)(A), this Agreement shall terminate and any Performance RSUs granted pursuant to this Agreement that have not previously been forfeited shall immediately become Common Shares and shall be delivered to the Participant within 30 days following such dissolution.
7.Income and Other Taxes: The Company shall not deliver Common Shares in respect of any vested Performance RSUs unless and until the Participant has made arrangements satisfactory to the Company to satisfy applicable withholding tax obligations for U.S. federal, state, and local income taxes (or the foreign counterpart thereof) and applicable employment taxes. Unless otherwise permitted by the Committee, withholding shall be effectuated by withholding Common Shares in connection with the vesting and/or settlement of Performance-Adjusted RSUs. Withholding shall be effected using a rate or method chosen by the Company consistent with ASC Topic 718 (or any successor applicable equity accounting standard applicable to this Award) and the U.S. Internal Revenue Service withholding regulations or other applicable tax requirements, not to exceed maximum statutory rates. The Participant acknowledges that the Company shall have the right to deduct any taxes required to be withheld by law in connection with the vesting or settlement of Performance-Adjusted RSUs from any amounts payable by it to the Participant (including, without limitation, future cash wages). The Participant acknowledges and agrees that amounts withheld by the Company for taxes may be less than amounts actually owed for taxes by the Participant in respect of the Award. Any vested Performance-Adjusted RSUs shall be reflected in the Company's records as issued on the respective dates of issuance set forth in this Agreement, irrespective of whether delivery of such Common Shares is pending the Participant's satisfaction of his or her withholding tax obligations.
8.Securities Laws: The Company may impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common Shares issued as a result of the vesting or settlement of the Performance RSUs, including without limitation (a) restrictions under an insider trading policy, and (b) restrictions as to the use of a specified brokerage firm for such resales or other transfers. Upon the acquisition of any Common Shares pursuant to the vesting or settlement of the Performance-Adjusted RSUs, the Participant will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement and the 2018 Plan. All accounts in which such Common Shares are held or any certificates for Common Shares shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or quotation system upon which the Common Shares are then listed or quoted, and any applicable federal or state securities law, and the Company may cause a legend or legends to be put on any such certificates (or other appropriate restrictions and/or notations to be associated with any accounts in which such Common Shares are held) to make appropriate reference to such restrictions.
Page 5 of 15
© 2023 Celanese Corporation

9.Non-Transferability of Award: The Performance RSUs may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company; provided, that the Participant may designate a beneficiary, on a form provided by the Company, to receive any portion of the Award payable hereunder following the Participant's death.
10.Other Agreements; Release of Claims: Subject to Sections 10(a), 10(b) and 10(c) of this Agreement, this Agreement and the 2018 Plan constitute the entire understanding between the Participant and the Company regarding the Award, and any prior and/or contemporaneous agreements, understandings, representations, discussions, commitments or negotiations concerning the Award, whether written or oral, are superseded. No oral statements or other prior written material not specifically incorporated into this Agreement, other than the 2018 Plan, shall be of any force or effect.
(a)The Participant acknowledges that as a condition to the receipt of the Award, the Participant:
(1)    shall have delivered to the Company an executed copy of this Agreement;
(2)    shall be subject to the Company's stock ownership guidelines, to the extent applicable to the Participant;
(3)    shall be subject to policies and agreements adopted by the Company from time to time, and applicable laws and regulations, requiring the repayment by the Participant of incentive compensation under certain circumstances, including that certain Celanese Corporation Incentive Compensation Recoupment Policy adopted by the Committee on October 16, 2019 (collectively, "Clawback Policies"), without any further act or deed or consent of the Participant; and
(4)    shall have delivered to the Company an executed copy of the current form of Long-Term Incentive Claw-Back Agreement, as determined by the Company in its sole discretion. For purposes hereof, "Long-Term Incentive Claw-Back Agreement" means an agreement between the Company and the Participant associated with the grant of long-term incentives of the Company, which contains terms, conditions, restrictions and provisions regarding one or more of (i) noncompetition by the Participant with the Company, and its customers and clients; (ii) non-solicitation and non-hiring by the Participant of the Company's employees, former employees or consultants; (iii) maintenance of confidentiality of the Company's and/or clients' information, including intellectual property; (iv) nondisparagement of the Company; and (v) such other matters deemed necessary, desirable or appropriate by the Company for such an agreement in view of the rights and benefits conveyed in connection with an award.
(b)The Participant acknowledges that if the Participant violates any of the terms or provisions of the Clawback Policies or the Long-Term Incentive Claw-Back Agreement, whether before or after termination of service, then the Company will, to the fullest extent permitted by applicable law, (i) terminate the Participant's rights in any unvested Performance RSUs under this Award, and (ii) claw back (i.e., recover) all Common Shares previously issued under this Award.
(c)If the Participant is a non-resident of the U.S., there may be an addendum containing special terms and conditions applicable to awards in the Participant's country. The
Page 6 of 15
© 2023 Celanese Corporation

issuance of the Award to any such Participant is contingent upon the Participant executing and returning any such addendum in the manner directed by the Company.
11.Not a Contract for Employment; No Acquired Rights; Agreement Changes: This Agreement and the Award evidenced hereby are not an employment agreement, and nothing in this Agreement, the International Supplement, if applicable, or the 2018 Plan shall alter the Participant's status as an "at-will" employee or service provider of the Company or your employment or service status at the Company. None of this Agreement, the International Supplement, if applicable, or the 2018 Plan shall be construed as guaranteeing your employment by or service with the Company, or as giving you any right to continue in the employ or engagement of the Company, during any period (including without limitation the period between the Date of the Agreement and the Vesting Date, or any portion of such period), nor shall they be construed as giving you any right to be reemployed or reengaged by the Company following any termination of employment or service. This Agreement and the Award evidenced hereby, and all other long-term incentive awards and other equity-based awards, are discretionary. This Award does not confer on the Participant any right or entitlement to receive another Award or any other equity-based award at any time in the future or in respect of any future period. The Company has made this Award to you in its sole discretion. This Award does not confer on you any right or entitlement to receive compensation in any specific amount for any future year, and does not diminish in any way the Company's discretion to determine the amount, if any, of your compensation. This Award is not part of your base salary or wages and will not be taken into account in determining any other employment- or service- related rights you may have, such as rights to pension or severance pay. The Company has the right, at any time and for any reason, to amend, suspend or terminate the 2018 Plan; provided, however, that no such amendment, suspension, or termination shall adversely affect the Participant's rights hereunder.
12.Severability: Should any provision of this Agreement be declared or held to be illegal, invalid or otherwise unenforceable, (a) such provision shall either be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise severed, (b) the remainder of this Agreement shall not be affected except to the extent necessary to reform or sever such illegal, invalid or unenforceable provision, and (c) in no event should such partial invalidity affect the remainder of this Agreement, which shall still be enforced.
13.Further Assurances: Each party shall cooperate and take such action as may be reasonably requested by either party hereto in order to carry out the provisions and purposes of this Agreement.
14.Binding Effect: The Award and this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns.
15.Electronic Delivery: By executing this Agreement, the Participant hereby consents to the delivery of any and all information (including, without limitation, information required to be delivered to the Participant pursuant to applicable securities laws), in whole or in part, regarding the Company and its subsidiaries, the 2018 Plan, and the Award via electronic mail, the Company's or a plan administrator's web site, or other means of electronic delivery.
16.Personal Data: By accepting the Award under this Agreement, the Participant hereby consents to the Company's use, dissemination and disclosure of any information pertaining to the Participant that the Company determines to be necessary or desirable for the implementation, administration and management of the 2018 Plan.
Page 7 of 15
© 2023 Celanese Corporation

17.Miscellaneous:
(a)Governing Law. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be governed by, construed under and interpreted in accordance with the laws of the State of Delaware, without regard to its conflicts of laws rules.
(b)Notice. The Participant is reminded to read the following carefully and after consulting with counsel of their choice:
The Participant agrees that the following provisions requiring arbitration, prohibiting recovery of attorneys' fees, waiving class actions and mass actions, waiving the right to a jury trial, waiving any right to seek punitive damages, limiting actual damages, and limiting remedies by waiving any right to injunctive or other equitable or legal relief are and were an important part of the Company's decision to adopt the Operative Documents and for Participant to be offered this Agreement. The Participant understands and agrees that absent the foregoing provisions, the Operative Documents would not have been offered or entered into or would have materially changed. The Participant acknowledges the benefits of receiving potential incentive awards. In reliance on the Participant's intent to abide by and enter into the following provisions, the parties have entered into the Operative Documents.
(c)MANDATORY ARBITRATION. All disputes arising out of or related in any manner to the Operative Documents shall be resolved exclusively by arbitration to be conducted only in the county and state of Dallas, Texas in accordance with the rules of the International Institute for Conflict Prevention and Resolution Rules for Non-Administered Arbitration ("CPR") applying the laws of Delaware and by a sole arbitrator. Within 45 days of the service of any demand for arbitration, the parties shall attempt to mutually agree on the appointment of an arbitrator and may seek names of potential arbitrators from CPR for their consideration. Failing agreement on selection of an agreed arbitrator, upon written request of either party, CPR shall appoint a single arbitrator in accordance with its rules, with the parties expressing a contractual preference for the selection of a retired judge with at least 10 years of judicial experience. Discovery shall be as provided by the CPR rules. The arbitration award shall be in writing and shall include a reasoned opinion by the Arbitrator. Consistent with the waiver of all claims to punitive or exemplary damages, the Arbitrator shall have no authority to award such damages. The parties understand that their right to appeal or to seek modification of any ruling or award of the arbitrator is severely limited, if any. Awards issued by the arbitrator shall be final and binding, and judgment may be entered on it in any court of competent jurisdiction. All parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrator. Any and all disputes regarding this arbitration provision and its enforceability shall be exclusively submitted to the United States District Court for the District of Delaware, if it has jurisdiction, and failing that, to the Delaware state court in Wilmington, Delaware.
(d)NO RECOVERY OF ATTORNEYS' FEES AND COSTS. Each party agrees that in any litigation or proceeding between the parties arising out of, connected with, related to, or incidental to the relationship between them in connection with the Operative Documents, each party shall bear all of its own attorneys' fees and costs regardless of which party prevails, except when prohibited by applicable law.
(e)CLASS ACTION AND MASS ACTION WAIVER. As part of this provision of arbitration as the contracted method of all dispute resolution under this Agreement, any claim, whether brought in a court of law or in arbitration, must be brought in the Participant's individual
Page 8 of 15
© 2023 Celanese Corporation

capacity, and not as a representative of any purported class or as a "mass action" (involving multiple plaintiffs) ("Class/Mass Action"). The parties expressly waive any ability to maintain any Class/Mass Action in any forum. The arbitrator shall not have authority to combine or aggregate similar claims or conduct any Class/Mass Action nor make an award to any person or entity not a party to the arbitration. Any claim that all or part of this Class/Mass Action waiver is unenforceable, unconscionable, void, or voidable may be determined only by a court of competent jurisdiction and not by an arbitrator. The Participant understands that but for this Agreement, he or she would have had a right to litigate through a court, to have a judge or jury decide the case and to be party to a Class/Mass Action. However, in exchange for the potential incentive awards provided herein and the receipt of the benefit of arbitration, the Participant understands and chooses to have only his or her individual claims decided, each in a separate case, by an arbitrator.
(f)WAIVER OF JURY TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW AND EXPRESSLY BECAUSE OF THE COMPLEXITY OF THE MATTERS IN THE OPERATIVE DOCUMENTS, EACH PARTY WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE ARISING OUT OF OR RELATING TO THE OPERATIVE DOCUMENTS.
(g)WAIVER OF PUNITIVE AND EXEMPLARY DAMAGE CLAIMS. The Participant waives, to the fullest extent allowed by law, any claims or rights to recover punitive, exemplary or similar damages.
(h)LIMIT ON ACTUAL DAMAGES. In no event may the actual damages awarded to the Participant in a dispute arising out of or relating to the Operative Documents exceed the Fair Market Value of the Performance RSU Target Award set forth on the first page of this Agreement as of the vesting date, reduced by the value of any shares or payments previously received under this Agreement (the "Damages Limit"). The Participant knowingly, voluntarily and irrevocably waives and releases any claim to damages in excess of this Damages Limit.
(i)LIMITATION OF REMEDIES. Except when prohibited by applicable law, the procedures and remedies set forth in this Agreement shall constitute the sole remedies available to the Participant. In no event shall the Participant seek equitable relief, injunctive relief, or otherwise bring claims directly or derivatively for ultra vires, corporate waste, breach of fiduciary duty, or any other claim or cause of action, whether legal or equitable, sounding in contract or tort. Nothing in this clause is intended to waive or limit any claim brought pursuant to any federal or state statute related to the protection of civil rights. Should any provision in this Agreement be found by a court of competent jurisdiction, after all appellate rights are exhausted, to be unenforceable or void, the Parties expressly agree to sever such provision and to otherwise proceed to dispute resolution with the remaining provisions in the Mandatory Arbitration provisions.
18.Performance RSUs Subject to Plan: By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the 2018 Plan and the 2018 Plan's prospectus. The Performance RSUs and the Common Shares issued upon settlement of such Performance RSUs are subject to the 2018 Plan, which is hereby incorporated by reference. In the event of any conflict between any term or provision of this Agreement and a term or provision of the 2018 Plan, the applicable terms and provisions of the 2018 Plan shall govern and prevail.
19.Validity of Agreement: This Agreement shall be valid, binding and effective upon the Company on the Grant Date. The Participant must accept this Agreement electronically pursuant to the
Page 9 of 15
© 2023 Celanese Corporation

online acceptance procedure established by the Company within 90 days; otherwise the Company may, in its sole discretion, rescind the Award in its entirety.
20.Headings: The headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect.
21.Compliance with Section 409A of the Internal Revenue Code: Notwithstanding any provision in this Agreement to the contrary, this Agreement will be interpreted and applied so that the Agreement does not fail to meet, and is operated in accordance with, the requirements of Section 409A of the Code. The Company reserves the right to change the terms of this Agreement and the 2018 Plan without the Participant's consent to the extent necessary or desirable to comply with the requirements of Code Section 409A. Further, in accordance with the restrictions provided by Treasury Regulation Section 1.409A-3(j)(2), any subsequent amendments to this Agreement or any other agreement, or the entering into or termination of any other agreement, affecting the Performance RSUs provided by this Agreement shall not modify the time or form of issuance of the Performance RSUs set forth in this Agreement. In addition, if the Participant is a "specified employee" within the meaning of Code Section 409A, as determined by the Company, any payment made in connection with the Participant's separation from service shall not be made earlier than six months and one day after the date of such separation from service to the extent required by Code Section 409A.
22.Definitions: The following terms shall have the following meanings for purposes of this Agreement, notwithstanding any contrary definition in the 2018 Plan:
(a)"Adjusted Earnings Per Share" or "Adjusted EPS" means a measure used by the Company's management to measure performance, defined as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, certain items, refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method and further adjusted for certain items as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
Note: The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities, where applicable, and specifically excludes changes in uncertain tax positions, discrete items and other material items adjusted out of our GAAP earnings for adjusted earnings per share purposes, and changes in management's assessments regarding the ability to realize deferred tax assets. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual GAAP tax rate in any given future period.
(b)"Adjusted EBIT" means net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, refinancing expense and taxes, and further adjusted for certain items attributable to Celanese Corporation as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
Page 10 of 15
© 2023 Celanese Corporation

(c)"Cause" means, as determined by the Company in its sole discretion, (i) the Participant's willful failure to perform the Participant's duties to the Company (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days following written notice by the Company to the Participant of such failure, (ii) the Participant's conviction of, or a plea of nolo contendere to, (x) a felony under the laws of the United States or any state thereof or any similar criminal act in a jurisdiction outside the United States or (y) a crime involving moral turpitude, (iii) the Participant's willful malfeasance or willful misconduct which is demonstrably injurious to the Company or its affiliates, (iv) any act of fraud by the Participant, (v) any violation of the Company's business conduct policy, (vi) any violation of the Company's policies concerning harassment or discrimination by the Participant, (vii) the Participant's conduct that causes harm to the business reputation of the Company or its affiliates, or (viii) the Participant's breach of any confidentiality, intellectual property, noncompetition or non-solicitation provisions applicable to the Participant under the Long-Term Incentive Claw-Back Agreement or any other agreement between the Participant and the Company. "Cause" shall be determined by the Company in its sole discretion, and such determination shall be final, binding, and conclusive on the Participant.
(d)"Change in Control" means:
(i)    any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the then-outstanding shares of common stock of the Company (the "Outstanding Company Common Stock") or (B) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the "Outstanding Company Voting Securities"); provided, however, that, for purposes of this subparagraph, the following acquisitions shall not constitute a Change of Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Affiliate, or (iv) any acquisition pursuant to a transaction that complies with clauses (A), (B) or (C) in paragraph (iii) of this definition; or
(ii)    individuals who, as of the effective date of this Agreement, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this Agreement whose election, or nomination for election by the Company's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii)    consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving the Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any of its subsidiaries (each, a "Business Combination"), in each case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially
Page 11 of 15
© 2023 Celanese Corporation

own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the Business Combination, and (C) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
(iv)    approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.
Notwithstanding the foregoing, if it is determined that an Award hereunder is subject to the requirements of Section 409A and the Change in Control is a "payment event" under Section 409A for such Award, the Company will not be deemed to have undergone a Change in Control unless the Company is deemed to have undergone a "change in control event" pursuant to the definition of such term in Section 409A.
(e)"Disability" has the same meaning as "Disability" in the Celanese Corporation 2008 Deferred Compensation Plan or such other meaning as determined by the Committee in its sole discretion, provided that in all events a "Disability" under this Agreement shall constitute a "disability" within the meaning of Treasury Regulation Section 1.409A-3(i)(4).
(f)"Operative Documents" means the 2018 Plan and this Agreement.
(g)"Peer Group" means, subject to the provisions below, entities included in the Dow Jones US Chemical Index as of December 31, 2022. This is a "closed group"; therefore, changes in the Peer Group during the period specified in the definition of Total Stockholder Return, shall be handled as follows:
(1)Closed Group: The composition of the Peer Group will be determined on the date specified above, and "frozen" as of that date; subsequent changes to the composition of the index will not change the Peer Group. Companies will not be market capitalization weighted.
(2)Multiple Class Companies: If a company in the Dow Jones US Chemical Index has more than one class of shares trading, only the "Class A" shares will be included in the Peer Group.
Page 12 of 15
© 2023 Celanese Corporation

(3)    Acquisitions: If a company in the Peer Group is acquired during the Performance Period, such company is excluded from the Peer Group for purposes of the TSR calculation.
(4)    Spinoffs: The surviving parent entity will be retained in the Peer Group, by treating the value of the spinco as a reinvested dividend in parent stock.
(5)    Bankruptcy: If a company in the Peer Group files for bankruptcy protection or is otherwise insolvent during the Performance Period, such company shall remain in the Peer Group but shall be assigned the lowest possible ranking for TSR.
(6)    No Trading: If a company is in the Dow Jones US Chemical Index but is not trading as of December 31, 2022, then it will be excluded from the Peer Group. If a company in the Peer Group is otherwise no longer publicly traded on the last day of the Performance Period (other than as a result of an acquisition as described in clause (3) above), such company shall remain in the Peer Group but shall be assigned the lowest possible ranking for TSR.
(h)"Performance Period" means the three-year period from January 1, 2023 through December 31, 2025.
(i)"Qualifying Disposition" means a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, and determined by the Committee to be a Qualifying Disposition.
(j) "Relative Total Stockholder Return" or "Relative TSR" is assessed in comparison of the percentile rank in TSR to the Peer Group. The lowest ranked company will be the 0% rank, the middle ranked company will be the 50th percentile rank and the top ranked company will be the 100th percentile rank.
(k)"Retirement" of the Participant shall mean a voluntary separation from service on or after the earlier of (i) the date when the Participant is both 55 years of age and has 10 years of service with the Company, as determined by the Company in its discretion based on payroll records or (ii) the date when the Participant is age 62 or greater; provided, however, that in the case of clause (ii), unless waived by the Board, (1) the Participant shall have provided at least 12 months' advance notice to the Board of such planned retirement from the Chief Executive Officer position, and (2) the Board shall have designated a successor Chief Executive Officer. Retirement shall not include voluntary separation from service in which the Company could have terminated the Participant's service for Cause.
(l)"Return on Capital Employed" or "ROCE" means a measure used by the Company's management to measure performance and is defined as Adjusted EBIT divided by capital employed, which is the beginning and end-of-year average of the sum of property, plant and equipment, net; trade working capital (calculated as trade receivables, net plus inventories less trade payables – third party and affiliates); goodwill; intangible assets, and investments in affiliates, adjusted to eliminate noncontrolling interests, and certain items as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
(m)"Settlement Date" means the date that Common Shares are delivered to the Participant following the Vesting Date.
Page 13 of 15
© 2023 Celanese Corporation

(n)"service" shall mean continued service as the Executive Chairman of the Board of Directors (but not service as another non-employee director that is not Executive Chairman), employee, contractor or consultant.
(o)"Total Stockholder Return" or "TSR" measures the percent change in share price from the beginning of the Performance Period to the end of the Performance Period and assumes immediate reinvestment of dividends when declared at the closing share price on the date declared. The beginning share price will be calculated as an average of 60 data points: the closing share price on December 31, 2022 and the closing share price for each of the 59 trading days preceding December 31, 2022. The ending share price will be calculated as an average of 60 data points: the closing share price on December 31, 2025 and the closing share price for each of the 59 trading days preceding December 31, 2025.
[signatures appear on following page]
Page 14 of 15
© 2023 Celanese Corporation

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer.

CELANESE CORPORATION
By:
Vanessa Dupuis
Senior Vice President and Chief Human Resources Officer
Page 15 of 15
© 2023 Celanese Corporation

APPENDIX A
CALCULATION OF THE PERFORMANCE-BASED VESTING
Performance-Based Vesting Calculation
The Performance RSUs are subject to adjustment based on the achievement of specified levels of:
(i) the Company's Adjusted EPS during the Performance Period, weighted 70%; and
(ii) the Company's ROCE during the Performance Period, weighted 30%.
In addition, the Performance RSUs will be subject to further adjustment based on the Company's Relative TSR during the Performance Period.
Each metric will be calculated separately based on the targets set forth below. The results of each metric will determine the number of Performance RSUs earned for that metric. The total award will be the addition of the total number of Performance RSUs earned for each of the two performance metrics, with such result then subject to adjustment based on the Company's Relative TSR during the Performance Period. The number of Performance RSUs determined after such adjustments (and subject further to the additional vesting requirements of Section 2(b) of the Agreement) are referred to as the "Performance-Adjusted RSUs." Fractional shares remaining after such adjustments will be rounded up to the nearest whole share. No fractional shares will be issued.

Page A-1
© 2023 Celanese Corporation

A. Calculation of Performance Adjustment based on the Adjusted EPS Results
The following table outlines the percentage of the Performance RSUs that may become earned based on Adjusted EPS performance during the Performance Period.
Adjusted EPS
(70% weighting)
Result
Goal Achievement for Performance Period1
Performance Adjustment Percentage
Below ThresholdLess than $[●]0%
Threshold$[●]50%
Target$[●]100%
Superior$[●]or more200%
The Performance Adjustment Percentage for Adjusted EPS for the Performance Period shall be calculated by straight-line interpolation for results achieved between Threshold and Target, or for results achieved between Target and Superior. No Performance RSUs will be earned for the Adjusted EPS component for the Performance Period if Goal Achievement is Below Threshold.

1 To the extent not otherwise included as an adjustment to Adjusted EPS (as defined) or ROCE (as defined), if
(a) the historic financial statements of the Company for period(s) ending prior to the Performance Period are retrospectively recast in connection with a change in accounting principle or method adopted during the Performance Period,
(b) the Company effects a material acquisition, disposition, merger, spin-off or other similar transaction, or enters/exits a joint venture, affecting the Company or any subsidiary or any portion thereof, during the Performance Period,
(c) the Company suffers or incurs items of gain, loss or expense determined to be unusual in nature, or charges for restructurings, discontinued operations, or any other unusual or infrequent items, or any other event materially outside the scope of those anticipated in the Company's operating plans,
(d) there are changes in tax law or other such laws or provisions affecting reported results,
(e) the Company establishes accruals or reserves, or impairs assets, for reorganization or restructuring programs, and/or
(f) the Company incurs or is adversely affected by any other eventuality contemplated by the last sentence of Section 13(b) of the 2018 Plan,
then in each such case where the amount is significant to the Company, the Committee shall, as determined appropriate in its sole discretion, adjust the performance goals or level of assessed performance, as described in this Appendix A to ensure that the Participant is not unfairly advantaged or disadvantaged by any of the events described in items (a)-(f).
Page A-2
© 2023 Celanese Corporation

B. Calculation of Performance Adjustment based on the ROCE Results
The following table outlines the percentage of the Performance RSUs that may become earned based on ROCE performance during the Performance Period.
ROCE
(30% weighting)
Result
Goal Achievement for Performance Period1
Performance Adjustment Percentage
Below ThresholdLess than [●]%0%
Threshold[●]%50%
Target[●]% - [●]%100%
Superior[●]% or more200%
The Performance Adjustment Percentage for ROCE for the Performance Period shall be calculated by straight-line interpolation for results achieved between Threshold and the low end of the Target range, or for results achieved between the high end of the Target range and Superior. No Performance RSUs will be earned for the ROCE component for the Performance Period if Goal Achievement is Below Threshold.
C. Calculation of Relative TSR Modifier
The sum of the Performance RSUs earned for the Adjusted EPS component and the Performance RSUs earned for the ROCE component will be subject to further adjustment by multiplying such aggregate Performance RSUs earned by the "Modifier Percentage" determined based on the Company's Relative TSR percentile ranking during the Performance Period in accordance with the following table.
Relative TSR Modifier
Relative TSR Percentile AchievedModifier Percentage
< 25%
80%
25% to 75%100%
> 75%
120%
D. Adjustments In Case of Certain Dispositions and Acquisitions
In the event of a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, if such transaction is determined by the Committee to constitute a "change in ownership or control" within the meaning of Section 280G of the Code (and regardless of whether such transaction also constitutes a "Change in Control" as defined in this Agreement) (e.g., a sale or other disposition of assets of the Company that have a gross fair market value equal to or more than one-third of the total gross fair market value of all assets of the Company immediately before such transaction), the Committee may, in addition to or in lieu of any permitted adjustments to the performance goals or performance provided above, in its discretion take any action as determined to be equitable to reflect the closing of the transaction, including, but not limited to: (i) adjust the performance vesting conditions in any manner, including substituting new or additional performance goals, over the remaining Performance Period, (ii) cease the measurement of performance as of the closing of the transaction and adjust the Award to a time-vesting Award over the remainder of the Performance Period (at target, based on actual or projected performance at the time of the transaction, or on any other basis as the Committee may determine), or (iii) accelerate the vesting of all or any portion of the Award.
Page A-3
© 2023 Celanese Corporation

In the event of an acquisition by the Company of one or more subsidiaries in a stock, asset, merger or other similar transaction or combination thereof (regardless of whether such transaction also constitutes a "Change in Control" as defined in this Agreement), the Committee may, in addition to or in lieu of any permitted or required adjustments to the performance goals or performance provided above, in its discretion take any action as determined to be equitable to reflect the closing of the transaction, including, but not limited to: (i) adjust the performance vesting conditions in any manner, including substituting new or additional performance goals, over the remaining Performance Period or (ii) cease the measurement of performance as of the closing of the transaction and adjust the Award to a time-vesting Award over the remainder of the Performance Period (at target, based on actual or projected performance at the time of the transaction, or on any other basis as the Committee may determine).
Page A-4
© 2023 Celanese Corporation
 EX-10.6 4 ex1063312310q.htm EX-10.6 Document

Exhibit 10.6
[Form of 2023 Time-Based Stock Option Award]





celogo3.jpg








CELANESE CORPORATION
2018 GLOBAL INCENTIVE PLAN

NONQUALIFIED STOCK OPTION AWARD AGREEMENT
DATED [Grant Date]



Pursuant to the terms and conditions of the Celanese Corporation 2018 Global Incentive Plan, you have been awarded Nonqualified Stock Options, subject to the restrictions described in this Agreement. In addition to the information included in this Agreement, the Participant's name and the number of Options can be found in the Grant Summary located in the electronic stock plan award administration system maintained by the Company or its designee that contains a link to this Agreement (which summary information is set forth in the appropriate records of the Company authorizing such award).


Stock Option Award

[Number of Common Shares Subject to Options] Shares



This grant is made pursuant to the Nonqualified Stock Option Award Agreement dated as of [Grant Date], between Celanese and [Participant Name], which Agreement is attached hereto and made a part hereof.


CELANESE CORPORATION

2018 GLOBAL INCENTIVE PLAN

NONQUALIFIED STOCK OPTION AWARD AGREEMENT
This Nonqualified Stock Option Award Agreement (the "Agreement") is made and entered into as of [Grant Date] (the "Grant Date") by and between Celanese Corporation, a Delaware corporation (the "Company"), and [Participant Name] (the "Participant"). Capitalized terms used, but not otherwise defined herein shall have the meanings ascribed to such terms in the Celanese Corporation 2018 Global Incentive Plan (as amended from time to time, the "2018 Plan").
1.Grant of Options: In order to encourage the Participant's contribution to the successful performance of the Company, the Company hereby grants to the Participant as of the Grant Date, pursuant to the terms of the 2018 Plan and this Agreement, an award (the "Award") of Nonqualified Stock Options (the "Options") to purchase all or any part of the number of Common Shares that are covered by such Options at the Exercise Price per share, in each case as specified below. The Participant hereby acknowledges and accepts such Award upon the terms and subject to the conditions, restrictions and limitations contained in this Agreement and the 2018 Plan.

Number of Common Shares Subject to Options:


[Number of Shares]



Exercise Price Per Share (the "Exercise Price"):


[Exercise Price]



Expiration Date:


[Expiration Date (Put 1 day before 10-year anniversary from Grant Date)]


Vesting Schedule:


Subject to Sections 4 and 6 of this Agreement, [33% of the Number of Shares] Options shall vest on [Vest Date 1], [33% of the Number of Shares] Options shall vest on [Vest Date 2] and [34% of the Number of Shares] Options shall vest on [Vest Date 3] (each date on which a portion of the Options vest and become exercisable, a "Vesting Date", and each period between the Grant Date and a Vesting Date, a "Vesting Period").

2.Non-Qualified Stock Option: The Options are not intended to qualify Incentive Stock Options and this Agreement will be interpreted accordingly.
3.Exercise of Options:
(a)The Options shall not be exercisable as of the Grant Date. After the Grant Date, to the extent not previously exercised, and subject to termination or acceleration as provided in this Agreement or in the 2018 Plan, the Options shall be exercisable to the extent the Options become vested, as described in this Agreement, to purchase up to that number of Common Shares as set forth in Section 1 above, subject to the Participant's continued employment with the Company (except as set forth in Section 4 or 6 below). The Vesting Period and/or exercisability of the Options may be adjusted by the Committee to reflect the decreased level of employment
Page 2
© 2023 Celanese Corporation

during any period in which the Participant is on an approved leave of absence or is employed on a less than full-time basis.
(b)To exercise the Options (or any part thereof), the Participant shall notify the Company and its designated stock plan administrator or agent, as specified by the Company, and indicate the number of whole Common Shares the Participant wishes to purchase pursuant to such Options.
(c)The Exercise Price of the Options is set forth in Section 1. The Company shall not be obligated to issue any Common Shares until the Participant shall have paid the total Exercise Price for that number of Common Shares. The Exercise Price may be paid in any of the following forms or in a combination thereof: (i) cash or its equivalent, (ii) withholding of Common Shares to be issued as a result of such exercise, or (iii) any other method approved by the Committee.
(d)Common Shares will be issued as soon as practical following exercise of the Options. Notwithstanding the above, the Company shall not be obligated to deliver any Common Shares during any period in which the Company determines that the exercisability of the Options or the delivery of Common Shares pursuant to this Agreement would violate any federal, state or other applicable laws.
4.Effects of Certain Events:
(a)Upon the termination of the Participant's employment by the Company without Cause or due to the Participant's death or Disability (other than as provided in Section 4(b)), a prorated portion of the unvested Options will vest, with such prorated amount equal to (i) the unvested Options in each Vesting Period, multiplied by (ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination without Cause or due to the Participant's death or Disability, and the denominator of which is the number of complete and partial calendar months in the applicable Vesting Period, such product to be rounded up to the nearest whole number (the "Pro-Rated Options"). The remaining unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment without Cause or due to the Participant's death or Disability. In the event of the Participant's termination without Cause, the Participant may exercise the vested portion of the Options until the earlier of (A) the 12-month anniversary of the date of such termination of employment or (B) the Expiration Date. In the event of the Participant's death or Disability, the Participant (or the Participant's estate, beneficiary or legal representative) may exercise the vested portion of the Options until the earlier of (A) the 5-year anniversary of the date of such termination of employment or (B) the Expiration Date.
(b)Except as otherwise provided in this Section 4(b), upon the termination of the Participant's employment (i) due to the Participant's Retirement but under circumstances not amounting to Cause or (ii) by the Company in connection with a Qualifying Disposition, as determined by the Company in its sole discretion, other than for Cause (and regardless of whether the Participant is offered employment with the acquiror or successor), any unvested Options will remain outstanding and vest and become exercisable on the same Vesting Dates that would have otherwise applied had the Participant remained in continuous employment with the Company through the last Vesting Date applicable to this Award. The Participant (or the Participant's estate, beneficiary or legal representative) may exercise any vested Options held by the Participant as of the date of termination or that otherwise vest pursuant to this Section 4(b) until (i) in the case of the Participant's Retirement under circumstances not amounting to Cause, the earlier of (A) the 7-
Page 3
© 2023 Celanese Corporation

year anniversary of the date of such termination of employment or (B) the Expiration Date, or (ii) in the case of a termination by the Company in connection with a Qualifying Disposition, the Expiration Date. To the extent permitted by applicable country, state or province law, as consideration for the continued vesting provisions upon Retirement contained in this paragraph, upon Retirement, the Participant shall enter into a departure and general release of claims agreement with the Company that includes two-year noncompetition and non-solicitation covenants in a form acceptable to the Company. In the event of a termination of the Participant's employment by the Company in connection with a Qualifying Disposition as described in this Section, if the Company determines that the Participant has been offered employment with the acquiror or successor and in connection with that employment will receive a substitute award from the acquiror or successor with an equivalent (or greater) economic value and no less favorable vesting conditions as this Award, the Company, in its sole discretion, may determine not to provide for the continued vesting under this Section 4(b).
(c)Upon the termination of a Participant's employment with the Company for any reason other than as set forth in Section 4(a), 4(b) or 4(d), (i) the unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment, and (ii) the Participant may exercise the vested Options until the earlier of (A) 30 days following the date of such termination of employment and (B) the Expiration Date.
(d)Notwithstanding anything in this Section 4 to the contrary, upon the termination of a Participant's employment with the Company for Cause, the Options (whether vested and unvested) shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment. If at any time on or before a Vesting Date the Company determines, in its sole discretion, that the Participant engaged in an act constituting Cause, the Participant's employment shall be considered to have been terminated for Cause, and his or her Award shall be forfeited and cancelled without consideration pursuant to this Section 4(d), regardless of whether the Participant's termination initially was considered to have been without Cause. In each such case, the provisions of Sections 4(a), 4(b) and 4(c) are inapplicable.
5.Rights as a Stockholder: The Participant shall have no voting, dividend or other rights as a stockholder with respect to the Award until the Options have been exercised and Common Shares have been delivered pursuant to this Agreement.
6.Change in Control; Dissolution:
(a)Notwithstanding any other provision of this Agreement to the contrary, upon the occurrence of a Change in Control, with respect to any unvested Options granted pursuant to this Agreement that have not previously been forfeited:
(i)If (A) the Participant's rights to the unvested Options are not adversely affected in connection with the Change in Control, or, if adversely affected, a substitute award with an equivalent (or greater) economic value and no less favorable vesting conditions is granted to the Participant in connection with the occurrence of a Change in Control, and (B) the Participant's employment is terminated by the Company (or its successor) without Cause within two years following the Change in Control, then the unvested Options (or, as applicable, the substitute award) shall immediately vest and become exercisable, and shall remain exercisable for such period (not less than 12 months, or through the Expiration Date if earlier) as specified by the Committee and communicated to the Participant.
Page 4
© 2023 Celanese Corporation

(ii)If the Participant's rights to the unvested Options are adversely affected in connection with the Change in Control and a substitute award is not made pursuant to Section 6(a)(i) above, then immediately prior to the occurrence of such Change in Control, the unvested Options shall immediately vest and become exercisable, and shall remain exercisable for such period as specified by the Committee and communicated to the Participant.
(b)Notwithstanding any other provision of this Agreement to the contrary, in the event of a corporate dissolution of the Company that is taxed under Section 331 of the Internal Revenue Code of 1986, as amended, then in accordance with Treasury Regulation Section 1.409A-3(j)(4)(ix)(A), this Agreement shall terminate and any unvested Options granted pursuant to this Agreement shall immediately vest and be automatically exercised, as specified by the Committee and communicated to the Participant.
7.Income and Other Taxes: The Company shall not deliver Common Shares in respect of the exercise of Options unless and until the Participant has made arrangements satisfactory to the Company to satisfy applicable withholding tax obligations for US federal, state, and local income taxes (or the foreign counterpart thereof) and applicable employment taxes. Such obligations may be paid in any of the following forms or in a combination thereof: (i) cash or its equivalent, (ii) withholding of Common Shares to be issued as a result of the exercise of the Option, or (iii) any other method approved by the Committee. Withholding shall be effected using a rate or method chosen by the Company consistent with ASC Topic 718 (or any successor applicable equity accounting standard applicable to this Award) and the U.S. Internal Revenue Service withholding regulations or other applicable tax requirements, not to exceed maximum statutory rates. The Participant acknowledges that the Company shall have the right to deduct any taxes required to be withheld by law in connection with the delivery of Common Shares issued in respect of any exercised Options from any amounts payable by it to the Participant (including, without limitation, future cash wages). The Participant acknowledges and agrees that amounts withheld by the Company for taxes may be less than amounts actually owed for taxes by the Participant in respect of the Award.
8.Securities Laws: The Company may impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common Shares issued as a result of the exercise of the Options, including without limitation (a) restrictions under an insider trading policy, and (b) restrictions as to the use of a specified brokerage firm for such resales or other transfers. Upon the acquisition of any Common Shares pursuant to the exercise of the Options, the Participant will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement and the 2018 Plan. All accounts in which such Common Shares are held or any certificates for Common Shares shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or quotation system upon which the Common Shares are then listed or quoted, and any applicable federal or state securities law, and the Company may cause a legend or legends to be put on any such certificates (or other appropriate restrictions and/or notations to be associated with any accounts in which such Common Shares are held) to make appropriate reference to such restrictions.
9.Non-Transferability of Award: The Options may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company; provided, that the Participant may designate a beneficiary, on a form provided by the Company, to receive any portion of the Award payable hereunder following the Participant's death.
Page 5
© 2023 Celanese Corporation

10.Other Agreements: Subject to Sections 10(a) and 10(b) of this Agreement, this Agreement and the 2018 Plan constitute the entire understanding between the Participant and the Company regarding the Award, and any prior and/or contemporaneous agreements, understandings, representations, discussions, commitments or negotiations concerning the Award, whether written or oral, are superseded. No oral statements or other prior written material not specifically incorporated into this Agreement, other than the 2018 Plan, shall be of any force or effect.
(a)The Participant acknowledges that as a condition to the receipt of the Award, the Participant:
(i)shall have delivered to the Company an executed copy of this Agreement;
(ii)shall be subject to the Company's stock ownership guidelines, to the extent applicable to the Participant;
(iii)shall be subject to policies and agreements adopted by the Company from time to time, and applicable laws and regulations, requiring the repayment by the Participant of incentive compensation under certain circumstances, including that certain Celanese Corporation Incentive Compensation Recoupment Policy adopted by the Committee on October 16, 2019, as the same may be amended (collectively, "Clawback Policies"), without any further act or deed or consent of the Participant; and
(iv)shall have delivered to the Company an executed copy of the current form of Long-Term Incentive Claw-Back Agreement. For purposes hereof, "Long-Term Incentive Claw-Back Agreement" means an agreement between the Company and the Participant associated with the grant of long-term incentives of the Company, which contains terms, conditions, restrictions and provisions regarding one or more of (i) noncompetition by the Participant with the Company, and its customers and clients; (ii) non-solicitation and non-hiring by the Participant of the Company's employees, former employees or consultants; (iii) maintenance of confidentiality of the Company's and/or clients' information, including intellectual property; (iv) nondisparagement of the Company; and (v) such other matters deemed necessary, desirable or appropriate by the Company for such an agreement in view of the rights and benefits conveyed in connection with an award.
(b)The Participant acknowledges that if the Participant violates any of the terms or provisions of the Clawback Policies or the Long-Term Incentive Claw-Back Agreement, whether before or after termination of employment, then the Company will, to the fullest extent permitted by applicable law, (i) terminate the Participant's rights in any unvested Options under this Award, and (ii) claw back (i.e., recover) all Common Shares previously issued upon exercise of the Option granted under this Award.
(c)If the Participant is a non-resident of the U.S., there may be an addendum containing special terms and conditions applicable to awards in the Participant's country. The issuance of the Award to any such Participant is contingent upon the Participant executing and returning any such addendum in the manner directed by the Company.
11.Not a Contract for Employment; No Acquired Rights; Agreement Changes: Nothing in the 2018 Plan, this Agreement or any other instrument executed in connection with the Award shall confer upon the Participant any right to continue in the Company's employ or service nor limit in any way the Company's right to terminate the Participant's employment at any time for any reason. The grant of Options hereunder, and any future grant of awards to the Participant under the 2018 Plan, is
Page 6
© 2023 Celanese Corporation

entirely voluntary and at the complete and sole discretion of the Company. Neither the grant of these Options nor any future grant of awards by the Company shall be deemed to create any obligation to grant any further awards, whether or not such a reservation is expressly stated at the time of such grants. The Company has the right, at any time and for any reason, to amend, suspend or terminate the 2018 Plan; provided, however, that no such amendment, suspension, or termination shall adversely affect the Participant's rights hereunder.
12.Severability: In the event that any provision of this Agreement is declared to be illegal, invalid or otherwise unenforceable by a court of competent jurisdiction, such provision shall be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise deleted, and the remainder of this Agreement shall not be affected except to the extent necessary to reform or delete such illegal, invalid or unenforceable provision.
13.Further Assurances: Each party shall cooperate and take such action as may be reasonably requested by either party hereto in order to carry out the provisions and purposes of this Agreement.
14.Binding Effect: The Award and this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns.
15.Electronic Delivery: By executing this Agreement, the Participant hereby consents to the delivery of any and all information (including, without limitation, information required to be delivered to the Participant pursuant to applicable securities laws), in whole or in part, regarding the Company and its subsidiaries, the 2018 Plan, and the Award via electronic mail, the Company's or a plan administrator's web site, or other means of electronic delivery.
16.Personal Data: By accepting the Award under this Agreement, the Participant hereby consents to the Company's use, dissemination and disclosure of any information pertaining to the Participant that the Company determines to be necessary or desirable for the implementation, administration and management of the 2018 Plan.
17.Miscellaneous:
(a)Governing Law. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be governed by, construed under and interpreted in accordance with the laws of the State of Delaware, without regard to its conflicts of laws rules.
(b)Notice. The Participant is reminded to read the following carefully and after consulting with counsel of their choice:
The Participant agrees that the following provisions requiring arbitration, prohibiting recovery of attorneys' fees, waiving class actions and mass actions, waiving the right to a jury trial, waiving any right to seek punitive damages, limiting actual damages, and limiting remedies by waiving any right to injunctive or other equitable or legal relief are and were an important part of the Company's decision to adopt the Operative Documents and for Participant to be offered this Agreement. The Participant understands and agrees that absent the foregoing provisions, the Operative Documents would not have been offered or entered into or would have materially changed. The Participant acknowledges the benefits of receiving potential incentive awards. In reliance on the Participant's intent to abide by and enter into the following provisions, the parties have entered into the Operative Documents.
Page 7
© 2023 Celanese Corporation

(c)MANDATORY ARBITRATION. All disputes arising out of or related in any manner to the Operative Documents shall be resolved exclusively by arbitration to be conducted only in the county and state of Dallas, Texas in accordance with the rules of the International Institute for Conflict Prevention and Resolution Rules for Non-Administered Arbitration ("CPR") applying the laws of Delaware and by a sole arbitrator. Within 45 days of the service of any demand for arbitration, the parties shall attempt to mutually agree on the appointment of an arbitrator and may seek names of potential arbitrators from CPR for their consideration. Failing agreement on selection of an agreed arbitrator, upon written request of either party, CPR shall appoint a single arbitrator in accordance with its rules, with the parties expressing a contractual preference for the selection of a retired judge with at least 10 years of judicial experience. Discovery shall be as provided by the CPR rules. The arbitration award shall be in writing and shall include a reasoned opinion by the arbitrator. Consistent with the waiver of all claims to punitive or exemplary damages, the arbitrator shall have no authority to award such damages. The parties understand that their right to appeal or to seek modification of any ruling or award of the arbitrator is severely limited, if any. Awards issued by the arbitrator shall be final and binding, and judgment may be entered on it in any court of competent jurisdiction. All parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrator. Any and all disputes regarding this arbitration provision and its enforceability shall be exclusively submitted to the United States District Court for the District of Delaware, if it has jurisdiction, and failing that, to the Delaware state court in Wilmington, Delaware.
(d)NO RECOVERY OF ATTORNEYS' FEES AND COSTS. Each party agrees that in any litigation or proceeding between the parties arising out of, connected with, related to, or incidental to the relationship between them in connection with the Operative Documents, each party shall bear all of its own attorneys' fees and costs regardless of which party prevails, except when prohibited by applicable law.
(e)CLASS ACTION AND MASS ACTION WAIVER. As part of this provision of arbitration as the contracted method of all dispute resolution under this Agreement, any claim, whether brought in a court of law or in arbitration, must be brought in the Participant's individual capacity, and not as a representative of any purported class or as a "mass action" (involving multiple plaintiffs) ("Class/Mass Action"). The parties expressly waive any ability to maintain any Class/Mass Action in any forum. The arbitrator shall not have authority to combine or aggregate similar claims or conduct any Class/Mass Action nor make an award to any person or entity not a party to the arbitration. Any claim that all or part of this Class/Mass Action waiver is unenforceable, unconscionable, void, or voidable may be determined only by a court of competent jurisdiction and not by an arbitrator. The Participant understands that but for this Agreement, he or she would have had a right to litigate through a court, to have a judge or jury decide the case and to be party to a Class/Mass Action. However, in exchange for the potential incentive awards provided herein and the receipt of the benefit of arbitration, the Participant understands and chooses to have only his or her individual claims decided, each in a separate case, by an arbitrator.
(f)WAIVER OF JURY TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW AND EXPRESSLY BECAUSE OF THE COMPLEXITY OF THE MATTERS IN THE OPERATIVE DOCUMENTS, EACH PARTY WAIVES THE RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE ARISING OUT OF OR RELATING TO THE OPERATIVE DOCUMENTS.
(g)WAIVER OF PUNITIVE AND EXEMPLARY DAMAGE CLAIMS. The Participant waives, to the fullest extent allowed by law, any claims or rights to recover punitive, exemplary or similar damages.
Page 8
© 2023 Celanese Corporation

(h)LIMIT ON ACTUAL DAMAGES. In no event may the actual damages awarded to the Participant in a dispute arising out of or relating to the Operative Documents exceed the Fair Market Value, less the applicable Exercise Price, of the Common Shares subject to the Award, as set forth in Section 1, as of the applicable Vesting Date, reduced by the value of any Common Shares previously received under this Agreement (the "Damages Limit"). The Participant knowingly, voluntarily and irrevocably waives and releases any claim to damages in excess of this Damages Limit.
(i)LIMITATION OF REMEDIES. Except when prohibited by applicable law, the procedures and remedies set forth in this Agreement shall constitute the sole remedies available to the Participant. In no event shall the Participant seek equitable relief, injunctive relief, or otherwise bring claims directly or derivatively for ultra vires, corporate waste, breach of fiduciary duty, or any other claim or cause of action, whether legal or equitable, sounding in contract or tort. Nothing in this clause is intended to waive or limit any claim brought pursuant to any federal or state statute related to the protection of civil rights. Should any provision in this Agreement be found by a court of competent jurisdiction, after all appellate rights are exhausted, to be unenforceable or void, the parties expressly agree to sever such provision and to otherwise proceed to dispute resolution with the remaining provisions in the Mandatory Arbitration provisions.
18.Options Subject to Plan: By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the 2018 Plan and the 2018 Plan's prospectus. The Options and the Common Shares issued upon exercise of such Options are subject to the 2018 Plan, which is hereby incorporated by reference. In the event of any conflict between any term or provision of this Agreement and a term or provision of the 2018 Plan, the applicable terms and provisions of the 2018 Plan shall govern and prevail.
19.Validity of Agreement: This Agreement shall be valid, binding and effective upon the Company on the Grant Date. However, the Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within 90 days; otherwise the Company may, in its sole discretion, rescind the Award in its entirety.
20.Headings: The headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect.
21.Definitions: The following terms shall have the following meanings for purposes of this Agreement, notwithstanding any contrary definition in the 2018 Plan:
(a)"Cause" means, as determined by the Company in its sole discretion, (i) the Participant's willful failure to perform the Participant's duties to the Company (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days following written notice by the Company to the Participant of such failure, (ii) the Participant's conviction of, or a plea of nolo contendere to, (x) a felony under the laws of the United States or any state thereof or any similar criminal act in a jurisdiction outside the United States or (y) a crime involving moral turpitude, (iii) the Participant's willful malfeasance or willful misconduct which is demonstrably injurious to the Company or its affiliates, (iv) any act of fraud by the Participant, (v) any violation of the Company's business conduct policy, (vi) any violation of the Company's policies concerning harassment or discrimination by the Participant, (vii) the Participant's conduct that causes harm to the business reputation of the Company or its affiliates, or (viii) the Participant's breach of any confidentiality, intellectual property, noncompetition or non-solicitation provisions applicable to the Participant under the Long-Term Incentive Claw-
Page 9
© 2023 Celanese Corporation

Back Agreement or any other agreement between the Participant and the Company. "Cause" shall be determined by the Company in its sole discretion, and such determination shall be final, binding, and conclusive on the Participant.
(b)"Change in Control" means:
(i)Any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the then-outstanding shares of common stock of the Company (the "Outstanding Company Common Stock") or (B) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the "Outstanding Company Voting Securities"); provided, however, that, for purposes of this subparagraph, the following acquisitions shall not constitute a Change in Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any affiliate, or (iv) any acquisition pursuant to a transaction that complies with clauses (A), (B) or (C) in paragraph (iii) of this definition; or
(ii)Individuals who, as of the effective date of this Agreement, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this Agreement whose election, or nomination for election by the Company's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii)Consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving the Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any of its subsidiaries (each, a "Business Combination"), in each case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the
Page 10
© 2023 Celanese Corporation

Business Combination, and (C) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
(iv)Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.
(c)"Disability" has the same meaning as "Disability" in the Celanese Corporation 2008 Deferred Compensation Plan or such other meaning as determined by the Committee in its sole discretion.
(d)"Operative Documents" means the 2018 Plan and this Agreement.
(e)"Qualifying Disposition" means a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, and determined by the Committee to be a Qualifying Disposition.
(f)"Retirement" of the Participant shall mean a voluntary separation from service on or after the date when the Participant is both 55 years of age and has ten years of service with the Company, as determined by the Company in its discretion based on payroll records. Retirement shall not include voluntary separation from service in which the Company could have terminated the Participant's employment for Cause.
Page 11
© 2023 Celanese Corporation

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer.

CELANESE CORPORATION
By:
Lori J. Ryerkerk
Chair, Chief Executive Officer and President
Page 12
© 2023 Celanese Corporation
 EX-10.7 5 ex1073312310q.htm EX-10.7 Document

Exhibit 10.7
[Form of 2023 Time-Based CEO Stock Option Award]





celogo1.jpg








CELANESE CORPORATION
2018 GLOBAL INCENTIVE PLAN

NONQUALIFIED STOCK OPTION AWARD AGREEMENT
DATED [Grant Date]



Pursuant to the terms and conditions of the Celanese Corporation 2018 Global Incentive Plan, you have been awarded Nonqualified Stock Options, subject to the restrictions described in this Agreement. In addition to the information included in this Agreement, the Participant's name and the number of Options can be found in the Grant Summary located in the electronic stock plan award administration system maintained by the Company or its designee that contains a link to this Agreement (which summary information is set forth in the appropriate records of the Company authorizing such award).


Stock Option Award

[Number of Common Shares Subject to Options] Shares



This grant is made pursuant to the Nonqualified Stock Option Award Agreement dated as of [Grant Date], between Celanese and [Participant Name], which Agreement is attached hereto and made a part hereof.


CELANESE CORPORATION

2018 GLOBAL INCENTIVE PLAN

NONQUALIFIED STOCK OPTION AWARD AGREEMENT
This Nonqualified Stock Option Award Agreement (the "Agreement") is made and entered into as of [Grant Date] (the "Grant Date") by and between Celanese Corporation, a Delaware corporation (the "Company"), and [Participant Name] (the "Participant"). Capitalized terms used, but not otherwise defined herein shall have the meanings ascribed to such terms in the Celanese Corporation 2018 Global Incentive Plan (as amended from time to time, the "2018 Plan").
1.Grant of Options: In order to encourage the Participant's contribution to the successful performance of the Company, the Company hereby grants to the Participant as of the Grant Date, pursuant to the terms of the 2018 Plan and this Agreement, an award (the "Award") of Nonqualified Stock Options (the "Options") to purchase all or any part of the number of Common Shares that are covered by such Options at the Exercise Price per share, in each case as specified below. The Participant hereby acknowledges and accepts such Award upon the terms and subject to the conditions, restrictions and limitations contained in this Agreement and the 2018 Plan.

Number of Common Shares Subject to Options:


[Number of Shares]



Exercise Price Per Share (the "Exercise Price"):


[Exercise Price]



Expiration Date:


[Expiration Date (Put 1 day before 10-year anniversary from Grant Date)]


Vesting Schedule:


Subject to Sections 4 and 6 of this Agreement, [33% of the Number of Shares] Options shall vest on [Vest Date 1], [33% of the Number of Shares] Options shall vest on [Vest Date 2] and [34% of the Number of Shares] Options shall vest on [Vest Date 3] (each date on which a portion of the Options vest and become exercisable, a "Vesting Date", and each period between the Grant Date and a Vesting Date, a "Vesting Period").

2.Non-Qualified Stock Option: The Options are not intended to qualify Incentive Stock Options and this Agreement will be interpreted accordingly.
3.Exercise of Options:
(a)The Options shall not be exercisable as of the Grant Date. After the Grant Date, to the extent not previously exercised, and subject to termination or acceleration as provided in this Agreement or in the 2018 Plan, the Options shall be exercisable to the extent the Options become vested, as described in this Agreement, to purchase up to that number of Common Shares as set forth in Section 1 above, subject to the Participant's continued service with the Company (except as set forth in Section 4 or 6 below). The Vesting Period and/or exercisability of the Options may be adjusted by the Committee to reflect the decreased level of service during any
Page 2
© 2023 Celanese Corporation

period in which the Participant is on an approved leave of absence or is employed on a less than full-time basis.
(b)To exercise the Options (or any part thereof), the Participant shall notify the Company and its designated stock plan administrator or agent, as specified by the Company, and indicate the number of whole Common Shares the Participant wishes to purchase pursuant to such Options.
(c)The Exercise Price of the Options is set forth in Section 1. The Company shall not be obligated to issue any Common Shares until the Participant shall have paid the total Exercise Price for that number of Common Shares. The Exercise Price may be paid in any of the following forms or in a combination thereof: (i) cash or its equivalent, (ii) withholding of Common Shares to be issued as a result of such exercise, or (iii) any other method approved by the Committee.
(d)Common Shares will be issued as soon as practical following exercise of the Options. Notwithstanding the above, the Company shall not be obligated to deliver any Common Shares during any period in which the Company determines that the exercisability of the Options or the delivery of Common Shares pursuant to this Agreement would violate any federal, state or other applicable laws.
4.Effects of Certain Events:
(a)Upon the termination of the Participant's service by the Company without Cause or due to the Participant's death or Disability (other than as provided in Section 4(b)), a prorated portion of the unvested Options will vest, with such prorated amount equal to (i) the unvested Options in each Vesting Period, multiplied by (ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination without Cause or due to the Participant's death or Disability, and the denominator of which is the number of complete and partial calendar months in the applicable Vesting Period, such product to be rounded up to the nearest whole number (the "Pro-Rated Options"). The remaining unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service without Cause or due to the Participant's death or Disability. In the event of the Participant's termination without Cause, the Participant may exercise the vested portion of the Options until the earlier of (A) the 12-month anniversary of the date of such termination of service or (B) the Expiration Date. In the event of the Participant's death or Disability, the Participant (or the Participant's estate, beneficiary or legal representative) may exercise the vested portion of the Options until the earlier of (A) the 5-year anniversary of the date of such termination of service or (B) the Expiration Date.
(b)Except as otherwise provided in this Section 4(b), upon the termination of the Participant's service (i) due to the Participant's Retirement but under circumstances not amounting to Cause or (ii) by the Company in connection with a Qualifying Disposition, as determined by the Company in its sole discretion, other than for Cause (and regardless of whether the Participant is offered employment with the acquiror or successor), any unvested Options will remain outstanding and vest and become exercisable on the same Vesting Dates that would have otherwise applied had the Participant remained in continuous service with the Company through the last Vesting Date applicable to this Award. The Participant (or the Participant's estate, beneficiary or legal representative) may exercise any vested Options held by the Participant as of the date of termination or that otherwise vest pursuant to this Section 4(b) until (i) in the case of the Participant's Retirement under circumstances not amounting to Cause, the earlier of (A) the 7-year anniversary of the date of such termination of employment or (B) the Expiration Date, or (ii)
Page 3
© 2023 Celanese Corporation

in the case of a termination by the Company in connection with a Qualifying Disposition, the Expiration Date. To the extent permitted by applicable country, state or province law, as consideration for the continued vesting provisions upon Retirement contained in this paragraph, upon Retirement, the Participant shall enter into a departure and general release of claims agreement with the Company that includes a general release of claims, covenants relating to the provision of transition assistance and cooperation (including reasonable transition support to any successor CEO and cooperation in litigation related to the time period of Participant's service) and two-year noncompetition and non-solicitation covenants in a form acceptable to the Company. In the event of a termination of the Participant's service by the Company in connection with a Qualifying Disposition as described in this Section, if the Company determines that the Participant has been offered employment with the acquiror or successor and in connection with that employment will receive a substitute award from the acquiror or successor with an equivalent (or greater) economic value and no less favorable vesting conditions as this Award, the Company, in its sole discretion, may determine not to provide for the continued vesting under this Section 4(b).
(c)Upon the termination of a Participant's service with the Company for any reason other than as set forth in Section 4(a), 4(b) or 4(d), (i) the unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service, and (ii) the Participant may exercise the vested Options until the earlier of (A) 30 days following the date of such termination of service and (B) the Expiration Date.
(d)Notwithstanding anything in this Section 4 to the contrary, upon the termination of a Participant's service with the Company for Cause, the Options (whether vested and unvested) shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service. If at any time on or before a Vesting Date the Company determines, in its sole discretion, that the Participant engaged in an act constituting Cause, the Participant's service shall be considered to have been terminated for Cause, and his or her Award shall be forfeited and cancelled without consideration pursuant to this Section 4(d), regardless of whether the Participant's termination initially was considered to have been without Cause. In each such case, the provisions of Sections 4(a), 4(b) and 4(c) are inapplicable.
5.Rights as a Stockholder: The Participant shall have no voting, dividend or other rights as a stockholder with respect to the Award until the Options have been exercised and Common Shares have been delivered pursuant to this Agreement.
6.Change in Control; Dissolution:
(a)Notwithstanding any other provision of this Agreement to the contrary, upon the occurrence of a Change in Control, with respect to any unvested Options granted pursuant to this Agreement that have not previously been forfeited:
(i)If (A) the Participant's rights to the unvested Options are not adversely affected in connection with the Change in Control, or, if adversely affected, a substitute award with an equivalent (or greater) economic value and no less favorable vesting conditions is granted to the Participant in connection with the occurrence of a Change in Control, and (B) the Participant's service is terminated by the Company (or its successor) without Cause within two years following the Change in Control, then the unvested Options (or, as applicable, the substitute award) shall immediately vest and become exercisable, and shall remain exercisable for such period (not less than 12 months, or through the Expiration Date if earlier) as specified by the Committee and communicated to the Participant.
Page 4
© 2023 Celanese Corporation

(ii)If the Participant's rights to the unvested Options are adversely affected in connection with the Change in Control and a substitute award is not made pursuant to Section 6(a)(i) above, then immediately prior to the occurrence of such Change in Control, the unvested Options shall immediately vest and become exercisable, and shall remain exercisable for such period as specified by the Committee and communicated to the Participant.
(b)Notwithstanding any other provision of this Agreement to the contrary, in the event of a corporate dissolution of the Company that is taxed under Section 331 of the Internal Revenue Code of 1986, as amended, then in accordance with Treasury Regulation Section 1.409A-3(j)(4)(ix)(A), this Agreement shall terminate and any unvested Options granted pursuant to this Agreement shall immediately vest and be automatically exercised, as specified by the Committee and communicated to the Participant.
7.Income and Other Taxes: The Company shall not deliver Common Shares in respect of the exercise of Options unless and until the Participant has made arrangements satisfactory to the Company to satisfy applicable withholding tax obligations for U.S. federal, state, and local income taxes (or the foreign counterpart thereof) and applicable employment taxes. Such obligations may be paid in any of the following forms or in a combination thereof: (i) cash or its equivalent, (ii) withholding of Common Shares to be issued as a result of the exercise of the Option, or (iii) any other method approved by the Committee. Withholding shall be effected using a rate or method chosen by the Company consistent with ASC Topic 718 (or any successor applicable equity accounting standard applicable to this Award) and the U.S. Internal Revenue Service withholding regulations or other applicable tax requirements, not to exceed maximum statutory rates. The Participant acknowledges that the Company shall have the right to deduct any taxes required to be withheld by law in connection with the delivery of Common Shares issued in respect of any exercised Options from any amounts payable by it to the Participant (including, without limitation, future cash wages). The Participant acknowledges and agrees that amounts withheld by the Company for taxes may be less than amounts actually owed for taxes by the Participant in respect of the Award.
8.Securities Laws: The Company may impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common Shares issued as a result of the exercise of the Options, including without limitation (a) restrictions under an insider trading policy, and (b) restrictions as to the use of a specified brokerage firm for such resales or other transfers. Upon the acquisition of any Common Shares pursuant to the exercise of the Options, the Participant will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement and the 2018 Plan. All accounts in which such Common Shares are held or any certificates for Common Shares shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or quotation system upon which the Common Shares are then listed or quoted, and any applicable federal or state securities law, and the Company may cause a legend or legends to be put on any such certificates (or other appropriate restrictions and/or notations to be associated with any accounts in which such Common Shares are held) to make appropriate reference to such restrictions.
9.Non-Transferability of Award: The Options may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company; provided, that the Participant may designate a beneficiary, on a form provided by the Company, to receive any portion of the Award payable hereunder following the Participant's death.
Page 5
© 2023 Celanese Corporation

10.Other Agreements: Subject to Sections 10(a) and 10(b) of this Agreement, this Agreement and the 2018 Plan constitute the entire understanding between the Participant and the Company regarding the Award, and any prior and/or contemporaneous agreements, understandings, representations, discussions, commitments or negotiations concerning the Award, whether written or oral, are superseded. No oral statements or other prior written material not specifically incorporated into this Agreement, other than the 2018 Plan, shall be of any force or effect.
(a)The Participant acknowledges that as a condition to the receipt of the Award, the Participant:
(i)shall have delivered to the Company an executed copy of this Agreement;
(ii)shall be subject to the Company's stock ownership guidelines, to the extent applicable to the Participant;
(iii)shall be subject to policies and agreements adopted by the Company from time to time, and applicable laws and regulations, requiring the repayment by the Participant of incentive compensation under certain circumstances, including that certain Celanese Corporation Incentive Compensation Recoupment Policy adopted by the Committee on October 16, 2019, as the same may be amended (collectively, "Clawback Policies"), without any further act or deed or consent of the Participant; and
(iv)shall have delivered to the Company an executed copy of the current form of Long-Term Incentive Claw-Back Agreement. For purposes hereof, "Long-Term Incentive Claw-Back Agreement" means an agreement between the Company and the Participant associated with the grant of long-term incentives of the Company, which contains terms, conditions, restrictions and provisions regarding one or more of (i) noncompetition by the Participant with the Company, and its customers and clients; (ii) non-solicitation and non-hiring by the Participant of the Company's employees, former employees or consultants; (iii) maintenance of confidentiality of the Company's and/or clients' information, including intellectual property; (iv) nondisparagement of the Company; and (v) such other matters deemed necessary, desirable or appropriate by the Company for such an agreement in view of the rights and benefits conveyed in connection with an award.
(b)The Participant acknowledges that if the Participant violates any of the terms or provisions of the Clawback Policies or the Long-Term Incentive Claw-Back Agreement, whether before or after termination of employment, then the Company will, to the fullest extent permitted by applicable law, (i) terminate the Participant's rights in any unvested Options under this Award, and (ii) claw back (i.e., recover) all Common Shares previously issued upon exercise of the Option granted under this Award.
(c)If the Participant is a non-resident of the U.S., there may be an addendum containing special terms and conditions applicable to awards in the Participant's country. The issuance of the Award to any such Participant is contingent upon the Participant executing and returning any such addendum in the manner directed by the Company.
11.Not a Contract for Employment; No Acquired Rights; Agreement Changes: Nothing in the 2018 Plan, this Agreement or any other instrument executed in connection with the Award shall confer upon the Participant any right to continue in the Company's employ or service nor limit in any way the Company's right to terminate the Participant's employment or service at any time for any reason. The grant of Options hereunder, and any future grant of awards to the Participant under the 2018
Page 6
© 2023 Celanese Corporation

Plan, is entirely voluntary and at the complete and sole discretion of the Company. Neither the grant of these Options nor any future grant of awards by the Company shall be deemed to create any obligation to grant any further awards, whether or not such a reservation is expressly stated at the time of such grants. The Company has the right, at any time and for any reason, to amend, suspend or terminate the 2018 Plan; provided, however, that no such amendment, suspension, or termination shall adversely affect the Participant's rights hereunder.
12.Severability: In the event that any provision of this Agreement is declared to be illegal, invalid or otherwise unenforceable by a court of competent jurisdiction, such provision shall be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise deleted, and the remainder of this Agreement shall not be affected except to the extent necessary to reform or delete such illegal, invalid or unenforceable provision.
13.Further Assurances: Each party shall cooperate and take such action as may be reasonably requested by either party hereto in order to carry out the provisions and purposes of this Agreement.
14.Binding Effect: The Award and this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns.
15.Electronic Delivery: By executing this Agreement, the Participant hereby consents to the delivery of any and all information (including, without limitation, information required to be delivered to the Participant pursuant to applicable securities laws), in whole or in part, regarding the Company and its subsidiaries, the 2018 Plan, and the Award via electronic mail, the Company's or a plan administrator's web site, or other means of electronic delivery.
16.Personal Data: By accepting the Award under this Agreement, the Participant hereby consents to the Company's use, dissemination and disclosure of any information pertaining to the Participant that the Company determines to be necessary or desirable for the implementation, administration and management of the 2018 Plan.
17.Miscellaneous:
(a)Governing Law. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be governed by, construed under and interpreted in accordance with the laws of the State of Delaware, without regard to its conflicts of laws rules.
(b)Notice. The Participant is reminded to read the following carefully and after consulting with counsel of their choice:
The Participant agrees that the following provisions requiring arbitration, prohibiting recovery of attorneys' fees, waiving class actions and mass actions, waiving the right to a jury trial, waiving any right to seek punitive damages, limiting actual damages, and limiting remedies by waiving any right to injunctive or other equitable or legal relief are and were an important part of the Company's decision to adopt the Operative Documents and for Participant to be offered this Agreement. The Participant understands and agrees that absent the foregoing provisions, the Operative Documents would not have been offered or entered into or would have materially changed. The Participant acknowledges the benefits of receiving potential incentive awards. In reliance on the Participant's intent to abide by and enter into the following provisions, the parties have entered into the Operative Documents.
Page 7
© 2023 Celanese Corporation

(c)MANDATORY ARBITRATION. All disputes arising out of or related in any manner to the Operative Documents shall be resolved exclusively by arbitration to be conducted only in the county and state of Dallas, Texas in accordance with the rules of the International Institute for Conflict Prevention and Resolution Rules for Non-Administered Arbitration ("CPR") applying the laws of Delaware and by a sole arbitrator. Within 45 days of the service of any demand for arbitration, the parties shall attempt to mutually agree on the appointment of an arbitrator and may seek names of potential arbitrators from CPR for their consideration. Failing agreement on selection of an agreed arbitrator, upon written request of either party, CPR shall appoint a single arbitrator in accordance with its rules, with the parties expressing a contractual preference for the selection of a retired judge with at least 10 years of judicial experience. Discovery shall be as provided by the CPR rules. The arbitration award shall be in writing and shall include a reasoned opinion by the arbitrator. Consistent with the waiver of all claims to punitive or exemplary damages, the arbitrator shall have no authority to award such damages. The parties understand that their right to appeal or to seek modification of any ruling or award of the arbitrator is severely limited, if any. Awards issued by the arbitrator shall be final and binding, and judgment may be entered on it in any court of competent jurisdiction. All parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrator. Any and all disputes regarding this arbitration provision and its enforceability shall be exclusively submitted to the United States District Court for the District of Delaware, if it has jurisdiction, and failing that, to the Delaware state court in Wilmington, Delaware.
(d)NO RECOVERY OF ATTORNEYS' FEES AND COSTS. Each party agrees that in any litigation or proceeding between the parties arising out of, connected with, related to, or incidental to the relationship between them in connection with the Operative Documents, each party shall bear all of its own attorneys' fees and costs regardless of which party prevails, except when prohibited by applicable law.
(e)CLASS ACTION AND MASS ACTION WAIVER. As part of this provision of arbitration as the contracted method of all dispute resolution under this Agreement, any claim, whether brought in a court of law or in arbitration, must be brought in the Participant's individual capacity, and not as a representative of any purported class or as a "mass action" (involving multiple plaintiffs) ("Class/Mass Action"). The parties expressly waive any ability to maintain any Class/Mass Action in any forum. The arbitrator shall not have authority to combine or aggregate similar claims or conduct any Class/Mass Action nor make an award to any person or entity not a party to the arbitration. Any claim that all or part of this Class/Mass Action waiver is unenforceable, unconscionable, void, or voidable may be determined only by a court of competent jurisdiction and not by an arbitrator. The Participant understands that but for this Agreement, he or she would have had a right to litigate through a court, to have a judge or jury decide the case and to be party to a Class/Mass Action. However, in exchange for the potential incentive awards provided herein and the receipt of the benefit of arbitration, the Participant understands and chooses to have only his or her individual claims decided, each in a separate case, by an arbitrator.
(f)WAIVER OF JURY TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW AND EXPRESSLY BECAUSE OF THE COMPLEXITY OF THE MATTERS IN THE OPERATIVE DOCUMENTS, EACH PARTY WAIVES THE RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE ARISING OUT OF OR RELATING TO THE OPERATIVE DOCUMENTS.
(g)WAIVER OF PUNITIVE AND EXEMPLARY DAMAGE CLAIMS. The Participant waives, to the fullest extent allowed by law, any claims or rights to recover punitive, exemplary or similar damages.
Page 8
© 2023 Celanese Corporation

(h)LIMIT ON ACTUAL DAMAGES. In no event may the actual damages awarded to the Participant in a dispute arising out of or relating to the Operative Documents exceed the Fair Market Value, less the applicable Exercise Price, of the Common Shares subject to the Award, as set forth in Section 1, as of the applicable Vesting Date, reduced by the value of any Common Shares previously received under this Agreement (the "Damages Limit"). The Participant knowingly, voluntarily and irrevocably waives and releases any claim to damages in excess of this Damages Limit.
(i)LIMITATION OF REMEDIES. Except when prohibited by applicable law, the procedures and remedies set forth in this Agreement shall constitute the sole remedies available to the Participant. In no event shall the Participant seek equitable relief, injunctive relief, or otherwise bring claims directly or derivatively for ultra vires, corporate waste, breach of fiduciary duty, or any other claim or cause of action, whether legal or equitable, sounding in contract or tort. Nothing in this clause is intended to waive or limit any claim brought pursuant to any federal or state statute related to the protection of civil rights. Should any provision in this Agreement be found by a court of competent jurisdiction, after all appellate rights are exhausted, to be unenforceable or void, the parties expressly agree to sever such provision and to otherwise proceed to dispute resolution with the remaining provisions in the Mandatory Arbitration provisions.
18.Options Subject to Plan: By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the 2018 Plan and the 2018 Plan's prospectus. The Options and the Common Shares issued upon exercise of such Options are subject to the 2018 Plan, which is hereby incorporated by reference. In the event of any conflict between any term or provision of this Agreement and a term or provision of the 2018 Plan, the applicable terms and provisions of the 2018 Plan shall govern and prevail.
19.Validity of Agreement: This Agreement shall be valid, binding and effective upon the Company on the Grant Date. However, the Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within 90 days; otherwise the Company may, in its sole discretion, rescind the Award in its entirety.
20.Headings: The headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect.
21.Definitions: The following terms shall have the following meanings for purposes of this Agreement, notwithstanding any contrary definition in the 2018 Plan:
(a)"Cause" means, as determined by the Company in its sole discretion, (i) the Participant's willful failure to perform the Participant's duties to the Company (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days following written notice by the Company to the Participant of such failure, (ii) the Participant's conviction of, or a plea of nolo contendere to, (x) a felony under the laws of the United States or any state thereof or any similar criminal act in a jurisdiction outside the United States or (y) a crime involving moral turpitude, (iii) the Participant's willful malfeasance or willful misconduct which is demonstrably injurious to the Company or its affiliates, (iv) any act of fraud by the Participant, (v) any violation of the Company's business conduct policy, (vi) any violation of the Company's policies concerning harassment or discrimination by the Participant, (vii) the Participant's conduct that causes harm to the business reputation of the Company or its affiliates, or (viii) the Participant's breach of any confidentiality, intellectual property, noncompetition or non-solicitation provisions applicable to the Participant under the Long-Term Incentive Claw-
Page 9
© 2023 Celanese Corporation

Back Agreement or any other agreement between the Participant and the Company. "Cause" shall be determined by the Company in its sole discretion, and such determination shall be final, binding, and conclusive on the Participant.
(b)"Change in Control" means:
(i)Any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the then-outstanding shares of common stock of the Company (the "Outstanding Company Common Stock") or (B) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the "Outstanding Company Voting Securities"); provided, however, that, for purposes of this subparagraph, the following acquisitions shall not constitute a Change in Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any affiliate, or (iv) any acquisition pursuant to a transaction that complies with clauses (A), (B) or (C) in paragraph (iii) of this definition; or
(ii)Individuals who, as of the effective date of this Agreement, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this Agreement whose election, or nomination for election by the Company's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii)Consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving the Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any of its subsidiaries (each, a "Business Combination"), in each case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the
Page 10
© 2023 Celanese Corporation

Business Combination, and (C) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
(iv)Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.
(c)"Disability" has the same meaning as "Disability" in the Celanese Corporation 2008 Deferred Compensation Plan or such other meaning as determined by the Committee in its sole discretion.
(d)"Operative Documents" means the 2018 Plan and this Agreement.
(e)"Qualifying Disposition" means a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, and determined by the Committee to be a Qualifying Disposition.
(f)"Retirement" of the Participant shall mean a voluntary separation from service on or after the earlier of (i) the date when the Participant is both 55 years of age and has ten years of service with the Company, as determined by the Company in its discretion based on payroll records, or (ii) the date when the Participant is age 62 or greater; provided, however, that in the case of clause (ii), unless waived by the Board, (1) the Participant shall have provided at least 12 months' advance notice to the Board of such planned retirement from the Chief Executive Officer position and (2) the Board shall have designated a successor Chief Executive Officer. Retirement shall not include voluntary separation from service in which the Company could have terminated the Participant's employment for Cause.
(g)"Service" shall mean continued service as the Executive Chairman of the Board of Directors (but not service as another non-employee director that is not Executive Chairman), employee, contractor or consultant.
Page 11
© 2023 Celanese Corporation

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer.

CELANESE CORPORATION
By:
Vanessa Dupuis
Senior Vice President and Chief Human Resources Officer
Page 12
© 2023 Celanese Corporation
 EX-31.1 6 ex31103312310-q.htm EX-31.1 Document

Exhibit 31.1
 
CERTIFICATION
PURSUANT TO 17 CFR 240.13a-14
PROMULGATED UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 

I, Lori J. Ryerkerk, certify that:
 
1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
 /s/ LORI J. RYERKERK
Lori J. Ryerkerk
Chair of the Board of Directors,
Chief Executive Officer and President
May 10, 2023

 EX-31.2 7 ex31203312310-q.htm EX-31.2 Document

Exhibit 31.2
 
CERTIFICATION
PURSUANT TO 17 CFR 240.13a-14
PROMULGATED UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 

I, Scott A. Richardson, certify that:
 
1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 /s/ SCOTT A. RICHARDSON
Scott A. Richardson
Executive Vice President and
Chief Financial Officer
May 10, 2023

 EX-32.1 8 ex32103312310-q.htm EX-32.1 Document

Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 
In connection with the Quarterly Report of Celanese Corporation (the "Company") on Form 10-Q for the period ending March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Lori J. Ryerkerk, Chairman of the Board of Directors, Chief Executive Officer and President of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 /s/ LORI J. RYERKERK
Lori J. Ryerkerk
Chair of the Board of Directors,
Chief Executive Officer and President
May 10, 2023









 EX-32.2 9 ex32203312310-q.htm EX-32.2 Document

Exhibit 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 
In connection with the Quarterly Report of Celanese Corporation (the "Company") on Form 10-Q for the period ending March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Scott A. Richardson, Executive Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 /s/ SCOTT A. RICHARDSON
Scott A. Richardson
Executive Vice President and
Chief Financial Officer
May 10, 2023





 EX-101.SCH 10 ce-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Unaudited Interim Consolidated Statement of Operations link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Unaudited Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Unaudited Interim Consolidated Statement Equity link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Unaudited Interim Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Description of the Company and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Acquisitions, Dispositions and Plant Closures link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Goodwill and Intangible Assets, net link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Current Other Liabilities link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Benefit Obligations link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Environmental link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Other (Charges) Gains, Net link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Recent Accounting Pronouncements (Policies) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures (Tables) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Goodwill and Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Current Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Benefit Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Environmental (Tables) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Other (Charges) Gains, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Description of the Company and Basis of Presentation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Current Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Debt - Schedule of Short-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Debt - Schedule of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Debt - Senior Credit Facilities Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Debt - Schedule of Revolving Credit Facility (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Debt - Senior Notes Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Debt - Accounts Receivable Securitization Facility Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Debt - Factoring and Discounting Agreements Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - Environmental (Schedule of Environmental Remediation Reserves) (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - Environmental - US Superfund Sites Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - Stockholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - Stockholders' Equity - Schedule of Treasury Stock (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - Other (Charges) Gains, Net - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - Income Taxes - Schedule of Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - Derivative Financial Instruments (Schedule of Interest Rate Swap Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 0000076 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 0000077 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 0000078 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 0000079 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000080 - Disclosure - Segment Information - Schedule of Business Segments (Details) link:presentationLink link:calculationLink link:definitionLink 0000081 - Disclosure - Revenue Recognition - Disaggregation of net sales (Details) link:presentationLink link:calculationLink link:definitionLink 0000082 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000082 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000083 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000084 - Disclosure - Earnings (Loss) Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 ce-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 ce-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 ce-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two Business Acquisition [Axis] Business Acquisition [Axis] Short-term borrowings, including amounts due to affiliates(1) Other Short-Term Borrowings Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Net earnings (loss) Net earnings (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Deferred income taxes Deferred Income Tax Assets, Net Entity Address, Postal Zip Code Entity Address, Postal Zip Code Indemnification ceiling amount Indemnification ceiling amount Ceiling amount above which the Company will indemnify Hoechst for. Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Debt Instrument [Axis] Debt Instrument [Axis] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Total debt Finance Lease, Liability Common stock dividends Payments of Ordinary Dividends, Common Stock Maximum borrowing base Line of Credit Facility, Maximum Borrowing Capacity Current installments of long-term debt Long-Term Debt and Lease Obligation, Current Long-Term Debt and Lease Obligation, Current Schedule of Defined Benefit Plans Disclosures Schedule of Defined Benefit Plans Disclosures [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization Amount of pro forma interest expense and debt issuance cost amortization related to borrowings under the Term Loan Facility and the issuance of Acquisition notes as if the business combination had been completed at the beginning of a period. Capital expenditures Property, Plant and Equipment, Additions Beginning balance Ending balance Restructuring Reserve Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Additional paid-in capital Additional Paid in Capital Gross amount not offset in the consolidated balance sheets Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash, Offset Against Derivative Asset Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Other, net Payments for (Proceeds from) Other Investing Activities Statistical Measurement [Domain] Statistical Measurement [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Stock awards (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Senior Unsecured Notes Due 2024 Senior Unsecured Notes Due 2024 [Member] USD Senior Unsecured Notes Due May 8, 2024 Schedule of Changes in Fair Value of Derivatives Derivative Instruments, Gain (Loss) [Table Text Block] Distributions to noncontrolling interests Proceeds from (Payments to) Noncontrolling Interests Current Other assets Current Other assets Other Current Assets [Member] Total expected contributions in current fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year Total Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Derivative liability, statement of financial position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Acquisitions, Dispositions and Plant Closures [Abstract] Acquisitions, Dispositions and Plant Closures [Abstract] Acquisitions, Dispositions and Plant Closures [Abstract]. Foreign currency forwards and swaps Foreign Currency Contracts, Liability, Fair Value Disclosure Purchases of treasury stock, including related fees Shares repurchased (in $ millions) Treasury Stock, Value, Acquired, Cost Method Net earnings (loss) attributable to Celanese Corporation Net earnings (loss) Net earnings (loss) attributable to Celanese Corporation Net Income (Loss) Attributable to Parent Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Covenants Not to Compete and Other Other Intangible Assets [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Operating cash provided by (used in) discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Secured Debt Secured Debt [Member] Debt instrument, redemption price, percentage Debt Instrument, Redemption Price, Percentage Variable Interbank Interest Rate Variable Interbank Interest Rate [Member] Certain interbank rates at current Company credit ratings Total assets Assets, Fair Value Disclosure Ownership [Axis] Ownership [Axis] Investment, Name [Domain] Investment, Name [Domain] Issuance cost of bridge facility Payments of Financing Costs Derivative liability, statement of financial position [Extensible Enumeration] Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Cash flows between transferor and transferee, proceeds from new transfers Trade Receivables Pledged As Collateral The amount of trade receivables pledged as collateral. Subtotal Long-Term Debt and Lease Obligation, Including Current Maturities Hedging Designation [Domain] Hedging Designation [Domain] Insurance contracts in nonqualified trusts, fair value Cash Surrender Value, Fair Value Disclosure China Revolving Credit Facility China Revolving Credit Facility [Member] Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount. Continuing operations - diluted (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Instrument [Axis] Gross amount not offset in the consolidated balance sheets Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Offset Schedule of Environmental Remediation Reserves Environmental Exit Costs by Cost [Table Text Block] Goodwill [Line Items] Goodwill [Line Items] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Schedule of Notional Amounts of Derivative and Nonderivative Instruments Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Weighted average interest rate, short-term borrowings Short-Term Debt, Weighted Average Interest Rate, at Point in Time Schedule of Current Other Liabilities Other Current Liabilities [Table Text Block] Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign Currency Denominated Debt [Member] Foreign Currency Denominated Debt [Member] Foreign Currency Denominated Debt [Member] Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates Debt, Current [Abstract] Benefit payments to nonqualified pension plans Other Pension Plan [Member] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Pension and postretirement benefits gain (loss), gross amount Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Operating leases Operating Lease, Liability, Current Net amount Derivative Asset Derivative Asset Gain (Loss) Recognized in Earnings (Loss) Amount of Ineffectiveness on Net Investment Hedges Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Proceeds collected on accounts receivable sold under factoring facilities Proceeds Collected on Accounts Receivable Sold under Factoring Facilities Proceeds Collected on Accounts Receivable Sold under Factoring Facilities Environmental Remediation Site [Axis] Environmental Remediation Site [Axis] Long-term debt, net of unamortized deferred financing costs Long-Term Debt, Excluding Current Maturities Revenue Recognition and Deferred Revenue [Abstract] Revenue Recognition and Deferred Revenue [Abstract] Proceeds from sale of businesses and assets, net Proceeds from Sale of Productive Assets Geographical [Axis] Geographical [Axis] Acquisitions (Note 3) Goodwill, Purchase Accounting Adjustments Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired Position [Axis] Position [Axis] Mitsubishi Gas Chemical Company Mitsubishi Gas Chemical Company [Member] Mitsubishi Gas Chemical Company Engineered Materials Engineered Materials [Member] Engineered Materials Derivatives (Note 12) Derivative Liability, Current Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Legal (Note 14) Loss Contingency, Accrual, Current Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Restructuring Type [Axis] Restructuring Type [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] China Working Capital Term Loan China Working Capital Term Loan [Member] CSIT senior unsecured working capital loan contract for CNY 800 million payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. Segments [Axis] Segments [Axis] Debt Debt Disclosure [Text Block] Entity Shell Company Entity Shell Company Deferred income taxes, net Deferred Income Tax Expense (Benefit) Noncurrent Other assets Assets for Plan Benefits, Defined Benefit Plan Offsetting Liabilities Offsetting Liabilities [Table Text Block] Developed Technology Developed Technology Rights [Member] Gain (Loss) Recognized in Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Consolidation Items [Domain] Consolidation Items [Domain] Subsequent Event Subsequent Event [Member] Number of parties included in USEPA order Number of Parties included in USEPA order Number of Parties included in USEPA order. Document Period End Date Document Period End Date Acquisition Notes Due March 2025 USD Senior Unsecured Notes Due 2025 [Member] USD 1.75 Billion 6.050% Senior Unsecured Notes Due 2025 Schedule of Other (Charges) Gains, Net Schedule of Other (Charges) Gains, Net [Table Text Block] Schedule of Other (Charges) Gains, Net [Table Text Block]. Number of divestiture agreements Number of divestiture agreements Number of divestiture agreements. Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Total assets Total assets Assets Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Sales and use tax/foreign withholding tax payable Sales and Excise Tax Payable, Current Total contributions year-to-date Defined Benefit Plan, Plan Assets, Contributions by Employer Antidilutive Securities [Axis] Antidilutive Securities [Axis] Interest Rate Swap [Member] Interest Rate Swap [Member] Balance as of the beginning of the period (in shares) Balance as of the end of the period (in shares) Shares, Issued Benefit obligations Liability, Defined Benefit Plan Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Site Contingency [Line Items] Site Contingency [Line Items] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Long-term debt, including current installments of long-term debt, fair value Long-Term Debt, Fair Value Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Salaries and benefits Employee-related Liabilities, Current Earnings (loss) from continuing operations before tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Demerger obligations (Note 14) Demerger obligations Demerger obligations. Schedule of Goodwill [Table] Schedule of Goodwill [Table] Earnings (Loss) Per Share Earnings Per Share [Text Block] Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Other Noncurrent Liabilities [Member] Other Noncurrent Liabilities [Member] Interest cost Defined Benefit Plan, Interest Cost Schedule of Short-term Debt Schedule of Short-Term Debt [Table Text Block] Senior Notes [Abstract] Senior Notes [Abstract] Total comprehensive income (loss), net of tax Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Payments to acquire businesses, gross Payments to Acquire Businesses, Gross Schedule of Carrying Values and Fair Values of Financial Instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Derivative Contract [Domain] Derivative Contract [Domain] Net Investment Hedging [Member] Net Investment Hedging [Member] Gross profit Gross Profit Entity Registrant Name Entity Registrant Name Discontinued operations - basic (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Foreign Currency Translation Gain (Loss) Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Customer- Related Intangible Assets Customer Relationships [Member] Entity Address, City or Town Entity Address, City or Town Benefit Obligations Retirement Benefits [Text Block] Other (charges) gains, net Total Other (charges) gains, net (Note 14) Other Nonrecurring (Income) Expense Europe and Africa EMEA [Member] Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Stock awards Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Total equity Balance as of the beginning of the period Balance as of the end of the period Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Eliminations Intersegment Eliminations Intersegment Eliminations [Member] Minimum Minimum [Member] Noncontrolling interests Balance as of the beginning of the period, noncontrolling interest Balance as of the end of the period, noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Site Contingency [Table] Site Contingency [Table] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Emerging Growth Company Entity Emerging Growth Company 364 Day Delayed-Draw Term Loan 364 Day Delayed-Draw Term Loan [Member] 364 Day Delayed-Draw Term Loan Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Payments to equity method investment Payments to Equity Method Investment The cash outflow associated with payments to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. Unamortized debt issuance costs Debt Issuance Costs, Net Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Pension Benefits Cash contributions to defined benefit pension plans Pension Plan [Member] Investment, Name [Axis] Investment, Name [Axis] Fair Value Measurements Fair Value Disclosures [Text Block] Trading Symbol Trading Symbol Entity File Number Entity File Number Average purchase price (in dollar per share) Treasury Stock Acquired, Average Cost Per Share Equity method investment, increase Equity Method Investment, Increase Increase in an equity method investment, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. Active sites Active sites Active sites. Accumulated Other Comprehensive Income (Loss), net [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Interest (Note 7) Interest Payable, Current Research and development expenses Research and Development Expense Comprehensive (income) loss attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Entity Information [Line Items] Entity Information [Line Items] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Schedule of Balances Available for Borrowing Schedule of Line of Credit Facilities [Table Text Block] Environmental Remediation Site [Domain] Environmental Remediation Site [Domain] Estimates and Assumptions Use of Estimates, Policy [Policy Text Block] Trade payables - third party and affiliates Increase (Decrease) in Accounts Payable Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Gain (loss) on cash flow hedges Gain (loss) on cash flow hedges, net amount Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Number of equal annual investments restructuring payment Number of Payments to Equity Method Investments Number of Payments to Equity Method Investments Derivative Liabilities [Abstract] Derivative Liability [Abstract] Income Taxes Income Tax Disclosure [Text Block] Business Combination, Pro Forma Information, Inventory Step Up Amortization Business Combination, Pro Forma Information, Inventory Step Up Amortization Amount of pro forma inventory step-up amortization as if the business combination had been completed at the beginning of a period. Earnings (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Finished goods Inventory, Finished Goods, Net of Reserves Credit Facility [Domain] Credit Facility [Domain] Amortization of intangible assets Amortization Amortization of Intangible Assets Schedule of Goodwill Schedule of Goodwill [Table Text Block] Net earnings (loss) - basic (in dollars per share) Earnings Per Share, Basic Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Amounts reclassified from accumulated other comprehensive income (loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Amended restated receivable securitization facility Amended Restated Receivable Securitization Facility [Member] An accounts receivable securitization facility which allows a wholly owned, bankruptcy-remote subsidiary to sell an undivided interest in a pool of trade receivables (received through contribution from certain subsidiaries that retain the responsibility of servicing the receivables) to financial institutions participating in the facility. Corporate, Non-Segment Corporate, Non-Segment [Member] Pension and Postretirement Benefits Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Gain (loss) on cash flow hedges, gross amount Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax Treasury Stock Treasury Stock [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Total Celanese Corporation shareholders' equity Celanese Corporation stockholders' equity Stockholders' Equity Attributable to Parent Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Mobility & Materials Mobility & Materials [Member] Mobility & Materials Divestiture obligations (Note 14) Divestiture obligations Divestiture obligations. Common stock dividends Dividends, Common Stock Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Ownership [Domain] Ownership [Domain] Entity Interactive Data Current Entity Interactive Data Current Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] As of December 31, 2022 As of March 31, 2023 Finite-Lived Intangible Assets, Accumulated Amortization Transfer of financial assets accounted for as sales, amount derecognized Transfer of Financial Assets Accounted for as Sales, Amount Derecognized Benefit obligations (Note 8) Liability, Pension and Other Postretirement and Postemployment Benefits, Current Changes in operating assets and liabilities Increase (Decrease) in Operating Capital [Abstract] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Dividends, common stock, cash Dividends, Common Stock, Cash Common Stock Common Stock [Member] Purchases of treasury stock, including related fees Payments for Repurchase of Common Stock Class of Stock [Axis] Class of Stock [Axis] Statement [Table] Statement [Table] Document Quarterly Report Document Quarterly Report Current Assets Assets, Current [Abstract] Operating lease liabilities Operating Lease, Liability, Noncurrent Acetyl Chain Acetyl Chain [Member] Acetyl Chain [Member] Acetyl Chain [Member] Schedule of Treasury Stock Class of Treasury Stock [Table Text Block] Statistical Measurement [Axis] Statistical Measurement [Axis] Non-trade receivables, net Nontrade Receivables, Current Purchases of treasury stock (in shares) Shares repurchased (in shares) Treasury Stock, Shares, Acquired Total other comprehensive income (loss), before tax Other Comprehensive Income (Loss), before Tax As of December 31, 2022 As of March 31, 2023 Indefinite-Lived Intangible Assets (Excluding Goodwill) Exchange rate changes Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments Retained earnings Retained Earnings (Accumulated Deficit) Other, net Other Operating Activities, Cash Flow Statement Trade receivables - third party and affiliates Accounts Receivable, after Allowance for Credit Loss, Current Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Equity Components [Axis] Equity Components [Axis] Fair Value, Recurring Fair Value, Recurring [Member] Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Current Other Liabilities [Line Items] Current Other Liabilities [Line Items] Current Other Liabilities [Line Items] Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Undistributed earnings in unconsolidated affiliates Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Indefinite-lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Variable Rate [Domain] Variable Rate [Domain] Indemnification Agreements Hoechst Indemnification Agreements Hoechst [Member] Indemnification Agreements Hoechst [Member]. Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] As of December 31, 2022 As of March 31, 2023 Finite-Lived Intangible Assets, Gross Selling, general and administrative expenses Selling, General and Administrative Expense Recent Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Operating Lease, Right-of-Use Asset Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Income (Loss), Net AOCI Attributable to Parent [Member] Aggregate Board of Directors repurchase authorizations during the period (in $ millions) StockRepurchaseProgramAuthorizedAmountInPeriod Amount of stock repurchase plan authorized in the period. Divestiture Agreements Divestiture Agreements [Member] Divestiture Agreements [Member]. Type of Restructuring [Domain] Type of Restructuring [Domain] Document Transition Report Document Transition Report Local Phone Number Local Phone Number Operating profit (loss) Operating profit (loss) Operating Income (Loss) Inventories Increase (Decrease) in Inventories New Accounting Pronouncements, Policy New Accounting Pronouncements, Policy [Policy Text Block] Equity investments without readily determinable fair values, carrying amount Equity Securities without Readily Determinable Fair Value, Amount Position [Domain] Position [Domain] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Investments in affiliates Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Goodwill As of December 31, 2022 As of March 31, 2023(1) Goodwill Current Other liabilities Other Current Liabilities [Member] Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Exchange rate changes Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Income tax (provision) benefit from discontinued operations Discontinued Operation, Tax Effect of Discontinued Operation Treasury stock, shares (in shares) Treasury Stock, Shares Total liabilities Liabilities, Fair Value Disclosure Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Goodwill and Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Income tax (provision) benefit Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Deferred income taxes Deferred Income Tax Liabilities, Net Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Proceeds from short-term borrowings Proceeds from Short-Term Debt Income Statement [Abstract] Income Statement [Abstract] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Hedging Relationship [Axis] Hedging Relationship [Axis] Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage Transfer Of Financial Assets Accounted For As Sales, Non-recourse Basis, Account Receivable Percentage Transfer Of Financial Assets Accounted For As Sales, Non-recourse Basis, Account Receivable Percentage Additional Paid-In Capital Additional Paid-in Capital [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Licenses Licensing Agreements [Member] Document Fiscal Period Focus Document Fiscal Period Focus Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Non-operating pension and other postretirement employee benefit (expense) income Non-operating pension and other postretirement employee benefit (expense) income Non-operating pension and other postretirement employee benefit (expense) income Earnings (loss) per common share - basic Earnings Per Share, Basic [Abstract] Cost of sales Cost of Goods and Services Sold Derivative [Line Items] Derivative [Line Items] Weighted average shares - diluted (in shares) Weighted average shares - diluted Weighted Average Number of Shares Outstanding, Diluted Net amount Commodity swaps Derivative Liability Accumulated depreciation, depletion and amortization, property, plant, and equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Gross amount recognized Derivative Liability, Subject to Master Netting Arrangement, before Offset Loss Contingencies [Line Items] Loss Contingencies [Line Items] Europe and Singapore Factoring Agreement Europe and Singapore Factoring Agreements [Member] Europe and Singapore Factoring Agreements Other (Charges) Gains, Net Other (Charges) Gains, Net [Text Block] Other (Charges) Gains, Net [Text Block]. Term Loan Facility Term Loan Facility [Member] Term Loan Facility Common stock, $0.0001 par value, 400,000,000 shares authorized (2023: 170,448,231 issued and 108,786,738 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding) Common Stock, Value, Issued Senior Unsecured Term Loan Due 2025 Senior Unsecured Term Loan Due 2025 [Member] Senior unsecured term loan due 2025 Senior Unsecured Notes Due 2025 EUR Senior Unsecured Notes Due 2025 [Member] Senior Unsecured Notes Due 2025 [Member] Discontinued operations - diluted (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Indemnification percentage, other Indemnification percentage, other Percentage of other liabilities the Company has agreed to indemnify Hoechst for as part of the Demerger Agreement. Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Asia-Pacific Asia Pacific [Member] Short-term Debt [Line Items] Short-Term Debt [Line Items] Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year Current Other liabilities Liability, Defined Benefit Plan, Current Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Uncertain tax positions Liability for Uncertainty in Income Taxes, Noncurrent Operating Segments Operating Segments [Member] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized USD Senior Unsecured Notes Due 2032 USD Senior Unsecured Notes Due 2032 [Member] USD 1 Billion 6.379% Senior Unsecured Notes Due 2032 Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Cash and cash equivalents Cash and cash equivalents as of beginning of period Cash and cash equivalents as of end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign currency translation gain (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Loans Payable Loans Payable [Member] Net (earnings) loss attributable to noncontrolling interests Net earnings (loss) attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Dividends to noncontrolling interests Noncontrolling Interest, Decrease from Dividends to Noncontrolling Interest Holders Decrease in noncontrolling interest balance from payment of dividends by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders. Goodwill, impaired, accumulated impairment loss Goodwill, Impaired, Accumulated Impairment Loss Number of patents Number Of Patents Represents the number of patents. Current Liabilities Liabilities, Current [Abstract] Common stock, shares issued (in shares) Common Stock, Shares, Issued Passaic River, New Jersey Passaic River, New Jersey [Member] Passaic River, New Jersey [Member]. Gain (loss) on cash flow hedges, income tax (provision) benefit Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax Accounts Receivable Securitization Facility [Abstract] Accounts Receivable Securitization Facility [Abstract] Accounts Receivable Securitization Facility [Abstract] Foreign exchange gain (loss), net Foreign Currency Transaction Gain (Loss), before Tax Retirement Plan Type [Domain] Retirement Plan Type [Domain] Derivative Assets [Abstract] Derivative Asset [Abstract] Derivatives Designated as Cash Flow Hedges Cash Flow Hedging [Member] Exchange rate changes Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Debt instrument, face amount Debt Instrument, Face Amount Earnings (loss) from operation of discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax Indemnification amount Indemnification floor amount The amount that the Company will indemnify Hoechst for in full. Total other comprehensive income (loss), net of tax Other comprehensive income (loss), net of tax Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Other Activities Corporate and Other [Member] Comprehensive income (loss) attributable to Celanese Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Proforma Net sales Business Acquisition, Pro Forma Revenue Restructuring (Note 18) Restructuring Reserve, Current Schedule of Business Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Pension and postretirement benefits gain (loss), income tax (provision) benefit Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Other liabilities Total Other Liabilities, Current Refunding loan for pollution control and industrial revenue bonds Refunding loan for pollution control and industrial revenue bonds [Member] Refunding loan for pollution control and industrial revenue bonds [Member] Other assets Other Assets, Noncurrent Earnings (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Korea Engineering Plastics Co., Ltd. Korea Engineering Plastics Co., Ltd. [Member] Korea Engineering Plastics Co., Ltd. [Member]. Cash payments Payments for Restructuring Net change in short-term borrowings with maturities of 3 months or less Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less Depreciation and amortization Depreciation, Depletion and Amortization Exchange rate changes Goodwill, Translation and Purchase Accounting Adjustments Employee Severance Employee Severance [Member] Commodity swaps Commodity Contract [Member] Derivative [Table] Derivative [Table] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Net amount presented in the consolidated balance sheets Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral Current Other Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Goodwill and intangible assets, net Intangible Assets, Net (Including Goodwill) Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Customer rebates Accrued Marketing Costs, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Exchange rate effects on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property, plant and equipment (net of accumulated depreciation - 2023: $3,791; 2022: $3,687) Property, Plant and Equipment, Net Depreciation, amortization and accretion Depreciation, Amortization and Accretion, Net Entities [Table] Entities [Table] Repayments of long-term debt Repayments of Long-Term Debt Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Unrecorded Unconditional Purchase Obligation, to be Paid, Year One Unrecorded Unconditional Purchase Obligation, to be Paid, Year One Share-Based Payment Arrangement, Option Share-Based Payment Arrangement, Option [Member] Acquisition Notes Acquisition Notes [Member] Acquisition Notes Postemployment Benefits [Abstract] Treasury stock, at cost (2023: 61,661,493 shares; 2022: 61,661,493 shares) Treasury Stock, Value Pension and postretirement benefits Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Senior Unsecured Notes Due 2026 USD Senior Unsecured Notes Due 2026 [Member] USD Senior Unsecured Notes Due 2026 [Member] Net amount presented in the consolidated balance sheets Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral Consolidated Ventures Consolidated Ventures [Member] Consolidated Ventures Pension and postretirement contributions Payment for Pension and Other Postretirement Benefits Long-term debt, including current installments of long-term debt, carrying amount Long-Term Debt Other income (expense), net Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Gain (Loss) Recognized in Other Comprehensive Income (Loss) Gain (Loss) On Non-Derivatives and Derivatives Used In Net Investment Hedge Adjustment in other comprehensive income reflecting gains (losses) on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect. Income taxes payable Accrued Income Taxes, Current Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Maximum Maximum [Member] Accumulated other comprehensive income (loss), net As of December 31, 2022 As of March 31, 2023 Accumulated Other Comprehensive Income (Loss), Net of Tax Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Total current assets Assets, Current Designated as Hedging Instrument Designated as Hedging Instrument [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Small Reporting Company Entity Small Business Measurement Frequency [Domain] Measurement Frequency [Domain] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Amounts attributable to Celanese Corporation Income Amounts Attributable to Parent, Disclosures [Abstract] Common stock, dividends, declared (in dollar per share) Common Stock, Dividends, Per Share, Declared Schedule of Net Periodic Benefit Costs Recognized Schedule of Net Benefit Costs [Table Text Block] Net book value Finite-Lived Intangible Assets, Net Earnings (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Acquisition Notes Due July 2024 USD Senior Unsecured Notes Due 2024 [Member] USD 2 Billion 5.900% Senior Unsecured Notes Due 2024 Line of Credit Facility [Table] Line of Credit Facility [Table] Distributions to noncontrolling interests Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Other long-term debt Other Long-Term Debt U.S. Superfund sites US Superfund sites US Superfund sites. Title of 12(b) Security Title of 12(b) Security Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Senior unsecured debt Unsecured Debt Current Other Liabilities [Table] Current Other Liabilities [Table] Current Other Liabilities [Table] Senior Unsecured Term Loan Due 2027 Senior Unsecured Term Loan Due 2027 [Member] Senior Unsecured Term Loan Due 2027 Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend Debt Instrument [Line Items] Debt Instrument [Line Items] Class of Stock [Line Items] Class of Stock [Line Items] Segment Information Segment Reporting Disclosure [Text Block] Gain (Loss) Recognized in Earnings (Loss) Derivative, Gain (Loss) on Derivative, Net 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Unrecorded unconditional purchase obligations Unrecorded Unconditional Purchase Obligation LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Environmental liability percentage Environmental Liability Percentage Estimated ultimate allocable share of cleanup costs. Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Number of facilities Number Of Facilities Represents the number of facilities. Gain (loss) on disposition of businesses and assets, net Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Inventories Total Inventory, Net Trade payables - third party and affiliates Accounts Payable, Current Restructuring Restructuring Charges Additions Restructuring Charges South America South America [Member] Other environmental remediation liabilities Other environmental remediation reserves Other environmental remediation reserves. 5 Year Delayed-Draw Term Loan 5 Year Delayed-Draw Term Loan [Member] 5 Year Delayed-Draw Term Loan Other assets Increase (Decrease) in Other Operating Assets Entity number of employees Entity Number of Employees Total Accrual for Environmental Loss Contingencies Continuing operations - basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Hedging Relationship [Domain] Hedging Relationship [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract] Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract] Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract] Entity Filer Category Entity Filer Category Gross amount offset in the consolidated balance sheets Derivative Asset, Subject to Master Netting Arrangement, Liability Offset Shareholders' Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Weighted average shares - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Schedule of Company Commitments to Fund Benefit Obligations Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block] Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block]. Indemnification percentage exceeding ceiling amount Indemnification percentage exceeding ceiling amount The percentage of the amount above the ceiling that the Company will indemnify Hoechst for. Senior Unsecured Notes Due 2028 EUR Senior Unsecured Notes Due 2028 [Member] EUR Senior Unsecured Notes Due 2028 Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Commitments and Contingencies Commitments and Contingencies Security Exchange Name Security Exchange Name Environmental Remediation Obligations [Abstract] Environmental Remediation Obligations [Abstract] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Derivative, notional amount Derivative, Notional Amount Preferred stock, $0.01 par value, 100,000,000 shares authorized (2023 and 2022: 0 issued and outstanding) Preferred Stock, Value, Issued 3 Year Delayed-Draw Term Loan 3 Year Delayed-Draw Term Loan [Member] 3 Year Delayed-Draw Term Loan Investment in affiliates Equity Method Investment Liability, Current Equity Method Investment Liability, Current Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Net sales Revenue from Contract with Customer, Excluding Assessed Tax Service cost Defined Benefit Plan, Service Cost Proforma Earnings (loss) from continuing operations before tax Business Acquisition, Pro Forma Income (Loss) From Continuing Operations Before Income Taxes, Noncontrolling Interest Amount before tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period. Short-term borrowings and current installments of long-term debt - third party and affiliates Total Debt, Current Increase (decrease) in accrued capital expenditures Increase (Decrease) of Accrued Capital Expenditures Increase (Decrease) of Accrued Capital Expenditures. Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] USD Senior Unsecured Notes Due 2027 USD Senior Unsecured Notes Due 2027 [Member] USD 2 Billion 6.165% Senior Unsecured Notes Due 2027 Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Work-in-process Inventory, Work in Process, Net of Reserves Revenue Recognition Revenue from Contract with Customer [Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Noncontrolling Interests Noncontrolling Interest [Member] Total liabilities and equity Liabilities and Equity Debt instrument, term Debt Instrument, Term Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] EUR Senior Unsecured Notes Due 2029 EUR Senior Unsecured Notes Due 2029 [Member] EUR 500 Million 5.337% Senior Unsecured Notes Due 2029 [Member] Incremental shares attributable to equity awards(1) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Europe Factoring Agreements Europe Factoring Agreements [Member] Europe Factoring Agreements Trade receivables - third party and affiliates, net Increase (Decrease) in Receivables Earnings (loss) per common share - diluted Earnings Per Share, Diluted [Abstract] Dividend income - equity investments Investment Income, Dividend Senior Unsecured Notes Due 2023 EUR Senior Unsecured Notes Due 2023 [Member] Senior Unsecured Notes Due 2023 [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Singapore Factoring Agreements Singapore Factoring Agreements [Member] Singapore Factoring Agreements Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Net earnings (loss) - diluted (in dollars per share) Earnings Per Share, Diluted Pension and postretirement net periodic benefit cost Pension and Other Postretirement Benefits Cost (Reversal of Cost) Trademarks and Trade Names Trademarks and Trade Names [Member] (Gain) loss on disposition of businesses and assets, net Gain (Loss) on Disposition of Property Plant Equipment Noncontrolling interest, ownership percentage by parent Noncontrolling Interest, Ownership Percentage by Parent Stock-based compensation, net of tax APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation Items [Axis] Consolidation Items [Axis] Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four Total current liabilities Liabilities, Current Other assets Other Assets, Current Celanese Corporation Celanese Corporation [Member] Celanese Corporation Other Sundry Liabilities, Current Other Sundry Liabilities, Current Equity investments without readily determinable fair values, fair value Equity Securities, FV-NI and without Readily Determinable Fair Value Notes offering related costs Notes Offering Related Costs Fees and expenses related to the notes offering, inclusive of underwriting discounts. Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Cost of EPA's plan estimate environmental Loss exposure for environmental contingencies at an individual site for which no accrual has been recorded based upon EPA determination. Gross amount offset in the consolidated balance sheets Derivative Liability, Subject to Master Netting Arrangement, Asset Offset Other comprehensive income (loss) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Earnings (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Gross amount recognized Derivative Asset, Subject to Master Netting Arrangement, before Offset Entity Address, Address Line One Entity Address, Address Line One Total other comprehensive income (loss), tax Income tax (provision) benefit Other Comprehensive Income (Loss), Tax Other, net Proceeds from (Payments for) Other Financing Activities Acquisition Notes Due July 2029 USD Senior Unsecured Notes Due 2029 [Member] USD 750 Million 6.330% Senior Unsecured Notes Due 2029 Loans Payable Short-Term Debt [Member] Class of Stock [Domain] Class of Stock [Domain] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Gain (Loss) Recognized in Other Comprehensive Income (Loss) Gain (Loss) On Non-Derivative Used In Net Investment Hedge Adjustment in other comprehensive income reflecting gains or losses on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect. Available for borrowing Line of Credit Facility, Remaining Borrowing Capacity Benefit obligations Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Interest expense Interest Expense Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Credit Facility [Axis] Credit Facility [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Total Long-Term Debt and Lease Obligation Inventories Inventory Disclosure [Text Block] Schedule of Long-term Debt Schedule of Long-Term Debt Instruments [Table Text Block] Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Acquisitions, Dispositions and Plant Closures Acquisitions, Dispositions and Plant Closures [Text Block] Acquisitions, Dispositions and Plant Closures [Text Block]. Entity Tax Identification Number Entity Tax Identification Number Net amount recognized Defined Benefit Plan, Funded (Unfunded) Status of Plan Foreign currency forwards and swaps Foreign Currency Contract, Asset, Fair Value Disclosure Noncurrent Other assets Other Noncurrent Assets [Member] Schedule of Short-term Debt [Table] Schedule of Short-Term Debt [Table] Recent Accounting Pronouncements [Abstract] Recent Accounting Pronouncements [Abstract] Recent Accounting Pronouncements [Abstract] Percentage of fair value of sales receivables Percentage of Fair Value of Sales Receivables Percentage of fair value of sales receivables. Schedule of Revenue by Major Customers by Reporting Segments Disaggregation of Revenue [Table Text Block] Environmental Environmental Loss Contingency Disclosure [Text Block] Guarantor obligations, maximum exposure Guarantor Obligations, Maximum Exposure, Undiscounted Currency Swap Currency Swap [Member] Schedule of Effective Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] EUR Senior Unsecured Notes Due 2026 EUR Senior Unsecured Notes Due 2026 [Member] EUR 1 Billion 4.777% Senior Unsecured Notes Due 2026 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Five Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Interest income Investment Income, Interest Measurement Frequency [Axis] Measurement Frequency [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Components of Other Comprehensive Income (Loss), Net Comprehensive Income (Loss) [Table Text Block] Loss Contingencies by Nature of Contingency [Axis] Loss Contingency Nature [Axis] City Area Code City Area Code ASSETS Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Revolving credit facilities(2) Line of Credit, Current Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Plant Closures [Abstract] Plant Closures [Abstract] Plant Closures [Abstract] Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Foreign currency translation gain (loss), gross amount Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Long-term debt, weighted average interest rate, at point in time Long-Term Debt, Weighted Average Interest Rate, at Point in Time Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Insurance contracts in nonqualified trusts, carrying amount Cash Surrender Value of Life Insurance Variable Rate [Axis] Variable Rate [Axis] Other liabilities Other Liabilities, Noncurrent Equity in net earnings (loss) of affiliates Income (Loss) from Equity Method Investments North America North America [Member] Loss contingency accrual, carrying value, payments Loss Contingency Accrual, Payments Other liabilities Increase (Decrease) in Other Operating Liabilities Notional Amount of Nonderivative Instruments Notional Amount of Nonderivative Instruments Capital expenditures on property, plant and equipment Payments to Acquire Property, Plant, and Equipment 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Schedule of Earnings (Loss) Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Foreign currency translation gain (loss), income tax (provision) benefit Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Senior Unsecured Notes Due 2027 EUR Senior Unsecured Notes Due 2027 [Member] EUR Senior Unsecured Notes Due 2027 [Member] Description of the Company and Basis of Presentation Business Description and Basis of Presentation [Text Block] Offsetting Assets Offsetting Assets [Table Text Block] Post-retirement Benefits Benefit payments to other postretirement benefit plans Other Postretirement Benefits Plan [Member] EX-101.PRE 14 ce-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 15 ce-20230331_g1.jpg begin 644 ce-20230331_g1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end GRAPHIC 16 celogo.jpg begin 644 celogo.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end GRAPHIC 17 celogo1.jpg begin 644 celogo1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end GRAPHIC 18 celogo2b.jpg begin 644 celogo2b.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end GRAPHIC 19 celogo3.jpg begin 644 celogo3.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end XML 20 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - shares
 3 Months Ended
Mar. 31, 2023
May 05, 2023
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Transition Report false  
Entity File Number 001-32410  
Entity Registrant Name CELANESE CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 98-0420726  
Entity Address, Address Line One 222 W. Las Colinas Blvd., Suite 900N  
Entity Address, City or Town Irving  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75039-5421  
City Area Code 972  
Local Phone Number 443-4000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Small Reporting Company false  
Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   108,787,807
Entity Central Index Key 0001306830  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Common Stock    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol CE  
Security Exchange Name NYSE  
Senior Unsecured Notes Due 2023    
Entity Information [Line Items]    
Title of 12(b) Security 1.125% Senior Notes due 2023  
Trading Symbol CE /23  
Security Exchange Name NYSE  
Senior Unsecured Notes Due 2025    
Entity Information [Line Items]    
Title of 12(b) Security 1.250% Senior Notes due 2025  
Trading Symbol CE /25  
Security Exchange Name NYSE  
EUR Senior Unsecured Notes Due 2026    
Entity Information [Line Items]    
Title of 12(b) Security 4.777% Senior Notes due 2026  
Trading Symbol CE /26A  
Security Exchange Name NYSE  
Senior Unsecured Notes Due 2027    
Entity Information [Line Items]    
Title of 12(b) Security 2.125% Senior Notes due 2027  
Trading Symbol CE /27  
Security Exchange Name NYSE  
Senior Unsecured Notes Due 2028    
Entity Information [Line Items]    
Title of 12(b) Security 0.625% Senior Notes due 2028  
Trading Symbol CE /28  
Security Exchange Name NYSE  
EUR Senior Unsecured Notes Due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 5.337% Senior Notes due 2029  
Trading Symbol CE /29A  
Security Exchange Name NYSE  
XML 21 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Interim Consolidated Statement of Operations - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Net sales $ 2,853 $ 2,538
Cost of sales (2,222) (1,793)
Gross profit 631 745
Selling, general and administrative expenses (285) (174)
Amortization of intangible assets (41) (11)
Research and development expenses (42) (24)
Other (charges) gains, net (23) (1)
Foreign exchange gain (loss), net 6 (1)
Gain (loss) on disposition of businesses and assets, net 5 (3)
Operating profit (loss) 251 531
Equity in net earnings (loss) of affiliates 15 56
Non-operating pension and other postretirement employee benefit (expense) income 1 24
Interest expense (182) (35)
Interest income 8 1
Dividend income - equity investments 34 37
Other income (expense), net (6) 2
Earnings (loss) from continuing operations before tax 121 616
Income tax (provision) benefit (25) (112)
Earnings (loss) from continuing operations 96 504
Earnings (loss) from operation of discontinued operations (3) 0
Income tax (provision) benefit from discontinued operations 0 0
Earnings (loss) from discontinued operations (3) 0
Net earnings (loss) 93 504
Net (earnings) loss attributable to noncontrolling interests (2) (2)
Net earnings (loss) attributable to Celanese Corporation 91 502
Amounts attributable to Celanese Corporation    
Earnings (loss) from continuing operations 94 502
Earnings (loss) from discontinued operations (3) 0
Net earnings (loss) $ 91 $ 502
Earnings (loss) per common share - basic    
Continuing operations - basic (in dollars per share) $ 0.87 $ 4.64
Discontinued operations - basic (in dollars per share) (0.03) 0
Net earnings (loss) - basic (in dollars per share) 0.84 4.64
Earnings (loss) per common share - diluted    
Continuing operations - diluted (in dollars per share) 0.86 4.61
Discontinued operations - diluted (in dollars per share) (0.03) 0
Net earnings (loss) - diluted (in dollars per share) $ 0.83 $ 4.61
Weighted average shares - basic (in shares) 108,634,068 108,185,912
Weighted average shares - diluted (in shares) 109,188,266 108,917,577
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Net earnings (loss) $ 93 $ 504
Other comprehensive income (loss), net of tax    
Foreign currency translation gain (loss) 13 (21)
Gain (loss) on cash flow hedges 4 15
Pension and postretirement benefits (1) 2
Total other comprehensive income (loss), net of tax 16 (4)
Total comprehensive income (loss), net of tax 109 500
Comprehensive (income) loss attributable to noncontrolling interests (2) (2)
Comprehensive income (loss) attributable to Celanese Corporation $ 107 $ 498
XML 23 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 1,167 $ 1,508
Trade receivables - third party and affiliates 1,606 1,379
Non-trade receivables, net 707 675
Inventories 2,749 2,808
Other assets 219 241
Total current assets 6,448 6,611
Investments in affiliates 1,049 1,062
Property, plant and equipment (net of accumulated depreciation - 2023: $3,791; 2022: $3,687) 5,588 5,584
Operating Lease, Right-of-Use Asset 414 413
Deferred income taxes 813 808
Other assets 553 547
Goodwill 7,139 [1] 7,142
Intangible assets, net 4,086 4,105
Total assets 26,090 26,272
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 1,386 1,306
Trade payables - third party and affiliates 1,445 1,518
Other liabilities 1,014 1,201
Income taxes payable 6 43
Total current liabilities 3,851 4,068
Long-term debt, net of unamortized deferred financing costs 13,396 13,373
Deferred income taxes 1,223 1,242
Uncertain tax positions 295 322
Benefit obligations 411 411
Operating lease liabilities 359 364
Other liabilities 425 387
Commitments and Contingencies
Shareholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2023 and 2022: 0 issued and outstanding) 0 0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2023: 170,448,231 issued and 108,786,738 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding) 0 0
Treasury stock, at cost (2023: 61,661,493 shares; 2022: 61,661,493 shares) (5,491) (5,491)
Additional paid-in capital 365 372
Retained earnings 11,289 11,274
Accumulated other comprehensive income (loss), net (502) (518)
Total Celanese Corporation shareholders' equity 5,661 5,637
Noncontrolling interests 469 468
Total equity 6,130 6,105
Total liabilities and equity $ 26,090 $ 26,272
[1] There were no accumulated impairment losses as of March 31, 2023.
XML 24 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Accumulated depreciation, depletion and amortization, property, plant, and equipment $ 3,791 $ 3,687
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 100,000,000 100,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 400,000,000 400,000,000
Common stock, shares issued (in shares) 170,448,231 170,135,425
Common stock, shares outstanding (in shares) 108,786,738 108,473,932
Treasury stock, shares (in shares) 61,661,493 61,661,493
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Interim Consolidated Statement Equity - USD ($)
$ in Millions
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity   $ 0 $ (5,492) $ 333 $ 9,677 $ (329)  
Balance as of the beginning of the period (in shares) at Dec. 31, 2021   108,023,735 61,736,289        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax       (7)      
Purchases of treasury stock (in shares) 0   0        
Purchases of treasury stock, including related fees     $ 0        
Stock awards (in shares)   283,606          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation $ 502       502    
Common stock dividends         (73)    
Other comprehensive income (loss), net of tax (4)         (4)  
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2021             $ 348
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 2           2
Dividends to noncontrolling interests             0
Distributions to noncontrolling interests             (4)
Balance as of the end of the period, noncontrolling interest at Mar. 31, 2022             346
Balance as of the end of the period (in shares) at Mar. 31, 2022   108,307,341 61,736,289        
Balance as of the end of the period at Mar. 31, 2022 4,953            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity 4,607 $ 0 $ (5,492) 326 10,106 (333)  
Celanese Corporation stockholders' equity 5,637 $ 0 $ (5,491) 372 11,274 (518)  
Balance as of the beginning of the period (in shares) at Dec. 31, 2022   108,473,932 61,661,493        
Balance as of the beginning of the period at Dec. 31, 2022 $ 6,105            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax       (7)      
Purchases of treasury stock (in shares) 0   0        
Purchases of treasury stock, including related fees     $ 0        
Stock awards (in shares)   312,806          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation $ 91       91    
Common stock dividends         (76)    
Other comprehensive income (loss), net of tax 16         16  
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2022 468           468
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 2           2
Dividends to noncontrolling interests             (1)
Distributions to noncontrolling interests             0
Balance as of the end of the period, noncontrolling interest at Mar. 31, 2023 469           $ 469
Balance as of the end of the period (in shares) at Mar. 31, 2023   108,786,738 61,661,493        
Balance as of the end of the period at Mar. 31, 2023 6,130            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity $ 5,661 $ 0 $ (5,491) $ 365 $ 11,289 $ (502)  
XML 26 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Interim Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating Activities    
Net earnings (loss) $ 93 $ 504
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities    
Depreciation, amortization and accretion 178 106
Pension and postretirement net periodic benefit cost 3 (21)
Pension and postretirement contributions (12) (12)
Deferred income taxes, net 1 4
(Gain) loss on disposition of businesses and assets, net (6) 3
Stock-based compensation 14 15
Undistributed earnings in unconsolidated affiliates 25 (30)
Other, net (1) 3
Operating cash provided by (used in) discontinued operations 1 (4)
Changes in operating assets and liabilities    
Trade receivables - third party and affiliates, net (216) (240)
Inventories 45 (32)
Other assets 99 0
Trade payables - third party and affiliates (22) 49
Other liabilities (298) (29)
Net cash provided by (used in) operating activities (96) 316
Investing Activities    
Capital expenditures on property, plant and equipment (164) (137)
Proceeds from sale of businesses and assets, net 9 0
Other, net (23) (12)
Net cash provided by (used in) investing activities (178) (149)
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less (300) 74
Proceeds from short-term borrowings 338 0
Repayments of long-term debt (7) (7)
Purchases of treasury stock, including related fees 0 (17)
Common stock dividends (76) (73)
Distributions to noncontrolling interests (1) (4)
Issuance cost of bridge facility 0 (44)
Other, net (23) (24)
Net cash provided by (used in) financing activities (69) (95)
Exchange rate effects on cash and cash equivalents 2 (3)
Net increase (decrease) in cash and cash equivalents (341) 69
Cash and cash equivalents as of beginning of period 1,508 536
Cash and cash equivalents as of end of period $ 1,167 $ 605
XML 27 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Description of the Company and Basis of Presentation
 3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of the Company and Basis of Presentation Description of the Company and Basis of Presentation
Description of the Company
Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals, for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles.
Definitions
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
Basis of Presentation
The unaudited interim consolidated financial statements for the three months ended March 31, 2023 and 2022 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.
In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with U.S. GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, 2022, filed on February 24, 2023 with the SEC as part of the Company's Annual Report on Form 10-K.
Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the entire year.
In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report.
For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as noncontrolling interests.
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension
and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.
XML 28 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Recent Accounting Pronouncements
 3 Months Ended
Mar. 31, 2023
Recent Accounting Pronouncements [Abstract]  
Recent Accounting Pronouncements Recent Accounting PronouncementsThere are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures.
XML 29 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Acquisitions, Dispositions and Plant Closures
 3 Months Ended
Mar. 31, 2023
Acquisitions, Dispositions and Plant Closures [Abstract]  
Acquisitions, Dispositions and Plant Closures Acquisitions, Dispositions and Plant Closures
Acquisitions
In November 2022, the Company acquired 100% ownership of entities and assets consisting of a majority of the Mobility & Materials business ("M&M") of DuPont de Nemours, Inc. ("DuPont") (the "M&M Acquisition") for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction. The Company acquired a global production network of 29 facilities, including compounding and polymerization, customer and supplier contracts and agreements, an intellectual property portfolio, including approximately 850 patents with associated technical and R&D assets, and approximately 5,000 employees across the manufacturing, technical, and commercial organizations. This acquisition of M&M enhances the engineered materials product portfolio by adding new polymers, brands, product technology, and backward integration in critical polymers, allowing the Company to accelerate growth in high-value applications including future mobility, connectivity and medical. The acquisition was accounted for as a business combination and the acquired operations are included in the Engineered Materials segment.
The Company preliminarily allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The purchase price allocation was based upon preliminary information and is subject to change if additional information about the facts and circumstances that existed at the acquisition date becomes available. The Company is in the ongoing process of conducting a valuation of the assets acquired and liabilities assumed related to the acquisition, including trade names and customer relationships, personal and real property, investment in equity affiliates and deferred taxes. The final fair value of the net assets acquired may result in adjustments to these assets and liabilities, including goodwill. During the measurement period to date, there were no adjustments that materially impacted the Company's goodwill initially recorded.
The following unaudited pro forma financial information presents the consolidated results of operations as if the M&M Acquisition had occurred at the beginning of 2022. M&M's pre-acquisition results have been added to the Company's historical results. The pro forma results contained in the table below include adjustments for (i) increased depreciation expense as a result of acquisition date fair value adjustments, (ii) amortization of acquired intangibles, (iii) interest expense and amortization of debt issuance costs of $172 million related to borrowings under the U.S Term Loan Facility (defined below) and the issuance of Acquisition Notes (defined below) as if these had taken place at the beginning of 2022 for the three months ended March 31, 2022 and (iv) net total inventory step up of inventory amortized to Cost of sales of $98 million for the three months ended March 31, 2022.
These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisitions occurred on the assumed dates, nor are they necessarily an indication of future operating results.
Three Months Ended
March 31, 2022
(In $ millions)
Unaudited Consolidated Pro Forma Results
Proforma Net sales
3,427 
Proforma Earnings (loss) from continuing operations before tax
312 
Korea Engineering Plastics Co. Restructuring
In April 2022, the Company completed the restructuring of Korea Engineering Plastics Co. ("KEPCO"), a joint venture owned 50% by the Company and 50% by Mitsubishi Gas Chemical Company, Inc. KEPCO was first formed in 1987 to manufacture and market polyoxymethylene ("POM") in Asia, with a particular focus on serving domestic demand in South Korea. KEPCO will now focus solely on manufacturing and supplying high quality products to its shareholders, who will independently market
them globally. As part of the restructuring of KEPCO, the Company paid KEPCO $5 million and will pay 5 equal annual installments of €24 million on October 1 of each year beginning in 2022. This resulted in an increase to the Company's investment in KEPCO of $134 million. The Company's joint venture partner will be making similar payments to KEPCO. The restructuring did not result in a change in ownership percentage of KEPCO, nor a change in control, and KEPCO will continue to be accounted for as an equity method investment.
XML 30 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories
 3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Inventories Inventories
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Finished goods1,811 1,820 
Work-in-process210 202 
Raw materials and supplies728 786 
Total2,749 2,808 
XML 31 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets, net
 3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net Goodwill and Intangible Assets, Net
Goodwill
Engineered
Materials		Acetyl ChainTotal
(In $ millions)
As of December 31, 20226,775 367 7,142 
Acquisitions (Note 3)
(18)— (18)
Exchange rate changes11 4 15 
As of March 31, 2023(1)
6,768 371 7,139 
______________________________
(1)There were no accumulated impairment losses as of March 31, 2023.
Intangible Assets, Net
Finite-lived intangible assets are as follows:
LicensesCustomer-
Related
Intangible
Assets		Developed
Technology		Covenants
Not to
Compete
and Other		Total
(In $ millions)
Gross Asset Value
As of December 31, 202242 2,455 601 55 3,153 
Exchange rate changes— 22 — — 22 
As of March 31, 202342 2,477 601 55 3,175 
Accumulated Amortization
As of December 31, 2022(39)(567)(50)(40)(696)
Amortization— (30)(11)— (41)
Exchange rate changes— (8)— — (8)
As of March 31, 2023(39)(605)(61)(40)(745)
Net book value3 1,872 540 15 2,430 
Indefinite-lived intangible assets are as follows:
Trademarks
and Trade Names
(In $ millions)
As of December 31, 20221,648 
Exchange rate changes8 
As of March 31, 20231,656 
During the three months ended March 31, 2023, the Company did not renew or extend any intangible assets.
Estimated amortization expense for the succeeding five fiscal years is as follows:
(In $ millions)
2024160 
2025160 
2026160 
2027160 
2028160 
XML 32 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Current Other Liabilities
 3 Months Ended
Mar. 31, 2023
Other Liabilities, Current [Abstract]  
Current Other Liabilities Current Other Liabilities
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Benefit obligations (Note 8)
25 25 
Customer rebates91 101 
Derivatives (Note 12)
39 63 
Interest (Note 7)
155 265 
Legal (Note 14)
22 21 
Operating leases88 83 
Restructuring (Note 18)
23 6 
Salaries and benefits123 151 
Sales and use tax/foreign withholding tax payable91 108 
Investment in affiliates94 79 
Other(1)
263 299 
Total1,014 1,201 
____________________________
(1)Includes $104 million and $166 million of liabilities related to the M&M Acquisition payable to DuPont as of March 31, 2023 and December 31, 2022, respectively.
XML 33 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Debt
 3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Debt Debt
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt551 506 
Short-term borrowings, including amounts due to affiliates(1)
617 500 
Revolving credit facilities(2)
218 300 
Total1,386 1,306 
______________________________
(1)The weighted average interest rate was 5.6% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.
(2)The weighted average interest rate was 3.4% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2023, interest rate of 1.125%
489 480 
Senior unsecured notes due 2024, interest rate of 3.500%
499 499 
Senior unsecured notes due 2024, interest rate of 5.900%
2,000 2,000 
Senior unsecured notes due 2025, interest rate of 1.250%
326 320 
Senior unsecured notes due 2025, interest rate of 6.050%
1,750 1,750 
Senior unsecured term loan due 2025, interest rate of 6.265%
750 750 
Senior unsecured notes due 2026, interest rate of 1.400%
400 400 
Senior unsecured notes due 2026, interest rate of 4.777%
1,088 1,067 
Senior unsecured notes due 2027, interest rate of 2.125%
542 531 
Senior unsecured notes due 2027, interest rate of 6.165%
2,000 2,000 
Senior unsecured term loan due 2027, interest rate of 6.265%
1,000 1,000 
Senior unsecured notes due 2028, interest rate of 0.625%
543 533 
Senior unsecured notes due 2029, interest rate of 5.337%
544 533 
Senior unsecured notes due 2029, interest rate of 6.330%
750 750 
Senior unsecured notes due 2032, interest rate of 6.379%
1,000 1,000 
Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%
163 164 
Bank loans due at various dates through 2026(1)
4 4 
Obligations under finance leases due at various dates through 2054
169 172 
Subtotal14,017 13,953 
Unamortized debt issuance costs(2)
(70)(74)
Current installments of long-term debt(551)(506)
Total13,396 13,373 
______________________________
(1)The weighted average interest rate was 1.3% and 1.3% as of March 31, 2023 and December 31, 2022, respectively.
(2)Related to the Company's long-term debt, excluding obligations under finance leases.
Senior Credit Facilities
In March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a term loan credit agreement (the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion. In September 2022, Celanese, Celanese U.S. and certain subsidiaries entered into an additional term loan credit agreement (the "September 2022 U.S. Term Loan Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Term Loan Credit Agreements"), pursuant to which lenders have provided delayed-draw term loans due 3 years from issuance in an amount equal to $750 million (the term loans represented by the U.S. Term Loan Credit Agreements collectively, the "U.S. Term Loan Facility"). The U.S. Term Loan Facility was fully drawn during the three months ended December 31, 2022.
Also in March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a new revolving credit agreement (the "U.S. Revolving Credit Agreement" and, together with the U.S. Term Loan Credit Agreements, the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027 (the "U.S. Revolving Credit Facility").
On February 21, 2023, the Company amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors"). The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.
On January 4, 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
Also on January 6, 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement," together with the China Revolving Credit Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn on January 10, 2023 and is supported by a letter of comfort from the Company. The Company expects that the China Credit Agreements will facilitate its efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of its U.S. debt to China at a lower average interest rate.
The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:
As of
March 31,
2023
(In $ millions)
U.S. Revolving Credit Facility
Borrowings outstanding— 
Available for borrowing1,750 
China Revolving Credit Facility
Borrowings outstanding218 
Available for borrowing37 
Senior Notes
The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date.
In July 2022, Celanese U.S. completed an offering of $7.5 billion aggregate principal amount of notes of various maturities in a public offering registered under the Securities Act (the "Acquisition USD Notes"). In July 2022, Celanese U.S. completed an offering of €1.5 billion in aggregate principal amount of euro-denominated senior unsecured notes due in 2026 and 2029 in a public offering registered under the Securities Act (collectively, the "Acquisition Euro Notes" and together with the Acquisition USD Notes, the "Acquisition Notes"). Certain of the Acquisition Notes were issued at a discount to par, which will be amortized to Interest expense in the consolidated statement of operations over the terms of the applicable Acquisition Notes. Fees and expenses of the offering of the Acquisition Notes, inclusive of underwriting discounts, were $65 million.
Accounts Receivable Purchasing Facility
In June 2021, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2024. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's unaudited consolidated balance sheet. The Company de-recognized $249 million and $1.1 billion of accounts receivable under this agreement for the three months ended March 31, 2023 and twelve months ended December 31, 2022, respectively, and collected $249 million and $1.1 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $109 million were pledged by the SPE as collateral to the Purchasers as of March 31, 2023.
Factoring and Discounting Agreements
The Company has factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $87 million and $320 million of accounts receivable under these factoring agreements for the three months ended March 31, 2023 and twelve months ended December 31, 2022, respectively, and collected $82 million and $325 million of accounts receivable sold under these factoring agreements during the same periods.
Covenants
The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. The Company is in compliance with the covenants in its material financing arrangements as of March 31, 2023.
XML 34 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Benefit Obligations
 3 Months Ended
Mar. 31, 2023
Retirement Benefits [Abstract]  
Benefit Obligations Benefit Obligations
The components of net periodic benefit cost are as follows:
Three Months Ended March 31,
20232022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Service cost4 — 3 — 
Interest cost32 — 17 — 
Expected return on plan assets
(33)— (41)— 
Total3 — (21)— 
Benefit obligation funding is as follows:
As of
March 31,
2023
Total
Expected
2023
(In $ millions)
Cash contributions to defined benefit pension plans6 27 
Benefit payments to nonqualified pension plans5 18 
Benefit payments to other postretirement benefit plans1 4 
The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.
Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of:
As of March 31, 2023As of December 31, 2022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Noncurrent Other assets166 — 160 — 
Current Other liabilities(21)(3)(21)(3)
Benefit obligations(371)(35)(372)(35)
Net amount recognized(226)(38)(233)(38)
XML 35 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Environmental
 3 Months Ended
Mar. 31, 2023
Environmental Remediation Obligations [Abstract]  
Environmental EnvironmentalThe Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.
The components of environmental remediation liabilities are as follows:
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Demerger obligations (Note 14)
19 20 
Divestiture obligations (Note 14)
14 14 
Active sites20 21 
U.S. Superfund sites9 10 
Other environmental remediation liabilities2 2 
Total64 67 
Remediation
Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (Note 14). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.
U.S. Superfund Sites
In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.
As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.
One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the Newark Bay Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the LPRSA and the Newark Bay Area.
In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. In September 2021, the EPA issued a Record of Decision selecting an interim remedial plan for the upper 9 miles of the Lower Passaic River ("Upper 9 Miles"). Pursuant to the EPA's Record of Decision, targeted dredging will be conducted in the Upper 9 Miles to address surface sediments with elevated contamination followed by the installation of an engineered cap at an EPA estimated cost of $441 million.
The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273 (MCA) (LDW) (U.S. District Court New Jersey) (the "2018 OCC Lawsuit"), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the 2018 OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs.
Separately, the United States lodged a Consent Decree in U.S. District Court for the District of New Jersey on December 16, 2022 that will resolve the Company's liability (and that of more than 80 other settling defendants) to the EPA for costs to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site in exchange for a collective payment of $150 million, United States v. Alden Leeds, Inc., No. 2:22-7326 (MCA) (LDW) (U.S. District Court New Jersey) ("Consent Decree Action"). The Consent Decree also will provide the Company protection from contribution claims by others for costs incurred to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site. The Company's proposed payment toward the $150 million collective settlement payment is not material to the Company's results of operations, cash flows or financial position. The Consent Decree is still subject to public comment and court approval.
On March 7, 2023, the U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit, pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. On March 24, 2023, OCC filed a new lawsuit against 40 parties, including a subsidiary of the Company, seeking to recover costs for remedial design work the EPA has ordered OCC to undertake for a portion of the LPRSA at an estimated cost of $71 million, Occidental Chemical Corporation v. Givaudan Fragrances Corporation, No. 2:23-cv-1699 (U.S. District Court New Jersey) (the "2023 OCC Lawsuit"). Like the earlier lawsuit, the 2023 OCC Lawsuit concerns the facility Essex County, New Jersey purchased and for which Essex County, New Jersey has agreed to defend and indemnify the Company. This new lawsuit does not change the Company's estimated liability for LPRSA cleanup costs.
The Company will continue to vigorously defend these matters and continues to believe that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, previously estimated at less than 1%, will not be material.
Other Environmental Matters
In April 2022, a methanol leak on a pipeline to our Bishop, Texas facility was discovered. The release has been contained, the leak has been repaired and the pipeline has resumed operation. The Company promptly disclosed the incident to state and federal authorities, including the Texas Commission on Environmental Quality and the EPA, and remediation activities are now completed. While the Company has not received a notice of violation nor been assessed any fines or penalties to date, the Company recorded a reserve in Other current liabilities based on anticipated clean-up costs and possible penalties to state or federal authorities. The Company does not believe that resolution of this matter will have a material impact on our financial condition or results of operations.
XML 36 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity
 3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Shareholders' Equity
Common Stock
The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by its existing Global Credit Agreements and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant.
The Company declared a quarterly cash dividend of $0.70 per share on its Common Stock on April 19, 2023, amounting to $76 million. The cash dividend will be paid on May 15, 2023 to holders of record as of May 1, 2023.
Treasury Stock
The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.
Total From
February 2008
Through
March 31, 2023
Shares repurchased69,324,429 
Average purchase price per share$83.71 
Shares repurchased (in $ millions)$5,803 
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)
$6,866 
The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of shareholders' equity.
The Company did not repurchase any Common Stock during the three months ended March 31, 2023 and 2022.
Other Comprehensive Income (Loss), Net
Three Months Ended March 31,
20232022
Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount		Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(4)17 13 (15)(6)(21)
Gain (loss) on cash flow hedges4 — 4 19 (4)15 
Pension and postretirement benefits gain (loss)(1)— (1)2 — 2 
Total(1)17 16 6 (10)(4)
Adjustments to Accumulated other comprehensive income (loss), net, are as follows:
Foreign
Currency
Translation Gain (Loss)
Gain (Loss)
on Cash
Flow
Hedges
Pension and
Postretirement
Benefits Gain (Loss)
Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2022(488)(22)(8)(518)
Other comprehensive income (loss) before reclassifications(4)2 (1)(3)
Amounts reclassified from accumulated other comprehensive income (loss)
— 2 — 2 
Income tax (provision) benefit17 — — 17 
As of March 31, 2023(475)(18)(9)(502)
XML 37 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Other (Charges) Gains, Net
 3 Months Ended
Mar. 31, 2023
Restructuring and Related Activities [Abstract]  
Other (Charges) Gains, Net Other (Charges) Gains, Net
Three Months Ended
March 31,
20232022
(In $ millions)
Restructuring(23)(1)
Total(23)(1)
During the three months ended March 31, 2023, the Company recorded $23 million of employee termination benefits primarily related to Company-wide business optimization projects.
The changes in the restructuring liabilities by business segment are as follows:
Engineered
Materials		Acetyl
Chain		OtherTotal
(In $ millions)
Employee Termination Benefits
As of December 31, 20224 1 1 6 
Additions21 1 1 23 
Cash payments(4)(1)(1)(6)
As of March 31, 202321 1 1 23 
XML 38 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
 3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Three Months Ended
March 31,
20232022
(In percentages)
Effective income tax rate21 18 
The effective income tax rate for the three months ended March 31, 2023, was higher compared to the same period in 2022, primarily due to increases in valuation allowances on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period, partially offset by increased earnings in low taxed jurisdictions during the three months ended March 31, 2023.
In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various final and proposed regulatory packages supplementing the TCJA provisions since 2018. There have been no material proposed or final regulatory packages during the three months ended March 31, 2023.
In August 2022, the Inflation Reduction Act (the "IRA") was enacted and included a 1% excise tax on share repurchases in excess of $1 million, and a corporate minimum tax of 15% on adjusted book earnings. The corporate minimum tax paid is creditable in future years to the extent that regular tax liability exceeds the minimum tax in any given year. The Company does not expect these provisions and any newly issued administrative guidance to have a material impact to future income tax expense. The IRA also provides various beneficial credits for energy efficient related manufacturing, transportation and fuels, hydrogen/carbon recapture and renewable energy, which the Company is evaluating in regard to planned projects.
The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense adjustments in the period the guidance is finalized or becomes effective.
Due to the TCJA and uncertainty as to future foreign source income, the Company previously recorded a valuation allowance on a substantial portion of its foreign tax credit carryforwards. The Company is currently evaluating tax planning strategies to enable the use of the Company's foreign tax credit carryforwards that may decrease the Company's effective tax rate in future periods as the valuation allowance is reversed.
The Company's tax returns have been under joint audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In September 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also proposed to apply these adjustments to open tax years through 2019. The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authorities. The Company is engaged in ongoing discussions with the other authorities regarding the ongoing examinations and will evaluate all additional potential remedies as the discussions progress.
In addition, the Company's income tax returns in Mexico are under audit for the years 2017 and 2018, and in Canada for the years 2016 through 2018. In January 2022, the Mexico tax authorities issued preliminary findings for disallowance of operating expenses on several of the applicable tax returns. The Company has analyzed the preliminary findings, engaged in preliminary
discussions with the Mexico tax authorities and has recorded the appropriate tax reserves as of March 31, 2023. The Company will continue discussions with the Mexico authorities in 2023. Related to Canada, the Company is discussing preliminary findings with the Canadian authorities and does not expect a material impact to income tax expense.
As of March 31, 2023, the Company believes that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised in the audits described above are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its positions, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded.
XML 39 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments
 3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
Derivatives Designated As Hedges
Net Investment Hedges
The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:
As of
March 31,
2023		As of
December 31,
2022
(In € millions)
Total5,652 5,639 
Concurrently with the offering of the Acquisition USD Notes in July 2022 (Note 7), the Company entered into cross-currency swaps to effectively convert $2.0 billion and $500 million of the Acquisition USD Notes into a euro-denominated borrowing at prevailing euro interest rates, maturing on July 15, 2027 and July 15, 2032, respectively. The swaps and €1.5 billion of the Acquisition Euro Notes qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investments of certain of its euro-denominated subsidiaries.
Derivatives Not Designated As Hedges
Foreign Currency Forwards and Swaps
Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Total1,892 1,314 
Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Three Months Ended March 31, Statement of Operations Classification
2023202220232022
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps— 17 1 — Cost of sales
Interest rate swaps— — (2)(2)Interest expense
Foreign currency forwards2 — (1)— Cost of sales
Total2 17 (2)(2)
Designated as Net Investment Hedges
Foreign currency denominated debt (Note 7)
(56)28 — — N/A
Cross-currency swaps(19)2 — — N/A
Total(75)30 — — 
Not Designated as Hedges
Foreign currency forwards and swaps
— — 2 (1)Foreign exchange gain (loss), net; Other income (expense), net
Total— — 2 (1)
See Note 13 for additional information regarding the fair value of the Company's derivative instruments.
Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement.
Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Derivative Assets
Gross amount recognized139 169 
Gross amount offset in the consolidated balance sheets1 — 
Net amount presented in the consolidated balance sheets138 169 
Gross amount not offset in the consolidated balance sheets26 16 
Net amount112 153 
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Derivative Liabilities
Gross amount recognized185 189 
Gross amount offset in the consolidated balance sheets1 — 
Net amount presented in the consolidated balance sheets184 189 
Gross amount not offset in the consolidated balance sheets26 16 
Net amount158 173 
XML 40 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:
Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.
Fair Value Measurement
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		TotalBalance Sheet Classification
(In $ millions)
As of March 31, 2023
Derivatives Designated as Cash Flow Hedges
Commodity swaps— 4 4 Current Other assets
Commodity swaps— 43 43 Noncurrent Other assets
Foreign currency forwards and swaps— 1 1 Current Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— 67 67 Current Other assets
Cross-currency swaps— 11 11 Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— 12 12 Current Other assets
Total assets— 138 138 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— (29)(29)Current Other liabilities
Cross-currency swaps— (145)(145)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— (10)(10)Current Other liabilities
Total liabilities— (184)(184)
Fair Value Measurement
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		TotalBalance Sheet Classification
(In $ millions)
As of December 31, 2022
Derivatives Designated as Cash Flow Hedges
Commodity swaps— 9 9 Current Other assets
Commodity swaps— 39 39 Noncurrent Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— 99 99 Current Other assets
Cross-currency swaps— 13 13 Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— 9 9 Current Other assets
Total assets— 169 169 
Derivatives Designated as Cash Flow Hedges
Commodity swaps— (2)(2)Current Other liabilities
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— (58)(58)Current Other liabilities
Cross-currency swaps— (126)(126)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— (3)(3)Current Other liabilities
Total liabilities— (189)(189)
Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
Fair Value Measurement
Carrying
Amount		Significant Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
(In $ millions)
As of March 31, 2023
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts21 21 — 21 
Long-term debt, including current installments of long-term debt
14,017 13,608 169 13,777 
As of December 31, 2022
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts22 23 — 23 
Long-term debt, including current installments of long-term debt
13,953 13,247 172 13,419 
In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement.
As of March 31, 2023, and December 31, 2022, the fair values of cash and cash equivalents, receivables, marketable securities, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.
XML 41 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Commitments
Guarantees
The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.
The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following:
•Demerger Obligations
In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (Note 9).
The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of March 31, 2023 are $108 million. Though the Company is significantly under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.
The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.
Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued.
•Divestiture Obligations
The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk (Note 9).
The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $126 million as of March 31, 2023. Other agreements do not provide for any monetary or time limitations.
Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued.
Purchase Obligations
In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of March 31, 2023, the Company had unconditional purchase obligations of $4.2 billion, of which $532 million will be paid in 2023, $675 million in 2024, $549 million in 2025, $419 million in 2026, $341 million in 2027 and the balance thereafter through 2042.
Contingencies
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position.
XML 42 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information

Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended March 31, 2023
Net sales1,630 1,250 — (27)(1)2,853 
Other (charges) gains, net (Note 18)
(21)(1)(1)— (23)
Operating profit (loss)112 278 (139)— 251 
Equity in net earnings (loss) of affiliates
11 1 3 — 15 
Depreciation and amortization112 54 6 — 172 
Capital expenditures45 51 12 — 108 (2)
As of March 31, 2023
Goodwill and intangible assets, net
10,800 425 — — 11,225 
Total assets
18,522 5,730 1,838 — 26,090 
Three Months Ended March 31, 2022
Net sales
910 

1,652 

— (24)(1)2,538 
Other (charges) gains, net (Note 18)
(1)— — — (1)
Operating profit (loss)
124 503 (96)— 531 
Equity in net earnings (loss) of affiliates
49 4 3 — 56 
Depreciation and amortization
46 56 4 — 106 
Capital expenditures
30 70 14 — 114 (2)
As of December 31, 2022
Goodwill and intangible assets, net
10,826 421 — — 11,247 
Total assets
20,611 5,471 190 — 26,272 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $56 million and $23 million for the three months ended March 31, 2023 and 2022, respectively.
XML 43 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue Recognition
 3 Months Ended
Mar. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]  
Revenue Recognition Revenue Recognition
The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of March 31, 2023, the Company had $1.4 billion of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $378 million of its remaining performance obligations as Net sales in 2023, $460 million in 2024, $319 million in 2025 and the balance thereafter.
Contract Balances
Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the unaudited consolidated balance sheets.
The Company does not have any material contract assets as of March 31, 2023.
Disaggregated Revenue
In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations.
The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects which are solutions-based and are tailored to each customer's unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment.
The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue.
Further disaggregation of Net sales by business segment and geographic destination is as follows:
Three Months Ended
March 31,
20232022
(In $ millions)
Engineered Materials
North America479 289 
Europe and Africa560 377 
Asia-Pacific548 221 
South America43 23 
Total1,630 910 
Acetyl Chain
North America365 425 
Europe and Africa460 592 
Asia-Pacific367 561 
South America31 50 
Total(1)
1,223 1,628 
______________________________
(1)Excludes intersegment sales of $27 million and $24 million for the three months ended March 31, 2023 and 2022, respectively.
XML 44 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share
 3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share Earnings (Loss) Per Share
Three Months Ended
March 31,
20232022
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations94 502 
Earnings (loss) from discontinued operations(3)— 
Net earnings (loss)91 502 
Weighted average shares - basic108,634,068 108,185,912 
Incremental shares attributable to equity awards(1)
554,198 731,665 
Weighted average shares - diluted109,188,266 108,917,577 
______________________________
(1)Excludes options to purchase 86,194 and 0 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively; and 72,574 and 61,297 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively, as their effect would have been antidilutive.
XML 45 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Recent Accounting Pronouncements (Policies)
 3 Months Ended
Mar. 31, 2023
Recent Accounting Pronouncements [Abstract]  
Estimates and Assumptions
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension
and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.
New Accounting Pronouncements, Policy There are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures.
XML 46 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Acquisitions, Dispositions and Plant Closures Plant Closures (Tables)
 3 Months Ended
Mar. 31, 2023
Plant Closures [Abstract]  
Business Acquisition, Pro Forma Information
Three Months Ended
March 31, 2022
(In $ millions)
Unaudited Consolidated Pro Forma Results
Proforma Net sales
3,427 
Proforma Earnings (loss) from continuing operations before tax
312 
XML 47 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories (Tables)
 3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventories
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Finished goods1,811 1,820 
Work-in-process210 202 
Raw materials and supplies728 786 
Total2,749 2,808 
XML 48 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets, Net (Tables)
 3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Engineered
Materials		Acetyl ChainTotal
(In $ millions)
As of December 31, 20226,775 367 7,142 
Acquisitions (Note 3)
(18)— (18)
Exchange rate changes11 4 15 
As of March 31, 2023(1)
6,768 371 7,139 
______________________________
(1)There were no accumulated impairment losses as of March 31, 2023.
Schedule of Finite-Lived Intangible Assets
Finite-lived intangible assets are as follows:
LicensesCustomer-
Related
Intangible
Assets		Developed
Technology		Covenants
Not to
Compete
and Other		Total
(In $ millions)
Gross Asset Value
As of December 31, 202242 2,455 601 55 3,153 
Exchange rate changes— 22 — — 22 
As of March 31, 202342 2,477 601 55 3,175 
Accumulated Amortization
As of December 31, 2022(39)(567)(50)(40)(696)
Amortization— (30)(11)— (41)
Exchange rate changes— (8)— — (8)
As of March 31, 2023(39)(605)(61)(40)(745)
Net book value3 1,872 540 15 2,430 
Schedule of Indefinite-Lived Intangible Assets
Indefinite-lived intangible assets are as follows:
Trademarks
and Trade Names
(In $ millions)
As of December 31, 20221,648 
Exchange rate changes8 
As of March 31, 20231,656 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Estimated amortization expense for the succeeding five fiscal years is as follows:
(In $ millions)
2024160 
2025160 
2026160 
2027160 
2028160 
XML 49 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Current Other Liabilities (Tables)
 3 Months Ended
Mar. 31, 2023
Other Liabilities, Current [Abstract]  
Schedule of Current Other Liabilities
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Benefit obligations (Note 8)
25 25 
Customer rebates91 101 
Derivatives (Note 12)
39 63 
Interest (Note 7)
155 265 
Legal (Note 14)
22 21 
Operating leases88 83 
Restructuring (Note 18)
23 6 
Salaries and benefits123 151 
Sales and use tax/foreign withholding tax payable91 108 
Investment in affiliates94 79 
Other(1)
263 299 
Total1,014 1,201 
____________________________
(1)Includes $104 million and $166 million of liabilities related to the M&M Acquisition payable to DuPont as of March 31, 2023 and December 31, 2022, respectively.
XML 50 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Debt (Tables)
 3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Short-term Debt
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt551 506 
Short-term borrowings, including amounts due to affiliates(1)
617 500 
Revolving credit facilities(2)
218 300 
Total1,386 1,306 
______________________________
(1)The weighted average interest rate was 5.6% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.
(2)The weighted average interest rate was 3.4% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.
Schedule of Long-term Debt
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2023, interest rate of 1.125%
489 480 
Senior unsecured notes due 2024, interest rate of 3.500%
499 499 
Senior unsecured notes due 2024, interest rate of 5.900%
2,000 2,000 
Senior unsecured notes due 2025, interest rate of 1.250%
326 320 
Senior unsecured notes due 2025, interest rate of 6.050%
1,750 1,750 
Senior unsecured term loan due 2025, interest rate of 6.265%
750 750 
Senior unsecured notes due 2026, interest rate of 1.400%
400 400 
Senior unsecured notes due 2026, interest rate of 4.777%
1,088 1,067 
Senior unsecured notes due 2027, interest rate of 2.125%
542 531 
Senior unsecured notes due 2027, interest rate of 6.165%
2,000 2,000 
Senior unsecured term loan due 2027, interest rate of 6.265%
1,000 1,000 
Senior unsecured notes due 2028, interest rate of 0.625%
543 533 
Senior unsecured notes due 2029, interest rate of 5.337%
544 533 
Senior unsecured notes due 2029, interest rate of 6.330%
750 750 
Senior unsecured notes due 2032, interest rate of 6.379%
1,000 1,000 
Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%
163 164 
Bank loans due at various dates through 2026(1)
4 4 
Obligations under finance leases due at various dates through 2054
169 172 
Subtotal14,017 13,953 
Unamortized debt issuance costs(2)
(70)(74)
Current installments of long-term debt(551)(506)
Total13,396 13,373 
______________________________
(1)The weighted average interest rate was 1.3% and 1.3% as of March 31, 2023 and December 31, 2022, respectively.
(2)Related to the Company's long-term debt, excluding obligations under finance leases.
Schedule of Balances Available for Borrowing
The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:
As of
March 31,
2023
(In $ millions)
U.S. Revolving Credit Facility
Borrowings outstanding— 
Available for borrowing1,750 
China Revolving Credit Facility
Borrowings outstanding218 
Available for borrowing37 
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Benefit Obligations (Tables)
 3 Months Ended
Mar. 31, 2023
Retirement Benefits [Abstract]  
Schedule of Net Periodic Benefit Costs Recognized
The components of net periodic benefit cost are as follows:
Three Months Ended March 31,
20232022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Service cost4 — 3 — 
Interest cost32 — 17 — 
Expected return on plan assets
(33)— (41)— 
Total3 — (21)— 
Schedule of Company Commitments to Fund Benefit Obligations
Benefit obligation funding is as follows:
As of
March 31,
2023
Total
Expected
2023
(In $ millions)
Cash contributions to defined benefit pension plans6 27 
Benefit payments to nonqualified pension plans5 18 
Benefit payments to other postretirement benefit plans1 4 
Schedule of Defined Benefit Plans Disclosures
Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of:
As of March 31, 2023As of December 31, 2022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Noncurrent Other assets166 — 160 — 
Current Other liabilities(21)(3)(21)(3)
Benefit obligations(371)(35)(372)(35)
Net amount recognized(226)(38)(233)(38)
XML 52 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Environmental (Tables)
 3 Months Ended
Mar. 31, 2023
Environmental Remediation Obligations [Abstract]  
Schedule of Environmental Remediation Reserves
The components of environmental remediation liabilities are as follows:
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Demerger obligations (Note 14)
19 20 
Divestiture obligations (Note 14)
14 14 
Active sites20 21 
U.S. Superfund sites9 10 
Other environmental remediation liabilities2 2 
Total64 67 
XML 53 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Treasury Stock
Total From
February 2008
Through
March 31, 2023
Shares repurchased69,324,429 
Average purchase price per share$83.71 
Shares repurchased (in $ millions)$5,803 
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)
$6,866 
Schedule of Components of Other Comprehensive Income (Loss), Net
Three Months Ended March 31,
20232022
Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount		Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(4)17 13 (15)(6)(21)
Gain (loss) on cash flow hedges4 — 4 19 (4)15 
Pension and postretirement benefits gain (loss)(1)— (1)2 — 2 
Total(1)17 16 6 (10)(4)
Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net
Adjustments to Accumulated other comprehensive income (loss), net, are as follows:
Foreign
Currency
Translation Gain (Loss)
Gain (Loss)
on Cash
Flow
Hedges
Pension and
Postretirement
Benefits Gain (Loss)
Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2022(488)(22)(8)(518)
Other comprehensive income (loss) before reclassifications(4)2 (1)(3)
Amounts reclassified from accumulated other comprehensive income (loss)
— 2 — 2 
Income tax (provision) benefit17 — — 17 
As of March 31, 2023(475)(18)(9)(502)
XML 54 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Other (Charges) Gains, Net (Tables)
 3 Months Ended
Mar. 31, 2023
Restructuring and Related Activities [Abstract]  
Schedule of Other (Charges) Gains, Net
Three Months Ended
March 31,
20232022
(In $ millions)
Restructuring(23)(1)
Total(23)(1)
Schedule of Restructuring Reserve by Type of Cost
The changes in the restructuring liabilities by business segment are as follows:
Engineered
Materials		Acetyl
Chain		OtherTotal
(In $ millions)
Employee Termination Benefits
As of December 31, 20224 1 1 6 
Additions21 1 1 23 
Cash payments(4)(1)(1)(6)
As of March 31, 202321 1 1 23 
XML 55 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
 3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Effective Tax Rate
Three Months Ended
March 31,
20232022
(In percentages)
Effective income tax rate21 18 
XML 56 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2023
Derivative [Line Items]  
Schedule of Changes in Fair Value of Derivatives
Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Three Months Ended March 31, Statement of Operations Classification
2023202220232022
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps— 17 1 — Cost of sales
Interest rate swaps— — (2)(2)Interest expense
Foreign currency forwards2 — (1)— Cost of sales
Total2 17 (2)(2)
Designated as Net Investment Hedges
Foreign currency denominated debt (Note 7)
(56)28 — — N/A
Cross-currency swaps(19)2 — — N/A
Total(75)30 — — 
Not Designated as Hedges
Foreign currency forwards and swaps
— — 2 (1)Foreign exchange gain (loss), net; Other income (expense), net
Total— — 2 (1)
Offsetting Assets
Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Derivative Assets
Gross amount recognized139 169 
Gross amount offset in the consolidated balance sheets1 — 
Net amount presented in the consolidated balance sheets138 169 
Gross amount not offset in the consolidated balance sheets26 16 
Net amount112 153 
Offsetting Liabilities
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Derivative Liabilities
Gross amount recognized185 189 
Gross amount offset in the consolidated balance sheets1 — 
Net amount presented in the consolidated balance sheets184 189 
Gross amount not offset in the consolidated balance sheets26 16 
Net amount158 173 
Net Investment Hedging [Member]  
Derivative [Line Items]  
Schedule of Notional Amounts of Derivative and Nonderivative Instruments
The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:
As of
March 31,
2023		As of
December 31,
2022
(In € millions)
Total5,652 5,639 
Not Designated as Hedging Instrument  
Derivative [Line Items]  
Schedule of Notional Amounts of Derivative and Nonderivative Instruments
Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:
As of
March 31,
2023		As of
December 31,
2022
(In $ millions)
Total1,892 1,314 
XML 57 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
Fair Value Measurement
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		TotalBalance Sheet Classification
(In $ millions)
As of March 31, 2023
Derivatives Designated as Cash Flow Hedges
Commodity swaps— 4 4 Current Other assets
Commodity swaps— 43 43 Noncurrent Other assets
Foreign currency forwards and swaps— 1 1 Current Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— 67 67 Current Other assets
Cross-currency swaps— 11 11 Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— 12 12 Current Other assets
Total assets— 138 138 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— (29)(29)Current Other liabilities
Cross-currency swaps— (145)(145)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— (10)(10)Current Other liabilities
Total liabilities— (184)(184)
Fair Value Measurement
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		TotalBalance Sheet Classification
(In $ millions)
As of December 31, 2022
Derivatives Designated as Cash Flow Hedges
Commodity swaps— 9 9 Current Other assets
Commodity swaps— 39 39 Noncurrent Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— 99 99 Current Other assets
Cross-currency swaps— 13 13 Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— 9 9 Current Other assets
Total assets— 169 169 
Derivatives Designated as Cash Flow Hedges
Commodity swaps— (2)(2)Current Other liabilities
Derivatives Designated as Net Investment Hedges
Cross-currency swaps— (58)(58)Current Other liabilities
Cross-currency swaps— (126)(126)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps— (3)(3)Current Other liabilities
Total liabilities— (189)(189)
Schedule of Carrying Values and Fair Values of Financial Instruments
Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
Fair Value Measurement
Carrying
Amount		Significant Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
(In $ millions)
As of March 31, 2023
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts21 21 — 21 
Long-term debt, including current installments of long-term debt
14,017 13,608 169 13,777 
As of December 31, 2022
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts22 23 — 23 
Long-term debt, including current installments of long-term debt
13,953 13,247 172 13,419 
XML 58 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Business Segments

Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended March 31, 2023
Net sales1,630 1,250 — (27)(1)2,853 
Other (charges) gains, net (Note 18)
(21)(1)(1)— (23)
Operating profit (loss)112 278 (139)— 251 
Equity in net earnings (loss) of affiliates
11 1 3 — 15 
Depreciation and amortization112 54 6 — 172 
Capital expenditures45 51 12 — 108 (2)
As of March 31, 2023
Goodwill and intangible assets, net
10,800 425 — — 11,225 
Total assets
18,522 5,730 1,838 — 26,090 
Three Months Ended March 31, 2022
Net sales
910 

1,652 

— (24)(1)2,538 
Other (charges) gains, net (Note 18)
(1)— — — (1)
Operating profit (loss)
124 503 (96)— 531 
Equity in net earnings (loss) of affiliates
49 4 3 — 56 
Depreciation and amortization
46 56 4 — 106 
Capital expenditures
30 70 14 — 114 (2)
As of December 31, 2022
Goodwill and intangible assets, net
10,826 421 — — 11,247 
Total assets
20,611 5,471 190 — 26,272 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $56 million and $23 million for the three months ended March 31, 2023 and 2022, respectively.
XML 59 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue Recognition (Tables)
 3 Months Ended
Mar. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]  
Schedule of Revenue by Major Customers by Reporting Segments
Further disaggregation of Net sales by business segment and geographic destination is as follows:
Three Months Ended
March 31,
20232022
(In $ millions)
Engineered Materials
North America479 289 
Europe and Africa560 377 
Asia-Pacific548 221 
South America43 23 
Total1,630 910 
Acetyl Chain
North America365 425 
Europe and Africa460 592 
Asia-Pacific367 561 
South America31 50 
Total(1)
1,223 1,628 
______________________________
(1)Excludes intersegment sales of $27 million and $24 million for the three months ended March 31, 2023 and 2022, respectively.
XML 60 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share (Tables)
 3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings (Loss) Per Share
Three Months Ended
March 31,
20232022
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations94 502 
Earnings (loss) from discontinued operations(3)— 
Net earnings (loss)91 502 
Weighted average shares - basic108,634,068 108,185,912 
Incremental shares attributable to equity awards(1)
554,198 731,665 
Weighted average shares - diluted109,188,266 108,917,577 
______________________________
(1)Excludes options to purchase 86,194 and 0 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively; and 72,574 and 61,297 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively, as their effect would have been antidilutive.
XML 61 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Description of the Company and Basis of Presentation (Narrative) (Details)
Mar. 31, 2023
Consolidated Ventures  
Variable Interest Entity [Line Items]  
Noncontrolling interest, ownership percentage by parent 100.00%
XML 62 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details)
€ in Millions, $ in Millions
 3 Months Ended
Nov. 01, 2022
USD ($)
employees
facility
patent
Apr. 01, 2022
USD ($)
annualInstallment
Apr. 01, 2022
EUR (€)
annualInstallment
Mar. 31, 2022
USD ($)
Korea Engineering Plastics Co., Ltd.        
Business Acquisition [Line Items]        
Payments to equity method investment   $ 5 € 24  
Number of equal annual investments restructuring payment | annualInstallment   5 5  
Equity method investment, increase   $ 134    
Celanese Corporation | Korea Engineering Plastics Co., Ltd.        
Business Acquisition [Line Items]        
Equity method investment, ownership percentage   50.00% 50.00%  
Mitsubishi Gas Chemical Company | Korea Engineering Plastics Co., Ltd.        
Business Acquisition [Line Items]        
Equity method investment, ownership percentage   50.00% 50.00%  
Mobility & Materials        
Business Acquisition [Line Items]        
Business Acquisition, Percentage of Voting Interests Acquired 100.00%      
Payments to acquire businesses, gross $ 11,000      
Number of facilities | facility 29      
Number of patents | patent 850      
Entity number of employees | employees 5,000      
Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization       $ 172
Business Combination, Pro Forma Information, Inventory Step Up Amortization       $ 98
XML 63 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2022
USD ($)
Restructuring and Related Activities [Abstract]  
Proforma Net sales $ 3,427
Proforma Earnings (loss) from continuing operations before tax $ 312
XML 64 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Finished goods $ 1,811 $ 1,820
Work-in-process 210 202
Raw materials and supplies 728 786
Total $ 2,749 $ 2,808
XML 65 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
Goodwill [Line Items]  
As of December 31, 2022 $ 7,142
Acquisitions (Note 3) (18)
Exchange rate changes 15
As of March 31, 2023(1) 7,139 [1]
Goodwill, impaired, accumulated impairment loss 0
Engineered Materials  
Goodwill [Line Items]  
As of December 31, 2022 6,775
Acquisitions (Note 3) (18)
Exchange rate changes 11
As of March 31, 2023(1) 6,768 [1]
Acetyl Chain  
Goodwill [Line Items]  
As of December 31, 2022 367
Acquisitions (Note 3) 0
Exchange rate changes 4
As of March 31, 2023(1) $ 371 [1]
[1] There were no accumulated impairment losses as of March 31, 2023.
XML 66 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2022 $ 3,153  
Exchange rate changes 22  
As of March 31, 2023 3,175  
As of December 31, 2022 (696)  
Amortization (41) $ (11)
Exchange rate changes (8)  
As of March 31, 2023 (745)  
Net book value 2,430  
Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend 0  
Licenses    
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2022 42  
Exchange rate changes 0  
As of March 31, 2023 42  
As of December 31, 2022 (39)  
Amortization 0  
Exchange rate changes 0  
As of March 31, 2023 (39)  
Net book value 3  
Customer- Related Intangible Assets    
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2022 2,455  
Exchange rate changes 22  
As of March 31, 2023 2,477  
As of December 31, 2022 (567)  
Amortization (30)  
Exchange rate changes (8)  
As of March 31, 2023 (605)  
Net book value 1,872  
Developed Technology    
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2022 601  
Exchange rate changes 0  
As of March 31, 2023 601  
As of December 31, 2022 (50)  
Amortization (11)  
Exchange rate changes 0  
As of March 31, 2023 (61)  
Net book value 540  
Covenants Not to Compete and Other    
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2022 55  
Exchange rate changes 0  
As of March 31, 2023 55  
As of December 31, 2022 (40)  
Amortization 0  
Exchange rate changes 0  
As of March 31, 2023 (40)  
Net book value $ 15  
XML 67 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) - Trademarks and Trade Names
$ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
Indefinite-lived Intangible Assets [Line Items]  
As of December 31, 2022 $ 1,648
Exchange rate changes 8
As of March 31, 2023 $ 1,656
XML 68 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)
$ in Millions
Mar. 31, 2023
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2024 $ 160
2025 160
2026 160
2027 160
2028 $ 160
XML 69 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Current Other Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current Other Liabilities [Line Items]    
Benefit obligations (Note 8) $ 25 $ 25
Customer rebates 91 101
Derivatives (Note 12) 39 63
Interest (Note 7) 155 265
Legal (Note 14) 22 21
Operating leases 88 83
Restructuring (Note 18) 23 6
Salaries and benefits 123 151
Sales and use tax/foreign withholding tax payable 91 108
Investment in affiliates 94 79
Other Sundry Liabilities, Current [1] 263 299
Total 1,014 1,201
Mobility & Materials    
Current Other Liabilities [Line Items]    
Other Sundry Liabilities, Current $ 104 $ 166
[1] Includes $104 million and $166 million of liabilities related to the M&M Acquisition payable to DuPont as of March 31, 2023 and December 31, 2022, respectively.
XML 70 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Schedule of Short-term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Current installments of long-term debt $ 551 $ 506
Short-term borrowings, including amounts due to affiliates(1) [1] 617 500
Total $ 1,386 $ 1,306
Loans Payable    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Weighted average interest rate, short-term borrowings 5.60% 5.80%
Revolving Credit Facility    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Weighted average interest rate, short-term borrowings 3.40% 5.80%
Revolving Credit Facility    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Revolving credit facilities(2) [2] $ 218 $ 300
Revolving Credit Facility | Revolving Credit Facility    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Revolving credit facilities(2) $ 0  
[1] The weighted average interest rate was 5.6% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.
[2] The weighted average interest rate was 3.4% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.
XML 71 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Schedule of Long-term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Total debt $ 169 $ 172
Subtotal 14,017 13,953
Unamortized debt issuance costs [1] (70) (74)
Long-Term Debt and Lease Obligation, Current (551) (506)
Total 13,396 13,373
Senior Unsecured Notes Due 2023    
Debt Instrument [Line Items]    
Senior unsecured debt $ 489 480
Debt Instrument, Interest Rate, Stated Percentage 1.125%  
Senior Unsecured Notes Due 2024    
Debt Instrument [Line Items]    
Senior unsecured debt $ 499 499
Debt Instrument, Interest Rate, Stated Percentage 3.50%  
Acquisition Notes Due July 2024    
Debt Instrument [Line Items]    
Senior unsecured debt $ 2,000 2,000
Debt Instrument, Interest Rate, Stated Percentage 5.90%  
Senior Unsecured Notes Due 2025    
Debt Instrument [Line Items]    
Senior unsecured debt $ 326 320
Debt Instrument, Interest Rate, Stated Percentage 1.25%  
Acquisition Notes Due March 2025    
Debt Instrument [Line Items]    
Senior unsecured debt $ 1,750 1,750
Debt Instrument, Interest Rate, Stated Percentage 6.05%  
Senior Unsecured Term Loan Due 2025    
Debt Instrument [Line Items]    
Senior unsecured debt $ 750 750
Debt Instrument, Interest Rate, Stated Percentage 6.265%  
Senior Unsecured Notes Due 2026    
Debt Instrument [Line Items]    
Senior unsecured debt $ 400 400
Debt Instrument, Interest Rate, Stated Percentage 1.40%  
EUR Senior Unsecured Notes Due 2026    
Debt Instrument [Line Items]    
Senior unsecured debt $ 1,088 1,067
Debt Instrument, Interest Rate, Stated Percentage 4.777%  
Senior Unsecured Notes Due 2027    
Debt Instrument [Line Items]    
Senior unsecured debt $ 542 531
Debt Instrument, Interest Rate, Stated Percentage 2.125%  
USD Senior Unsecured Notes Due 2027    
Debt Instrument [Line Items]    
Senior unsecured debt $ 2,000 2,000
Debt Instrument, Interest Rate, Stated Percentage 6.165%  
Senior Unsecured Term Loan Due 2027    
Debt Instrument [Line Items]    
Senior unsecured debt $ 1,000 1,000
Debt Instrument, Interest Rate, Stated Percentage 6.265%  
Senior Unsecured Notes Due 2028    
Debt Instrument [Line Items]    
Senior unsecured debt $ 543 533
Debt Instrument, Interest Rate, Stated Percentage 0.625%  
EUR Senior Unsecured Notes Due 2029    
Debt Instrument [Line Items]    
Senior unsecured debt $ 544 533
Debt Instrument, Interest Rate, Stated Percentage 5.337%  
Acquisition Notes Due July 2029    
Debt Instrument [Line Items]    
Senior unsecured debt $ 750 750
Debt Instrument, Interest Rate, Stated Percentage 6.33%  
USD Senior Unsecured Notes Due 2032    
Debt Instrument [Line Items]    
Senior unsecured debt $ 1,000 1,000
Debt Instrument, Interest Rate, Stated Percentage 6.379%  
Refunding loan for pollution control and industrial revenue bonds    
Debt Instrument [Line Items]    
Other long-term debt $ 163 164
Refunding loan for pollution control and industrial revenue bonds | Minimum    
Debt Instrument [Line Items]    
Debt Instrument, Interest Rate, Stated Percentage 4.05%  
Refunding loan for pollution control and industrial revenue bonds | Maximum    
Debt Instrument [Line Items]    
Debt Instrument, Interest Rate, Stated Percentage 5.00%  
Loans Payable    
Debt Instrument [Line Items]    
Other long-term debt [2] $ 4 $ 4
Long-term debt, weighted average interest rate, at point in time 1.30% 1.30%
[1] Related to the Company's long-term debt, excluding obligations under finance leases.
[2] The weighted average interest rate was 1.3% and 1.3% as of March 31, 2023 and December 31, 2022, respectively.
XML 72 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Senior Credit Facilities Narrative (Details)
¥ in Millions, $ in Millions
Jan. 06, 2023
CNY (¥)
Sep. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Jan. 04, 2023
CNY (¥)
364 Day Delayed-Draw Term Loan | Term Loan Facility        
Debt Instrument [Line Items]        
Debt instrument, term     364 days  
Debt instrument, face amount     $ 500  
5 Year Delayed-Draw Term Loan | Term Loan Facility        
Debt Instrument [Line Items]        
Debt instrument, term     5 years  
Debt instrument, face amount     $ 1,000  
3 Year Delayed-Draw Term Loan | Term Loan Facility        
Debt Instrument [Line Items]        
Debt instrument, term   3 years    
Debt instrument, face amount   $ 750    
Revolving Credit Facility | Revolving Credit Facility        
Debt Instrument [Line Items]        
Maximum borrowing base     $ 1,750  
China Revolving Credit Facility | Revolving Credit Facility        
Debt Instrument [Line Items]        
Maximum borrowing base | ¥       ¥ 1,750
China Working Capital Term Loan | China Working Capital Term Loan        
Debt Instrument [Line Items]        
Debt instrument, term 12 months      
Debt instrument, face amount | ¥ ¥ 800      
China Working Capital Term Loan | China Working Capital Term Loan | Variable Interbank Interest Rate        
Debt Instrument [Line Items]        
Debt instrument, basis spread on variable rate 0.50%      
XML 73 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Schedule of Revolving Credit Facility (Details) - Revolving Credit Facility - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Line of Credit Facility [Line Items]    
Revolving credit facilities(2) [1] $ 218 $ 300
Revolving Credit Facility    
Line of Credit Facility [Line Items]    
Revolving credit facilities(2) 0  
Available for borrowing 1,750  
China Revolving Credit Facility    
Line of Credit Facility [Line Items]    
Revolving credit facilities(2) 218  
Available for borrowing $ 37  
[1] The weighted average interest rate was 3.4% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.
XML 74 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Senior Notes Narrative (Details)
$ in Millions, € in Billions
 3 Months Ended
Jul. 31, 2022
USD ($)
Mar. 31, 2023
Jul. 31, 2022
EUR (€)
Debt Instrument [Line Items]      
Debt instrument, redemption price, percentage   100.00%  
Acquisition Notes      
Debt Instrument [Line Items]      
Debt instrument, face amount $ 7,500   € 1.5
Notes offering related costs $ 65    
XML 75 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Accounts Receivable Securitization Facility Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Amended restated receivable securitization facility | Secured Debt    
Line of Credit Facility [Line Items]    
Percentage of fair value of sales receivables 100.00%  
Secured Debt | Amended restated receivable securitization facility    
Line of Credit Facility [Line Items]    
Transfer of financial assets accounted for as sales, amount derecognized $ 249 $ 1,100
Proceeds collected on accounts receivable sold under factoring facilities 249 $ 1,100
Cash flows between transferor and transferee, proceeds from new transfers $ 109  
XML 76 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Factoring and Discounting Agreements Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Europe Factoring Agreements    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage 100.00%  
Singapore Factoring Agreements    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage 90.00%  
Europe and Singapore Factoring Agreement    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, amount derecognized $ 87 $ 320
Proceeds collected on accounts receivable sold under factoring facilities $ 82 $ 325
XML 77 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Pension Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Service cost $ 4 $ 3
Interest cost 32 17
Expected return on plan assets (33) (41)
Total 3 (21)
Post-retirement Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Service cost 0 0
Interest cost 0 0
Expected return on plan assets 0 0
Total $ 0 $ 0
XML 78 R59.htm IDEA: XBRL DOCUMENT v3.23.1
Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
Cash contributions to defined benefit pension plans  
Defined Benefit Plan Disclosure [Line Items]  
Total contributions year-to-date $ 6
Total expected contributions in current fiscal year 27
Benefit payments to nonqualified pension plans  
Defined Benefit Plan Disclosure [Line Items]  
Total contributions year-to-date 5
Total expected contributions in current fiscal year 18
Benefit payments to other postretirement benefit plans  
Defined Benefit Plan Disclosure [Line Items]  
Total contributions year-to-date 1
Total expected contributions in current fiscal year $ 4
XML 79 R60.htm IDEA: XBRL DOCUMENT v3.23.1
Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Pension Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Noncurrent Other assets $ 166 $ 160
Current Other liabilities (21) (21)
Benefit obligations (371) (372)
Net amount recognized (226) (233)
Post-retirement Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Noncurrent Other assets 0 0
Current Other liabilities (3) (3)
Benefit obligations (35) (35)
Net amount recognized $ (38) $ (38)
XML 80 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Environmental (Schedule of Environmental Remediation Reserves) (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Environmental Remediation Obligations [Abstract]    
Demerger obligations (Note 14) $ 19 $ 20
Divestiture obligations (Note 14) 14 14
Active sites 20 21
U.S. Superfund sites 9 10
Other environmental remediation liabilities 2 2
Total $ 64 $ 67
XML 81 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Environmental - US Superfund Sites Narrative (Details) - Passaic River, New Jersey
$ in Millions
 3 Months Ended
Mar. 24, 2023
USD ($)
Dec. 16, 2022
USD ($)
Sep. 30, 2021
USD ($)
Mar. 31, 2016
USD ($)
Mar. 31, 2023
Site Contingency [Line Items]          
Number of parties included in USEPA order 40       70
Cost of EPA's plan estimate $ 71 $ 150 $ 441 $ 1,400  
Environmental liability percentage         1.00%
XML 82 R63.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
Apr. 19, 2023
Mar. 31, 2023
Dec. 31, 2022
Class of Stock [Line Items]      
Common stock, par value (in dollars per share)   $ 0.0001 $ 0.0001
Subsequent Event      
Class of Stock [Line Items]      
Common stock, dividends, declared (in dollar per share) $ 0.70    
Dividends, common stock, cash $ 76    
XML 83 R64.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Schedule of Treasury Stock (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 182 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Stockholders' Equity Note [Abstract]      
Shares repurchased (in shares) 0 0 69,324,429
Average purchase price (in dollar per share)     $ 83.71
Shares repurchased (in $ millions)     $ 5,803
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)     $ 6,866
XML 84 R65.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Stockholders' Equity Note [Abstract]    
Foreign currency translation gain (loss), gross amount $ (4) $ (15)
Foreign currency translation gain (loss), income tax (provision) benefit 17 (6)
Foreign currency translation gain (loss) 13 (21)
Gain (loss) on cash flow hedges, gross amount 4 19
Gain (loss) on cash flow hedges, income tax (provision) benefit 0 (4)
Gain (loss) on cash flow hedges, net amount 4 15
Total other comprehensive income (loss), before tax (1) 6
Total other comprehensive income (loss), tax (17) 10
Total other comprehensive income (loss), net of tax 16 (4)
Pension and postretirement benefits gain (loss), gross amount (1) 2
Pension and postretirement benefits gain (loss), income tax (provision) benefit 0 0
Pension and postretirement benefits $ (1) $ 2
XML 85 R66.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss), net [Line Items]    
As of December 31, 2022 $ (518)  
Other comprehensive income (loss) before reclassifications (3)  
Amounts reclassified from accumulated other comprehensive income (loss) 2  
Income tax (provision) benefit 17 $ (10)
As of March 31, 2023 (502)  
Foreign Currency Translation Gain (Loss)    
Accumulated Other Comprehensive Income (Loss), net [Line Items]    
As of December 31, 2022 (488)  
Other comprehensive income (loss) before reclassifications (4)  
Amounts reclassified from accumulated other comprehensive income (loss) 0  
Income tax (provision) benefit 17  
As of March 31, 2023 (475)  
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent    
Accumulated Other Comprehensive Income (Loss), net [Line Items]    
As of December 31, 2022 (22)  
Other comprehensive income (loss) before reclassifications 2  
Amounts reclassified from accumulated other comprehensive income (loss) 2  
Income tax (provision) benefit 0  
As of March 31, 2023 (18)  
Pension and Postretirement Benefits    
Accumulated Other Comprehensive Income (Loss), net [Line Items]    
As of December 31, 2022 (8)  
Other comprehensive income (loss) before reclassifications (1)  
Amounts reclassified from accumulated other comprehensive income (loss) 0  
Income tax (provision) benefit 0  
As of March 31, 2023 $ (9)  
XML 86 R67.htm IDEA: XBRL DOCUMENT v3.23.1
Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Restructuring and Related Activities [Abstract]    
Restructuring $ (23) $ (1)
Total $ (23) $ (1)
XML 87 R68.htm IDEA: XBRL DOCUMENT v3.23.1
Other (Charges) Gains, Net - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Restructuring and Related Activities [Abstract]    
Restructuring Charges $ (23) $ (1)
XML 88 R69.htm IDEA: XBRL DOCUMENT v3.23.1
Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Restructuring Reserve [Roll Forward]    
Additions $ 23 $ 1
Employee Severance    
Restructuring Reserve [Roll Forward]    
Beginning balance 6  
Additions 23  
Cash payments (6)  
Ending balance 23  
Employee Severance | Engineered Materials    
Restructuring Reserve [Roll Forward]    
Beginning balance 4  
Additions 21  
Cash payments (4)  
Ending balance 21  
Employee Severance | Acetyl Chain [Member]    
Restructuring Reserve [Roll Forward]    
Beginning balance 1  
Additions 1  
Cash payments (1)  
Ending balance 1  
Employee Severance | Other Activities    
Restructuring Reserve [Roll Forward]    
Beginning balance 1  
Additions 1  
Cash payments (1)  
Ending balance $ 1  
XML 89 R70.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes - Schedule of Effective Tax Rate (Details)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]    
Effective income tax rate 21.00% 18.00%
XML 90 R71.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details)
€ in Millions, $ in Millions
Mar. 31, 2023
EUR (€)
Dec. 31, 2022
EUR (€)
Jul. 31, 2022
EUR (€)
Jul. 31, 2022
USD ($)
Foreign Currency Denominated Debt [Member] | Net Investment Hedging [Member]        
Derivative [Line Items]        
Notional Amount of Nonderivative Instruments | € € 5,652 € 5,639    
USD Senior Unsecured Notes Due 2027 | Currency Swap        
Derivative [Line Items]        
Derivative, notional amount | $       $ 2,000
USD Senior Unsecured Notes Due 2032 | Currency Swap        
Derivative [Line Items]        
Derivative, notional amount | $       $ 500
Acquisition Notes | Net Investment Hedging [Member]        
Derivative [Line Items]        
Notional Amount of Nonderivative Instruments | €     € 1,500  
XML 91 R72.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Not Designated as Hedging Instrument | Foreign Exchange Contract [Member]    
Derivative [Line Items]    
Derivative, notional amount $ 1,892 $ 1,314
XML 92 R73.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Not Designated as Hedging Instrument    
Derivative [Line Items]    
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ 0 $ 0
Gain (Loss) Recognized in Earnings (Loss) 2 (1)
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument    
Derivative [Line Items]    
Gain (Loss) Recognized in Other Comprehensive Income (Loss) 0 0
Gain (Loss) Recognized in Earnings (Loss) $ 2 $ (1)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Foreign exchange gain (loss), net, Other income (expense), net Foreign exchange gain (loss), net, Other income (expense), net
Derivatives Designated as Cash Flow Hedges    
Derivative [Line Items]    
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ 2 $ 17
Gain (Loss) Recognized in Earnings (Loss) (2) (2)
Derivatives Designated as Cash Flow Hedges | Commodity swaps    
Derivative [Line Items]    
Gain (Loss) Recognized in Other Comprehensive Income (Loss) 0 17
Gain (Loss) Recognized in Earnings (Loss) $ 1 $ 0
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of Goods and Services Sold Cost of Goods and Services Sold
Derivatives Designated as Cash Flow Hedges | Foreign Exchange Contract [Member]    
Derivative [Line Items]    
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ 2 $ 0
Gain (Loss) Recognized in Earnings (Loss) $ (1) $ 0
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of Goods and Services Sold Cost of Goods and Services Sold
Derivatives Designated as Cash Flow Hedges | Interest Rate Swap [Member]    
Derivative [Line Items]    
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ 0 $ 0
Gain (Loss) Recognized in Earnings (Loss) $ (2) $ (2)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Interest Expense Interest Expense
Net Investment Hedging [Member]    
Derivative [Line Items]    
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ (75) $ 30
Gain (Loss) Recognized in Earnings (Loss) 0 0
Net Investment Hedging [Member] | Currency Swap    
Derivative [Line Items]    
Gain (Loss) Recognized in Earnings (Loss) 0 0
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax (19) 2
Foreign Currency Denominated Debt [Member] | Net Investment Hedging [Member]    
Derivative [Line Items]    
Gain (Loss) Recognized in Other Comprehensive Income (Loss) (56) 28
Gain (Loss) Recognized in Earnings (Loss) $ 0 $ 0
XML 93 R74.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Derivative Assets [Abstract]    
Gross amount recognized $ 139 $ 169
Gross amount offset in the consolidated balance sheets 1 0
Net amount presented in the consolidated balance sheets 138 169
Gross amount not offset in the consolidated balance sheets 26 16
Net amount $ 112 $ 153
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other assets, Other Assets, Noncurrent Other assets, Other Assets, Noncurrent
XML 94 R75.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Derivative Liabilities [Abstract]    
Gross amount recognized $ 185 $ 189
Gross amount offset in the consolidated balance sheets 1 0
Net amount presented in the consolidated balance sheets 184 189
Gross amount not offset in the consolidated balance sheets 26 16
Net amount $ 158 $ 173
Derivative liability, statement of financial position [Extensible Enumeration] Other liabilities, Other liabilities Other liabilities, Other liabilities
XML 95 R76.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset $ 112 $ 153
Commodity swaps $ (158) $ (173)
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other assets Other assets
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other Assets, Noncurrent Other Assets, Noncurrent
Derivative liability, statement of financial position [Extensible Enumeration]   Other liabilities
Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 138 $ 169
Total liabilities (184) (189)
Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 0 0
Total liabilities 0 0
Fair Value, Recurring | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 138 169
Total liabilities (184) (189)
Current Other assets | Fair Value, Recurring | Not Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 12 9
Current Other assets | Fair Value, Recurring | Not Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 0 0
Current Other assets | Fair Value, Recurring | Not Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 12 9
Current Other liabilities | Fair Value, Recurring | Not Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps (10) (3)
Current Other liabilities | Fair Value, Recurring | Not Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 0 0
Current Other liabilities | Fair Value, Recurring | Not Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps (10) (3)
Derivatives Designated as Cash Flow Hedges | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 1  
Derivatives Designated as Cash Flow Hedges | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 0  
Derivatives Designated as Cash Flow Hedges | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 1  
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Fair Value, Recurring | Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Commodity swaps   (2)
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Fair Value, Recurring | Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Commodity swaps   0
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Commodity swaps   (2)
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset 4 9
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset 0 0
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset 4 9
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Noncurrent Other assets | Fair Value, Recurring | Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset 43 39
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Noncurrent Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset 0 0
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Noncurrent Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset 43 39
Currency Swap | Net Investment Hedging [Member] | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 67 99
Currency Swap | Net Investment Hedging [Member] | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 0 0
Currency Swap | Net Investment Hedging [Member] | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 67 99
Currency Swap | Net Investment Hedging [Member] | Noncurrent Other assets | Fair Value, Recurring | Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 11 13
Currency Swap | Net Investment Hedging [Member] | Noncurrent Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 0 0
Currency Swap | Net Investment Hedging [Member] | Noncurrent Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 11 13
Currency Swap | Net Investment Hedging [Member] | Current Other liabilities | Fair Value, Recurring | Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps (29) (58)
Currency Swap | Net Investment Hedging [Member] | Current Other liabilities | Fair Value, Recurring | Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 0 0
Currency Swap | Net Investment Hedging [Member] | Current Other liabilities | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps (29) (58)
Currency Swap | Net Investment Hedging [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Recurring | Designated as Hedging Instrument    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps (145) (126)
Currency Swap | Net Investment Hedging [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Recurring | Designated as Hedging Instrument | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 0 0
Currency Swap | Net Investment Hedging [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps $ (145) $ (126)
XML 96 R77.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Equity investments without readily determinable fair values, carrying amount $ 170 $ 170    
Equity investments without readily determinable fair values, fair value 0 0    
Insurance contracts in nonqualified trusts, carrying amount 21 22    
Insurance contracts in nonqualified trusts, fair value 21 23    
Long-term debt, including current installments of long-term debt, carrying amount 14,017 13,953    
Long-term debt, including current installments of long-term debt, fair value 13,777 13,419    
Cash and cash equivalents 1,167 1,508 $ 605 $ 536
Significant Other Observable Inputs (Level 2)        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Equity investments without readily determinable fair values, fair value 0 0    
Insurance contracts in nonqualified trusts, fair value 21 23    
Long-term debt, including current installments of long-term debt, fair value 13,608 13,247    
Unobservable Inputs (Level 3)        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Equity investments without readily determinable fair values, fair value 0 0    
Insurance contracts in nonqualified trusts, fair value 0 0    
Long-term debt, including current installments of long-term debt, fair value $ 169 $ 172    
XML 97 R78.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies - Narrative (Details) - 281 months ended Mar. 31, 2023
€ in Millions, $ in Millions
USD ($)
EUR (€)
USD ($)
Loss Contingencies [Line Items]      
Unrecorded unconditional purchase obligations     $ 4,200
Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year     532
Unrecorded Unconditional Purchase Obligation, to be Paid, Year One     675
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two     549
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three     419
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four     $ 341
Indemnification Agreements Hoechst      
Loss Contingencies [Line Items]      
Number of divestiture agreements   19 19
Indemnification amount | €   € 250  
Indemnification ceiling amount | €   € 750  
Indemnification percentage exceeding ceiling amount   33.33% 33.33%
Loss contingency accrual, carrying value, payments $ 108    
Indemnification percentage, other   33.33% 33.33%
Divestiture Agreements      
Loss Contingencies [Line Items]      
Guarantor obligations, maximum exposure     $ 126
XML 98 R79.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information - Schedule of Business Segments (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Net sales $ 2,853 $ 2,538  
Other (charges) gains, net (Note 14) (23) (1)  
Operating profit (loss) 251 531  
Equity in net earnings (loss) of affiliates 15 56  
Depreciation and amortization 172 106  
Capital expenditures [1] 108 114  
Goodwill and intangible assets, net 11,225   $ 11,247
Total assets 26,090   26,272
Increase (decrease) in accrued capital expenditures (56) (23)  
Engineered Materials      
Segment Reporting Information [Line Items]      
Net sales 1,630 910  
Acetyl Chain      
Segment Reporting Information [Line Items]      
Net sales [2] 1,223 1,628  
Operating Segments | Engineered Materials      
Segment Reporting Information [Line Items]      
Net sales 1,630 910  
Other (charges) gains, net (Note 14) (21) (1)  
Operating profit (loss) 112 124  
Equity in net earnings (loss) of affiliates 11 49  
Depreciation and amortization 112 46  
Capital expenditures 45 30  
Goodwill and intangible assets, net 10,800   10,826
Total assets 18,522   20,611
Operating Segments | Acetyl Chain      
Segment Reporting Information [Line Items]      
Net sales 1,250 1,652  
Other (charges) gains, net (Note 14) (1) 0  
Operating profit (loss) 278 503  
Equity in net earnings (loss) of affiliates 1 4  
Depreciation and amortization 54 56  
Capital expenditures 51 70  
Goodwill and intangible assets, net 425   421
Total assets 5,730   5,471
Corporate, Non-Segment | Other Activities      
Segment Reporting Information [Line Items]      
Net sales 0 0  
Other (charges) gains, net (Note 14) (1) 0  
Operating profit (loss) (139) (96)  
Equity in net earnings (loss) of affiliates 3 3  
Depreciation and amortization 6 4  
Capital expenditures 12 14  
Goodwill and intangible assets, net 0   0
Total assets 1,838   190
Eliminations      
Segment Reporting Information [Line Items]      
Net sales [3] (27) (24)  
Other (charges) gains, net (Note 14) 0 0  
Operating profit (loss) 0 0  
Equity in net earnings (loss) of affiliates 0 0  
Depreciation and amortization 0 0  
Capital expenditures 0 0  
Goodwill and intangible assets, net 0   0
Total assets 0   $ 0
Eliminations | Acetyl Chain      
Segment Reporting Information [Line Items]      
Net sales $ 27 $ 24  
[1] Includes a decrease in accrued capital expenditures of $56 million and $23 million for the three months ended March 31, 2023 and 2022, respectively.
[2] Excludes intersegment sales of $27 million and $24 million for the three months ended March 31, 2023 and 2022, respectively.
[3] Includes intersegment sales primarily related to the Acetyl Chain.
XML 99 R80.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue Recognition - Disaggregation of net sales (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue, Major Customer [Line Items]    
Net sales $ 2,853 $ 2,538
Engineered Materials    
Revenue, Major Customer [Line Items]    
Net sales 1,630 910
Acetyl Chain    
Revenue, Major Customer [Line Items]    
Net sales [1] 1,223 1,628
Intersegment Eliminations    
Revenue, Major Customer [Line Items]    
Net sales [2] (27) (24)
Intersegment Eliminations | Acetyl Chain    
Revenue, Major Customer [Line Items]    
Net sales 27 24
North America | Engineered Materials    
Revenue, Major Customer [Line Items]    
Net sales 479 289
North America | Acetyl Chain    
Revenue, Major Customer [Line Items]    
Net sales 365 425
Europe and Africa | Engineered Materials    
Revenue, Major Customer [Line Items]    
Net sales 560 377
Europe and Africa | Acetyl Chain    
Revenue, Major Customer [Line Items]    
Net sales 460 592
Asia-Pacific | Engineered Materials    
Revenue, Major Customer [Line Items]    
Net sales 548 221
Asia-Pacific | Acetyl Chain    
Revenue, Major Customer [Line Items]    
Net sales 367 561
South America | Engineered Materials    
Revenue, Major Customer [Line Items]    
Net sales 43 23
South America | Acetyl Chain    
Revenue, Major Customer [Line Items]    
Net sales $ 31 $ 50
[1] Excludes intersegment sales of $27 million and $24 million for the three months ended March 31, 2023 and 2022, respectively.
[2] Includes intersegment sales primarily related to the Acetyl Chain.
XML 100 R81.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue Recognition Remaining Performance Obligations (Details)
$ in Millions
Mar. 31, 2023
USD ($)
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 1,400
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01  
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 378
Revenue, remaining performance obligation, expected timing of satisfaction, period 9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 460
Revenue, remaining performance obligation, expected timing of satisfaction, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 319
Revenue, remaining performance obligation, expected timing of satisfaction, period 1 year
XML 101 R82.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Amounts attributable to Celanese Corporation    
Earnings (loss) from continuing operations $ 94 $ 502
Earnings (loss) from discontinued operations (3) 0
Net earnings (loss) $ 91 $ 502
Weighted average shares - basic (in shares) 108,634,068 108,185,912
Incremental shares attributable to equity awards(1) [1] 554,198 731,665
Weighted average shares - diluted 109,188,266 108,917,577
[1] Excludes options to purchase 86,194 and 0 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively; and 72,574 and 61,297 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively, as their effect would have been antidilutive.
XML 102 R83.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share - Narrative (Details) - shares
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-Based Payment Arrangement, Option    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 86,194 0
Antidilutive securities excluded from computation of earnings per share, amount 86,194 0
Restricted Stock Units (RSUs)    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 72,574 61,297
Antidilutive securities excluded from computation of earnings per share, amount 72,574 61,297
XML 103 ce-20230331_htm.xml IDEA: XBRL DOCUMENT 0001306830 2023-01-01 2023-03-31 0001306830 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2023Member 2023-01-01 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2025Member 2023-01-01 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2026Member 2023-01-01 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2027Member 2023-01-01 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2028Member 2023-01-01 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2029Member 2023-01-01 2023-03-31 0001306830 2023-05-05 0001306830 2022-01-01 2022-03-31 0001306830 2023-03-31 0001306830 2022-12-31 0001306830 us-gaap:CommonStockMember 2022-12-31 0001306830 us-gaap:CommonStockMember 2021-12-31 0001306830 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001306830 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001306830 us-gaap:CommonStockMember 2023-03-31 0001306830 us-gaap:CommonStockMember 2022-03-31 0001306830 us-gaap:TreasuryStockMember 2022-12-31 0001306830 us-gaap:TreasuryStockMember 2021-12-31 0001306830 us-gaap:TreasuryStockMember 2023-01-01 2023-03-31 0001306830 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001306830 us-gaap:TreasuryStockMember 2023-03-31 0001306830 us-gaap:TreasuryStockMember 2022-03-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001306830 us-gaap:RetainedEarningsMember 2022-12-31 0001306830 us-gaap:RetainedEarningsMember 2021-12-31 0001306830 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001306830 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001306830 us-gaap:RetainedEarningsMember 2023-03-31 0001306830 us-gaap:RetainedEarningsMember 2022-03-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001306830 2022-03-31 0001306830 us-gaap:NoncontrollingInterestMember 2022-12-31 0001306830 us-gaap:NoncontrollingInterestMember 2021-12-31 0001306830 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001306830 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001306830 us-gaap:NoncontrollingInterestMember 2023-03-31 0001306830 us-gaap:NoncontrollingInterestMember 2022-03-31 0001306830 2021-12-31 0001306830 ce:ConsolidatedVenturesMember 2023-03-31 0001306830 ce:MobilityMaterialsMember 2022-11-01 0001306830 ce:MobilityMaterialsMember 2022-11-01 2022-11-01 0001306830 ce:MobilityMaterialsMember 2022-01-01 2022-03-31 0001306830 ce:CelaneseCorporationMember ce:KoreaEngineeringPlasticsCoLtdMember 2022-04-01 0001306830 ce:MitsubishiGasChemicalCompanyMember ce:KoreaEngineeringPlasticsCoLtdMember 2022-04-01 0001306830 ce:KoreaEngineeringPlasticsCoLtdMember 2022-04-01 2022-04-01 0001306830 ce:KoreaEngineeringPlasticsCoLtdMember 2022-04-01 0001306830 ce:EngineeredMaterialsMember 2022-12-31 0001306830 ce:AcetylChainMember 2022-12-31 0001306830 ce:EngineeredMaterialsMember 2023-01-01 2023-03-31 0001306830 ce:AcetylChainMember 2023-01-01 2023-03-31 0001306830 ce:EngineeredMaterialsMember 2023-03-31 0001306830 ce:AcetylChainMember 2023-03-31 0001306830 us-gaap:LicensingAgreementsMember 2022-12-31 0001306830 us-gaap:CustomerRelationshipsMember 2022-12-31 0001306830 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001306830 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0001306830 us-gaap:LicensingAgreementsMember 2023-01-01 2023-03-31 0001306830 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-03-31 0001306830 us-gaap:DevelopedTechnologyRightsMember 2023-01-01 2023-03-31 0001306830 us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-03-31 0001306830 us-gaap:LicensingAgreementsMember 2023-03-31 0001306830 us-gaap:CustomerRelationshipsMember 2023-03-31 0001306830 us-gaap:DevelopedTechnologyRightsMember 2023-03-31 0001306830 us-gaap:OtherIntangibleAssetsMember 2023-03-31 0001306830 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001306830 us-gaap:TrademarksAndTradeNamesMember 2023-01-01 2023-03-31 0001306830 us-gaap:TrademarksAndTradeNamesMember 2023-03-31 0001306830 ce:MobilityMaterialsMember 2023-03-31 0001306830 ce:MobilityMaterialsMember 2022-12-31 0001306830 us-gaap:RevolvingCreditFacilityMember 2023-03-31 0001306830 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001306830 us-gaap:ShortTermDebtMember 2023-03-31 0001306830 us-gaap:ShortTermDebtMember 2022-12-31 0001306830 us-gaap:RevolvingCreditFacilityMember 2023-03-31 0001306830 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2023Member 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2023Member 2022-12-31 0001306830 ce:SeniorUnsecuredNotesDue2024Member 2023-03-31 0001306830 ce:SeniorUnsecuredNotesDue2024Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2024Member 2023-03-31 0001306830 ce:USDSeniorUnsecuredNotesDue2024Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2025Member 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2025Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2025Member 2023-03-31 0001306830 ce:USDSeniorUnsecuredNotesDue2025Member 2022-12-31 0001306830 ce:SeniorUnsecuredTermLoanDue2025Member 2023-03-31 0001306830 ce:SeniorUnsecuredTermLoanDue2025Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2026Member 2023-03-31 0001306830 ce:USDSeniorUnsecuredNotesDue2026Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2026Member 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2026Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2027Member 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2027Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2027Member 2023-03-31 0001306830 ce:USDSeniorUnsecuredNotesDue2027Member 2022-12-31 0001306830 ce:SeniorUnsecuredTermLoanDue2027Member 2023-03-31 0001306830 ce:SeniorUnsecuredTermLoanDue2027Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2028Member 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2028Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2029Member 2023-03-31 0001306830 ce:EURSeniorUnsecuredNotesDue2029Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2029Member 2023-03-31 0001306830 ce:USDSeniorUnsecuredNotesDue2029Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2032Member 2023-03-31 0001306830 ce:USDSeniorUnsecuredNotesDue2032Member 2022-12-31 0001306830 srt:MinimumMember ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember 2023-03-31 0001306830 srt:MaximumMember ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember 2023-03-31 0001306830 ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember 2023-03-31 0001306830 ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember 2022-12-31 0001306830 us-gaap:LoansPayableMember 2023-03-31 0001306830 us-gaap:LoansPayableMember 2022-12-31 0001306830 ce:A364DayDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-03-31 2022-03-31 0001306830 ce:A364DayDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-03-31 0001306830 ce:A5YearDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-03-31 2022-03-31 0001306830 ce:A5YearDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-03-31 0001306830 ce:A3YearDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-09-30 2022-09-30 0001306830 ce:A3YearDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-09-30 0001306830 us-gaap:RevolvingCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001306830 us-gaap:RevolvingCreditFacilityMember ce:ChinaRevolvingCreditFacilityMember 2023-01-04 0001306830 ce:ChinaWorkingCapitalTermLoanMember ce:ChinaWorkingCapitalTermLoanMember 2023-01-06 0001306830 ce:ChinaWorkingCapitalTermLoanMember ce:ChinaWorkingCapitalTermLoanMember 2023-01-06 2023-01-06 0001306830 ce:ChinaWorkingCapitalTermLoanMember ce:ChinaWorkingCapitalTermLoanMember ce:VariableInterbankInterestRateMember 2023-01-06 2023-01-06 0001306830 us-gaap:RevolvingCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2023-03-31 0001306830 us-gaap:RevolvingCreditFacilityMember ce:ChinaRevolvingCreditFacilityMember 2023-03-31 0001306830 ce:AcquisitionNotesMember 2022-07-31 0001306830 ce:AcquisitionNotesMember 2022-07-31 2022-07-31 0001306830 ce:AmendedRestatedReceivableSecuritizationFacilityMember us-gaap:SecuredDebtMember 2023-01-01 2023-03-31 0001306830 us-gaap:SecuredDebtMember ce:AmendedRestatedReceivableSecuritizationFacilityMember 2023-03-31 0001306830 us-gaap:SecuredDebtMember ce:AmendedRestatedReceivableSecuritizationFacilityMember 2022-12-31 0001306830 us-gaap:SecuredDebtMember ce:AmendedRestatedReceivableSecuritizationFacilityMember 2023-01-01 2023-03-31 0001306830 us-gaap:SecuredDebtMember ce:AmendedRestatedReceivableSecuritizationFacilityMember 2022-01-01 2022-12-31 0001306830 ce:EuropeFactoringAgreementsMember 2023-03-31 0001306830 ce:SingaporeFactoringAgreementsMember 2023-03-31 0001306830 ce:EuropeAndSingaporeFactoringAgreementsMember 2023-03-31 0001306830 ce:EuropeAndSingaporeFactoringAgreementsMember 2022-12-31 0001306830 ce:EuropeAndSingaporeFactoringAgreementsMember 2023-01-01 2023-03-31 0001306830 ce:EuropeAndSingaporeFactoringAgreementsMember 2022-01-01 2022-12-31 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-03-31 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-01-01 2023-03-31 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-03-31 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-03-31 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2023-03-31 0001306830 us-gaap:OtherPensionPlansDefinedBenefitMember 2023-01-01 2023-03-31 0001306830 us-gaap:OtherPensionPlansDefinedBenefitMember 2023-03-31 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-03-31 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-12-31 0001306830 ce:PassaicRiverNewJerseyMember 2023-01-01 2023-03-31 0001306830 ce:PassaicRiverNewJerseyMember 2016-03-31 2016-03-31 0001306830 ce:PassaicRiverNewJerseyMember 2021-09-30 2021-09-30 0001306830 ce:PassaicRiverNewJerseyMember 2022-12-16 2022-12-16 0001306830 ce:PassaicRiverNewJerseyMember 2023-03-24 2023-03-24 0001306830 ce:PassaicRiverNewJerseyMember 2023-03-31 0001306830 us-gaap:SubsequentEventMember 2023-04-19 2023-04-19 0001306830 2008-02-01 2023-03-31 0001306830 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001306830 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001306830 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001306830 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001306830 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001306830 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0001306830 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001306830 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001306830 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0001306830 us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-03-31 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2023-03-31 2023-03-31 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-12-31 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2027Member us-gaap:CurrencySwapMember 2022-07-31 0001306830 ce:USDSeniorUnsecuredNotesDue2032Member us-gaap:CurrencySwapMember 2022-07-31 0001306830 ce:AcquisitionNotesMember us-gaap:NetInvestmentHedgingMember 2022-07-31 2022-07-31 0001306830 us-gaap:NondesignatedMember 2023-01-01 2023-03-31 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-03-31 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-03-31 0001306830 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001306830 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-03-31 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-03-31 0001306830 us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001306830 us-gaap:CashFlowHedgingMember 2022-01-01 2022-03-31 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-03-31 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-03-31 0001306830 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-03-31 0001306830 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-03-31 0001306830 us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-03-31 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-01-01 2023-03-31 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0001306830 us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CashFlowHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-03-31 0001306830 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001306830 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001306830 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-03-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-03-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-03-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001306830 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001306830 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:FairValueInputsLevel2Member 2023-03-31 0001306830 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001306830 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001306830 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001306830 ce:IndemnificationAgreementsHoechstMember 2023-03-31 0001306830 ce:IndemnificationAgreementsHoechstMember 1999-11-01 2023-03-31 0001306830 ce:DivestitureAgreementsMember 2023-03-31 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2023-01-01 2023-03-31 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2023-01-01 2023-03-31 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2023-01-01 2023-03-31 0001306830 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-03-31 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2023-03-31 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2023-03-31 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2023-03-31 0001306830 us-gaap:IntersegmentEliminationMember 2023-03-31 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2022-01-01 2022-03-31 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2022-01-01 2022-03-31 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2022-01-01 2022-03-31 0001306830 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-03-31 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2022-12-31 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2022-12-31 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2022-12-31 0001306830 us-gaap:IntersegmentEliminationMember 2022-12-31 0001306830 2023-04-01 2023-03-31 0001306830 2024-01-01 2023-03-31 0001306830 2025-01-01 2023-03-31 0001306830 srt:NorthAmericaMember ce:EngineeredMaterialsMember 2023-01-01 2023-03-31 0001306830 srt:NorthAmericaMember ce:EngineeredMaterialsMember 2022-01-01 2022-03-31 0001306830 us-gaap:EMEAMember ce:EngineeredMaterialsMember 2023-01-01 2023-03-31 0001306830 us-gaap:EMEAMember ce:EngineeredMaterialsMember 2022-01-01 2022-03-31 0001306830 srt:AsiaPacificMember ce:EngineeredMaterialsMember 2023-01-01 2023-03-31 0001306830 srt:AsiaPacificMember ce:EngineeredMaterialsMember 2022-01-01 2022-03-31 0001306830 srt:SouthAmericaMember ce:EngineeredMaterialsMember 2023-01-01 2023-03-31 0001306830 srt:SouthAmericaMember ce:EngineeredMaterialsMember 2022-01-01 2022-03-31 0001306830 ce:EngineeredMaterialsMember 2022-01-01 2022-03-31 0001306830 srt:NorthAmericaMember ce:AcetylChainMember 2023-01-01 2023-03-31 0001306830 srt:NorthAmericaMember ce:AcetylChainMember 2022-01-01 2022-03-31 0001306830 us-gaap:EMEAMember ce:AcetylChainMember 2023-01-01 2023-03-31 0001306830 us-gaap:EMEAMember ce:AcetylChainMember 2022-01-01 2022-03-31 0001306830 srt:AsiaPacificMember ce:AcetylChainMember 2023-01-01 2023-03-31 0001306830 srt:AsiaPacificMember ce:AcetylChainMember 2022-01-01 2022-03-31 0001306830 srt:SouthAmericaMember ce:AcetylChainMember 2023-01-01 2023-03-31 0001306830 srt:SouthAmericaMember ce:AcetylChainMember 2022-01-01 2022-03-31 0001306830 ce:AcetylChainMember 2022-01-01 2022-03-31 0001306830 us-gaap:IntersegmentEliminationMember ce:AcetylChainMember 2023-01-01 2023-03-31 0001306830 us-gaap:IntersegmentEliminationMember ce:AcetylChainMember 2022-01-01 2022-03-31 0001306830 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001306830 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001306830 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001306830 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001306830 us-gaap:EmployeeSeveranceMember ce:EngineeredMaterialsMember 2022-12-31 0001306830 us-gaap:EmployeeSeveranceMember ce:AcetylChainMember 2022-12-31 0001306830 us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2022-12-31 0001306830 us-gaap:EmployeeSeveranceMember 2022-12-31 0001306830 us-gaap:EmployeeSeveranceMember ce:EngineeredMaterialsMember 2023-01-01 2023-03-31 0001306830 us-gaap:EmployeeSeveranceMember ce:AcetylChainMember 2023-01-01 2023-03-31 0001306830 us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2023-01-01 2023-03-31 0001306830 us-gaap:EmployeeSeveranceMember 2023-01-01 2023-03-31 0001306830 us-gaap:EmployeeSeveranceMember ce:EngineeredMaterialsMember 2023-03-31 0001306830 us-gaap:EmployeeSeveranceMember ce:AcetylChainMember 2023-03-31 0001306830 us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2023-03-31 0001306830 us-gaap:EmployeeSeveranceMember 2023-03-31 shares iso4217:USD iso4217:USD shares pure ce:facility ce:patent ce:employees ce:annualInstallment iso4217:EUR iso4217:CNY 0001306830 --12-31 2023 Q1 false http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2022#InterestExpense http://fasb.org/us-gaap/2022#InterestExpense http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2022#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2022#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2022#OtherAssetsCurrent http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#OtherAssetsCurrent http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#OtherAssetsCurrent http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#OtherAssetsCurrent http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent P9M P1Y P1Y 10-Q true 2023-03-31 false 001-32410 CELANESE CORPORATION DE 98-0420726 222 W. Las Colinas Blvd., Suite 900N Irving TX 75039-5421 972 443-4000 Common Stock, par value $0.0001 per share CE NYSE 1.125% Senior Notes due 2023 CE /23 NYSE 1.250% Senior Notes due 2025 CE /25 NYSE 4.777% Senior Notes due 2026 CE /26A NYSE 2.125% Senior Notes due 2027 CE /27 NYSE 0.625% Senior Notes due 2028 CE /28 NYSE 5.337% Senior Notes due 2029 CE /29A NYSE Yes Yes Large Accelerated Filer false false false 108787807 2853000000 2538000000 2222000000 1793000000 631000000 745000000 285000000 174000000 41000000 11000000 42000000 24000000 23000000 1000000 6000000 -1000000 5000000 -3000000 251000000 531000000 15000000 56000000 1000000 24000000 182000000 35000000 8000000 1000000 34000000 37000000 -6000000 2000000 121000000 616000000 25000000 112000000 96000000 504000000 -3000000 0 0 0 -3000000 0 93000000 504000000 2000000 2000000 91000000 502000000 94000000 502000000 -3000000 0 91000000 502000000 0.87 4.64 -0.03 0 0.84 4.64 0.86 4.61 -0.03 0 0.83 4.61 108634068 108185912 109188266 108917577 93000000 504000000 13000000 -21000000 4000000 15000000 1000000 -2000000 16000000 -4000000 109000000 500000000 2000000 2000000 107000000 498000000 1167000000 1508000000 1606000000 1379000000 707000000 675000000 2749000000 2808000000 219000000 241000000 6448000000 6611000000 1049000000 1062000000 3791000000 3687000000 5588000000 5584000000 414000000 413000000 813000000 808000000 553000000 547000000 7139000000 7142000000 4086000000 4105000000 26090000000 26272000000 1386000000 1306000000 1445000000 1518000000 1014000000 1201000000 6000000 43000000 3851000000 4068000000 13396000000 13373000000 1223000000 1242000000 295000000 322000000 411000000 411000000 359000000 364000000 425000000 387000000 0.01 0.01 100000000 100000000 0 0 0 0 0 0 0.0001 0.0001 400000000 400000000 170448231 108786738 170135425 108473932 0 0 61661493 61661493 5491000000 5491000000 365000000 372000000 11289000000 11274000000 -502000000 -518000000 5661000000 5637000000 469000000 468000000 6130000000 6105000000 26090000000 26272000000 108473932 0 108023735 0 312806 0 283606 0 108786738 0 108307341 0 61661493 -5491000000 61736289 -5492000000 0 0 0 0 61661493 -5491000000 61736289 -5492000000 372000000 333000000 -7000000 -7000000 365000000 326000000 11274000000 9677000000 91000000 502000000 76000000 73000000 11289000000 10106000000 -518000000 -329000000 16000000 -4000000 -502000000 -333000000 5661000000 4607000000 468000000 348000000 2000000 2000000 1000000 0 0 4000000 469000000 346000000 6130000000 4953000000 93000000 504000000 178000000 106000000 3000000 -21000000 12000000 12000000 1000000 4000000 6000000 -3000000 14000000 15000000 -25000000 30000000 -1000000 3000000 1000000 -4000000 216000000 240000000 -45000000 32000000 -99000000 0 -22000000 49000000 -298000000 -29000000 -96000000 316000000 164000000 137000000 9000000 0 23000000 12000000 -178000000 -149000000 -300000000 74000000 338000000 0 7000000 7000000 0 17000000 76000000 73000000 -1000000 -4000000 0 44000000 -23000000 -24000000 -69000000 -95000000 2000000 -3000000 -341000000 69000000 1508000000 536000000 1167000000 605000000 Description of the Company and Basis of Presentation<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of the Company</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals, for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definitions</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim consolidated financial statements for the three months ended March 31, 2023 and 2022 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with U.S. GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, 2022, filed on February 24, 2023 with the SEC as part of the Company's Annual Report on Form 10-K.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the entire year.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as noncontrolling interests.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension </span></div>and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates. 1 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension </span></div>and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates. Recent Accounting PronouncementsThere are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures. There are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures. Acquisitions, Dispositions and Plant Closures<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company acquired 100% ownership of entities and assets consisting of a majority of the Mobility &amp; Materials business ("M&amp;M") of DuPont de Nemours, Inc. ("DuPont") (the "M&amp;M Acquisition") for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction. The Company acquired a global production network of 29 facilities, including compounding and polymerization, customer and supplier contracts and agreements, an intellectual property portfolio, including approximately 850 patents with associated technical and R&amp;D assets, and approximately 5,000 employees across the manufacturing, technical, and commercial organizations. This acquisition of M&amp;M enhances the engineered materials product portfolio by adding new polymers, brands, product technology, and backward integration in critical polymers, allowing the Company to accelerate growth in high-value applications including future mobility, connectivity and medical. The acquisition was accounted for as a business combination and the acquired operations are included in the Engineered Materials segment.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company preliminarily allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The purchase price allocation was based upon preliminary information and is subject to change if additional information about the facts and circumstances that existed at the acquisition date becomes available. The Company is in the ongoing process of conducting a valuation of the assets acquired and liabilities assumed related to the acquisition, including trade names and customer relationships, personal and real property, investment in equity affiliates and deferred taxes. The final fair value of the net assets acquired may result in adjustments to these assets and liabilities, including goodwill. During the measurement period to date, there were no adjustments that materially impacted the Company's goodwill initially recorded.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information presents the consolidated results of operations as if the M&amp;M Acquisition had occurred at the beginning of 2022. M&amp;M's pre-acquisition results have been added to the Company's historical results. The pro forma results contained in the table below include adjustments for (i) increased depreciation expense as a result of acquisition date fair value adjustments, (ii) amortization of acquired intangibles, (iii) interest expense and amortization of debt issuance costs of $172 million related to borrowings under the U.S Term Loan Facility (defined below) and the issuance of Acquisition Notes (defined below) as if these had taken place at the beginning of 2022 for the three months ended March 31, 2022 and (iv) net total inventory step up of inventory amortized to Cost of sales of $98 million for the three months ended March 31, 2022.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisitions occurred on the assumed dates, nor are they necessarily an indication of future operating results.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited Consolidated Pro Forma Results</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proforma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proforma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from continuing operations before tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Korea Engineering Plastics Co. Restructuring</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company completed the restructuring of Korea Engineering Plastics Co. ("KEPCO"), a joint venture owned 50% by the Company and 50% by Mitsubishi Gas Chemical Company, Inc. KEPCO was first formed in 1987 to manufacture and market polyoxymethylene ("POM") in Asia, with a particular focus on serving domestic demand in South Korea. KEPCO will now focus solely on manufacturing and supplying high quality products to its shareholders, who will independently market </span></div>them globally. As part of the restructuring of KEPCO, the Company paid KEPCO $5 million and will pay 5 equal annual installments of €24 million on October 1 of each year beginning in 2022. This resulted in an increase to the Company's investment in KEPCO of $134 million. The Company's joint venture partner will be making similar payments to KEPCO. The restructuring did not result in a change in ownership percentage of KEPCO, nor a change in control, and KEPCO will continue to be accounted for as an equity method investment. 1 11000000000 29 850 5000 172000000 98000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited Consolidated Pro Forma Results</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proforma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proforma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from continuing operations before tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 3427000000 312000000 0.50 0.50 5000000 5 24000000 134000000 Inventories<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,749 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,749 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1811000000 1820000000 210000000 202000000 728000000 786000000 2749000000 2808000000 Goodwill and Intangible Assets, Net<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acetyl Chain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,768 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,139 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">There were no accumulated impairment losses as of March 31, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Licenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Customer-<br/>Related<br/>Intangible<br/>Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Developed<br/>Technology</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Covenants<br/>Not to<br/>Compete<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Asset Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,175 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(745)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net book value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,430 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trademarks<br/>and Trade Names</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, the Company did not renew or extend any intangible assets.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated amortization expense for the succeeding five fiscal years is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acetyl Chain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,768 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,139 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">There were no accumulated impairment losses as of March 31, 2023.</span></div> 6775000000 367000000 7142000000 -18000000 0 -18000000 11000000 4000000 15000000 6768000000 371000000 7139000000 0 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Licenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Customer-<br/>Related<br/>Intangible<br/>Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Developed<br/>Technology</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Covenants<br/>Not to<br/>Compete<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Asset Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,175 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(745)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net book value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,430 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> 42000000 2455000000 601000000 55000000 3153000000 0 -22000000 0 0 -22000000 42000000 2477000000 601000000 55000000 3175000000 39000000 567000000 50000000 40000000 696000000 0 30000000 11000000 0 41000000 0 8000000 0 0 8000000 39000000 605000000 61000000 40000000 745000000 3000000 1872000000 540000000 15000000 2430000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trademarks<br/>and Trade Names</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 1648000000 8000000 1656000000 0 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated amortization expense for the succeeding five fiscal years is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 160000000 160000000 160000000 160000000 160000000 Current Other Liabilities<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and use tax/foreign withholding tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes $104 million and $166 million of liabilities related to the M&amp;M Acquisition payable to DuPont as of March 31, 2023 and December 31, 2022, respectively.</span></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and use tax/foreign withholding tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes $104 million and $166 million of liabilities related to the M&amp;M Acquisition payable to DuPont as of March 31, 2023 and December 31, 2022, respectively.</span></div> 25000000 25000000 91000000 101000000 39000000 63000000 155000000 265000000 22000000 21000000 88000000 83000000 23000000 6000000 123000000 151000000 91000000 108000000 94000000 79000000 263000000 299000000 1014000000 1201000000 104000000 166000000 Debt<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current installments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings, including amounts due to affiliates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 5.6% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 3.4% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2023, interest rate of 1.125%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2024, interest rate of 3.500%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2024, interest rate of 5.900%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2025, interest rate of 1.250%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2025, interest rate of 6.050%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan due 2025, interest rate of 6.265%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2026, interest rate of 1.400%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2026, interest rate of 4.777%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2027, interest rate of 2.125%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2027, interest rate of 6.165%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan due 2027, interest rate of 6.265%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2028, interest rate of 0.625%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2029, interest rate of 5.337%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2029, interest rate of 6.330%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2032, interest rate of 6.379%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans due at various dates through 2026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligations under finance leases due at various dates through 2054</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,017 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,953 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current installments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,396 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 1.3% and 1.3% as of March 31, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to the Company's long-term debt, excluding obligations under finance leases.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Credit Facilities</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a term loan credit agreement (the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion. In September 2022, Celanese, Celanese U.S. and certain subsidiaries entered into an additional term loan credit agreement (the "September 2022 U.S. Term Loan Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Term Loan Credit Agreements"), pursuant to which lenders have provided delayed-draw term loans due 3 years from issuance in an amount equal to $750 million (the term loans represented by the U.S. Term Loan Credit Agreements collectively, the "U.S. Term Loan Facility"). The U.S. Term Loan Facility was fully drawn during the three months ended December 31, 2022.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a new revolving credit agreement (the "U.S. Revolving Credit Agreement" and, together with the U.S. Term Loan Credit Agreements, the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027 (the "U.S. Revolving Credit Facility").</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2023, the Company amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors"). The Subsidiary Guarantors are listed in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ief634c046ae2468c9fc2dc04efe3e175_19-2-1-1-209438" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 22.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to this Quarterly Report.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on January 6, 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement," together with the China Revolving Credit Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn on January 10, 2023 and is supported by a letter of comfort from the Company. The Company expects that the China Credit Agreements will facilitate its efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of its U.S. debt to China at a lower average interest rate.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for borrowing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">China Revolving Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for borrowing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, Celanese U.S. completed an offering of $7.5 billion aggregate principal amount of notes of various maturities in a public offering registered under the Securities Act (the "Acquisition USD Notes"). In July 2022, Celanese U.S. completed an offering of €1.5 billion in aggregate principal amount of euro-denominated senior unsecured notes due in 2026 and 2029 in a public offering registered under the Securities Act (collectively, the "Acquisition Euro Notes" and together with the Acquisition USD Notes, the "Acquisition Notes"). Certain of the Acquisition Notes were issued at a discount to par, which will be amortized to Interest expense in the consolidated statement of operations over the terms of the applicable Acquisition Notes. Fees and expenses of the offering of the Acquisition Notes, inclusive of underwriting discounts, were $65 million.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable Purchasing Facility</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2024. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's unaudited consolidated balance sheet. The Company de-recognized $249 million and $1.1 billion of accounts receivable under this agreement for the three months ended March 31, 2023 and twelve months ended December 31, 2022, respectively, and collected $249 million and $1.1 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $109 million were pledged by the SPE as collateral to the Purchasers as of March 31, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Factoring and Discounting Agreements</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $87 million and $320 million of accounts receivable under these factoring agreements for the three months ended March 31, 2023 and twelve months ended December 31, 2022, respectively, and collected $82 million and $325 million of accounts receivable sold under these factoring agreements during the same periods.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. The Company is in compliance with the covenants in its material financing arrangements as of March 31, 2023.</span></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current installments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings, including amounts due to affiliates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 5.6% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 3.4% and 5.8% as of March 31, 2023 and December 31, 2022, respectively.</span></div> 551000000 506000000 617000000 500000000 218000000 300000000 1386000000 1306000000 0.056 0.058 0.034 0.058 <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2023, interest rate of 1.125%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2024, interest rate of 3.500%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2024, interest rate of 5.900%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2025, interest rate of 1.250%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2025, interest rate of 6.050%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan due 2025, interest rate of 6.265%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2026, interest rate of 1.400%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2026, interest rate of 4.777%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2027, interest rate of 2.125%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2027, interest rate of 6.165%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan due 2027, interest rate of 6.265%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2028, interest rate of 0.625%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2029, interest rate of 5.337%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2029, interest rate of 6.330%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2032, interest rate of 6.379%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans due at various dates through 2026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligations under finance leases due at various dates through 2054</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,017 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,953 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current installments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,396 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 1.3% and 1.3% as of March 31, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to the Company's long-term debt, excluding obligations under finance leases.</span></div> 0.01125 489000000 480000000 0.03500 499000000 499000000 0.05900 2000000000 2000000000 0.01250 326000000 320000000 0.06050 1750000000 1750000000 0.06265 750000000 750000000 0.01400 400000000 400000000 0.04777 1088000000 1067000000 0.02125 542000000 531000000 0.06165 2000000000 2000000000 0.06265 1000000000 1000000000 0.00625 543000000 533000000 0.05337 544000000 533000000 0.06330 750000000 750000000 0.06379 1000000000 1000000000 0.0405 0.0500 163000000 164000000 4000000 4000000 169000000 172000000 14017000000 13953000000 70000000 74000000 551000000 506000000 13396000000 13373000000 0.013 0.013 P364D 500000000 P5Y 1000000000 P3Y 750000000 1750000000 1750000000 800000000 P12M 0.005 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for borrowing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">China Revolving Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for borrowing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> 0 1750000000 218000000 37000000 1 7500000000 1500000000 65000000 1 249000000 1100000000 249000000 1100000000 109000000 1 0.90 87000000 320000000 82000000 325000000 Benefit Obligations<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.116%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit obligation funding is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash contributions to defined benefit pension plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments to nonqualified pension plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments to other postretirement benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.116%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4000000 0 3000000 0 32000000 0 17000000 0 33000000 0 41000000 0 3000000 0 -21000000 0 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit obligation funding is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash contributions to defined benefit pension plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments to nonqualified pension plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments to other postretirement benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 6000000 27000000 5000000 18000000 1000000 4000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 166000000 0 160000000 0 21000000 3000000 21000000 3000000 371000000 35000000 372000000 35000000 -226000000 -38000000 -233000000 -38000000 EnvironmentalThe Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of environmental remediation liabilities are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demerger obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active sites</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Superfund sites</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other environmental remediation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remediation</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Superfund Sites</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the Newark Bay Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the LPRSA and the Newark Bay Area.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. In September 2021, the EPA issued a Record of Decision selecting an interim remedial plan for the upper 9 miles of the Lower Passaic River ("Upper 9 Miles"). Pursuant to the EPA's Record of Decision, targeted dredging will be conducted in the Upper 9 Miles to address surface sediments with elevated contamination followed by the installation of an engineered cap at an EPA estimated cost of $441 million.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273 (MCA) (LDW) (U.S. District Court New Jersey) (the "2018 OCC Lawsuit"), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the 2018 OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, the United States lodged a Consent Decree in U.S. District Court for the District of New Jersey on December 16, 2022 that will resolve the Company's liability (and that of more than 80 other settling defendants) to the EPA for costs to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site in exchange for a collective payment of $150 million, United States v. Alden Leeds, Inc., No. 2:22-7326 (MCA) (LDW) (U.S. District Court New Jersey) ("Consent Decree Action"). The Consent Decree also will provide the Company protection from contribution claims by others for costs incurred to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site. The Company's proposed payment toward the $150 million collective settlement payment is not material to the Company's results of operations, cash flows or financial position. The Consent Decree is still subject to public comment and court approval.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 7, 2023, the U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit, pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. On March 24, 2023, OCC filed a new lawsuit against 40 parties, including a subsidiary of the Company, seeking to recover costs for remedial design work the EPA has ordered OCC to undertake for a portion of the LPRSA at an estimated cost of $71 million, Occidental Chemical Corporation v. Givaudan Fragrances Corporation, No. 2:23-cv-1699 (U.S. District Court New Jersey) (the "2023 OCC Lawsuit"). Like the earlier lawsuit, the 2023 OCC Lawsuit concerns the facility Essex County, New Jersey purchased and for which Essex County, New Jersey has agreed to defend and indemnify the Company. This new lawsuit does not change the Company's estimated liability for LPRSA cleanup costs.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to vigorously defend these matters and continues to believe that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, previously estimated at less than 1%, will not be material.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Environmental Matters</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, a methanol leak on a pipeline to our Bishop, Texas facility was discovered. The release has been contained, the leak has been repaired and the pipeline has resumed operation. The Company promptly disclosed the incident to state and federal authorities, including the Texas Commission on Environmental Quality and the EPA, and remediation activities are now completed. While the Company has not received a notice of violation nor been assessed any fines or penalties to date, the Company recorded a reserve in Other current liabilities based on anticipated clean-up costs and possible penalties to state or federal authorities. The Company does not believe that resolution of this matter will have a material impact on our financial condition or results of operations.</span></div> <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of environmental remediation liabilities are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demerger obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active sites</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Superfund sites</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other environmental remediation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 19000000 20000000 14000000 14000000 20000000 21000000 9000000 10000000 2000000 2000000 64000000 67000000 70 1400000000 441000000 150000000 150000000 40 71000000 0.01 Shareholders' Equity<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by its existing Global Credit Agreements and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company declared a quarterly cash dividend of $0.70 per share on its Common Stock on April 19, 2023, amounting to $76 million. The cash dividend will be paid on May 15, 2023 to holders of record as of May 1, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total From<br/>February 2008<br/>Through<br/>March 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,324,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average purchase price per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased (in $ millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate Board of Directors repurchase authorizations during the period (in $ millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of shareholders' equity.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not repurchase any Common Stock during the three months ended March 31, 2023 and 2022.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Comprehensive Income (Loss), Net</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.413%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to Accumulated other comprehensive income (loss), net, are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.560%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">on Cash </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flow </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedges</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Benefits Gain (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income<br/>(Loss), Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (provision) benefit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.0001 0.70 76000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total From<br/>February 2008<br/>Through<br/>March 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,324,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average purchase price per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased (in $ millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate Board of Directors repurchase authorizations during the period (in $ millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 69324429 83.71 5803000000 6866000000 0 0 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.413%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> -4000000 -17000000 13000000 -15000000 6000000 -21000000 4000000 0 4000000 19000000 4000000 15000000 1000000 0 1000000 -2000000 0 -2000000 -1000000 -17000000 16000000 6000000 10000000 -4000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to Accumulated other comprehensive income (loss), net, are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.560%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">on Cash </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flow </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedges</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Benefits Gain (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income<br/>(Loss), Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (provision) benefit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -488000000 -22000000 -8000000 -518000000 -4000000 2000000 -1000000 -3000000 0 2000000 0 2000000 -17000000 0 0 -17000000 -475000000 -18000000 -9000000 -502000000 Income Taxes<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the three months ended March 31, 2023, was higher compared to the same period in 2022, primarily due to increases in valuation allowances on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period, partially offset by increased earnings in low taxed jurisdictions during the three months ended March 31, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various final and proposed regulatory packages supplementing the TCJA provisions since 2018. There have been no material proposed or final regulatory packages during the three months ended March 31, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Inflation Reduction Act (the "IRA") was enacted and included a 1% excise tax on share repurchases in excess of $1 million, and a corporate minimum tax of 15% on adjusted book earnings. The corporate minimum tax paid is creditable in future years to the extent that regular tax liability exceeds the minimum tax in any given year. The Company does not expect these provisions and any newly issued administrative guidance to have a material impact to future income tax expense. The IRA also provides various beneficial credits for energy efficient related manufacturing, transportation and fuels, hydrogen/carbon recapture and renewable energy, which the Company is evaluating in regard to planned projects.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense adjustments in the period the guidance is finalized or becomes effective.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the TCJA and uncertainty as to future foreign source income, the Company previously recorded a valuation allowance on a substantial portion of its foreign tax credit carryforwards. The Company is currently evaluating tax planning strategies to enable the use of the Company's foreign tax credit carryforwards that may decrease the Company's effective tax rate in future periods as the valuation allowance is reversed.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's tax returns have been under joint audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In September 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also proposed to apply these adjustments to open tax years through 2019. The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authorities. The Company is engaged in ongoing discussions with the other authorities regarding the ongoing examinations and will evaluate all additional potential remedies as the discussions progress.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company's income tax returns in Mexico are under audit for the years 2017 and 2018, and in Canada for the years 2016 through 2018. In January 2022, the Mexico tax authorities issued preliminary findings for disallowance of operating expenses on several of the applicable tax returns. The Company has analyzed the preliminary findings, engaged in preliminary </span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discussions with the Mexico tax authorities and has recorded the appropriate tax reserves as of March 31, 2023. The Company will continue discussions with the Mexico authorities in 2023. Related to Canada, the Company is discussing preliminary findings with the Canadian authorities and does not expect a material impact to income tax expense.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company believes that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised in the audits described above are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its positions, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 0.21 0.18 Derivative Financial Instruments<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives Designated As Hedges</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In € millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the offering of the Acquisition USD Notes in July 2022 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the Company entered into cross-currency swaps to effectively convert $2.0 billion and $500 million of the Acquisition USD Notes into a euro-denominated borrowing at prevailing euro interest rates, maturing on July 15, 2027 and July 15, 2032, respectively. The swaps and €1.5 billion of the Acquisition Euro Notes qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investments of certain of its euro-denominated subsidiaries.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives Not Designated As Hedges</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forwards and Swaps</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.707%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statement of Operations Classification</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Cash Flow Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzUtOS0xLTEtMjA5NDM4_18133942-4f1c-4b21-930f-8af61254d1b3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzUtOS0xLTEtMjA5NDM4_52ead107-df70-4840-8110-4a04b144aa50">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzYtOS0xLTEtMjA5NDM4_1a0022aa-f993-4b65-a478-ded102dd0806"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzYtOS0xLTEtMjA5NDM4_25e47079-8c28-4715-bc1a-89a035c8b663">Interest expense</span></span></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzgtOS0xLTEtMjA5NDM4_0c4cc87f-c30b-4ca9-a667-e95909413337"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzgtOS0xLTEtMjA5NDM4_98f8201e-2a3d-454c-987a-e173b0c8600a">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Designated as Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzIxLTktMS0xLTIwOTQzOA_979932a3-93cf-4f1f-aa8d-de04fca46cfc"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzIxLTktMS0xLTIwOTQzOA_d8964ca9-d878-4ae5-b0fe-167026d67596">Foreign exchange gain (loss), net; Other income (expense), net</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the fair value of the Company's derivative instruments.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo2ZDcxZTQzN2Y5ZGE0MGFiODA1NmZmZjg5OTE1MDY1NS90YWJsZXJhbmdlOjZkNzFlNDM3ZjlkYTQwYWI4MDU2ZmZmODk5MTUwNjU1XzItMC0xLTEtMjM1MzIw_11ae4e18-64d7-44ae-a2bb-f8960b666906"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo2ZDcxZTQzN2Y5ZGE0MGFiODA1NmZmZjg5OTE1MDY1NS90YWJsZXJhbmdlOjZkNzFlNDM3ZjlkYTQwYWI4MDU2ZmZmODk5MTUwNjU1XzItMC0xLTEtMjM1MzIw_e49dcf85-6b71-4944-9ae2-b9b86b117f7d">Derivative Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount presented in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount not offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo3OTYxNzU1NGI2ZGQ0ODMwOTJjZDM5ZDVlM2EzMjQzNy90YWJsZXJhbmdlOjc5NjE3NTU0YjZkZDQ4MzA5MmNkMzlkNWUzYTMyNDM3XzItMC0xLTEtMjM1MzE3_0cd4daf4-f528-420f-8865-e616bd6e8edd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo3OTYxNzU1NGI2ZGQ0ODMwOTJjZDM5ZDVlM2EzMjQzNy90YWJsZXJhbmdlOjc5NjE3NTU0YjZkZDQ4MzA5MmNkMzlkNWUzYTMyNDM3XzItMC0xLTEtMjM1MzE3_7edcff03-b874-4a0a-9f30-24236469390b">Derivative Liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount presented in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount not offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In € millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5652000000 5639000000 2000000000 500000000 1500000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1892000000 1314000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.707%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statement of Operations Classification</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Cash Flow Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzUtOS0xLTEtMjA5NDM4_18133942-4f1c-4b21-930f-8af61254d1b3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzUtOS0xLTEtMjA5NDM4_52ead107-df70-4840-8110-4a04b144aa50">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzYtOS0xLTEtMjA5NDM4_1a0022aa-f993-4b65-a478-ded102dd0806"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzYtOS0xLTEtMjA5NDM4_25e47079-8c28-4715-bc1a-89a035c8b663">Interest expense</span></span></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzgtOS0xLTEtMjA5NDM4_0c4cc87f-c30b-4ca9-a667-e95909413337"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzgtOS0xLTEtMjA5NDM4_98f8201e-2a3d-454c-987a-e173b0c8600a">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Designated as Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzIxLTktMS0xLTIwOTQzOA_979932a3-93cf-4f1f-aa8d-de04fca46cfc"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo0MjFkODU4YmIwYzE0OWI0YmQ0Mzc3YTI4ZWMwNGRlNi90YWJsZXJhbmdlOjQyMWQ4NThiYjBjMTQ5YjRiZDQzNzdhMjhlYzA0ZGU2XzIxLTktMS0xLTIwOTQzOA_d8964ca9-d878-4ae5-b0fe-167026d67596">Foreign exchange gain (loss), net; Other income (expense), net</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div> 0 17000000 1000000 0 0 0 -2000000 -2000000 2000000 0 -1000000 0 2000000 17000000 -2000000 -2000000 -56000000 28000000 0 0 -19000000 2000000 0 0 -75000000 30000000 0 0 0 0 2000000 -1000000 0 0 2000000 -1000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo2ZDcxZTQzN2Y5ZGE0MGFiODA1NmZmZjg5OTE1MDY1NS90YWJsZXJhbmdlOjZkNzFlNDM3ZjlkYTQwYWI4MDU2ZmZmODk5MTUwNjU1XzItMC0xLTEtMjM1MzIw_11ae4e18-64d7-44ae-a2bb-f8960b666906"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo2ZDcxZTQzN2Y5ZGE0MGFiODA1NmZmZjg5OTE1MDY1NS90YWJsZXJhbmdlOjZkNzFlNDM3ZjlkYTQwYWI4MDU2ZmZmODk5MTUwNjU1XzItMC0xLTEtMjM1MzIw_e49dcf85-6b71-4944-9ae2-b9b86b117f7d">Derivative Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount presented in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount not offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 139000000 169000000 1000000 0 138000000 169000000 26000000 16000000 112000000 153000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo3OTYxNzU1NGI2ZGQ0ODMwOTJjZDM5ZDVlM2EzMjQzNy90YWJsZXJhbmdlOjc5NjE3NTU0YjZkZDQ4MzA5MmNkMzlkNWUzYTMyNDM3XzItMC0xLTEtMjM1MzE3_0cd4daf4-f528-420f-8865-e616bd6e8edd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMDkvZnJhZzo4OGMwZjFlMWI1MDE0ZmZiYjZjYzU0NmU3YmIxZTQ0Ny90YWJsZTo3OTYxNzU1NGI2ZGQ0ODMwOTJjZDM5ZDVlM2EzMjQzNy90YWJsZXJhbmdlOjc5NjE3NTU0YjZkZDQ4MzA5MmNkMzlkNWUzYTMyNDM3XzItMC0xLTEtMjM1MzE3_7edcff03-b874-4a0a-9f30-24236469390b">Derivative Liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount presented in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount not offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 185000000 189000000 1000000 0 184000000 189000000 26000000 16000000 158000000 173000000 Fair Value Measurements<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices <br/>in Active <br/>Markets for <br/>Identical <br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant <br/>Other<br/>Observable <br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZToyYTcwNGZlZDRkZWE0M2RjOWVhMzc5NzZmYmQ4MTEwMi90YWJsZXJhbmdlOjJhNzA0ZmVkNGRlYTQzZGM5ZWEzNzk3NmZiZDgxMTAyXzUtNy0xLTEtMjA5NDM4_27d0ac62-e209-4285-ada1-d21e8fd09dbc">Current Other assets</span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZToyYTcwNGZlZDRkZWE0M2RjOWVhMzc5NzZmYmQ4MTEwMi90YWJsZXJhbmdlOjJhNzA0ZmVkNGRlYTQzZGM5ZWEzNzk3NmZiZDgxMTAyXzYtNy0xLTEtMjA5NDM4_4726260f-d6d0-48bb-8fd9-d483f8928bbc">Noncurrent Other assets</span></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices <br/>in Active <br/>Markets for <br/>Identical <br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant <br/>Other<br/>Observable <br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZTphYjIzZTNiZDdlMWY0NjYwYjkxNjU5Zjc0MDFhODE1ZC90YWJsZXJhbmdlOmFiMjNlM2JkN2UxZjQ2NjBiOTE2NTlmNzQwMWE4MTVkXzI4LTctMS0xLTIwOTQzOA_2f938ed5-0f1d-4e8c-a6c7-e02daee97129">Current Other assets</span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZTphYjIzZTNiZDdlMWY0NjYwYjkxNjU5Zjc0MDFhODE1ZC90YWJsZXJhbmdlOmFiMjNlM2JkN2UxZjQ2NjBiOTE2NTlmNzQwMWE4MTVkXzI5LTctMS0xLTIwOTQzOA_da25611c-b4c9-4e1a-b951-20ee6d673c27">Noncurrent Other assets</span></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZTphYjIzZTNiZDdlMWY0NjYwYjkxNjU5Zjc0MDFhODE1ZC90YWJsZXJhbmdlOmFiMjNlM2JkN2UxZjQ2NjBiOTE2NTlmNzQwMWE4MTVkXzQwLTctMS0xLTIzNTI3MQ_bcd096cc-2db0-4519-afea-ceff54079602">Current Other liabilities</span></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying values and fair values of financial instruments that are not carried at fair value are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying <br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable <br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unobservable <br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts in nonqualified trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current installments of long-term debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts in nonqualified trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current installments of long-term debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,419 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement.</span></div>As of March 31, 2023, and December 31, 2022, the fair values of cash and cash equivalents, receivables, marketable securities, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices <br/>in Active <br/>Markets for <br/>Identical <br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant <br/>Other<br/>Observable <br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZToyYTcwNGZlZDRkZWE0M2RjOWVhMzc5NzZmYmQ4MTEwMi90YWJsZXJhbmdlOjJhNzA0ZmVkNGRlYTQzZGM5ZWEzNzk3NmZiZDgxMTAyXzUtNy0xLTEtMjA5NDM4_27d0ac62-e209-4285-ada1-d21e8fd09dbc">Current Other assets</span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZToyYTcwNGZlZDRkZWE0M2RjOWVhMzc5NzZmYmQ4MTEwMi90YWJsZXJhbmdlOjJhNzA0ZmVkNGRlYTQzZGM5ZWEzNzk3NmZiZDgxMTAyXzYtNy0xLTEtMjA5NDM4_4726260f-d6d0-48bb-8fd9-d483f8928bbc">Noncurrent Other assets</span></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices <br/>in Active <br/>Markets for <br/>Identical <br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant <br/>Other<br/>Observable <br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZTphYjIzZTNiZDdlMWY0NjYwYjkxNjU5Zjc0MDFhODE1ZC90YWJsZXJhbmdlOmFiMjNlM2JkN2UxZjQ2NjBiOTE2NTlmNzQwMWE4MTVkXzI4LTctMS0xLTIwOTQzOA_2f938ed5-0f1d-4e8c-a6c7-e02daee97129">Current Other assets</span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZTphYjIzZTNiZDdlMWY0NjYwYjkxNjU5Zjc0MDFhODE1ZC90YWJsZXJhbmdlOmFiMjNlM2JkN2UxZjQ2NjBiOTE2NTlmNzQwMWE4MTVkXzI5LTctMS0xLTIwOTQzOA_da25611c-b4c9-4e1a-b951-20ee6d673c27">Noncurrent Other assets</span></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc1NTgwMDJjYjc5NzRkYTBhZWU2YzM1M2U3N2I3ZTg2L3NlYzo3NTU4MDAyY2I3OTc0ZGEwYWVlNmMzNTNlNzdiN2U4Nl8xMTUvZnJhZzo1NTI2NGU4YTY5NGY0MTVhYTU2NGM2MTU3MDJiNDI0Yy90YWJsZTphYjIzZTNiZDdlMWY0NjYwYjkxNjU5Zjc0MDFhODE1ZC90YWJsZXJhbmdlOmFiMjNlM2JkN2UxZjQ2NjBiOTE2NTlmNzQwMWE4MTVkXzQwLTctMS0xLTIzNTI3MQ_bcd096cc-2db0-4519-afea-ceff54079602">Current Other liabilities</span></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table> 0 4000000 4000000 0 43000000 43000000 0 1000000 1000000 0 67000000 67000000 0 11000000 11000000 0 12000000 12000000 0 138000000 138000000 0 29000000 29000000 0 145000000 145000000 0 10000000 10000000 0 184000000 184000000 0 9000000 9000000 0 39000000 39000000 0 99000000 99000000 0 13000000 13000000 0 9000000 9000000 0 169000000 169000000 0 2000000 2000000 0 58000000 58000000 0 126000000 126000000 0 3000000 3000000 0 189000000 189000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying values and fair values of financial instruments that are not carried at fair value are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying <br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable <br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unobservable <br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts in nonqualified trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current installments of long-term debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts in nonqualified trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current installments of long-term debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,419 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 170000000 0 0 0 21000000 21000000 0 21000000 14017000000 13608000000 169000000 13777000000 170000000 0 0 0 22000000 23000000 0 23000000 13953000000 13247000000 172000000 13419000000 Commitments and Contingencies<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following:</span></div><div style="margin-top:11pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Demerger Obligations</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of March 31, 2023 are $108 million. Though the Company is significantly under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued.</span></div><div style="margin-top:11pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Divestiture Obligations</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $126 million as of March 31, 2023. Other agreements do not provide for any monetary or time limitations.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Obligations</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of March 31, 2023, the Company had unconditional purchase obligations of $4.2 billion, of which $532 million will be paid in 2023, $675 million in 2024, $549 million in 2025, $419 million in 2026, $341 million in 2027 and the balance thereafter through 2042.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position.</span></div> 19 250000000 750000000 0.3333 108000000 0.3333 126000000 4200000000 532000000 675000000 549000000 419000000 341000000 Segment Information<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>Activities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,853 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,800 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,225 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,538 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,826 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes intersegment sales primarily related to the Acetyl Chain.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes a decrease in accrued capital expenditures of $56 million and $23 million for the three months ended March 31, 2023 and 2022, respectively.</span></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>Activities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,853 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,800 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,225 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,538 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i7558002cb7974da0aee6c353e77b7e86_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,826 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes intersegment sales primarily related to the Acetyl Chain.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes a decrease in accrued capital expenditures of $56 million and $23 million for the three months ended March 31, 2023 and 2022, respectively.</span></div> 1630000000 1250000000 0 -27000000 2853000000 21000000 1000000 1000000 0 23000000 112000000 278000000 -139000000 0 251000000 11000000 1000000 3000000 0 15000000 112000000 54000000 6000000 0 172000000 45000000 51000000 12000000 0 108000000 10800000000 425000000 0 0 11225000000 18522000000 5730000000 1838000000 0 26090000000 910000000 1652000000 0 -24000000 2538000000 1000000 0 0 0 1000000 124000000 503000000 -96000000 0 531000000 49000000 4000000 3000000 0 56000000 46000000 56000000 4000000 0 106000000 30000000 70000000 14000000 0 114000000 10826000000 421000000 0 0 11247000000 20611000000 5471000000 190000000 0 26272000000 -56000000 -23000000 Revenue Recognition<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of March 31, 2023, the Company had $1.4 billion of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $378 million of its remaining performance obligations as Net sales in 2023, $460 million in 2024, $319 million in 2025 and the balance thereafter.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the unaudited consolidated balance sheets.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have any material contract assets as of March 31, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects which are solutions-based and are tailored to each customer's unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further disaggregation of Net sales by business segment and geographic destination is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Engineered Materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe and Africa</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acetyl Chain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Excludes intersegment sales of $27 million and $24 million for the three months ended March 31, 2023 and 2022, respectively.</span></div> 1400000000 378000000 460000000 319000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further disaggregation of Net sales by business segment and geographic destination is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Engineered Materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe and Africa</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acetyl Chain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Excludes intersegment sales of $27 million and $24 million for the three months ended March 31, 2023 and 2022, respectively.</span></div> 479000000 289000000 560000000 377000000 548000000 221000000 43000000 23000000 1630000000 910000000 365000000 425000000 460000000 592000000 367000000 561000000 31000000 50000000 1223000000 1628000000 27000000 24000000 Earnings (Loss) Per Share<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions, except share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Celanese Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634,068 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,185,912 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental shares attributable to equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,665 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,188,266 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,917,577 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Excludes options to purchase 86,194 and 0 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively; and 72,574 and 61,297 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively, as their effect would have been antidilutive.</span></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions, except share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Celanese Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634,068 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,185,912 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental shares attributable to equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,665 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,188,266 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,917,577 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Excludes options to purchase 86,194 and 0 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively; and 72,574 and 61,297 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively, as their effect would have been antidilutive.</span></div> 94000000 502000000 -3000000 0 91000000 502000000 108634068 108185912 554198 731665 109188266 108917577 86194 0 72574 61297 Other (Charges) Gains, Net<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, the Company recorded $23 million of employee termination benefits primarily related to Company-wide business optimization projects.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the restructuring liabilities by business segment are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 23000000 1000000 23000000 1000000 23000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the restructuring liabilities by business segment are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4000000 1000000 1000000 6000000 21000000 1000000 1000000 23000000 4000000 1000000 1000000 6000000 21000000 1000000 1000000 23000000 The weighted average interest rate was 5.6% and 5.8% as of March 31, 2023 and December 31, 2022, respectively. Includes $104 million and $166 million of liabilities related to the M&M Acquisition payable to DuPont as of March 31, 2023 and December 31, 2022, respectively. Includes intersegment sales primarily related to the Acetyl Chain. The weighted average interest rate was 1.3% and 1.3% as of March 31, 2023 and December 31, 2022, respectively. The weighted average interest rate was 3.4% and 5.8% as of March 31, 2023 and December 31, 2022, respectively. Excludes options to purchase 86,194 and 0 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively; and 72,574 and 61,297 shares of Common Stock for the three months ended March 31, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes intersegment sales of $27 million and $24 million for the three months ended March 31, 2023 and 2022, respectively. There were no accumulated impairment losses as of March 31, 2023. Related to the Company's long-term debt, excluding obligations under finance leases. Includes a decrease in accrued capital expenditures of $56 million and $23 million for the three months ended March 31, 2023 and 2022, respectively. EXCEL 104 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

T>_,O!WA*+6K=(D3'!#C M'A,N;KLQM>C@!M%9[RK?)T6I!E\8%>#9HH:X?M_%?6(T.KBR+:A6'[SGJ:)M MTO?J3:,5-(35GI+N0G^PUA\,R\JWC.NS?_64<-Q'\W;L0GVP5A\,B\I$ <8K MR)2:FPP<4-]6NW =HEV'P(ZRW4^-/R=8$I/U[PE=: [1FD- MM%#F7/VF9UP+78@2V?I-#3:<:T'CZNCL*;OAJ1$>#@B-9SWAHK94VH\([$?/ M&Q.=/D9SFJL#C[K3V@U!YU]F9KXN3@41K48$]ID9RQ,NT*>\*$'5L=0YETK] MWJE!5[-?/($37SQWNU FHI6)!-9[ER7W6?-W85)$FQ2!Y>[0K." \1<,:LBZDBFBI(K 3O:!EP4&U+:L+ MM_*T6WFP6\$MRS=>TV!5MVRE[?)KW?*LZY9G5;=LI>WR:]WRK.E60Y([P+YC M;EFF813"<6W!M6%YKS6LAH"J99G).KDD:>N:)%N6U1!4U[+@LK9\VK*\AA-0 MGZX0W+9,OX"?P*DOGK9=F):G35=.RE;;+KTW+LV9:#4G>8#0:F=N6 M\4(*.*XMN#8M[[6FU1!0M:U@8D3K0K4\K5J>+=5J"*KM6UVHEJ]5RW^-:HU, MH'#B2^>LK;1=?JU:OG75\JVJEJVT77ZM6KXUU6I(PO5'AZ9A%,)Q;<&U:OFO M5:V&@*IGFWR:],*K)E60Y(_(*3FZ- TC$(XKBVX-JW@M:;5$%"UK4/CT2%UE6MYYNWMW,QDR47U"?WW(U;M/=SXQ+<[;6Z,%S=[NF5W M3'_>?Y1P->ZU%+QBM>*B1I)M;D>O\,ME1LR 1N(7SN[5R6]D3%D)\8>Y>%?< MCA*#B)5LK8T*"E]'MF1E:30!CC\[I:-^3C/P]/>#]I\:X\&8%55L*:%W MMZ-\A JVH8=2?Q+W_V>=01.C;RU*U7RB^TXV&:'U06E1=8,!0<7K]IM^Z1QQ M,@#T^ >0;@ 9#L@" ])N0-H8VB)KS'I#-5W<2'&/I)$&;>9'XYMF-%C#:[., M=UK"OQS&Z<7GFAX*KEF!WM6:25ZAI:B5*'E!SX,NOK]$WR->H_>\+,W]F[$&3$;S>-W-_[J=GP3F3]%[4>N=0F_K@A7G MX\=@2V\0>3#H-8DJ?$_E-4KQ"T02DGKP+!\_G$3@I+U_TT9?&M#WKEZ+BIWX M\;=7*Z4E1._O/F>URC*_,I/2+]6>KMGM"')6,7EDH\4/W^%I\J//TF=2=F9W MUMN=Q;0O/D %4K1DWI!HATZ;H:;.'!X0F:=X+G:&:]*@F451+ MH9I(#B)KAT].)KTBQ 3"&32/%)[-4S^V:8]M&L7V/RF40GLI-ES[H$V=2::UIO^:IDB"K%M!=M[@+) MAD[VR&#LQSKOLK,-(]^81!?K'95;IB[1%KH%]0+5S!NWG;)S#,-D]PD%?(I/J U'<0+/ XO7 MX$2 6F]9 Q1=E)!GEV&XV,VS(5A7) B66+ DGOX6&X* +;C:"\4?@G=U4" / M8:O:_&L".&P#<0 .,\XC[P04V=^,AEFFD=H MDH8\;9D)QZGI[9\'KK^:M@7M]O$-UL>,F!L/W]3.: PHYW79G) M-(#;.D]<'45\)Z^&NE3;A()J$A'C1DFDNVT:#5?M2?&4,K:!P-XO1%9-+ M,-TT)5[C7&IS%L45"984RWTX3GY-\\E47_"\V%QVN\+YL.+YI-( !V)+@CC. M@CV^B.M<$LN'V%R14#1;EL-QFGO#C[Q@$ 0M,NC,V4-\'P&P"05_&+LTEF9# MO!Z960"PI3H[MH"YLI*C0&O8J MO#Z8_!-V,[1BL)UF2-,O/@.(2VV8#)/*(S3%@8I!+ &2. %VFP\ ABZ@(A^Y MJ1B7#P7!"]9#;618W7Q"&(<\;AF0Q!GP\1[W(G<);3Z,$X_,) G4+F)9C\19 MSXN[!VL(!T;ULXM"0JRNS"0)66$YE,RCITJPMST MKW\[\BA%/_6 M&AY6 X],H%BEEJ?3.$\_LEAU6J:Q[/#(A!U[P_X7Y["I9?8TSNQ+;\_:68\N8!M<0,6F4C5^:ASD7\]V MFMEI*%WGL^&*NE+9]33 /ZDE]C1.[&_\:?$M9K03Y:=9DUPG3N(\FN53R_+I MDUG^+!2?8L74L0(6PZE;KE1D,6PSD,Z>);\*7A[T\*%.AS_:;CPYPYY)V[D_ M;$^1QGN*4(9U]C]E67/?L@ZW,1XI6-; 24)JFXHTOC$/Y]@W&#)_7):Y&_= MEF6V'/K,]0Q;O&?[!E-.%B1GC[M]Q,L=Y M3J;#'/&*YG,\F\R&)UCCDZ?G%9/;YJ4"!14-6NSVN7-_MW]QX57SN'YP_S5^ MN6Q?/[!JVKZ'%OGE&OQ):BZKYN6.T8-(( MP/\;(?3#A9F@?\UC\3=02P,$% @ ,(.J5J6%'9N! P \0H !@ !X M;"]W;W)K^\C0S=L)?SK-!'WV!=64OYS0X^)0LOL$288VRL"4:O M/:XPSZTEXOA>&?7J/:WB\?>S]??.>7)FS32N9/X/3TRV\*8>)+AAN]Q\E8>/ M6#DTLO9BF6OWA$,E&W@0[[211:5,! 47Y9L]58$X4B [W0I1I1 U%89G% :5 MPL Y6I(YM]XQPY9S)0^@K#19LQ\N-DZ;O.'"IO'!*%KEI&>6CX+M$FXP@4_" MH.(%K*30,N<)LY,/AEZ4-:-!;FBIH'\ELTG<(RG$LD"X^%-J?0E7\/CP#BY> M7<(KX +N>)Y3FO3<-T1I]_+CBNBV)(K.$ W@3@J3:?A#))BUB].SB M;=1K\(ZI:QB$;R *HD$'S^KGU:,>G$$=\8&S-SQC[S.=361*<)%JN,AM\+J" M5!H9.R/V+.Z7,X+?'W.W14;!L)8Y@1O6<$.G-#@#]\5DJ" ^R3.O\NQ0WX @ M?OH7#'OJPA[V^6YKTHW>LA@7'FV@4>W16[[^+1P'OW]Q)_ M>($"8HR9SF!#91HR3%+L/(GC%L6PP=F6"$?=F),:<]*+>5_= 4PDL)7:*#1< MN1H#:Q2XX:83==(.6-A@;8M$W:C3&G7:B_J7-"P'^:MG8MJ.X;B!WA:Y.G.2 M9S7[["?8?X%ZUJ8.9@WLMLPH"+JYP^#E1@IZR4]OF8L2^A(L-#!C%%_O#%OG M"$:"D+0JC))TVXB4'*0[#'7W'U1M>WKF&@[URYPZ='3%AO_!H9,DM!RBAH8) M*F9TUZJM5*[<=#H3MHI_&$R:WK2%AK-IPQW_J'DH4*6NI]+TY^R$*2_9>K;N MV]ZZ;J4Q?VO[.=>4O)@IFT&Z0E,N-.2X(9/!]83BJ\K^JAP8N74MREH::GC< M9T8]*2HK0.L;*RG9EBQ^.,7T(8XEW4N> M>TG>K*2JF(9+]32M M-XJSO'&JRBF)HF1:L4*,KBZ:>W?JZD)N=5D(?J=0O:TJIEYO>"E?+D=XM+_Q MI7A::W-C>G6Q84_\GNN'S9V"J^FAE;RHN*@+*9#BJ\O1-3Z_C8EQ:"S^4_"7 MNO<=F5 >I?QF+C[FEZ/((.(ES[1I@L&_9[[D96E: AQ_[!H='?HTCOWO^];_ MT00/P3RRFB]E^=\BU^O+T7R$=K;1"&7; M6LMJYPP(JD*T_]GW72)Z#CCV.)"= QDZ4(\#W3G0M_80[QSB)C-M*$T>;IEF M5Q=*OB!EK*$U\Z5)9N,-X1?"C/N]5O"T #]]]2#8-B\TS]%2BEJ61<[,Q0TK MF<@XNC<-UVB"'NYOT?MW'] [5 CTN2A+&+3Z8JH!@FEHFNVZNVF[(Y[N/C-U MAB@>(Q(1ZG"_#;O?\NS@3H[=IQ#X(7IRB)XT[5%/>\NM4EQH=%W7$*8KG-8_ M=ON;17E>;UC&+T>PZFJNGOGHZJ]_P4GTBRNXG]384:CT$"H-M7ZU9/4:,9&C MS'SA?VR+9U9"[,ZHVZ:2IBE3.9ZO,$[2B^ES/QJ'T2R:'XR.4,8'E'$0Y5?% M<@[U)., [['D=1O_!.EUH7*T84J_-E&PU:HH"YBK3OQM)[,^M"1*!O@=1C1= MN/'/#OAG0?R_2C'1PQC&2'#M@CFS$*31,,NV39+.W""3 \@D"/*C>(:!EZIP M)R^Q>B1IO!C D MU*R$6MR6"C^\N3U2<3P?X',8)=@#<'$ N#@YGK6NS&(VU3F\-!;VK(^LT749 M)<2-$D<=U41!G'<*Y HLX#': +OH9AV;0K0QT-%[6"1(KD )9-MJ6S8TE'.H MA!G$ FRSKP2&.<[1.SI.%_B7A@B:JV2>?G#R463%,IO-A\/BMHH]$??(%8=G M-,0+X,43^L1!G(Q1HZLFQ4G=BY'P^F! M:!U]X3!__5/*_ 74D1.633@IIH.EMSS1P6_X=Z=L-0M0P:F5+6U#W2RF>6H>NDHZ?29B?V[I:AFUDF#V/I>*I3-KD2.DH)M98VT9T M[I&KI*,L$J:LI:RJ8K=S-.2TE,+DE<-J]V -MN=6%086),L?E6,_J[7CH#OBI&'BO%/["EEKF7T; MHW?1683;#D";H&=6;F%[BJ-H'+5_[;/:) OFQE:#GFM8X;W9?S>3I=UZ1ZBH MZRT\,+?D5H.H$SG,(>=FG-JD.Q3A09/CZ#M:IF%:-M-EL#(M[Z!6G=+R@Y'3^;#%@Y2]D M"QPG\Q0N*VI3M([8>N(.R1<%D%B^& M7'+2[#BX3CO0L':XSO.&AT&X;5B13X">,[8I0,@YP=K2@";#8NTR\FTC:2B@=A(?J(/[J<,6$S-8"$/\+BOJX73::0X:UAR_2LBQT$J6I9%(A0"5 MSSVRG3JD1V+-%9>1+\V=]* G=LM-F@,YM/>X">S2A]A<5KX#I;C3"'%X)]R" MZ^FVPUFU&^RNN?Z[,-\ 4&W8_OM,Q7AQFO-_P[U]A]7'T8CZ$/#I5 M+RHH=*HY=#?KT$37G,!\9BI;M]1'\;C]8BK\F4N"3'OOG"NNGIIW]S4L]ZW0 M[5O)P]WV]P$W^'S9O$8?W+^.S0\'W$_(_B<%TZZ+]@<)@/6I$#7L %;07726 MPA10[3O^]D++3?/6^U%J+:OFZYHS6+G& )ZOI-3["]/!X9<65_\'4$L#!!0 M ( #"#JE8\U*U=AP, !(, 8 >&PO=V]R:W-H965T&ULK5?;;N,V$/T50ET4"9!&5TMV:@M('"S:AP6,==,^%'U@)-HB0I%:DK(W M^_4=4HK6;H5\404A>M&5%[LEIMQ)I_;:0J9346M&.5E(I.JRQ/+U M@3"QG3F^\W;A,UT7VEQPTVF%UV1)]%.UD#!S.Y:_^&N;B)T /SH0$+0!P;D!81L06J.-,FOK$6N<3J78(FG0P&8& M-C.ZYQJDJ.YX$HPFF,S>< ,\XR@I2%6Z&J!)>&Z M()IFF%VC7]#3\A%=?;A&'Q#EZ!-E#.Z)FKH:)!EB-VNW?VBV#PYL_PG+6Q3Z M-RCP@G @?'X\_)%D77C0#W4+#_ M-;B'(M5(K-!'RB$'%#.T M$(K:HOO[_EEI":7WSY#5ACL:YC;G\4Y5.",S!PZ<(G)#G/3GG_S8^W7(^/]$ MUDM#V*4A/,:>WF=97=;,5D).8 /(@O%_8V:,-.>/YPB70FKZK5VK)#QPF8@ 4CY,.U#,8=0:CHP87 M\*P@4H(]. "RC&$FTPJPFZ@GK.!6-8*@1VD"J@]*^'U#=;)#O"O%MO7_T) M4$_]J%,_NDR]U:@0KG4A)/T&"\9%L,_VE'E>^UG3_\YR)Z)N#,1_Y ) MJE1]VD#\3M:^\&.(GN"D$YS\D&!X-RH-I4[Y^I3JY*3J8XB>ZG&G>GQ4]5R4 M)9S6_U#F#?^D7\'>NT(_">O)GW3R)Q?(O[C.)^_2&1VH\W.0/0>^]_T-ZUWN MX;PR;YE[QR_QHF@&PO=V]R:W-H M965T&ULO9WADIFM0:@SM]U, MN[W[<',?B*W$3#%D 2?M?W\"$V,)63;)L_F2V([T>V6]3P1Z)-D7CWGQO5QQ M7ED_UFE67HY6577_83PN%RN^CLOW^3W/Q%]N\V(=5^)I<3+YM*ZW3L M3";>>!TGV>CJHGGMNKBZR#=5FF3\NK#*S7H=%S\_\C1_O!S9HZ<7OB1WJZI^ M87QU<1_?\:^\^G9_78AGXQUEF:QY5B9Y9A7\]G+TJ_V!N=.Z0E/BWPE_+/<> M6_5;N?+72TBUE7W'_\1*?- MFQ=OYB8N^3Q/_Y,LJ]7E:#:REOPVWJ35E_R1\?8--0UV[*3D;78 ME%6^;BN+%JR3;/L[_M%VQ%X%FQRHX+05G%,KD+8"42M,#U1PVPJN4L'Q#U28 MMA6F:H39@0I>6\%3*DSM Q7\MH*O-NG0>YBU%69-=K?I:'(9Q%5\=5'DCU91 MEQ:T^D$CB*:V2&&2U=K]6A7BKXFH5UU]R^+-,JGXTOJ45;Q(UM8\S\H\399Q M_>+72OP24JVL\,]-4OVTSJQO7P/KS2]OK5^L)+-^2])42+"\&%>B,35RO&@# M?]P&=@X$_B.OXE13;6ZN-L_7:R'YKU6^^*ZI'1P)*OZ]RTWQ\V#]T%S_UZ7H M*_%^X]2ZCI/EV:?,FL?WB?Z=4#/K"Z_$T"+Z.(R++,GN='T8'6G.8K%9;](F M4[]7*UZ(Y*W%$+:JQY8'+E*ZR-?<>O.OO"S?OK,^\TH3@YEC?,X%)*N*7"0Z MN]NJA)>5TMJQD-U.>\Y.>TZ#)@?0HGEU/D0# [Y]]+;65).;59XN>5'^XTEW M__TB&F")X>HQ+I;_T\EM&\O5QZHO 1_*^WC!+T>B@TI>//#1U=__9GN3?^I$ MB(0%2%B(A%$D+$+"& @FZ9+L=$E,]"MQ)8TS017_3<5]7L3-1;:45,D;5>ID M:$0/E>$6YC6P^B[DX6IR,7[8UU:_Q-G4/7?D4F&_%"%$+D/[9Y MB*&F7,6B"6^MN++$$/3>(O8[RYDXMBZQQKA#$[N%3??ZT9[,)@[QR51)<+^D M9_O$]N(?.@4:J4,5B(0%2%CH M]8;0,^6Z1I'Q(B2,@6"2KOR=KGRCKJXWQ6(E5+6]EC[-G9H[H?W+ITY:?J_/ ME3N7N3'T4+T<#1(L-1)"Q"PA@()JGL?*>R\^,7.RNN;ZO*8Z.0D314 M2N>],<:9$6_B*3?LR)@A$D:1L @)8R"8I"=[TEF@DY,5I34RC=6'RJBEF2;U MT( AE$:AM A*8RB:K*,]*]TVZNBSN-GFK9EKO4EKT]6*JZI(;C95?)-RJ\HM MG;>DU9S=4\ETHM@Z79@>((ZWU!: *6%4!IM:?*\D*B:@KK:*)JLJ<[7MLW&]G:-:"&M M$27M&E&Z72,R&P8M7^HR5QV4D YX *6%4!J%TJ(3^I:A(LKZZ;QU&V2N"QW) MRX9)NVQXDM-N;L7@ 0U)"Z"T$$JC4%H$I;&6)BU!N;.=O&5!=GZ\_9J&O UU MY*&T $H+H30*I450&D/19(%VQKQM=N9/F1(<&"KU]WI]+[LW*8 :\5!:"*51 M*"V"TI@Q4;*8.C?>-MOQP=,L8+!JD!;S'$H+H+002J-06@2E,=NTY"$+K//O M;;.!'R3E=FBJM_0-%AG4MX?2 B@MA-(HE!9!::RE'9B3R"KK_'O;;.#W9Q%B M3!LP?_@M+G;S!T>K1*CM#Z4%4%H(I5$H+8+2F-U??2&NIY>BTSG_CMGY/T&* MZCZQH^HSAQR\$76BVRE&)CYQ;6750%/TP%8Q:!,IE!9!:0Q%D_75K0@XYA6! M4_1UDJ;Z]K=[/E6\RKFY,8-W+4.7 Z T"J5%4!I#T63)=>L&SJMNJL?NJL=N MJ\?NJ\=NK,?NK,=NK?\K%B&<;A'"^0MWUSM]D]SU)KXZ$![?-Z\IHMLXKXE' M'&7'!]44LB>VNC$DTA0[ZVW#9^;>>VYV.HO?,5O\+\N.VU^E]4@O.WTKN)>= M?I$Z.[::G7X\XCMJ=OJ%;-OQ734[_6)G4WNF9@=DBLO9Z?QNQVA78DXWZ.\P MH-YW2U/N6EV?G!-'376_J&=[GNV>$S7;4-,:2HN@-(:BR2KK3&O';%J?KK*3 ME.7U_I<]>S)5!P6H:PVEA5 :A=(B*(VA:++P.H/;\5_SWA7J>D-I 9060FD4 M2HN@-(:BR0+M#'+';) _]Z"-&3M8BE!O'$H+'8UCK!ZV@4:,H#2&HLD"Z[QQ MQ^R-O^#$C=-W2-4C-^;@@X5S-& (#4BAM A*8RB:?&"],[*)V<@&';TQ1QDZ M3D%I 3FZ;SZ$!J106@2E,11-EEOG:Q.SKSWD#(X9-5A3?2>(DR..^,D' M<O?5U1-H2(:BR9KJ?'QB]O%??!"': QV3QV3H!O0 MH;002J-06G1"WS)41%D_G4-/0 []R0=QM-8]Z6]B=KV9*C.H&"#NO106@BE42@M M@M(8Z:]NG-EZA;F=3>^:;?H7'; QLX>J#$H+H+002J-06@2E,;>_9__ *2ZW M,^?=%V\Z/_E\#=$*4;,;W5/.&,S-C1RL+ZB=#Z51*"V"TIC;_QBA_53)"NM< M>M?LTK_PV(Q>5%!GW^U_MHL]F?DSSR?*_#70%#VP 1':1 JE15 :0]%D?77N MO6MV[Y]Q;$:OJ;Y7[=E$W15A;LS@D0KJW4-I%$J+H#2&HLF2V_O8>/<5G0X7 MNA( I0506@BE42@M@M(8BB8+M%LR<,U+!B\ZF-&RI4\3%)^R):L?U6K.V3*K]OOF/I)J^J?-T\7/%8I*4N(/Y^F^?5TY/Z:YMVWTUV M]7]02P,$% @ ,(.J5MBM_!%3!P ?2 !@ !X;"]W;W)KZ>7:G5N:Q, MP06[4DA794G5PSM6R+N+43IZ?/"%W^R,?3!9G>_I#;MFYNO^2L'=I-62\Y() MS:5 BFTO1F_3-^MI8AF]W%Z&R$M\XXF !Z/$OP,T"W%\P#2P@ MS0+B#*V1.;/>4T-7YTK>(66E09N]<+YQJ\$:+FP8KXV";SFL,ZNO@E8Y-RQ' ME\(PQ4NTED++@N?4/KPV\ %1,QK)+5I3O4,?(/(:C='7Z_?HY,=7Z$?$!?K( MBP*BHL\G!D!9U9.L ?"N!H # CZ*(79:?2+R%E^O'X"QK06X4>+WN&HPH]4 MO48D/44XP<2#9_W\Y3@"A[0.)DX?">C[O&>*&BYNT%N;L=QPYO52K67JUV*+ M^8W>TXQ=C*!:-5.W;+3ZZ8=TGOSL,_&%E!T9/&T-GL:TKSY![V%4"3!9HY-" M:OW*9V^M9.Z4V%YSNUI"M&X/K1B*S))I*W,$;M:"FT6C\3;_"VJJ3F@CH0]E M4F2\8$@,45L!^SBS6;]7\I9#@J+- SJI-%QP\0K)-K@T&MS92P;WA90=^6_> M^F\>#>Y[!DHS3FT+/D6TE,KP?VC=D$4.7L@4LW<^)]2:9P?A3!=GO9![9)*Y M/^2+%O(B"OFJX1R+;R^UL0"5ZVDNNA!!+G.>H0T3;,LAW"#C@[\80.OGZU!B MC%,_^+,6_-E_!0^9:Q3?5";4=\^&<%+<@QR7.8*\;"$OGTB1+5/*%4@F2X8, MO6?ZU/K:!W(Y#'@/XE BT /2I..\) KQY%=JJ]=6.0+GYER#;[G+8F"Y3:5! M7FNFZYR&*Q,VH/FI(Q?.>R9X9$C A@/>3J,V7!N9?1O;"2:'5"AAK-,T5'F- MJB,O3_L8/3*S $C<@<11D%\%^+;.4H#9]E<8&"I(CH,Y@VZWO("VXF^?S:\< M8L.S/OZAS)@D 0,Z\DZC5+GZ;'9,A6-//.73QS64"<6^8]@T3K'=3!'A)O"\ M;1%<5/"@(:K0A#9]L@H](N-0'79DG,;9>+VCXH:Y?#A@4E=OKO0@(S:0%B%6 M35^45E]*V[$O.F)-X\SZNZ(YLP,)X[=T4S!=ZQXCL^,*FC]5YJ'N1VVIA/-R M2*/ 1(.NY).:ADJFH]LTSK>7XA;H2:I0T(8L.1W4LH=)28"6THY*TSB7NEIN MTLN+;$B&RV4?V5 FY+".+],X8=:1W].'9X;=BWW(DF/<)WN/T'3I1X\[+L5Q M+JV]^D2E8@])XF5_^/-+!0!V1(GC1/GI949X/.3'\;)?4AXAD@;F5]RQ*,;1 M-FDK2C]C"XFC9/R]_?"EM!T;W3$OCC/OFNZYH05B]S#:Y-Q4\"-V6(,H0L3, MPRG:%Q3&8%L;[.^*[^U0[/6*CZ3G_?''*T46@=!U3(WC3'VE9,98KM%6R1)I M"CO-[YXP\9!Z^VW)(Q)H2[@C9QPEO"=&GV;Q<:WV-T0^H=#V G=,B>-,^41! M\[9:GBAH#_T--Z1>J6#7[$@2+Z(E_8$+*K)GE'24:[^[I%](V['1'0'C. &[ MP+F1STY\>B>5&1NF2K21"I2YK<$=-SM44BAWYQ-;+025]0FA!)Z!JO'ZR;.1 M)4G2#^90:A$88G%'WSA.W[T2]UGE13PD8T(&V3<4"M0UZ0B;Q G["X-1HSW2 M+:2XJ>'F;..M=.)AY44/9USF&&A'W"1.W%>5@FS1=1(8Q:BNU /2=M][:@\7 MBBJW!:18X;:06Q8X6!UR0UO9TLQ.H0]>L#&.;+#Z-KDAL!V1DO]# MI.0Y1.H5"@'KB)3\+R+=MAP5)U+BH8[\3O([_IH!"'4O/ '$,Z\B-Q\EN'<,)0Z^J2W7!A#_WL37W4[K7 M*DWG?8KT2,V3?@%,#E[D MEDS=N/?;&KI<)4S]!K1]VKY#?^O>'/>>OTO?K.LWX9V:^L7\1ZH@)!HFJ2VH M3%XOP)VJ?M==WQBY=Z^+-](86;K+':,Y4U8 OM]*:1YO[ ^T_W&P^A=02P,$ M% @ ,(.J5A-+/;_)" F18 !@ !X;"]W;W)K+*QKI$!EZY:^M:1+..F1B]7IZ??+!NIS.SJ(MZ[S?H;[U55![ZQO+IH947W%'YK[QRNEH.54C5DO+)& M.-I7LE!TB345@"Q+_MG1+6K,A MN/%[MCD;CN2-X]^]]>]B[(AE+3W=6OT/58;Z\KQ?,WV M"JM]_"MV>>WI3!2=#[;)F^%!HTSZ+Q\R#E^R894WK*+?Z:#HY1L9Y-6%LSOA M>#6L\8\8:MP-YY3AI-P'AZ<*^\+5&_*%4VU$R&Y$J$G]VS>K M)PW^)-U"G+V:B]7IZNP)>V<##&?1WMDC]GYVE33JWS&\.1 PWFI5RE0XP&$< M/L/QG3+2%$IJ<8^;A"H-7OSS>NV#0YW]ZQA"R8'SXPXP]U[[5A9T.6OY++>E MV=6?_O#JF]._/!'>^1#>^5/6_V]9?O*4XS$\YVCQQ"806!HLQ0W76G=(D4(& M?+?VJE32*?+B!;@1R;\EO9]'([-L9?92X%0I*FW7R"$KG2KP@^WXECBQ80^: M!7+XZ461MBW$KR-/6F?+KL!!-9@O6G)1(DU!@DP%:,A1*5JK]PTYC^-E$-*1 MZ#QN*_@LMNPGSD&$;.)D*W5'0K:MAC,N"/*<.Z9#@(DMN7TI]T*KK3+5Y)"OO%@[*\M^*_!Q80.N61'K MA4\ID3"'!'NT)!Q"ICP!9A-<$$.ANQ+6A>P@D9:3/!_EL2P5WP($!98'UQ6) MV7S5(1^I8C(0<4--_K!A6,*8PN <7I"K]@)Z[-"K@*S2P66YV%A;QM5K#CT^ M;M$.0\*PL%AF*L\WVVP6)/DH 70UG]3-V"&L"O00E.8TO:&-,BJ%_LZ@EE"] MOW32(>M([7MB% 5XP(U*O#H]^46\F'WZ?/8R<8 K!43(-)IQ9XWU:8]2"Q6( MT[7<<9D5D_OPT-CP&>]2OJ>GB-\6]XOQ46%2$L-VT/2PY5Y\;S7GV(L??[R= M.*)5HP)HI)5<*ZU0C9FA3[EU7&K8VQ-H3N!EWYVB1_BQ8J,!=9'H?SR'.X@&N$&M=%DE"H!>QNK8 MJ5#'Z\YP06$96*!:%(BHN#S!\#T_IS;T1P!%$^.*72H&?XW21DFC0#@GXJ_7 MUW=00XZ&%0+5J&SI19L@HC(3A=E&T6!VP'^BR_,(>!083H?=<9@3.;;@1I:L ML9[3 [E">?(1'F=CZ;.VD>DIO]9@%,L._THI(A\$*TY@RPCU<[O*QTN Q,,F MJ&G H8)K;/'LG#,6%E;=Z+$R:3+F6LHX/9[?.8Y%OGRRLE.LPGOB)>G^7*L"VD([4 M1Z$R4">.93[D,J+%Y70 9 ($^F.LOCAB)@@<:,B/_@N$(^!P]L&S>22KHYI' M^RTG%-C1#-VG,Q9.XJY%'B3SO6 Z0.)CFG?&SDW$"4!=3),84G M66%I.+[7=:P. M*6=5IW/SS,R]9WP2@WC%VX>BEJ:*#&J4CV]=+V;W;V]G+R-C_/,X@Y+M-+=& MP>^,&=X/G4DO9='+:3/X AK&$!+L283WF'&R^+Y!EILU*)KU=Q5[-2.%]DAK MUW$!K,ZS-@_G(TZVBRR$3Y0-+ET;T\&%S_OL#POQ[EX'B'K()[K%9@[UV$1>8X>?/&L M;>, #N=SZ@4RY5$/\*/]<<$.'M)WT(&^ M;(Y#A&DC9@<600_K4]^,C19@&S#U](\]FPAVH9A%)H+M@N>W&E\C(S7F3=#A MJP%4'_/$7=>P.AAK\I"B8UOI5RW$6W2@)HY8#,8UX]>FHOFU[@>ZX>/!<_5OE(5C'C72^#YDK6T13:*_N0IWRRY. M!0=#<9J.D^]"W*O*8!XK)((Y8-?FOL]*@9I3;IAK*KS\[936+(,!)%<\HXY0 M2 JFK:E.\#Y,97X&L>O0"Z2/(VI!O9M)*[FJ^)TU.5I8/S'V(@?R4E3P"0)F^' YWA^^NU^ESXV%Y^FB+ MAH;76 ^N;;#U=/'GK_&6ESZ$I@OTB/CQ<6T#WM/CSQIS #E>@.<\./47?,#P M-?KJ/U!+ P04 " P@ZI6=?)RKVH" "Q!0 & 'AL+W=OZ:%>6?;BGJ60%6HGC0:+FUDT'TX6 M8Q\? KY);-V1#;Z2M3&/WOE2S*+$"T*%.7D&P9\G7*)2GHAE_-IS1GU*#SRV M#^PWH7:N92T<+HWZ+@LJ9]%U! 5N1*/HSK2?<5_/I>?+C7+A']HN=CR.(&\< MF6H/9@65U-U7/._/X0APG;P 2/> -.CN$@65'P6);&I-"]9',YLW0JD!S>*D M]I=R3Y9W)>,HN\,<-<$\STVC2>HMK*S1;.?(1T]N&A-G\;%QOF=<=(SI"XPC MN#6:2@>?=('%W_B8U?42TX/$17J6\%;8 8R&%Y FZ>@,WZ@O>13X1J\L&7[, MUXXLOY>?IZKOR,>GR7T/35PMA"Z$+>"A+@2A ^E<@P6L=T EPHW40N=2J%,8!POC MH6TI\S*DP.>:FY7A9/B-$UI&JAW(B@^4 N'2L*UW[QQL>NK:..D[_ )X5%D1 M33OVO!/>#?, M^,UNI7:@<,/09/#^,@+;#8C.(5.'IEP;XA8/9LDS%:T/X/V-,71P?()^2F>_ M 5!+ P04 " P@ZI6'VA.]Z<( ">% &0 'AL+W=O/3K>6B]DA4?:LQ\N5C\,&^DMK.K"WYW MYZ\N7!>-MNK.B] UC?2[%\JX[>7L9-:_>*O7=:07\ZN+5J[5.Q7?MW<>3_-! M2J4;98-V5GBUNIQ=GSQ_<4;[>_>^D_L>_PI9!!W3CS#UW%^G+V="8JM9*=B6_= M]F\J^W-.\DIG O\OMFGO^9.9*+L079,/PX)&V_17WF<<)@>>+KYR8)D/+-GN MI(BM?"FCO+KP;BL\[88T^L&N\FD8IRT%Y5WT6-4X%Z^NRT^=#IH0"D?BI0ZM MRT]"VDK<&6FCN#$N=%Z%BWF$2CHX+[/X%TG\\BOB3\6ML[$.XI6M5+5_?@Y3 M!WN7O;TOEM\4>"O]L3@].1++Q?+T&_).!_]/6=[I_\-_\<_K(D2/3/K70U D M36AY:6:K+&/_ M.^RFN\5K*]ZXC6H*Y2F2RR,1:R5N7--*NT.I8JM7E3A9+/XJW-8J'VK="K<2 MRD:(4$F##$'%($I(U"%JNZ8=$N7QP7D==_1$8F]=H0T]?R>;]D=Q*Z/R6IH@ MBB[ SQ#$P>R6UVYGAW3H97>'K$5QBS>J<9V'=Z]M>8QM:06[#DAP?VKJ&]9 ME;"B[7Q9@R]$ZW6I2.RCDY/CA8 M!ON.P(/%!W"3B$X@IVR0F:>J#RA[\%Z$ M6HUG_#/F<2E#/=UW+'Y_"#$IUL85TD"KJ[HDT:I(U$@F+)^)E2P)#6!(XDO3 M501<"4&NL_R;H&V=V36 Z=\RLK&)BA M6@Q=VQJ-!R#/Y9##L?9*9<-AM;81 M9 L/NV1.JSQBT#H?5PX(3+7+%NOW&B2KS$X\/5^(%C\A"&P8:XJS*S7>5"*J MLK:ZA$32^);Q?YD3X2A9L2?K_&BQ6 C5M,;M%*5-Z1T"3M%KI.T 1NP\3#@: M)2BL+2##F7XS+B M( J$KV(8+)I8!A[.% AVA;_]"3;0&;?>)0L+67[<2E\QT&O/YE'"E,A]1F@4 MA01R6](PK3+DG2Q+]$<<56(-P@'4.%^CD3W>2-,IPM) 5*K9,5RK#J !P%Q7 M1Y0'EMKLAJJ,;&M412:D))UBM96$78E4HVARI>#%6(F O= V^4*"8G^>4*04 MRL9(Z$\&*0* ][T:\1YK/*@UI>1^N8##C$8WE5XC1PB=,F47]GQ9M_$S'P"< MKHB(5EH61O4T--8@[#98RF5&ZQT X>D!3K"QV@L%RFI8[4KBD1&GS0^IK+ O MN?"9>=GV'MJDHFOQ./JX T!I?.M110)/V ?R[!IPKC@/:1.29^](@7&.;5H- MQ5YJ7W9-B'VZRRC4/5B8_(\/VB\*A>B2BQNI#2&W'Q0=^D ZNW:49\C\DI(" M@"##F,Z(+!@JV9<>J_J3$0 D*<[N0V,W ?'Z?T0S.BPD1M M,5:T"1/QR'(D;:,2BY-3"GJH,E8K6 0+DEP,C\J3N5'>JY# 6&D2."9$[R$X M_ LO&[F#VH#YD_O$V#>R?V$$9A^/J;-KYZHM6M(QNI[O*:)1DIHVFP^'M&/( M*(C2I)1B@>"$"M%<_)U97CZ?YWBNMY89.*@I/-2;>" 9Z2<2P0G2= MS^0R'_SM15&OQ25KI+O(Y%/0O:JGPKUP$+D>Z$-:0W(2+U0*=E(C)1/5/2YV MG"*B5\+CT^=5.\G%O='D0$.V;-#&O/ M!%2J0#:C7(E7X'-(D7MT\F2)ZP]/3M,J+ISWG"H!N5*A1 F8]\?OQ._*-^)7 MAS'DIS3O[,0!ZHWQ8\@.A_8R:(.>:1*\<52H7YSJ$P<.4)I$^1'1;8TD,OY* MIG H.&0U)B3T3;X2*;H2H5.!S_L;S9*-.M";0R[XZ"*G^0:(.] XV+4%N9/8 M\65&,.%Q \!H.4@ S\ ]>SK@]J>MX!0,#R7AF,_(I%;ZW,-I>I146AMN4+@' MD'9KTC @F2HB7"(V3SU7VXH'B\W <%^M4RSN<+?O3#51S]#O4W@82S;UV('V M*8^1AI:F#:^2P*DQ/*Q6>= A _* D^U (">U2=A-+[7B )>91SW(X5"\'TCK M9LI#=P"3/R2(M]E3O$GHOD&L4\1.C\Z63\:%5]);3NX#W*(@>N5=PT2@; H ZPZ)A.B[_+L2[>Q:XP3YH&K&$76 MJ)[$_=XQ /4?U!S,?GEU=_/;[! CJ/B GAX%I2UCNZ6B.L?]#O/OWN7/#J]O M=<28HM%NQ<](A)M:-6N^E;$*GGY6VB/]";K$DB?/GCZAJA@G_40ZC?0? M5>3YV-UC1([USBBK8.[=;W0%Q-'KH.51OGW@,H(**SLC/81C&J#\HCLP^5O1 M2(-5,%?#HY45[S MU0F:P3KJ=Q9$GSM@$:%&*M?.5#S@;VLG&PO=V]R:W-H965TE!M0B3*!J' M->,RR*?>=Z?SJ=I:P27>:3#;NF;Z98%"M;,@#G:.)=]4UCG"?-JP#=ZC_='< M:;+"@:7D-4K#E02-ZUDPCR\6(Q?O WYR;,W>&EPF*Z4>G7%3SH+("4*!A74, MC*8GO$0A'!')^--S!L.1#KB_WK%?^]PIEQ4S>*G$ R]M-0NR $ISY_X>]@!9] H@Z0&)U]T=Y%5> M,E>Y1[JVF7$\[F-_()I56:HYF&E@B=.RQZ\*(# M)Z^ 4[A5TE8&OLH2R__Q(0D9U"0[-8OD*.$MTV>0QB>01$EZA"\=LDL]7_I& M=B]PQ4TAE-EJA%_SE;&:RN'WH8P[PM%A0M!Q] M.2)W-,@='6-_ZS&.@@]+VV.$N0&U[L>/-Q+>4ST)0:UA/L$UEYR*J(2-4J6! M^"2+8S=IH5: QD,21>QY8LI8*T:+F3!A@LJ3&;AKA3IHD&4RR M,7Q7E@E(3B:CSS1F40:'+BG&ULG59M;]LV$/XK!W4H$L"-WB4WM0TX3MH%6(N@S;H/PS#0TMDB M2I$N2<7)?OV.DJTJG>UU,V#J2-X]]\HC)UNEOY@*T<)C+:29>I6UFTO?-T6% M-3,7:H.2=E9*U\S25*]]L]'(RE:H%GX4!)E?,RZ]V:1=N].SB6JLX!+O-)BF MKIE^ND*AME,O]/8+'_FZLF[!GTTV;(V?T/ZZN=,T\WN4DM/6#&APGBR5^N(FM^74"YQ!*+"P#H'1YP$7*(0#(C.^[C"]7J43 M'-)[]+>M[^3+DAE<*/$;+VTU]<8>E+ABC; ?U?9GW/F3.KQ""=..L.UXT]B# MHC%6U3MALJ#FLONRQUTK.7 M+\(L>'/"AZ3W(3F%_J^9^W XRF:NA&DM 1>;QC7U+HL4!D9 MTL\.Z+TX%LNW7'*+KP2U*\+ZQL.ZZF3:D;!2@CJJN81?>$%-DI0LVG:!^A4% M](':[8;$%^H!)9,D=C@![S09V&F'STPT>#0EE(5HE*0I9$$(](E'81H?"?<^ M(R2V)P=+!Y/0P>?Y )XJ8#Z(ZKQ6VO*_6-O-CUEY%K^FJDBSW(T!#8D;LM?9 M^7/YOF9BMQ^&@RI*PF-5U+,,BFZX=KBZ6HNR('5CN+\'A_VBT32#*X; MS>4:;(7TUXA0=YT?7>?_3F34LBT4G0[Y!"4OZ=Q8NMDEW=U* SY:D@*W]P\? M+^#&6%ZW=<"&><3'C2M^ZLOE:5#WY(5/31.1))+W9*?S,5HH6G6DBS#"IK MFXLP-'F%-3-GJD%)EE+IFEF:ZFUH&HVL\$&U"),HFH8UXS)8+?S:G5XM5&L% MEWBGP;1US?3S!H7:+8,XV"_<\VUEW4*X6C1LBP]H_VSN-,W" :7@-4K#E02- MY3)8QQ>;L?/W#G]QW)F#,3@EF5+?W.2Z6 :1(X0"<^L0&+T>\1*%<$!$XWN/ M&0Q;NL##\1[]H]=.6C)F\%*)OWEAJV4P"Z# DK7"WJO=)^SU3!Q>KH3Q3]AU MOBDYYZVQJNZ#B4'-9?=F3_TY' 3,HE<"DCX@\;R[C3S+*V;9:J'5#K3S)C0W M\%)]-)'CTEW*@]5DY11G5Y>MUB@M?+$5:KCA+.."6XYF$5J"=TYAWD-M.JCD M%:@4;I6TE8$/LL#BU_B0: WMJ<=+7\'[ M3>,(]O+_66?&:DJ1?U_2W<&.7X9U97-A&I;C,J"Z,*@?,5B]?1-/H_='2(\' MTN-CZ/_M@OXG%*P-J+)_GEY+.*%4$X*JQKR##4HLN065";YEKI0,G,)G91%F M\ Z2B?M?^DPE5(T9LX0XCR&.8KA"S1^9*[PA*$XH*IW#-(5K:9%.S.Y-YV2) M)P0XG< -;ID88L9NIP22&+XTJ E0;D$@5:.!V0QF*=P3C&YSVVIGVH=Y@BE, MX8$)IIU2)@O(.D6&J*2T7^RLO:DU")8]A=3MJ)XE%:.M*B4*!TKKT+!GE@GL MY,U( FSM3M43AVF+.E ._EC.)_W!WT:$PE2F\SG\(>RI"H>1:0H'B5T0E^/ M_'SHM7\+Z_Q[ MRPWW#7&OA5RNVCLJ76 ^ :CL\FJH.[_3%>989Z2E7TU&M(%IT+=4\7SV4IZ' M!TV),F/K6Z^!7+72=OUI6!VZ^[IK:C_=NT\#,=IR2CN!)85&9^>3 '37;KN) M58UO<9FRE(9^6-$7"K5S('NI*!WZB=M@^.:M?@!02P,$% @ ,(.J5GCF MV\*,#@ ."\ !D !X;"]W;W)K&ULO5H);QLW M%OXKA)IV;4"1-3KM-@G@.&DW10]OG&Q1+!8+:H:2V(QF5'+&BO;7[_<>.97=EPJ5;2]M*U2O#+ M/#4KF>&C65S9M5$RXDVK^&K0[T^N5E(GG1?/^+M[\^)9FF>Q3M2]$39?K:39 MOE1QNGG>"3K%%V_U8IG1%U&5*S"C"A(_/.H[E0<$R&P\:>G MV2F/I(WU]P7U[UEVR#*35MVE\6\ZRI;/.]<=$:FYS./L;;KYN_+RC(E>F,:6 M7\7&K1U,.R+,;9:N_&9PL-*)^U=^]'JH;;CN']@P\!L&S+<[B+E\)3/YXIE) M-\+0:E"C-RPJ[P9S.B&C/&0&OVKLRUZ\4K/LV54&2O3Y*O2[7KI=@P.[AN+G M-,F65KQ.(A4U]U^!@Y*-0<'&R\%1@C]+TQ/#H"L&_<'P"+UA*=:0Z0V/B"5> M:1O&J=X![J\RCZKSXYJM@TO_N M"*>CDM/1,>H'#7!ZE[BU(IW[UXLWB7@"@,0QL&XOQ<,R-=G3=\JLQ,O4@">= M+*R0223N!V+R%6:$XDH5R)+A:Q. MN@@NQ228@DQ?O%6/:?Q(ZT.C(IV)N0RQ+M.T;G I!L&U&&+=NQ1,B: [O)[0 M*QCXS]'_^)!W2R4V[,,J$O)1&80D< BFE\SOF4<.>Z,O(#)M(3)PN!B/ M!F(\##Z#P*07D!Z.FG5/H>V$6*$!DPC.P,=U"Y%^;^+$&4*P1_O]U%NN%)-8M=! A^LUU(I-0B5BA5CM):CS" MV3S,>BO<)DI/)]'^A6TYJVMJ<3PA3F[G$(',B!W(C9=%MAIVAS<3_FP\]YCY4)D/_@LJNB MIY&1FXH7A\\AT!_)K77N4>(+ N%P5QH)]6<.E."P)U0)^<3-PI]]S%ALE31G MGA+T^F+F3NF1*1[4.G,(^2+FP(D1= KJ=-XITS0//VD>8J(+*18*NPT:JFS) M@#W?PEU>WSFQRAX'PA)>6:'A* ^Q3(4]0O[LWIJQ(SB#B4A+YUM68A3,B", MQ7'AY^UR>Z?<=BY[''8._,SQ9I['\5:0D)2,#<4 YG&)\\3*-8VDGY:0@PHU MMBF)_27]/E$;2E_-QF$78$RQ:B_.1M0IY=;UV8(>2K=6VXPCY1S,PNVFX\+O MA-W-[7MRS O57S!+$MC+(#T1\RN@FEBO= :DKF3F# *-48UT5/:ZS7^%C=7, MY-)LT6-U?0M02P$ J;-I89 P1;T@"5WX4"JJ13U5"^CR A<;E"\$#90RE?A, MZ\G5\++2DX@W6I*!++@#N/%""FZF M0$?76I6Y+GN66[3L%OEVK8Q/@#Z8%>=MQ0^.V]38PK5:?V3)8N"$42U>?USJ M&42'QP0N%VLK_H'5L#S8>ZO6J%?8:C_*A(TV*FQ6JN'B88F2;"GU)8([]B72 MQ^)W1K(Y[M)>5_R41>*B<_?PYAU%.NF=FT";QCKB6J#4'F+'CN=1(8(U[&:$ M[@1U@0?[+GQW_?%N"30<<\A+$CQ?6Y1EK.Y5&NFY"W@E4;*CM]TZ V" PSI%= M9E3KEECU> QS$HWLM>.[Z,^/JJ7AJ[6":X:D4I6$J((+]YSKCR0,U<(.=J?T MC:1TP+4<\#EPIQ7@)B7@@)U=7.QIE>:VK%.YUE0+NU* .A$90L54'?[R^W5_ M)^UY;?SF-]_YS54TKK)YIR5TGQ+9AVZW;#]R<4JH$=H/1P>RQ:$<\4.XTAMPRM8%"D4*X4B#!E6FPC9W1Q!S9W,;XR>[^'?BNF8)0M2;,>!;R$D5A# M NO>0[@4[@P=[R7_&AJ"?JW3 ))LOJ80Y8#4R%GI"M;.G'2U^.I!ZI.-^DA] M"0N3';7 !G I/)3T T\2:C[7H2:&$>$E=;?<]]+ATBZ+UH8MA?>T9NM:-N(= MFXM*"3\A@X 4S"(%B>/)T"&\G7>!AN,.K$+2= -!6YNUAHC()[P;@*#\YS)* M,2.M(@UY1CE/]4:CX\\.6Y3Q*+>0Z5 %IAO[[8'YX/$BH3YB3O.,5WG?6R M,*B+ Q2I@K^]6,Q8:99"U"GNRSF32(B-_45(:ZU">COGK"0[ 9Q-6-12 K1] M9:0DJG=?(=7Y1B S],$YF3:U$8,O3F%MGM!TG;\0^=6:/0L[0S?6I)F1)XXO M43*N$9&<<^" .(=N16+E[4&(W8F>$^/^:($LT>QBD.46Z- MF,>D2U"12$^FO:H.J2J472EIJ9ORX4TQV/+Z(Y!1W[B+V;,@Z]+J;?AGKBWW MYN+]PZL*AI\E$T+ <#+Z+JA)ID\)IW*3/H4Q$%\3V5J'54-.U\M,V$HT,?T+ MTK=X8ET7K\&55X9SE+W\WJJY%DJE1N]\)O9PWEO3<'3VB$C;D-4$X*VEZ?J1 M V>ZF1+5J!*_ORGR"R5,J*[ ?+-^KY?HM5Z%BE513!=LP6'-7?:8[:%)]*G* M'UANJP.B55#?"%J*!%C#-MJ0;;"G$!F+6!U/)N,B,:'P#-UO2!^ATH_,V7UN M0@1YVEOF$,9NPD/UH-FZ[LVE*#"S0KQO%Y&:!/,M#;TICK,T :+SU%X7<^MW MOJTMOB\6UWN9*G6["%X(59U2',*=[G4+:JL$]3R= $'K_R)8(+ %XIFIL'BZK A&,<[JR"FY2\%XW(4CJV"$D MN.9B==03[\M(<1[376[X[)QF?V#WH"G+ZI;8HDR=&<6@H@0EXZ+<,Z6T^(G* M&ZH:*-/D[CX+!;H6ZC,5RMPJIZU2GQ5G90U;/NMA5V=T:XM>H#GD/RB%_QTR M-*MSYR9QXC&0#<$R/-[AN+XI-R&Y!W\Z+ M5CTU=L?_J!QRE<&^*EAAY%S.V,9+C6;7A?EZB0-$*R3Y.%?%-Z"H'FG@?%@] MD#J/,S_J XA5F"X2770HQT2V>[W7W\@[9 XA:;Y73QV^.Q%\^:@)@D@]]8=2 M+GHR&-TT'ED\"7I!60[00*9%]T6>1HE:P7CNM=HR3FYYJ)5M5/QX:NK'-8>IS62=DM?-?FXA;Y!6!?*O3R%*LX4T'D4C58="O6.%,B(HK6E23?@XG M;IX/^QCWN(!^J*)PZP/ 'J5)0)@OXM"S0)]PZ7.MF][MH>;5IFJ1=G72VO42 M#_A5HC=6KD8ZD";(FR@P,^QIVXV#?Q&H#T&\9C1N<)(T8=3E!K[%S4WA:(5[ M\7&?%G'+>&L_*>#:,I!]:L"M^Z+_:I9OE>GM&>"38FF-[)<.GW\Y9ZL"O%^)04C?AR4)2#L>:N?#C3 M'#FM*&KHJIPC-H55V3'H%I&/)=$B/UVL3>/(Y_S?9!"B6!D M/=_/FG= ':E*7;5K&DV7T^R=S*]F;9?-;N,1'S47I^#3FGK:+M!>U6XSKY19 M\)UM@A_\P%UL+K\MKX7?NMO0U7)WIQRG+9!K1*SFV-KO3<<=!%V^I^T^9.F: M[T;/T@R8YK=+)>%9M "_SU.T1?X#'5!>EG_Q/U!+ P04 " P@ZI6LE;H M![<# "0 &0 'AL+W=OACW0TLDB2I$J2<7)_OH=*9EQLL38 ML!?YR+O[[KL?)#T_*/W=5(@6[FHAS2*JK&TNX]CD%=;,#%6#DC2ETC6SM-3[ MV#0:6>&=:A&GH]$DKAF7T7+N][9Z.5>M%5SB5H-IZYKI^S4*=5A$273#EOV!YOT'YKMII6<4 I>(W2<"5!8[F(5LGE>NSLO<%O' _F1 :7R4ZI M[VYQ52RBD2.$ G/K$!C]W.(&A7! 1.-'CQF%D,[Q5#ZB_^)SIUQVS.!&B=]Y M8:M%-(N@P)*UPEZKPZ_8YW/A\'(EC/_"H;/-*&+>&JOJWIG6-9?=+[OKZW#B M,!N]X)#V#JGGW07R+#\PRY9SK0Z@G36A.<&GZKV)')>N*3=6DY:3GUVN46+) M+7S9";YGKE!F'EL"=NHX[T'6'4CZ D@&GY2TE8&/LL#BL7],A *K],AJG9X% M_,3T$++D':2C-#N#EX4L,X^7O8!WC99KI%FRT"=LX(_5SEA-4_'G./G M\=Q)N30-RW$1T5$PJ&\Q6KYYE4Q&[\^P'0>VXW/H_[8G_QD$OE8(N:H;):D2 M!E0)DHY]@YJK@N>PZUUR92PPC< ,E$K0N367Y*L1'_49J$MY%=KD/BEL^_.Z M)8R?]4/97]H?7$EX38,MA&/X%FZHECS'CL,8WKR:I4GZ'K(@74F+5/*>998& M13(-XL>[A@X],:1 K99 <1O!Z HP!BGO09:]#;:# E)]_'/A>0S)[U4;9"#0W5\J0I(:[W3:@/ M;G(V-#E,WO]D@,K/Z4)$GZ8[2]^&-\.SK)_D2#>ONY:!@D.CU2TW?IO0W$Z8 M%:UL?WFOR)BT[JD9!CV3Q3GF=%O3-T<7+E=[R?\BI1KWW;Z\K*@%V#U38#<_[JGO5'LR[_P94]CTG MG@)+&ULM5K;RJ-SK MT5!:'LZ.CYX>EU-7HS2O^ M[64:7^A*75GAFK*4=OM6%6;S>C0=I1^N]7+EZ8?#-Z]JN50WRO]:7UE\ M.VQ7R76I*J=-):Q:O!Z=3U^^/:'Q/. WK3:N]UG02>;&W-*7#_GKT1$)I J5 M>5I!XL]:7:BBH(4@QI>XYJC=DB;V/Z?5W_/9<9:Y=.K"%+_KW*]>CUZ,1*X6 MLBG\M=G\J.)YOJ?U,E,X_E=LPMB3LY'(&N=-&2=#@E)7X:_\&O70F_#BZ)X) MLSAAQG*'C5C*2^GEFU?6;(2ET5B-/O!1>3:$TQ49Y<9;/-68Y]^\J];:F@IJ M]K)X=>BQ)#TXS.+TMV'Z[)[IQ^*3J?S*B7=5KO+A_$.(TLHS2_*\G3VXX"=I M)^)X.A:SH]GQ ^L=M^<[YO6.'W,^<:U*E6O)>/@\+_22/SKQS_.Y\Q8(^=<^ M%80=3O;O0%[STM4R4Z]'< NG[%J-WOSM+]/G1W]_0/Z35OZ3AU;_MGW^Q/1? M5DI:0=JF$68C:%$7C9>6=T!4VH@%26UY]([VR8Z&K M#%; & BVEE:3_7AW>&.#P7)I53"+P%-' BZL*2/4H#FO/9D*)\B4I?W$O,$P MG JGG6\'=@"L3,5CZ9!PUUS1\?%SQB-:\]!7C*1=,7@HONV1"-0QUX4FNT(\ MH).P6R#2N9?BG.>&?P\^5.()-%D4=.JGXA)KP$7L0!<'XF<#-4]/Q%,Q/0,# MBLO^ >\;>4+_GW-T$TX#^#1S-A6_3FXFXJ:IE5TT $!X=":F1^(S=&(?>:H9 M_OO%T(CG)^+YZ8!"+QMV$G2-86<+K2I.O;AEU?F5-LUQU2!B8%@,*M1PB M8CPPV$HZ_MX-"+@*,J@$GXR4+YF"2!BSJ>)Q\=M&D;_PLX 7E8\1MX/^QX!$ MO2*'L/OU=8 (SX+/*7]Y.A$PI,QS3:*,:=E:6D\69CPFJ[:@Q32_4:H:'(K. M_:-1VD@ MC0Z^K*N&B:5:FV*M I]OE UD'@7%6R;DW8IF,3GN4 F:E,T6D&G M60&>S8P@W@#!^5T XB'[F*S-?*0I5JL2#*C!$4@ /)TG,$ M$MV'0-Q^#(KS'&L>MR!,C225B:BG0V(]B;"[(+H*<6$KEH!'A6 %(H9F=USB MAEWB0UB4GHUWC$Z*Z0> 01@KI"[!R$P(GIB95U^ @RU1@*7X[U4*7,P@2P4] M*!:UMGI-CT$T&A8&?\!HC74-EN>M,+D)LQJ_,I9<)/!Z28PF-^RZY*TZP_KV M+L](J-NK(&QRI:W N95M#RS>1W%IHE4KJDY@@=TLDQU5C7D4A@0L$+(^MNN> M9XR_Z=F+(^81B$#3",?T F3Z7,FM*1U"ZM!Z+R:/61J.GC'RX M&B%WV>V<%4I631T1"="F:,EN/!'G !0>W7%O,(BR(2C'"#G&ZEG1Y.32 U ^ M(KJ. V+G1(DA_Z(SD ^U&A[J\LK")J& .R19LP'BA,#"ZNKZ";@,:.H_ 9LE69*5 $IQ4 M*=*/"T]94Z:O5TX6>AD/SK)L%O%W<4G(V(5E3TD32IZ8J9F?$5,=#U$2%J01O&0( M/MJSG@*PX$O0CX#)AD)#6MN0\D.@>)CP^^&4N:,M5"+PW6#(CGHBVD+V0B%, MEL3J@83Q'2JNPI2.=%"JR(PU8)59C"-UQR1^I>MDU'N62ZD8+&(ING%-Q+D8 M\J..]\<\B-8K8PSD0^?.-<*Z M[>J?@-6D_G0DL#48)T2)-76Q^.F@4F'(K[53;F<="D0U7 ,,RM^IX96G-(+I M)J%+5Z$CR/%EC7HY)$F?*Q48EOU3A_4O-:DHQQEO9:%W$HIQ\N 08E#CT8Z+ M0?**/.)9Y+EA[/EH-F0S"2@ Y-<(CF!G@ CQ%3X-VOYX=7W#T:+=A)7!TZ:G MSU"1$66B/*%,,;C7<#4LL6\/",/I>@3?SVHC[:UX"R-UVP]31AIZ>A11UL4? M"@0IRK +?L(:LZ.C4W&>P\-]9*589%H!()B?"6H32N@!!%XF& M.EJBTW;,EE@^>O*N%;N!I5[:GI?T%NP74FS4?;H/6@=7?Y(6!IT=39^/6Q5I MYZB*('*C#)OR-.X)8:=+E%PNY.M,I4FP?BH?T1&@\V)R3-6\:@/MO8I+^*$9 MGVC&"+7452]QC>*!+N[*,^ZMW2X@2E3:7"HAPUI2:2JK6\YCZ"]I!?6LJI;@ M $4I8B;K=@K(#D1>A/0!PT@OR?MSIB5V/:* K_PC6.3)='(BYJ%UPC7^/0_T:Q MU**D0[,623"NTN8VY2;D2U:=-VUVD,V>G)R,DT-I2'1F WU*X"#0TK(.>[C.P1- M]!^/M=89^"4$R3TP"T7FBCM:#;=+D8N1ZV>I!>Q#-T=C'&^X?42".!A]OK@@ZN70V62QPHA+[T2:MC2) MP*1Z5 -QMA6US\[3Z5FDYT3(Y"J,C5B\$D1#3D#CG5IS+9C+DK+W<:>.5'2A M $*I&8I92RV#1:H@8DTS!<^'K8])HBXR+KAJHBP!)V/ZA%_TR&^G-_2-"/LM MI:XG8C8%KBXPIH&L[\U7<8ZZ#P/'L$^&0E_AS,58_&PP].7TQ;.+WYY-I[/3 M8W'PZ>+\J3CX>/D[_N4*[I*"ED8F>V$:ZXF?Q4_4E=AB D[(DL+F%%\1,W4 MZ-#X2JH.'179Q6-.O_* )89V']8R 7L;)O81.72_B!!6WT3\3HY*E5[L5 P* M6?K2RE@$&2EUX-N.+O.E: M;7B!%KZ@:&$KRSCGUE510>2S9*2'T&BB5Y(50 MHZJR2M$TP9',SP R*A1_V4I6R\&E GBM8X5AE14@,BBM)L3:,I1JX8"_5GR6 M&ZJB<33#H42VV068$B(25^RS:>+J]F?8JG=$Z@TC0><802$8<6(6M,(D"[U3 M8;!SFNX,!R&T2UZV-)8)IQ(O4O;$B3=AI8/&TQ[CW^,\$?C:\KYX93B(Y#@DIL%_YK-GIT> MSY[_2=\:[=CNG#F&PF((#X.'?%?#UH@MTP'^ZJ[MPM7&@-E2)V\;S.%Z^D9> MUZ2^U/]!\8- ]QUW!>BN+6]U[@URP9 6]G7?-T^HVGATFJ6#C[5=U"$??.?V M-U#'_?8I-'"W;;M7\73SZDGOO3YIWHG96*L0AP; " MQWLO;Q-1[ 3N6,IPHK/C]BSXV'$GHB/^C:0AI(6J8U-JD_Q@J;K9D^K<1[!C:MNO=9"N M.S+V+:C@X3 \_>NXN]&:JY8V)_%>>=C _Q1/A2S_O+:ZX%R [CE+1:N9 BO+ M6\H8X!NZ5O0&"TD)((JWVJU,/1:_J*]4AB3,;-+%X)H<+6@;V;4"6KHF,"=_ M=',[CFT*;-(^M,B%M(W8X@Y$VIF&$-N7_?O&.U>,9>W)>I"!KR!C.1?<,UU& MA$_&LD'3]*":M(]4=>?X/?;NC<1*K/I M+@N0[ZZHT[5[Y446!,4IV)_YTWB=,8H @5B85L XZTS2"Q4N%GIT)QZN6M)K M+>QT=WN17'GSXO'=*&+X@)/42>QW)MM^(UT:9KH.;$AP?M9=$G!KR<4+FO[^ M0>T4BN]J?6C#UM<'OK4;PK2+3AGPOGO9&OOU-+KIAW]J(.ATP;$W=9CL>S/L ML/<6'[]'0.\J4E,45!=>Z&M_;5^'/ ]O 7;#P[N4"))+ZFL7:H&I1Y/3[T?" MAO<3PQ=O:GXG$*F9-R5_7"D)I=$ /%\8Y'_Q"VW0OB3ZYC]02P,$% @ M,(.J5AW< 2JI!@ \ \ !D !X;"]W;W)K&UL ME5==<]LV%OTK=]1,*\]H+(F293NU/2,[39J9IO4TW=V'G7V R"L1#0DP &C' M_?5[+D#*E..Z[8,MD 3./>=^ ;BXM^Z3+YD#?:DKXR]'90C-Z^G4YR77RA_; MA@V^;*VK5<"CVTU]XU@5<5%=3;/9;#6ME3:CJXOX[M9=7=@V5-KPK2/?UK5R M#]=Y1"UVR\MH8<;R]'Z_GK MZZ7,CQ/^K?G>#\8D2C;6?I*']\7E:":$N.(\"(+"SQW?<%4)$&A\[C!'>Y.R M<#CNT=]&[="R49YO;/4?783R;BL?_]-]FKLX M'5'>^F#K;C$8U-JD7_6E\\-@P=GL3Q9DW8(L\DZ&(LLW*JBK"V?OR+B8!B#+]VG>H5PGE.Q/ M4!;TP9I0>OK!%%P(%O,5>YB+B+?Z! M3/K9!J;_KC<^."3'_YZ3G5"7SZ-*P;SVC'3U[3?SU>S[%S@O M]YR7+Z'_[=#\!4JI'#]5?F/K&B41+=!O)*:?-;H)ZWOR.F10L5;Q35?5 ZD[I2FTJIFUK"C_! MTL^MJENG5['@VF\VI M8=0O"A?:Y8^D8$X@$8Q0=>[) +#U."5&\"FZTC'RUR5'3&BKC3*Y MAI=R:^"E&#,,8SFW>-V[5Q BAV1MJQ*K4'9J7N1>BVO@?*!5?*=,.!Y63._% MXJ44WTJZGLX&R6I3QAW4(0;KQNF*YN>I[TVZ-)/ (EZO3E?8 :H*:A*%0RM] MF!JE8U5] ._Y24*2Y5T/$#:09B%3Q8OR$CMDA#V0MG6VIH#-/-8)?J, S_OU*>0^9=%_JOJFD$&YXP+ 0^WK(F1IG=T[55%A.55JJ.ZD-5&2C M4Q92H8(PMP&Y]58D?4SX V!:G4\6V7*RS,YIC:J$$AK8T#D/LN 5G2V.3^?/ MP8RA]U4?;G^$\ M16J[SP@?(XE,;W-.3=6T]09:,*GS,PY]/B <,)4R=*CH,!:M3SUOV#1QQ$0@ M:W0(G_S=Q00Q#;K2?_0*'C,R<7JL;*1U8YUX!W8;ZZ7M#8M5Y;D4E(^FGBAK M?8^?6Q^H9CBP2-W6Y%5;B.C#%4JV1"%LC21K[X?]9LMQLWW2+G3LQP>A,D\V MY$&P0HF^3W4Z7+$0 D?O');TZV7=5R_&[P\S"*=DG(%-M[WAF( ^;'R50KG# M_8#&E="@\?*(YJMCAY4,G%#NY?TK??G&7S M['N,YN<)YH1NNQM"W,80.>D7:8M GAG>2I\]L Y+/8Z,L_U3UI6VO!5^*UIA M/$N$U\7O.(VG+1A-;)WG;=U"'#_FWM#QNG-\E1QO.*";RV:[/TZ]WCLLZ?ZI MUWTCNM^*[A^3[G$ZJWNH]KI7.\3KUIYAZ9#RT]BM8\]^PSG'DNY2 M(8/RLS.)3H9_,CB9X_\O?Z47CD>!2?EC;_1>;W7>]2'Q9!8=/%[ :IVJ\7$> MJ,6]0OT3]PX"^#CJ$C6H+S1&'[F+QYZC/B4DOOW<_A>OUMV.>% .X^6I9*DH M'Y^+#V;9T7/'^^G@%E:SV\6[IJ?8<=*%;/]V?YU=IUOK$ E^UTJ[25(1-1=IZHH*:^'.3(.: M=Y;&UH)X:E>I:RR*,H!JE6;]_GE:"ZF3Z3BL7=GIV*Q)28U7%MRZKH7=SE&9 MS209)+N%:[FJR"^DTW$C5O@)Z7-S97F6=BREK%$[:3187$Z2V>!B/O+VP>"+ MQ(W;&X./)#?FIY^\*R=)WPM"A05Y!L&O6UR@4IZ(9?QJ.9/.I0?NCW?LKT/L M'$LN'"Z,^BI+JB;)BP1*7(JUHFNS>8MM/,\\7V&4"_^PB;8C-B[6CDS=@EE! M+75\B]]M'O8 +_H/ +(6D 7=T5%0>2E(3,?6;,!Z:V;S@Q!J0+,XJ7U1/I'E M7;W5FG1&TV5@U>Z MQ/(0G[*N3ERV$S?/CA*^%_8,AH-3R/K9\ C?L MV&/B&#_!=HR.[+FAMI5Z! MT"5!Z&!TOP-_@RY<(PJ<)'Q%'-I;3*9/ M'@W.^R^/R!]U\D?'V/^S5D>Y[E?ZL .XJ2SB07U#4?Q?!KUW&A[SZ52*+QKC M#O/ZFEW&;??+CV>O(CH&=:U]47?%/@]G"U(W06VX&A;'> MZ#$K:-V"60+6C3);9B*T?%=$N/SHWS*MPXA7SM. MDW-@&I*U_!,)&FM^< ]Q9YP$A*(2FI,#4@=)]B!4)44N53Q'^?:.S^&*&QF! ML C"P=(H;H;N@A.Y8@.TX00B;17$$K29^B>MKW;AW>R%-]^%-W,^!9=88)TS M19NY#$8PX-\YS,I2>H2#;!"6.'<+X2IHQ-:+<] ;Q<*$Y_RD93PLQ![XOA.= M[G6B&OD4^7[KH#!K3;$I=:M=2Y_%3G9G'K\'[)>3XT#ADJ']L^?/$K"QQ\8) MF2;TM=P0=\DPK/BSA-8;\/[2&-I-O(/N0S?]"U!+ P04 " P@ZI6,L_& M_:P( .%@ &0 'AL+W=OS=I53+E^2AU0>AD"#&"\P \\,1#%?G],] Q#D M4G+R(A' ]/WTZ08NM\[_%FJBJ.[;QH:K61UC]WJQ"$5-K0YGKB.+)Y7SK8ZX M])M%Z#SI4H3:9K$Z/W^Q:+6QL^M+N??17U^Z/C;&TD>O0M^VVN_>4..V5[/E M;+CQR6SJR#<6UY>=WM!GBE^[CQY7BU%+:5JRP3BK/%57LYOEZS?/^+P<^(>A M;9C\5AS)VKG?^.)=>34[9X>HH2*R!HU_=W1+3<.*X,;WK',VFF3!Z>]!^R\2 M.V)9ZT"WKOFG*6-]-7LU4R55NF_B)[?]E7(\SUE?X9H@?]4VG;VXF*FB#]&U M61@>M,:F__H^YV$B\.K\ 8%5%EB)W\F0>/E61WU]Z=U6>3X-;?Q#0A5I.&OW]G"M:2^Z'L*EXL(C7Q_463I-TEZ]8#TA?K@;*R#^MF65![* M+^#)Z,YJ<.?-ZE&%'[0_4Q?+N5J=KRX>T7O0Z8*N9NB"0/Z.9M=_^L/RQ?E?'_'WV>COL\>T M_[ <_[NT^E)[HH/Z2%+YSTH]>6=51[X@&]%ZX:GZN:I(&D29I"0B95Y'4JNE M6KZ"-E+TX!F0@XHX$<5FFVR2V$1%BWHLZ5QM=5 U6H6\@HY.>YR)3J2#ADYX M95P)"^+H7'7>@"U,LU-E3WP2ML$^ 1'BS)UN>IW:NP&_:%O@/JZ^GGT^8Z_0 ME%;@>E,@. ME+TW=B.^3Q7G&."[]M' L1T45@$,N]Z-[D.-]A;B$@=\9S=Q]QMTAM((9QU8 M^&%NSQ2*^I8*:M=([NI\^7(N@@S^VQY1L>_OW3JHFR*J)_QH]N7V_%1#P(300_X.U7)]4)6QNA%M MG7>=XX@];?I&1P+QH:H]>F,7$GGA.:BT]/;4"AMCNU :*LZ$P.W3()X'[I M$+AU4;JK8 L@URD,)'8]*9D#V%L!B=[#P\ .ZW5# M7!,2RQV=/$(%P2;!)>,EW!H@O29+E2E86\I4$.;#7;_9<G=ANP"-+*6;:?0G3C)ASP,;*4HR1)( MM#: :9RD#\6C3(9 MV$5&Z8BA-LUVEJ2-OR&S(;#O&^!+:""VR^Q(?K!Q,SG MJ1;,?I(\P6.NP3[7\'?BR9^Y\QMV LUHXE@ZL8.X'#N%XX-&-$J)R>PIGJI( MQC+3@[0%2^8)P3]''TSF&_.?U/]K8DT3$CM3;U-X(\.P4SUD40YC@5L=)M@X M9/_LV/P@XQV/#: "8$QA27>?&$C2DN Y[!S:1F$J8("/()L90X_.J<."<9OV M'IB(L#RIN?0QEYHOI"-H8TB" A,Q>MC['CF%V:."_6A02KNW&EU*:7H=*=C/ MBG$EV/-'JI=4FJ5.90@Q(9ODP=X'P4*U*"0H H[VO-^#K;WZYE YI7MV>%A! M$EMA6EPPO[M^4_/%3$Y3=] MK)T'B"G,GLHP^$Q='.;K:GD("*" D )&0>EU%0_< [VCZ'E&<86FP&98,C=4 MT(M]IY#G-D$72;: M(W?XI4]2G\E_G\F_'*)Q<'-J:,LSNL^8X_5*@ZPTZKW!O&43*3/-*(T7,2!0 M]$BVPDA(96X>PBK%J)J&B$;"^Y@)4AB6K="LL5;?L:R \SE9^Z$]^ O%>1)C M'XMI\1 "ZD,:,UL3$[.^[2-S+'*@][']KA7);K!6R+[J[,9QY4YJS&U.W#(H56ER_)WC:6QDU6G1MS1VV=0)U!R9#RE1@_3\ MJ(6G*WUN-\3T@>Y- :1(04N)X&2SO11?>4>;YWU'W6JK2_W[HR^F:'HE/@T+ MYKYY1]H>I#^IM#*<),J#]4K9H-H2H)[1;,8Q]8L=Q9^>%BZD&.;]%O$T.YXO,H1.N#"?HF%ZX"0B'@B1L\?6QIF2743?8HV)@X_R MXBG51A3'6^O#\_TQ3PX2;;.J3YE;T,>IH(?M9,*HDB?^J;J,9D3>, \^T4)/TR95J4 MZ/>)29O2I&\Q:S8.&+/"+@?T\:O;,OJ2EPX4PV89B *#Q'V8X4C&6D#&7$=E M2N*XJZ!ITAXF_0!?M+R_YOTHJ\'B6GBSYGFT=KP*RTM&<,U=.LI9QEZ88K?@ M45GL]]7:#W>I2@XM=_.D_KT-?<$O*U7?L-Z2*I+2RVXS+H''--PW)8?H40Z3 MOP&D&93$'J[.X18(VW4*JT\3LL!R%"1!@^JYI$H.3J? M0@8Z+G2H506*.7+D27@ZMNS9J0]!B\DWNA9;O'R)%"]L3)_KQKOCQ\Z;](UO M?SQ]*07@-P;^-%1!]/SLY?.9\NGK8[J(KI,O?FL7HVOE9TW LN<#>%XYS(U\ MP0;&3\#7_P502P,$% @ ,(.J5CD, A4F!@ &ULQ5A;<]HX%/XK&MKIAAD*V Z$7&<(:=KL]#9- MN_NPLP_"%EA36W(E.33[Z_>39!L3",GN/NP#H,NY?.?H7"3.5E)]URECAOS, M,Z'/.ZDQQ49X-P.!P/R-!D7[+,BNLQSJNXO6297YYV@4R]\X>F/2\,^F0A"UHF9DO M<4,!#D7_I?^K/S08I@,'V$(*X;0X?:* M',HK:NC%F9(KHBPUI-F!,]5Q QP7]E!NC<(N!Y^YN&**WU'K&7+-!14QIQFY M$=JH$JXW^FQ@H,72#N)*XJ67 ,2(?I#"I)F]$PI)-_@'0-1##&N)EN%?@ M!ZKZ) IZ)!R&T1YY46-RY.1%3YO<,I10D9!W+%ERL213&RO<<*;)%==Q)G6I M&/EC.@O7@3CX>D>DPX;DP[W M2?]7I[A7XFZ\3ZDA:P([UGPIJ&$)F6KG62Q^1)FY$=@VEJ%>_9HR8J2!,"%M MKF) $I'=-0; MCT+['1V3F11>L\GND;\F)086R<4"[D T09*=3^,?)=?<%:-OMU?DHS30SP7Y MM00;@CLD!VZ1')%NS[',9%Y0<4\@F2E8P861NTW%.H,^5^,@+98P5!GR,NP/ MR=Q#=WYZ.1H.:UN> @:9E+!2R==ME\^E0G1:NZ@AB(T[RC,[LX26"4"U(0JT MNH=*94KO@\K,8.3R^,B!::U$80\U7A>U!7T7%-XV2UH=0] ?->;L0/_&8O#P M?Y0TXXM[QYQ21.R<,?&LB*CD5K[_16]'(/L9IU0LF;,2L\+7!P"PC)M2G;P8 M9X$&:8<<*UL^U>5<\X13A8K3W\@B&+,[DZXK4+,:%!965"7>7;?.<6]MI*QS MZHYFY=J^+:L6;0'>\V!]X+)G9LW+K7P)>I/C$-]1<(@*X&\3OK$OH=2&B/>I MRPB'CW+E(6^?2+(N1!:LD.)U:XFW*A+7&SC?VE,X> ^W=,D7%LNEX'^YO"*? MH$$Y%8JE]M+AVD,LNB]T:^-+%&\SZ M5##E_*#)+*-:\P6/O5]LL_-%83UZZ-FKC:.949V2:]A9APB,R67"35TCD$-A M$)Z2X(@$S60FM4.B:0:6FW;^/F"K?P_"KOLTM$@ .(PU(;D=4>&:.>@^HMJ' M26C1U1HV[=O=.[:4;K6'=5$E!Z-QEX23+9,^#J9DMJNL'@3'W1;Z-KW'>W T MZI)HN$VQF;=T*V_WI=U#8:%S6\W95)^E"\C,AES/5IW3*HAY%;;5N?C-"N]N MT;<(5^>D(+)X"$T27A4-OC-7_T&"MK*Q3V;K0KC)$&_&:F^SD]2+.UN?]=MS MBAE2+>=FHZ^BPUG7:&9,AE*29;9QNBN>7O?QV-Y$F"JH CJ3*EDN4S1^ MJ:#W+ARY[:^$+I'Y"2D+V<)2%31V5R5]]6@@<#2C"BW06&3"^[CR3(VC!SU( M>*J(Z\9XD('8@C:N RME(\$"Z#]25:VPI>L#_DJUH[\]4CJMYRSAFF^A76MS MJZ6@)T3V#^) MF]7F#X6I?T>OR?V_$>C7> EJDK$%6(?]HU&'*/_"]Q,C"_>JGDN#-[H;IHPB ME2P!]A<2];2:6 7-WRP7?P-02P,$% @ ,(.J5@PR_A)M!@ ]Q4 !D M !X;"]W;W)K&ULS5AM4]LX$/XKFO2F1V;2)+8# M(128@5"FS)0>5]K>AYO[H,A*K$&6C"03N%]_NY+C.)#00AGF)HY?9.UJ]]D7 M[VI_KLV5S3AWY#:7RAZT,N>*O5[/LHSGU'9UP16\F6J34P>/9M:SA>$T]42Y M[,7]_DXOIT*U#O?]V(4YW->EDT+Q"T-LF>?4W!USJ><'K:BU&/@B9IG#@=[A M?D%G_)*[;\6%@:=>S245.5=6:$4,GQZTCJ*]XP'.]Q.^"SZWC7N"FDRTOL*' ML_2@U4>!N.3,(0<*EQL^YE(B(Q#CNN+9JI=$PN;]@ONIUQUTF5#+QUK^)5*7 M';1V6R3E4UI*]T7//_)*GVWDQ[2T_DSF86XR:!%66J?SBA@DR(4*5WI;X= @ MV.UO((@K@MC+'1;R4IY01P_WC9X3@[.!&]YX53TU""<4&N72&7@K@,X=GE)A MR'K]#T0JI8L M7DAV'#_*\)R:+DFB#HG[B(LDQJ5M>3OHXEU!ISCGW4Z M!Y:#]2PQ8/9L01D_:$%$6&YN>.OP[9MHI__^$8$'M<"#Q[@_Q33/8D2^9IR, M=5Y0=?>[)5.AJ&*"2D*MY?":JI1(02=""B< *6HXR0-]2J@C4V1[X]EB>$&( MLM(8H688)@+F T\M(>KM'CGA1MQ0#,#&.D(!\F6012@FRY3#U7& TA%#'2=V M3@O;(4SGN4Z%NZL'C+;V'2['%:M&O;R0I2 .%:E?P<"D*A;WJDDN07$P%HTM5G0[2+!T"40D2@*ZOX@" CIY@N-*)Y M\PO>A G+I M)4Q".( .Z/.V-F=%L\&JF>"&&I;==![3"4$ M"2>7_L,\KF1@ ::M,T5^@X^!E/!DV^3($CTEY[ABG3 ;$6?AWL(*U 4=QFC] M4[3^1Y[.X/5X%5WR]LUN',7OR0!^8X^C(W^ NF:1&382)'A\UHJMHSK]"=,L M.$7P6[OT9K4^ U!G"L:=1WBAVSI'6:RR,\1CO8J/T441'IOT;(KX6;M[8E9R M/0F,&(^U8@9OJ1[J^<\7P"0E8!';]$0(_@]Z2 3D9X_(RC_[)_ MC49X/",6$SQ>+18W0K@^$G=&_O\"MMN*V_Z_V85?-MRW=]OA].QPCW?:U?F5 MPSUI^_\S@WW4KLYC:LP=%D/^ U^5%_4'WT?I^EK695 =8^T Y1)46% 3/RB8 M\6VS/MZ06&H1FCDEZ/---4J8H-!/U04?KDMT+E&[@X6.TV70KQ-LZH6\@]H, MJSU0#5DW-8Z&_1JI^]"$&X_ M:35[AVO"TA.H*D,S@'HOW ;AI5(&>4$IN4)!HD&G'PTA$71V^KLAZI+.<#C< MF$S_#RC$!,Q1HY"\ I)9[2-Z; 3#P",88RW@V@$4I$95U"3RHXO6_E#[:O^ MJ^X6G%>;3O0-KUVY*"=2,( &%,.I&! P%Y!IPK.8O0[';K/G)!,N!<>PQP79 M_6@K"J-O18Y=P))]]RD(^X8&.HD5I*;BUFL)+06T%]BR^@S0(?-,8!.V; Q# M*RA4R@L.)\#_!J[0HA3PG<=7D*>Y#(ZSVD_X1F==6[& S'#L4P BOVT G.D/ M&L4 7+/C?F!]Z+AQ>RK%9KQNJ2#%&)W#DL*D[PIJP.H3JJY",JMDNH;JI9J, MH\#G%WN>AZ)J<)Q9M48)6)HJJ]WL/_ %!+ P04 " P@ZI6!:X$.!4* #3&P &0 'AL+W=O5"%LWL]FOJA4+?W4;E2#)ROK:AGPU:UG?N.4+/E0;6;ST]/+62UU M,[FYXK5/[N;*ML'H1GURPK=U+=W^3AF[NYZ<3;J%7_6Z"K0PN[G:R+7ZK,+? M-Y\.U;813J^O)[=G[NW/:SQO^H=7.9Y\%>;*T]H&^?"RO)Z=D MD#*J""1!XM]6W2MC2!#,^#W)G/0JZ6#^N9/^%_8=OBRE5_?6_%.7H;J>O)V( M4JUD:\*O=O>32OYDS M!^;IP)SMCHK8R@\RR)LK9W?"T6Y(HP_L*I^&<;JAI'P.#D\USH6;>UO7.B#* MP0O9E.+>-D$W:]446OFK68 *VC@KDKB[*&[^C+B%^!D"*B_^W)2J/#P_@VF] M??/.OKOY%P7^+-U4+,Y.Q/QTOOB"O$7O[X+E+;[%7_%!^\)8WSHE_G6[],$! M-/\^%H6HY/RX$BJD]WXC"W4]0:5XY;9J7IS]^P87SWH7S+TG_^I3] M#^)$_O2OK72R"0K+OU6*'FUDLQ>5Q,&U4ZH4P8IUMTE8)S104#=ZM1>ATJX4 M&^D"2069"-5LM;,-B9:&-=M0*2>,EDMM-._;M,ZWD$:"I=A*IU78"[N*^MBJ M$R@I3%O"9"&]!XV1J&7KX:;WHD3-^Z #I30_9!1*&?]Q(!A>S!ZS"-)F6Y\O M[W2HA%RM8)X,<+?@",#0J;@UH;+MND)M-FPA?/&(P=+HM23^\=@-3W4C:MNH M (D+3,$(H#DX#7"'#>>Q$# =BL:&\3&V:TN%7BSJ/)]TZ=9* K7PBX*KS2& M3B[ETBCV!Y3M;8.O>T$1J?D!P(XP4.!L$7V*/N+P0V-W,%:&0+9 8F&DKJ-6 M>!8?Y_[%/"CR'!88T#UR\EY\_]W;^?SR1_$!071K)/B7[,S'AL+2)(IFW73\ M)ZN*R@?0:SQSPJN=JP/8!GRE$R?LJD:NC%H#5HA9 1A8AZA25+JDYB!K(<2Q M@D[=D/,<74]!FTL9AY"S#<*6L?DX[4F&THSQE;/U2%8I:S1!J!,H/>6P\G)R M#W%K"Z3<3EY1!J*E9^^>034D(E(S;(/"G"@"6?VT,E,_AWDOQ1_LT&) M=^+5 ;!^\%F2OSKF&K"7FPULBK8/&H4,!(W%Y?F/\XM3M#9CH& J/JY87#)6 M/08J3?YX+%P>16=*;"L($4G>FT$>Q5.N$2'8KPY0],=^/>N6@$=&$WLLVT N M0FP3*S/"PD(NX0/SD5BU+C%>5M/W;=T:2:,*V'(? M\YHA]'CB4?M0AEX)ANB:)3"GQ(NST[=#;'^+%)77$JSW>@VW=0&>!3=$7>1V M%A[D\$D"3T!D<"8Y^8QAE80?2P6B5)'GEM(10A/UD06@.&C'VM$$1]+IY"#, MW$+ 3_M$W>41&C3>1G.#?%",@>/5_95I)P)XJ5]EZ64VPG;BRZ%8#W@A5 Z MA@!,B;'L.S5+1810*03TSK9:B;!69 M$G.) >GB]AZ;#R/&:_Q*VYQJ]AB4<5#FTOP8%]'_7B5 -SW\R.]_"DX20(# MF2(%>V!CQM0PM09F66Y?_OI8D]2^ARY*-W!]WQ:%=11ELS_LF)WB6I8CV5#X M1[B?BCO,2F47L($_U5::-F(#L4N(1&'*K=2&QPO=Q&LCMAQ@ &*,+![H6 I# MK*Z11X=.@*#(ASB\!-5Q*T8JDMGC(!M)H)-KE'1SC_"<95G;EEDSCDO3843) M2"R?4O(<=E'"8%^J&*%A#CPZFG !ONX+&B7A$]PH.(S<'N=,)C3%^H-Q! MT\6$' 442IW<0UIWN-#2?]J^Q(R'6[N/<>6K1],/E3LP+PI?)RV%W:H&WY'> MSW&PS&89(M!NG#L^\B"FJ(.R+4*^1/*#:Q.8GLSSHZ+JTAP-6@^WB]YVX0,> M25WANKN*:C+;"@Z8%$"C3 Q8(M/1TN)&L9#'0KN-6 MGCF8KA<$D2?Q!3:R\*;9:L#B%*-#?VOYQCM+I'&>U\K>O/GIXDWTNA_"4O61 M,LQ G-^C)H\@D4@WWFWZ><@?I!B4^.)L?MG/?L>FHJGXA3&0'?LF6O]_4") ML"0"^S(IDCT1QXG$L;M0 %(9NWUOSE>Q9U8TWT"@GQ*4QG<[]HK<-4 2)@]% MISN(']K'=QN]IS-1-5SV#V*YV9+_&S-6- M4\MV_YIN 8P[?L?)U"+IXAQM&C&+>M1AI(*QFI)A*#E,;8>IS9S.4XMIH8Q] MA(;II^-"=#,OT3P)/4/3 XXV-9-"Y3DY>-]"=]IU[)XQG/N#QW"))N34WY)W M+,NNPDX>4#DL/U+88P_HQMFW2N"OQU).;Y#RXGPZ%\O(&">T$(GLQ<5BWA/) M#O_1 %!PFN?.J._%Y9N+_)Z)U7.L7IR_&ZU>8/7\;+QZB=7%^=EH]4V\_59T M4S(<4!+KX#6M/EDFXI@!W=F2& MWH;)G6\U)R+>MWC*X?:3O]X!/7*W3 VDK^R&YX"#TN9;!,//QJFZ>Y$D_;'! MP9!"W!.O:S.I'MZ-W*=(RD^+L)>EBI5JI) MS8H&GRZC.P+H^*5"(VO%%UN9SLEH_PG_AM)WSLZS5Z^?7/4O5TW6%S:,GQ[LUQI,QWC:V0OA(KYEJZ0VNB+SJ/X'%&IL?>U,^R M'UKXND$_)Q'3@X'C;R[]:O^+U6W\H6;8'G_N GNMJ4$9M<+1T^F;BPGF1?X) M*7X)=L,_VRQM"+;FCY4"A!QMP/.5Q5B9OI""_G>\F_\"4$L#!!0 ( #"# MJE:73A,Q!P0 +T) 9 >&PO=V]R:W-H965T SM1'#)1J(PT$2T2_+(GC_;L1B]@%Z;'@*O?@46#C*DLWVO;SD>HE$ MOZ0>8D*HB:,'GY5%B$= !:W*/>_HTI.X4N#FGLY&ZT6@F!2&2**8P9L.") M,MY!6!;#S?>5L$\@:K\+]<2@1N#=I.O. I'400IRSK.CILTH.FORKG18BBO M8<;(VW#H-1HEHUV6!F$TCEZ5FNU)/8X=R2!C>^JD6Z$SXGZKT'OZ_OQT:R_* MS5+(H@1ZX\&.($M^3>UT#.F>VMG@%;73@;-)]R0<'!:;,CRD_.Q9TOM.[&O, ML9I3>KK$OE5O1MNS^*#>Z?"YWBP*!U3.69@.J>[&T;[:C*KTWZ-_/OFW=2Y7 M!<5#'J$VF_[2%D"C!9WH0C[1,2U]Y[ *2/-MG[DJ2? S'W1'P^GLS.D:8=#I MP_-F$:=G_O2*V0RM9=' SD:E7;]G3M9KN[R45[)._,VXL-.4&-UX#$!4&C MLV$6@&XO"^W JL8?T'-EZ;CWKR7=KU [ UI?*/I$-@.W07=CF_T/4$L#!!0 M ( #"#JE9&PO=V]R:W-H965T;K>X:ZV&O'ANN'M40-AW/.G!F2)VOK;GU!%,1=J8T_'10A5,>CD4\+*J4? MVHH,OBRM*V7 J\M'OG(DLSBIU*-D/-X?E5*9P=E)'+MQ9R>V#EH9NG'"UV4I MW>:"M%V?#B:#;N"SRHO Z.SDTKF](7"[]6-P]NH]Y*IDHQ7U@A'R]/!^>3X M8L;VT> /16O_X%DPDH6UM_SR(3L=C#D@TI0&]B#Q;T67I#4[0AC?6I^#?DF> M^/"Y\_X^8@>6A?1T:?6?*@O%Z>!P(#):REJ'SW;]*[5XYNPOM=K'7[%N;.?) M0*2U#[9L)R."4IGFO[QK>7@PX7#\S(2DG9#$N)N%8I17,LBS$V?7PK$UO/%# MA!IG(SAE."E?@L-7A7GA[#.MR-0D/E-J-D^09)U/Q MT9I0>'%M,LJVYX\04!]5TD5UD;SH\*-T0S&=[(IDG$Q?\#?M44ZCO^GK40II M,G%%2W*.,M$9_'6^\,%!*G__B(5FD=F/%^'R.?:53.ET@/KPY%8T./OYI\G^ M^)<7(,QZ"+.7O+\V4?_;B?A:D+BT927-1A32BY1<0#&+%"EE)KP(A0PHP C* M!!'D+>U9MU?)#48;A](Y:7)"M<(>D]>%2@M,[%V_\:(B%YN(24G8A5:YY/6] MH+M R(5=D1,EBDE5FL2&I/-#<>Z%70K( =XZ/>P^](N0,[$S&<[$0FG->&#O MB-N1,OFS:SK2,B#OP6[!Z3$/MVBANXHB$183(W/? ;FJG+U3: RD-V)G>G"( M^NQ#4,&_(@S0_0F-UTM-D;8&WLYL?]S[:D9G&)U.CAZ-SJ.(F8V%U-$YGM&: MEX%0/YLBRRZD%=:6L6BHR&J77H&LQ%UI5C+RO 8R-E M4EVS$7!?UC"!#/G;)VO2]O4WAKX%#+8<9&UDG2E.-K+KK599S'S'6&R=C_*= M64PW-D!<*PYB(SC+3DG=*P3A>@HQ@T\$.A17RLL\=Y3'I;JJ^V!$3H:3!W$EHQ3$[*++&46+&8:V2H74,0"#2V5*E("\FA(5 ? M5.H[&4*F6,N44VR682%JII/L%NI#,A+DJS:9:U%=@^D%39)('T<[QO. MLD?MQD5Q8G"-[VU:H7_L\SX&=6UR>"!.]L>6VZXN=* M5<0M;K?M-R LQ5K #[<(1(J%L^@/L3?Q0.O#M_8L+2BBCK'N\>:>]9)##]36 M-2TB8NZ8 ];:J&_()^+/ /&F468S(X_:0I0W1<:FQ2 MHN\HL[*:I29,72Z0'<2:J26J(<*T>A-K"[SV-*#*1.VY-.Z;)MKH'H^A-6F5 M/DB!BT6YW3A97;FQ+!5@7$N7;2NE)DSEIG^Z:>-YP&D(D"Q*D4V'2S;S@CM8X?'X?+GF.4I01G*Y5*&+G53XRG+O8 ],8:&DSTC$,S5G'Q,RI5=PA M&^GM@>44Y9-V6\!0O*]=;.U/6]']U@G9/)'2-J'@ THW]XV5!:V9E6-@=41; M1]C8QODG$6_1M7>Z?=>_^['\/UG$*,Z1<= G9@='(CD\$M>U0RN,@9POXY==EHLD1$K:3'/0G&(YO)YGU[UU["3$999,,BLG8WEWC3$X-ER7+ MA:]U>C/\T1E[].!B!(1YO/[Q)H'C1W-'ZD?[&^9Y<[&Z-V^NIP@"B?<0[A)3 MQ\.#^4"XYLK7O 1;Q6O6P@;L$_&QP"V9'!O@^]+:T+WP OV]^^P_4$L#!!0 M ( #"#JE9'9BL$40, *,' 9 >&PO=V]R:W-H965TU*!) C=YL64YL TF680'6(FBZ]<,P#+1TLHA0I$I2 M151[4BBB-XSQJ&9?!:N'7[O1JH7HKN,0[#:9O6Z:? MKU"H[3)(@OW"![YIK%N(5HN.;? >[1_=G:99-+)4O$5IN)*@L5X&E\GYU<39 M>X,_.6[-P1A<)&NE'MSDMEH&L1.$ DOK&!C]/>(U"N&(2,;G'6 M_5W#D5?["+%LMM-J"=M;$Y@8^5(\F<5RZ M2[FWFG8YX>SJAFG)Y<; R>_*F%.X0PWW#=.XB"S1.Z.HW%%=#53I=Z@R>*>D M;0SC"H'S%8O7F5Y/'%$;&34>SD&/O_NY@? MI(*/C4;\ZMK\6;M/"B>W$EY3S@E!Y6-"P*<2.PO&(RM*ME.X;%4OK0%FK>;K MWK*U0+ *J,J8I".!:Z4[I9DOP"\RA)=1:]5"2;ZY[&D=J-$,E@;F$YC&Z8$ZR4WCSJDB3] +>4S?#;\#SQ'-^\G5*4/9(T T.\1AXZXJ;EY#$ M19AGDS#."S].BFDX3U*XE:5&ZD:6B3WDVZCQ<\_M,[ MTQ6Y34YA.IV$R;R M&65QGD^/.*^XZ-U&$L_)91&F>>[=SY-9.)W-X)^C/^_LYJD4?45LJAM.A"1U MO2X;:EI0Y"1D DQ6$.^]JIKNIVWI:NZM*A^ 6CS8AD+Q6=$.68$^*Z@4RV:L M14_C1*F\]G/CA21@F5G6^#:^5I:;NAPV]HJB= >W72MG]Q#D8W^75OU!+ M P04 " P@ZI6[8K%3K0# #=" &0 'AL+W=O\/QWW?&N^QQ%?"0!\ ?,[_YS9>'V=[YIU B1GBNC WSK(RQOLOS($NL M1!BZ&BW=[)RO1*2M+_)0>Q0J*54F'X]&[_)*:)LM9NEL[1>=GF/HG2%-FAGP>-NGBUO[E:W M+)\$_M*X#R=K8$^VSCWQY@\UST9," W*R B"?K[A/1K#0$3C:X>9]299\71] M1/^8?"=?MB+@O3-_:Q7+>?8^ X4[T9CXX/:_8^=/(BB=">D;]JWL=)J!;$)T M5:=,#"IMVU_QW,7A1.']Z(+"N%,8)]ZMH<3R-Q'%8N;='CQ+$QHODJM)F\AI MRTG91$^WFO3BX@$EV@A+*5UCH[8%K+VSM)9(H8\!WJR=T5)C>#O+(QEDM5QV MX*L6?'P!? *?G8UE@ ]6H7JMGQ/1GNWXR'8UO@KX6?@A3&X&,!Z-)U?P)KWW MDX0W^5[O_UEN0_14.O^>\[X%GYX'YW:Z"[60.,^H7P+Z;Y@M?OSAYMWHURO4 MISWUZ37TQ8<0-14E!A!6P3)05]5Q(<_2P22JX47J;'<#AHK M&J4C*M VHM<52)*DPE&"#W?:"BNU,! B';2AU9:%^%G1\4!5'TMX'&Z&\&FY M7%.[?VTT<:%2M_0VL 9$1[LG!'S%3)PPBZ6(('8[ZGA:(Z'4SC,!47%^ U,E M>8RMJM%BJXV.5-P#4#I(XT+CD:6(&9<#FSVO *(UP0ZR J^_)PH,>XGJ%WJ3 M@S#,#I_I%0Y'EXUQ,D'*4OB"3E7CN7A?@'A7$P6GAK#1A=4[+04Y\Q([NHWT M9G-4=54+[5L^9+9P3NVU,0-V0]A";PV>1L&1&0_&V>)G0R^JZNX&4#>>" 6N M#BWQ2),S,R!:U$>-C"U1Z<(KL#>=(V^A($XD;C&R>>DJA"B>.01U-PFN],YM MWSNW5WOG"PV+BST_@/3B'<[UT758:@RJ'D$?Z\CA_S\M&PJF$E[!8ZU2"C25 M+H5O>TB)^]B7QQF= "O'JOM2RS*9X(J07 .I+;C<*-Z'E,NN^N\=K>WAIW!2 M>;4+FC,R !KKW+]D@U)#(XQ2[T\$7]HA#,]%/#\9.152[GBP!DC$V^G3G_:S M>]F.K!?Q=O#3HUY0TL'@CE1'PU\HRKX=INTFNCH-L*V+- [3LJ3_'^A9@.YW MSL7CA@WT_V@6_P%02P,$% @ ,(.J5BNKEMN @ E 4 !D !X;"]W M;W)K&UL?53;;MLP#/T5PAN&#@CJQ$DOZ!(#2=IA M?>@0]+(]#'M0;"86*DNN*#?=WX^2'3!B-O+^P>&7Q WMG,%7LC3FT0O7^23J>T*H,',>0?#O&>>HE =B&D\M M9M2E](&[YRWZ]U [U[(4A'.C?LO<%9/H/((<5Z)6[M9L?F!;SXG'RXRB\(5- MXWO6CR"KR9FR#68&I=3-7[RT][ 3G IJ3*M!$+GL%!".Y@K0[5%>B\> MW8NE0OHZCAU3\8!QUJ:=-6F3#](.X<9H5Q!P!MV]S(,>,,/\-Y5^F>Z)&>YA?[NJ[6!&NV'\F-U097(4V@!S]Y M_Y#@9H)A;Y2F5-"1DGE[IF/?!ZLJ)IV"5R"((3+]P) M">R[W'AG4DJTZ[ /B/%J[9JAZ;3=RIDVD_;JWNPK[KBUY*P*5QS:/SX[B< V M.Z 1G*G"W"V-XRD.QX+7)EKOP/:5,6XK^ 3=(D[_ U!+ P04 " P@ZI6 M?0(2.V8" Q!0 &0 'AL+W=OM-J\V!+1P6LEE9T&I7/U91C:O,2*VS-=HZ*=I385=Q2:56AK M@[SH0)4,611=A!47*L@FW=J]R2:Z<5(HO#=@FZKBYFV.4K?3( ZV"P]B53J_ M$&:3FJ_P$=WW^MY0% XLA:A06:$5&%Q.@UE\.1_Y_"[AA\#6[LS!5[+0^L4' MM\4TB+P@E)@[S\#IL\8KE-(3D8S?&\Y@.-(#=^=;]INN=JIEP2U>:?DL"E=. M@S2 I>\D>Y!M]]P4\^YY\NUM-T(;9^;L #RQCI=;<"DH!*J__+7S7_8 :31 M.P"V ;!.=W]0I_*:.YY-C&[!^&QB\Y.NU Y-XH3RE_+H#.T*PKGL5JU1.6T$ M6CAZX@N)]G@2.F+V^V&^89GW+.P=E@3NM'*EA:^JP.)??$B*!EEL*VO.#A+> M<7,&27P"+&+) ;YD*#/I^)+_E/D&U\+F4MO&(/R<+:PSU!>_]E7<$X[V$WJO M7-J:YS@-R P6S1J#[-.'^"+Z/9+WBD8BZ"7LW- ^F0>)]LN< M6<_;CT>W"CY28TE)'K''<".4H&XJ8*5U82$^2>/8CRR"9[+7J5"GM=$Y6@LL MCOSUP -OJ2,=&L&E!:X*3PITV MKM"L.K-:R'6C7-_1P^KP'LQZ&_Q-[Q\3ZI^54!8D+@D:G8W/ S"]0?O Z;HS MQ4([LE@W+>E-0^,3:'^IM=L&_H#AE",$ M !F"P &0 'AL+W=OU#3AO;8"V")JL^S , RV=+:*4Z))4G.S7[RC9JC+(0C;,'^@C MQ7M_[GBSG53?=8YHX*D0I9X[N3';\\E$ISD63)_*+9;T92U5P0QMU6:BMPI9 M5C,58N*[;CPI&"^=Q:P^NU.+F:R,X"7>*=!543#U?(%"[N:.YQP.OO)-;NS! M9#';L@W>H_EU>Z=H-VFE9+S 4G-9@L+UW%EZYQ>)O5]?^,9QISLT6$]64GZW MF]ML[KC6(!28&BN!T=\C7J(05A"9\6,OTVE56L8N?9!^4_M.OJR8QDLI?N.9 MR>?.U($,UZP2YJOE8>6&KP3"4FLT>@Q?"!HP M]2$47RLMBM,L5BA.F3$AWB<)!$$<0+)V M]$O6CXIK; M1P E^D00A@ M!"?>= 1OWTQ]SW_?;*Z?TIRBCZ 8W6EH#9X'(7C17A]E/\W;]!/?R"J,IQ D MGE48G,&?@[^:Y2$G+V%GEU)26TBKHA*D- ->;!E7U'(,4-8UZ6<]>D\'G;,;7G*#[SY1=^K!8%\F!V7WHVVO1-1*^$\EK $Z4Y:$M134I?4Y?.(I M-5X*P&7=@E"]HV0_4@O?$ONE?,22E<36#XX/BH+7F _?F*CP*%P((?XXC"*( M70_H+QA[47 $"@>T$-N![!SU J01GR0=\83.92?CRT(JP_]B]0MQS,J3X(P0 M&\6)75U:0KO$9_'H)7^+Y\!^][P.PD/O&,+;*YV"Z)[U([^V*'8CNWH'BY*0 M]K9AVT<0'NO(!^"-IXD/4>C:.J)P!"X, #AN 1R_&L"WU-S7_QK$@_+[0=Q1 M]%H@/RB6T1A#(\ZK>Y@WCL/ID6Q-^_-!+%$\%-:D#6OR/_6%,=Q4QCY,+R!X M_;2U==L7[T'%_?&^UH87=9VPKA)LE%"0%9@<::!+4\2,EQM8D[&TZ)3:PC,R MI8'K%_GX9Q(H?-3@8]<2T8&(#T1R(*8UT1?@26?VH3ZUJ2<\#:FL2M.,0>UI M.T0NF]GIY_5F J6DTANH0>":6-W3A/JL:J:Z9F/DMIZD5M)04ZS)G 9A5/8" M?5]+>M_V&ZN@':T7?P-02P,$% @ ,(.J5J4BB<5) P ^@8 !D !X M;"]W;W)K&UL?55_;]LX#/TJA*\86B"H?R5ITB8! MDO8.*[#>BK:W_3$,!]FF8V&RY$ERTW[[HV3'RW!M@L"61/+I/8FD%SNE?Y@* MT<)++:19!I6US648FKS"FIESU: D2ZETS2Q-]38TC496^*!:A$D43<.:<1FL M%G[M7J\6JK6"2[S78-JZ9OIU@T+MED$<[!<>^+:R;B%<+1JVQ4>T_S3WFF;A M@%+P&J7A2H+&*W$5U[8:AG, BBP9*VP#VKW$7L] M$X>7*V'\$W:=;TK.>6NLJOM@8E!SV;W92W\.!P&SZ)V I ](/.]N(\_RAEFV M6FBU ^V\"2X=)?R:#59.<79U76K-4H+GVV%&CYQEG'!+4<#IT\L M$VC.%J&E?9QWF/>8FPXS>0Y"8Y"GC']#FD M\0B2*$F/X*6#Z-3CI>_@_4_L"/;G\&V=&:LI5[Z_I;N#';\-Z^KGTC0LQV5 M!6)0/V.P^O!'/(VNCI >#Z3'Q]!7CU2/12L05 GOWMI;I(_#KHT#[)ZGMQ). M*,N$H((Q9[!!B26WH#+!M\Q5$:4%_*TLP@S.()FX_[5/4J*A,6.6$F<>0QS% M<(.:/S-7RI!OHY(_A M8M[?S&E,)$AM,I_#D[*D*AY%I"@>)71"_Q[Y^=!;F8NV(,R3.!KO[\63/8FG MTV&!;DX<%*Y&040*L J(!-Q]8'5S=0?K_&?+#?>]<*^%7&[:>RI68#X!J-#R M:J@TO],-YEAGI*5?34:T@6G0=U/Q>OY69H<'_8@R8^N[KH%]NF;*4AGY8T<<)M7,@>ZDH M'?J)VV#XW*W^ U!+ P04 " P@ZI6=T61\$$% #G#P &0 'AL+W=O M2T:P+1>N$]O#L>>3U/9W'7YGL-%[]\1:,I/RBWWX4%ST?*L0<,B- M)5#\6<,5<&Y!J,8_6V:O&=(*[M_OZ.^=[6C+C&JXDOP/5ICE16_8(P7,:<7- MK=S\"EM[$LO+)=>N)9NZ;YST2%YI(\NM,&I0,E'_TONM'_8$AOXS N%6('1Z MUP,Y+:^IH>-S)3=$V=Y(LS?.5">-RC%A)V5J%'YE*&?&US SY.2.SCCHT_.! M0:3],,BWXI-:/'Q&/"*?I#!+37X1!11/Y0>H2J-/N--G$G8"/U'ED2CHD] / MHPY>U-@7.5[49=\UTSF7NE) _KR<::,P%OYJ,[9FQ>TLNS[.](KF<-'#!:!! MK:$W?O,J2/UW'9K&C:9Q%WT\Q?565!R(G)/I4BKSUH JB36@3=5NV*6VF+H] M^2#(3Q@[G.,RT*=;^)V%3Z1"+9E8:$)%0:XJI4 8\D%H0SG'M6< ]H:6L+**H@!A)Z.-()\$I28,,,3ZYA;7D:]L_5U P0^8TQWZ&V7[A*0F# M(8FPWYU$I4C0CX:I;5&!OSO_W"!W2R ;M[RA('0-"G.EKYXW$&^*-LQK#.5\V\>R^7D,.Y0S4[FW8Q\U-K\!M3_S!<_J^<,C(BW_$ MD!W1FS31F[PX>C\V4_U<\':SNH+W(!2G()A4I!(:!1'2AH8-%FM]_\!G M" R\($Q>DW@XPLL_ HA; )&' 8> TUF665/\X="V:78$DK5 PCHNDC@D211\!R#U NN'SFG]RJ'M(.?0P"&"%\3' ML 7B>VEM3H3F1$< H]8HC:+, N+O!*0(\%\8%U'8#LA&3_UP(SFO7#678]FA ML%JRVQL3!19*BN'.KF - I$S*8H:3@U94\5DA8\N;9BEDM5B:4?U#T;5V(J% MS2)S)4N,*Q]=B$DG\6R !FF$5TPF5'QQDWAT %R<-G_$^/_;C+,%M:IK]$&! M>_&<"2IR(!RPJ#R*2F(<>T2"+"33:F;J-!;W?7.J!^-4O>313\P>P9>5*>R M^N9_9<];X-2.AE-G/A9'UC7)W"_*S/DD?GIRI%IDR/3%^?(">66 MKLGEFC)NRV^")ZS'@JPM:W;2VZO3NR?FNRF=[4:V[MQ55_2)%DTEMG4%PQ[Z M))')3M M@-_G$C?5[8,=H#G;C_\#4$L#!!0 ( #"#JE:.S&PO=V]R:W-H965TQ:32RPBO5(D['XRRN M&9?1&JOJ7ID\J+GL_NRAS\.>POEK"FFOD'J_.T/> MRVMFV7*NU0ZTVTUH3O"A>FURCDM'RIW5M,I)SRZO4&+)+7S;"+YE+E$&1O=L M(]"%./-[D%;Q;M%PC%96%/G(#?UUNC-54'G\?"KC#FQ[&C-8W_36<[(.3",P M Z42U-_F NXKC?BL#(!(S*O HOND%$K7UVO">*^?6'EM?G0CX3=J "%328G8>]HFCP-[I5E8L_8*-U;/$+\+! _^V7B5T0$DX_N7W-;>T:L M@D^M+.! ]QXJ@:/&#I? @*P",I1DD E)]WG.C-(S@_J M*%NAAH8*8J^R@EVOFU Q'2$P"P1FOTS@=1_@X-':&[KF)A?*M)3Q0Y0=AQ^Z MA%$-' F'[BOZYFBHP(OW,K\[&ULC51M3]LP M$/XKIVR:0)J:EX8"71NI!:;Q@8$H;!^F?7";2V/AV)GM4/;O=W9"5J2V0HD2 MO]SSW'-GWTTV2C^9$M'"2R6DF0:EM?4X#,VJQ(J9@:I1TDZA=,4L3?4Z-+5& MEGM0)<(DBD9AQ;@,LHE?N]/91#56<(EW&DQ354S_G:-0FVD0!Z\+]WQ=6K<0 M9I.:K7&!]K&^TS0+>Y:<5R@-5Q(T%M-@%H_GJ;/W!C\X;LS6&%PD2Z6>W.0Z MGP:1$X0"5]8Q,/H]XP4*X8A(QI^.,^A=.N#V^)7]JX^=8EDR@Q=*_.2Y+:?! M60 Y%JP1]EYMOF$7SXGC6REA_!Y26S+)MHM0'MK(G-#7RH'DWBN'2'LK":=CGA;'8EG[E6DM)L MF8"C![84:(XGH25N9Q&N.IYYRY/LX1G"C9*V-' E<\S?XD/2U M+7H7-DX.$ M-TP/8!A_AB1*A@?XAGV@0\\W?%>@]UAASIF_&+=+P==^:.#7;&FLIJOR>U<* M6@_I;@^N?,:F9BNK?R@15JJJE217QKG&-Z[UEFO!V9(+;CD:8!J!&2B4H*(W8YAY M;/L]NI;PD:ZR$"[CQW!)''J-&M36.1S!=V41XA2.(3ZG.P"75+S&!PL!K!H:M1%(_-NZQSB"&YM2:[?%U5"SX-R%J,41J>P MZU3#K5+T<;F&8RB)C;1M5?:K?4^;M:7\W[QMB%0!:TX1"BP(&@U.3P+0;9-I M)U;5OK"7RE*;\,.2^C)J9T#[A:+,=!/GH._TV3]02P,$% @ ,(.J5I3K MM!0J! 5PH !D !X;"]W;W)K&ULG5;;;MLX M$/V5@;KHRH 16;*M.*EMP$Z:-D O09/N/BSV@99&$C>4J))4G/3K=ZA;[-;U MMOM@B:1FSES.S)CSK53W.D,T\)B+0B^,[W<$G MGF;&'GC+>(%"6"!RXTN+Z?0FK>+NND._JF.G6#9,XX44 M?_+89 MGYD",":N$^22W;[&-9VKQ(BET_81M(WM*PE&EC76*/K*2<\L M;XV,[C,I8E3Z=WC]I>+F"=P[MA&H!W//D DKZ$4MW+J!"WX -X;WLC"9AM=% MC/&^OD>N]?X%G7_KX"C@>Z9.8.P/(1@%XR-XXS[><8TW_I5X/TB#\-=JHXVB M*OG[4-@-ZN0PJNV<4N=&%<" M029P1YVG*_4$=2"'/#V*==C3.VF8@"LE<[C-&!U3NY65BC(J]QC"L^$XF PG MP1FL'E!1JT+W$4K%(WHBM;E5A-]@-CXY]0_!N+R@SSD7@KI1#V@]'UF#7&E>)&"R6KS7!XR$ YG80A' M&)CV#$Q_FH$+F9>RP,)HN_M(#JCZ3&%F9]4#PG41R1S!?2>U'@SA YI#/!VW M>)*/(1F>0#'U_X%[O9X5F&4VJ@F:+4EA$3T U7VA1 M9Q52FN+@"NLWN),!^*?@C\'UI[0-Z1?X WBS(T,J$=,9)#3;@5*4$N<3>/EB M%OC!*UKY9PW,%&[:.MC%U*?GQ_^* MERJ';B5(0R(23&N>\*@=#K;H@KI"W#%9S65E\_DL1ZXE=MJQ7TGO3@4^KUK. M#7L$MU3R@=NT#;J:M@7:R79O.FK2\$T_NY-3VV8V5 MUE<:38Y3C,W_?G_:WYI6S67A6;RY89F-D65\= M-M+01:1>9G3S0V4%Z'LBB?5V8PWT=\GEOU!+ P04 " P@ZI6HU) (O " M #A!@ &0 'AL+W=O 2'S68,L^9WLU1J.TDZ ;[@R7?9-8=A--QP3;X MA/9;\:AI%S8H*<]1&JXD:%Q/@EEW-!\X>2_PG>/6'*S!>1(K]>PV]^DDZ#A" M*#"Q#H'1ZP47*(0#(AJ_:\R@,>D4#]=[](_>=_(E9@872OS@JQ2;3]C[8\GF"AA_!.VE>R@$T!2&JOR6ID8Y%Q6;_9:Q^% X>:<0E0K1)YW M9FUH M==NP4I:)9GO!V4'C[."_G3VVN:P""_$.5KO""RR4.>GW11.GL[7*$)*,28HJ M< D49AI"A^8%9S$75:T0A;@T!&L,&-S0U++ - (SL%:")I\944 W)(#:5QG: MG:AS5T?LG_#>Y850.TK'"C7U/?,S;(X2U]P:F!GG[2TFF,<$4;=&!'WHTF\( MLS3E3L- U/5'E,4%,QD4;.?(&6CUJWSY_[!=(U*C)5G3:0?*IQ(9'HR='*G\ MW' UD*A2VFH"-:?-_)Y58^NO>#7\R2X%QX# -:EVKM]3PG0U4*N-584?8K&R M-!+],J-O$&HG0/=KI>Q^XPPT7[7I'U!+ P04 " P@ZI6P6W@!CH" $ M!0 &0 'AL+W=O(!O8U%SHEE3'-- AT7F%-]4@V*.Q.*55-C0W5-M"-0EIX4,V#:#R^ M#FK*!,D2O[9062);PYG A0+=UC55KS/D2D!P6EFQ;&;<09$E#M[A"\[U9 M*!L% TO!:A2:20$*RY3260($E;;E9RMTW M[/U<.;Y<J1A"'GR :1_$9 MOGCP&7N^^+\^X8'IG$O=*H1?=QMME*V,WZ?SFC=S+HG9QCSU:V^XJ6(\@2'LL2??%Z^4MJ\)3:LWRGU:XKA?CF MS_GK=I\(+N8"&E0Y"F.[4U\>R6#=91JK1EDU$(40WL(IU\%19=:HMK[_-.2R M%:8KTF%U:/&[KK+_I7?O@ZV(+1,:.)86.A[=7!%07<]U@9&-K_.--+9K_+2R MSQ0JEV#W2RG-(7 '# ]?]A=02P,$% @ ,(.J5I5Y<(%$!0 +A( !D M !X;"]W;W)K&ULQ5AM;]LX#/XK1#;L$J"K8[MY MZ5N -ENW 'T9UM[NPW ?%)N)A=E23E*:]G[]4;+C.(OK]G8[[$,D&WV_?5*C$[DT*1?X28%>9AE3C^>8RM5IRV^M7WSF\\38%][H M9,'F>(OF]\4G14]>J27F&0K-I0"%L]/6F7]T[@=6P,WXPG&E*_=@79E*^M80MBG+%E:C[+U4^9C0Q<<,%$Q%D*$Z&-6E+LC8;V'9NFJ#LGGB%S5LB+"M7GN>K@"=4A7$EA M$@WO18SQMKQ',$NLP1KK>="H\(JI?0C]/0BZ0=B@+RQ]#YV^\'G?OU[2&$P, M9OK/.D]S10?UBFSE'.D%B_"T1:6A4=UC:_3FE=_O'C? /"AA'C1I']U2)<;+ M%$'.8)PP,4<-7, %XPJ^L'3I!C:^Z#K\S18F(B_OO-+F3,5,Y%SPOS&V)F_(@G(F%":V"Y"BB8ADANOY3\N^9TJ0!WH]>I@>"'A-59FF5J)#2=!\ M+DA=;)T<,YW !?D)'S&V@21G,AES\PAZQ18:WKP:!GYP#/X _/)A++5#HAE5 M'7ELD!AE@%#A=V+K_W;0<;]R+CY0S]94T%)14Q+41I1"$3U2V-6*DJLAV C[ MG2=,WTE#K2"PZ-86MOV[IC5C(HAPQD6O<'+':(Q"4N-R4C%.#;3A6I(S R"E MO7X'@N&.2]?>&8P5Y>YMJ2;WO>T?=BKHJ_-SO.U!KP-A=W>&--_!?PIO&23+ MY/J(!RYL:TE\R"L%YHZ0J:7<'@@TQP6)>4';(B_Y8(&W5G5#T^B53:/76-(W MLYE&8VP=GVFZJ^T*C2KJNUI]J[#=8&[S!2R32UOG32VBV@]LD.W$C9S%O>XY M2\&65#"4L(@*3*8\=MF;LI16*JH'N^SM])0S9SV_[E9HB2(/"WRHP":/RC;B MAX?@]P^WQ[?1-6':%+0MDT+>R$T M$*Q?$JS_4H)=\?NUIU%//LA>FL&+XZ3P.>_3[E7D<'NP"^*]Y[!$W M!HUY')1Y'#3FL::+VYQ^O<)LBJIV,]2H\ N.[[0W3M125_EC9?M?YU6BYWJ\[(IAQZXU8@RDKP2YXSZS8 M%F)4MQS'6RNJ<&PNJ93D"RQ3V-B>J;["_L%QI<+SE;&WU^\%]DJ-N"$C?G=S MTNDV,[UV"V#)O@EX[2FG4>T/$LFO'-#\G\7X0M-/1AILD :_C/3-INM=RSMN MR7AW=BEW)CNLK]GWV2Z]3?$7$AK;U[H7]0RV:O

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end XML 105 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 106 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 107 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 323 365 1 true 103 0 false 10 false false R1.htm 0000001 - Document - Cover Sheet http://www.celanese.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - Unaudited Interim Consolidated Statement of Operations Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations Unaudited Interim Consolidated Statement of Operations Statements 2 false false R3.htm 0000003 - Statement - Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) Statements 3 false false R4.htm 0000004 - Statement - Unaudited Consolidated Balance Sheets Sheet http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets Unaudited Consolidated Balance Sheets Statements 4 false false R5.htm 0000005 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical) Sheet http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical Unaudited Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 0000006 - Statement - Unaudited Interim Consolidated Statement Equity Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity Unaudited Interim Consolidated Statement Equity Statements 6 false false R7.htm 0000007 - Statement - Unaudited Interim Consolidated Statements of Cash Flows Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows Unaudited Interim Consolidated Statements of Cash Flows Statements 7 false false R8.htm 0000008 - Disclosure - Description of the Company and Basis of Presentation Sheet http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation Description of the Company and Basis of Presentation Notes 8 false false R9.htm 0000009 - Disclosure - Recent Accounting Pronouncements Sheet http://www.celanese.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 9 false false R10.htm 0000010 - Disclosure - Acquisitions, Dispositions and Plant Closures Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosures Acquisitions, Dispositions and Plant Closures Notes 10 false false R11.htm 0000011 - Disclosure - Inventories Sheet http://www.celanese.com/role/Inventories Inventories Notes 11 false false R12.htm 0000012 - Disclosure - Goodwill and Intangible Assets, net Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsnet Goodwill and Intangible Assets, net Notes 12 false false R13.htm 0000013 - Disclosure - Current Other Liabilities Sheet http://www.celanese.com/role/CurrentOtherLiabilities Current Other Liabilities Notes 13 false false R14.htm 0000014 - Disclosure - Debt Sheet http://www.celanese.com/role/Debt Debt Notes 14 false false R15.htm 0000015 - Disclosure - Benefit Obligations Sheet http://www.celanese.com/role/BenefitObligations Benefit Obligations Notes 15 false false R16.htm 0000016 - Disclosure - Environmental Sheet http://www.celanese.com/role/Environmental Environmental Notes 16 false false R17.htm 0000017 - Disclosure - Stockholders' Equity Sheet http://www.celanese.com/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 0000018 - Disclosure - Other (Charges) Gains, Net Sheet http://www.celanese.com/role/OtherChargesGainsNet Other (Charges) Gains, Net Notes 18 false false R19.htm 0000019 - Disclosure - Income Taxes Sheet http://www.celanese.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 0000020 - Disclosure - Derivative Financial Instruments Sheet http://www.celanese.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 20 false false R21.htm 0000021 - Disclosure - Fair Value Measurements Sheet http://www.celanese.com/role/FairValueMeasurements Fair Value Measurements Notes 21 false false R22.htm 0000022 - Disclosure - Commitments and Contingencies Sheet http://www.celanese.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 22 false false R23.htm 0000023 - Disclosure - Segment Information Sheet http://www.celanese.com/role/SegmentInformation Segment Information Notes 23 false false R24.htm 0000024 - Disclosure - Revenue Recognition Sheet http://www.celanese.com/role/RevenueRecognition Revenue Recognition Notes 24 false false R25.htm 0000025 - Disclosure - Earnings (Loss) Per Share Sheet http://www.celanese.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 25 false false R26.htm 0000026 - Disclosure - Recent Accounting Pronouncements (Policies) Sheet http://www.celanese.com/role/RecentAccountingPronouncementsPolicies Recent Accounting Pronouncements (Policies) Policies http://www.celanese.com/role/RecentAccountingPronouncements 26 false false R27.htm 0000027 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures (Tables) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables Acquisitions, Dispositions and Plant Closures Plant Closures (Tables) Tables 27 false false R28.htm 0000028 - Disclosure - Inventories (Tables) Sheet http://www.celanese.com/role/InventoriesTables Inventories (Tables) Tables http://www.celanese.com/role/Inventories 28 false false R29.htm 0000029 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.celanese.com/role/GoodwillandIntangibleAssetsnet 29 false false R30.htm 0000030 - Disclosure - Current Other Liabilities (Tables) Sheet http://www.celanese.com/role/CurrentOtherLiabilitiesTables Current Other Liabilities (Tables) Tables http://www.celanese.com/role/CurrentOtherLiabilities 30 false false R31.htm 0000031 - Disclosure - Debt (Tables) Sheet http://www.celanese.com/role/DebtTables Debt (Tables) Tables http://www.celanese.com/role/Debt 31 false false R32.htm 0000032 - Disclosure - Benefit Obligations (Tables) Sheet http://www.celanese.com/role/BenefitObligationsTables Benefit Obligations (Tables) Tables http://www.celanese.com/role/BenefitObligations 32 false false R33.htm 0000033 - Disclosure - Environmental (Tables) Sheet http://www.celanese.com/role/EnvironmentalTables Environmental (Tables) Tables http://www.celanese.com/role/Environmental 33 false false R34.htm 0000034 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.celanese.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.celanese.com/role/StockholdersEquity 34 false false R35.htm 0000035 - Disclosure - Other (Charges) Gains, Net (Tables) Sheet http://www.celanese.com/role/OtherChargesGainsNetTables Other (Charges) Gains, Net (Tables) Tables http://www.celanese.com/role/OtherChargesGainsNet 35 false false R36.htm 0000036 - Disclosure - Income Taxes (Tables) Sheet http://www.celanese.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.celanese.com/role/IncomeTaxes 36 false false R37.htm 0000037 - Disclosure - Derivative Financial Instruments (Tables) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsTables Derivative Financial Instruments (Tables) Tables http://www.celanese.com/role/DerivativeFinancialInstruments 37 false false R38.htm 0000038 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.celanese.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.celanese.com/role/FairValueMeasurements 38 false false R39.htm 0000039 - Disclosure - Segment Information (Tables) Sheet http://www.celanese.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.celanese.com/role/SegmentInformation 39 false false R40.htm 0000040 - Disclosure - Revenue Recognition (Tables) Sheet http://www.celanese.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.celanese.com/role/RevenueRecognition 40 false false R41.htm 0000041 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.celanese.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.celanese.com/role/EarningsLossPerShare 41 false false R42.htm 0000042 - Disclosure - Description of the Company and Basis of Presentation (Narrative) (Details) Sheet http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails Description of the Company and Basis of Presentation (Narrative) (Details) Details http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation 42 false false R43.htm 0000043 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) Details http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables 43 false false R44.htm 0000044 - Disclosure - Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresBusinessAcquisitionProFormaInformationDetails Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details) Details 44 false false R45.htm 0000045 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails Inventories - Schedule of Inventories (Details) Details 45 false false R46.htm 0000046 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) Details 46 false false R47.htm 0000047 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) Details 47 false false R48.htm 0000048 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) Details 48 false false R49.htm 0000049 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Details 49 false false R50.htm 0000050 - Disclosure - Current Other Liabilities (Details) Sheet http://www.celanese.com/role/CurrentOtherLiabilitiesDetails Current Other Liabilities (Details) Details http://www.celanese.com/role/CurrentOtherLiabilitiesTables 50 false false R51.htm 0000051 - Disclosure - Debt - Schedule of Short-term Debt (Details) Sheet http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails Debt - Schedule of Short-term Debt (Details) Details 51 false false R52.htm 0000052 - Disclosure - Debt - Schedule of Long-term Debt (Details) Sheet http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails Debt - Schedule of Long-term Debt (Details) Details 52 false false R53.htm 0000053 - Disclosure - Debt - Senior Credit Facilities Narrative (Details) Sheet http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails Debt - Senior Credit Facilities Narrative (Details) Details 53 false false R54.htm 0000054 - Disclosure - Debt - Schedule of Revolving Credit Facility (Details) Sheet http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails Debt - Schedule of Revolving Credit Facility (Details) Details 54 false false R55.htm 0000055 - Disclosure - Debt - Senior Notes Narrative (Details) Notes http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails Debt - Senior Notes Narrative (Details) Details 55 false false R56.htm 0000056 - Disclosure - Debt - Accounts Receivable Securitization Facility Narrative (Details) Sheet http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails Debt - Accounts Receivable Securitization Facility Narrative (Details) Details 56 false false R57.htm 0000057 - Disclosure - Debt - Factoring and Discounting Agreements Narrative (Details) Sheet http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails Debt - Factoring and Discounting Agreements Narrative (Details) Details 57 false false R58.htm 0000058 - Disclosure - Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) Sheet http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) Details 58 false false R59.htm 0000059 - Disclosure - Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details) Sheet http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details) Details 59 false false R60.htm 0000060 - Disclosure - Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) Sheet http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) Details 60 false false R61.htm 0000061 - Disclosure - Environmental (Schedule of Environmental Remediation Reserves) (Details) Sheet http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails Environmental (Schedule of Environmental Remediation Reserves) (Details) Details http://www.celanese.com/role/EnvironmentalTables 61 false false R62.htm 0000062 - Disclosure - Environmental - US Superfund Sites Narrative (Details) Sheet http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails Environmental - US Superfund Sites Narrative (Details) Details 62 false false R63.htm 0000063 - Disclosure - Stockholders' Equity - Narrative (Details) Sheet http://www.celanese.com/role/StockholdersEquityNarrativeDetails Stockholders' Equity - Narrative (Details) Details 63 false false R64.htm 0000064 - Disclosure - Stockholders' Equity - Schedule of Treasury Stock (Details) Sheet http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails Stockholders' Equity - Schedule of Treasury Stock (Details) Details 64 false false R65.htm 0000065 - Disclosure - Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) Sheet http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) Details 65 false false R66.htm 0000066 - Disclosure - Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) Sheet http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) Details 66 false false R67.htm 0000067 - Disclosure - Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) Sheet http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) Details http://www.celanese.com/role/OtherChargesGainsNetTables 67 false false R68.htm 0000068 - Disclosure - Other (Charges) Gains, Net - Narrative (Details) Sheet http://www.celanese.com/role/OtherChargesGainsNetNarrativeDetails Other (Charges) Gains, Net - Narrative (Details) Details http://www.celanese.com/role/OtherChargesGainsNetTables 68 false false R69.htm 0000069 - Disclosure - Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) Sheet http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) Details http://www.celanese.com/role/OtherChargesGainsNetTables 69 false false R70.htm 0000070 - Disclosure - Income Taxes - Schedule of Effective Tax Rate (Details) Sheet http://www.celanese.com/role/IncomeTaxesScheduleofEffectiveTaxRateDetails Income Taxes - Schedule of Effective Tax Rate (Details) Details 70 false false R71.htm 0000072 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details) Details 71 false false R72.htm 0000073 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details) Details 72 false false R73.htm 0000074 - Disclosure - Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) Details http://www.celanese.com/role/DerivativeFinancialInstrumentsTables 73 false false R74.htm 0000075 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) Details http://www.celanese.com/role/DerivativeFinancialInstrumentsTables 74 false false R75.htm 0000076 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) Details http://www.celanese.com/role/DerivativeFinancialInstrumentsTables 75 false false R76.htm 0000077 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 76 false false R77.htm 0000078 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) Sheet http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) Details 77 false false R78.htm 0000079 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 78 false false R79.htm 0000080 - Disclosure - Segment Information - Schedule of Business Segments (Details) Sheet http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails Segment Information - Schedule of Business Segments (Details) Details 79 false false R80.htm 0000081 - Disclosure - Revenue Recognition - Disaggregation of net sales (Details) Sheet http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails Revenue Recognition - Disaggregation of net sales (Details) Details 80 false false R81.htm 0000082 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details) Sheet http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails Revenue Recognition Remaining Performance Obligations (Details) Details 81 false false R82.htm 0000083 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) Sheet http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) Details http://www.celanese.com/role/EarningsLossPerShareTables 82 false false R83.htm 0000084 - Disclosure - Earnings (Loss) Per Share - Narrative (Details) Sheet http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails Earnings (Loss) Per Share - Narrative (Details) Details http://www.celanese.com/role/EarningsLossPerShareTables 83 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. ce-20230331.htm 4 [dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 12 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. ce-20230331.htm 4 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 - ce-20230331.htm 4 ce-20230331.htm ce-20230331.xsd ce-20230331_cal.xml ce-20230331_def.xml ce-20230331_lab.xml ce-20230331_pre.xml ex1043312310q.htm ex1053312310q.htm ex1063312310q.htm ex1073312310q.htm ex31103312310-q.htm ex31203312310-q.htm ex32103312310-q.htm ex32203312310-q.htm ce-20230331_g1.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 110 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ce-20230331.htm": { "axisCustom": 0, "axisStandard": 29, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 957, "http://xbrl.sec.gov/dei/2022": 48 }, "contextCount": 323, "dts": { "calculationLink": { "local": [ "ce-20230331_cal.xml" ] }, "definitionLink": { "local": [ "ce-20230331_def.xml" ] }, "inline": { "local": [ "ce-20230331.htm" ] }, "labelLink": { "local": [ "ce-20230331_lab.xml" ] }, "presentationLink": { "local": [ "ce-20230331_pre.xml" ] }, "schema": { "local": [ "ce-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 608, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 20, "http://xbrl.sec.gov/dei/2022": 5, "total": 25 }, "keyCustom": 37, "keyStandard": 328, "memberCustom": 39, "memberStandard": 52, "nsprefix": "ce", "nsuri": "http://www.celanese.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://www.celanese.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "ce:AcquisitionsDispositionsandPlantClosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Acquisitions, Dispositions and Plant Closures", "menuCat": "Notes", "order": "10", "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosures", "shortName": "Acquisitions, Dispositions and Plant Closures", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "ce:AcquisitionsDispositionsandPlantClosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Inventories", "menuCat": "Notes", "order": "11", "role": "http://www.celanese.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Goodwill and Intangible Assets, net", "menuCat": "Notes", "order": "12", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsnet", "shortName": "Goodwill and Intangible Assets, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Current Other Liabilities", "menuCat": "Notes", "order": "13", "role": "http://www.celanese.com/role/CurrentOtherLiabilities", "shortName": "Current Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Debt", "menuCat": "Notes", "order": "14", "role": "http://www.celanese.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Benefit Obligations", "menuCat": "Notes", "order": "15", "role": "http://www.celanese.com/role/BenefitObligations", "shortName": "Benefit Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EnvironmentalLossContingencyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Environmental", "menuCat": "Notes", "order": "16", "role": "http://www.celanese.com/role/Environmental", "shortName": "Environmental", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EnvironmentalLossContingencyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Stockholders' Equity", "menuCat": "Notes", "order": "17", "role": "http://www.celanese.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "ce:OtherChargesGainsNetTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Other (Charges) Gains, Net", "menuCat": "Notes", "order": "18", "role": "http://www.celanese.com/role/OtherChargesGainsNet", "shortName": "Other (Charges) Gains, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "ce:OtherChargesGainsNetTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "19", "role": "http://www.celanese.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Unaudited Interim Consolidated Statement of Operations", "menuCat": "Statements", "order": "2", "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations", "shortName": "Unaudited Interim Consolidated Statement of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Derivative Financial Instruments", "menuCat": "Notes", "order": "20", "role": "http://www.celanese.com/role/DerivativeFinancialInstruments", "shortName": "Derivative Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "21", "role": "http://www.celanese.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "22", "role": "http://www.celanese.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Segment Information", "menuCat": "Notes", "order": "23", "role": "http://www.celanese.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Revenue Recognition", "menuCat": "Notes", "order": "24", "role": "http://www.celanese.com/role/RevenueRecognition", "shortName": "Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Earnings (Loss) Per Share", "menuCat": "Notes", "order": "25", "role": "http://www.celanese.com/role/EarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Recent Accounting Pronouncements (Policies)", "menuCat": "Policies", "order": "26", "role": "http://www.celanese.com/role/RecentAccountingPronouncementsPolicies", "shortName": "Recent Accounting Pronouncements (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables", "shortName": "Acquisitions, Dispositions and Plant Closures Plant Closures (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Inventories (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.celanese.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Goodwill and Intangible Assets, Net (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables", "shortName": "Goodwill and Intangible Assets, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Unaudited Interim Consolidated Statements of Comprehensive Income (Loss)", "menuCat": "Statements", "order": "3", "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss", "shortName": "Unaudited Interim Consolidated Statements of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Current Other Liabilities (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.celanese.com/role/CurrentOtherLiabilitiesTables", "shortName": "Current Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Debt (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.celanese.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Benefit Obligations (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.celanese.com/role/BenefitObligationsTables", "shortName": "Benefit Obligations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EnvironmentalExitCostsByCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Environmental (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.celanese.com/role/EnvironmentalTables", "shortName": "Environmental (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EnvironmentalExitCostsByCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Stockholders' Equity (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.celanese.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Other (Charges) Gains, Net (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.celanese.com/role/OtherChargesGainsNetTables", "shortName": "Other (Charges) Gains, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.celanese.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Derivative Financial Instruments (Tables)", "menuCat": "Tables", "order": "37", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "shortName": "Derivative Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "38", "role": "http://www.celanese.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Segment Information (Tables)", "menuCat": "Tables", "order": "39", "role": "http://www.celanese.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Unaudited Consolidated Balance Sheets", "menuCat": "Statements", "order": "4", "role": "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "shortName": "Unaudited Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Revenue Recognition (Tables)", "menuCat": "Tables", "order": "40", "role": "http://www.celanese.com/role/RevenueRecognitionTables", "shortName": "Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Earnings (Loss) Per Share (Tables)", "menuCat": "Tables", "order": "41", "role": "http://www.celanese.com/role/EarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "ie23ecf0ff7844734ba22a4effe59bead_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Description of the Company and Basis of Presentation (Narrative) (Details)", "menuCat": "Details", "order": "42", "role": "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails", "shortName": "Description of the Company and Basis of Presentation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "ie23ecf0ff7844734ba22a4effe59bead_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i2146d50e08db4190a846411fcb0d4b1d_D20220401-20220401", "decimals": "-6", "first": true, "lang": "en-US", "name": "ce:PaymentsToEquityMethodInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details)", "menuCat": "Details", "order": "43", "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "shortName": "Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i2146d50e08db4190a846411fcb0d4b1d_D20220401-20220401", "decimals": "-6", "first": true, "lang": "en-US", "name": "ce:PaymentsToEquityMethodInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "idad9ddda77fc4c68bdb976c068ffb34e_D20220101-20220331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details)", "menuCat": "Details", "order": "44", "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresBusinessAcquisitionProFormaInformationDetails", "shortName": "Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "idad9ddda77fc4c68bdb976c068ffb34e_D20220101-20220331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Inventories - Schedule of Inventories (Details)", "menuCat": "Details", "order": "45", "role": "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails", "shortName": "Inventories - Schedule of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "id9548a799c35400eb5a92b186c275bac_I20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details)", "menuCat": "Details", "order": "46", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:GoodwillPurchaseAccountingAdjustments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "id9548a799c35400eb5a92b186c275bac_I20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details)", "menuCat": "Details", "order": "47", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "id9548a799c35400eb5a92b186c275bac_I20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "if1d1d4d622e64f75a30ca2987426aea8_I20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details)", "menuCat": "Details", "order": "48", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "if1d1d4d622e64f75a30ca2987426aea8_I20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "menuCat": "Details", "order": "49", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "5", "role": "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical", "shortName": "Unaudited Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Current Other Liabilities (Details)", "menuCat": "Details", "order": "50", "role": "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails", "shortName": "Current Other Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Debt - Schedule of Short-term Debt (Details)", "menuCat": "Details", "order": "51", "role": "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "shortName": "Debt - Schedule of Short-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherShortTermBorrowings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Debt - Schedule of Long-term Debt (Details)", "menuCat": "Details", "order": "52", "role": "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "shortName": "Debt - Schedule of Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i32eea5b9fa87491daff99e19e69e9a9e_D20220331-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Debt - Senior Credit Facilities Narrative (Details)", "menuCat": "Details", "order": "53", "role": "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "shortName": "Debt - Senior Credit Facilities Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i32eea5b9fa87491daff99e19e69e9a9e_D20220331-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i412fb5cd295f4433a02716db686c807e_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LinesOfCreditCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Debt - Schedule of Revolving Credit Facility (Details)", "menuCat": "Details", "order": "54", "role": "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "shortName": "Debt - Schedule of Revolving Credit Facility (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i737cfb2fb21e44de96b595cb1fc32e31_I20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Debt - Senior Notes Narrative (Details)", "menuCat": "Details", "order": "55", "role": "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "shortName": "Debt - Senior Notes Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i4a8d10f01c904f0eb70eac2fdad9c57b_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "ce:PercentageOfFairValueOfSalesReceivables", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Debt - Accounts Receivable Securitization Facility Narrative (Details)", "menuCat": "Details", "order": "56", "role": "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "shortName": "Debt - Accounts Receivable Securitization Facility Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i4a8d10f01c904f0eb70eac2fdad9c57b_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "ce:PercentageOfFairValueOfSalesReceivables", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "id6e9d7082c12483bae313d89606727a1_I20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "ce:TransferOfFinancialAssetsAccountedForAsSalesNonRecourseBasisAccountReceivablePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Debt - Factoring and Discounting Agreements Narrative (Details)", "menuCat": "Details", "order": "57", "role": "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "shortName": "Debt - Factoring and Discounting Agreements Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "id6e9d7082c12483bae313d89606727a1_I20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "ce:TransferOfFinancialAssetsAccountedForAsSalesNonRecourseBasisAccountReceivablePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i347bd1a019004019941992cf23dfa635_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details)", "menuCat": "Details", "order": "58", "role": "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails", "shortName": "Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i347bd1a019004019941992cf23dfa635_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i347bd1a019004019941992cf23dfa635_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details)", "menuCat": "Details", "order": "59", "role": "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "shortName": "Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i347bd1a019004019941992cf23dfa635_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i899176047dd84614b29bb7b75f6fe357_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Unaudited Interim Consolidated Statement Equity", "menuCat": "Statements", "order": "6", "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "shortName": "Unaudited Interim Consolidated Statement Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i899176047dd84614b29bb7b75f6fe357_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "ic09cdb3f4048407f9c76fc1d49822c43_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details)", "menuCat": "Details", "order": "60", "role": "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "shortName": "Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "ic09cdb3f4048407f9c76fc1d49822c43_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EnvironmentalExitCostsByCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "ce:DemergerObligations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - Environmental (Schedule of Environmental Remediation Reserves) (Details)", "menuCat": "Details", "order": "61", "role": "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails", "shortName": "Environmental (Schedule of Environmental Remediation Reserves) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EnvironmentalExitCostsByCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "ce:DemergerObligations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i8a7bda39181045a19c1755ba0d51eac1_D20230324-20230324", "decimals": "INF", "first": true, "lang": "en-US", "name": "ce:NumberOfPartiesIncludedInUsepaOrder", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - Environmental - US Superfund Sites Narrative (Details)", "menuCat": "Details", "order": "62", "role": "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails", "shortName": "Environmental - US Superfund Sites Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i8a7bda39181045a19c1755ba0d51eac1_D20230324-20230324", "decimals": "INF", "first": true, "lang": "en-US", "name": "ce:NumberOfPartiesIncludedInUsepaOrder", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - Stockholders' Equity - Narrative (Details)", "menuCat": "Details", "order": "63", "role": "http://www.celanese.com/role/StockholdersEquityNarrativeDetails", "shortName": "Stockholders' Equity - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i3435d2e8dfae4f0295fc0e4f8c4c0750_D20230419-20230419", "decimals": "2", "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "us-gaap:TreasuryStockSharesAcquired", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockSharesAcquired", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - Stockholders' Equity - Schedule of Treasury Stock (Details)", "menuCat": "Details", "order": "64", "role": "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails", "shortName": "Stockholders' Equity - Schedule of Treasury Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i6fe3679eeb244482b0b153ca6ee666b9_D20080201-20230331", "decimals": "INF", "lang": "en-US", "name": "us-gaap:TreasuryStockSharesAcquired", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details)", "menuCat": "Details", "order": "65", "role": "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "shortName": "Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "id9548a799c35400eb5a92b186c275bac_I20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details)", "menuCat": "Details", "order": "66", "role": "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "shortName": "Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details)", "menuCat": "Details", "order": "67", "role": "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails", "shortName": "Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - Other (Charges) Gains, Net - Narrative (Details)", "menuCat": "Details", "order": "68", "role": "http://www.celanese.com/role/OtherChargesGainsNetNarrativeDetails", "shortName": "Other (Charges) Gains, Net - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details)", "menuCat": "Details", "order": "69", "role": "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "shortName": "Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "ie8f28483016647a3bc69818cc71f504c_I20221231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - Unaudited Interim Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "7", "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows", "shortName": "Unaudited Interim Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DepreciationAmortizationAndAccretionNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - Income Taxes - Schedule of Effective Tax Rate (Details)", "menuCat": "Details", "order": "70", "role": "http://www.celanese.com/role/IncomeTaxesScheduleofEffectiveTaxRateDetails", "shortName": "Income Taxes - Schedule of Effective Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "id39340e11fc84ad989941e471b8be6ed_D20230331-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NotionalAmountOfNonderivativeInstruments", "reportCount": 1, "unique": true, "unitRef": "eur", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details)", "menuCat": "Details", "order": "71", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "shortName": "Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "id39340e11fc84ad989941e471b8be6ed_D20230331-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NotionalAmountOfNonderivativeInstruments", "reportCount": 1, "unique": true, "unitRef": "eur", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i807a97e53dd5419daca3322e6ae5b906_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details)", "menuCat": "Details", "order": "72", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "shortName": "Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i807a97e53dd5419daca3322e6ae5b906_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i8edbde8db77348759c738c88c3bf5fb7_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details)", "menuCat": "Details", "order": "73", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "shortName": "Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i8edbde8db77348759c738c88c3bf5fb7_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Assets) (Details)", "menuCat": "Details", "order": "74", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails", "shortName": "Derivative Financial Instruments (Schedule of Offsetting Assets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000076 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details)", "menuCat": "Details", "order": "75", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails", "shortName": "Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000077 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "menuCat": "Details", "order": "76", "role": "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i8d13c56ce7f74acf8d3eac026a50861e_I20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000078 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details)", "menuCat": "Details", "order": "77", "role": "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "shortName": "Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000079 - Disclosure - Commitments and Contingencies - Narrative (Details)", "menuCat": "Details", "order": "78", "role": "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000080 - Disclosure - Segment Information - Schedule of Business Segments (Details)", "menuCat": "Details", "order": "79", "role": "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "shortName": "Segment Information - Schedule of Business Segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - Description of the Company and Basis of Presentation", "menuCat": "Notes", "order": "8", "role": "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation", "shortName": "Description of the Company and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000081 - Disclosure - Revenue Recognition - Disaggregation of net sales (Details)", "menuCat": "Details", "order": "80", "role": "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "shortName": "Revenue Recognition - Disaggregation of net sales (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i9ac0e11b26c2436181d54812abcbcec4_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000082 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details)", "menuCat": "Details", "order": "81", "role": "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails", "shortName": "Revenue Recognition Remaining Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i082af3b78117493c8376187592761b51_I20230331", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000083 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)", "menuCat": "Details", "order": "82", "role": "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "shortName": "Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": "INF", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "link:footnote", "span", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i34a3870c6bad4537810aab534087408b_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000084 - Disclosure - Earnings (Loss) Per Share - Narrative (Details)", "menuCat": "Details", "order": "83", "role": "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails", "shortName": "Earnings (Loss) Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Recent Accounting Pronouncements", "menuCat": "Notes", "order": "9", "role": "http://www.celanese.com/role/RecentAccountingPronouncements", "shortName": "Recent Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230331.htm", "contextRef": "i642518a1685d4c9594646d478719f0df_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 103, "tag": { "ce_A364DayDelayedDrawTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "364 Day Delayed-Draw Term Loan", "label": "364 Day Delayed-Draw Term Loan [Member]", "terseLabel": "364 Day Delayed-Draw Term Loan" } } }, "localname": "A364DayDelayedDrawTermLoanMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_A3YearDelayedDrawTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "3 Year Delayed-Draw Term Loan", "label": "3 Year Delayed-Draw Term Loan [Member]", "terseLabel": "3 Year Delayed-Draw Term Loan" } } }, "localname": "A3YearDelayedDrawTermLoanMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_A5YearDelayedDrawTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "5 Year Delayed-Draw Term Loan", "label": "5 Year Delayed-Draw Term Loan [Member]", "terseLabel": "5 Year Delayed-Draw Term Loan" } } }, "localname": "A5YearDelayedDrawTermLoanMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_AccountsReceivableSecuritizationFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts Receivable Securitization Facility [Abstract]", "label": "Accounts Receivable Securitization Facility [Abstract]", "terseLabel": "Accounts Receivable Securitization Facility [Abstract]" } } }, "localname": "AccountsReceivableSecuritizationFacilityAbstract", "nsuri": "http://www.celanese.com/20230331", "xbrltype": "stringItemType" }, "ce_AcetylChainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acetyl Chain [Member]", "label": "Acetyl Chain [Member]", "terseLabel": "Acetyl Chain [Member]", "verboseLabel": "Acetyl Chain" } } }, "localname": "AcetylChainMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "ce_AcquisitionNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition Notes", "label": "Acquisition Notes [Member]", "terseLabel": "Acquisition Notes" } } }, "localname": "AcquisitionNotesMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "ce_AcquisitionsDispositionsandPlantClosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisitions, Dispositions and Plant Closures [Abstract].", "label": "Acquisitions, Dispositions and Plant Closures [Abstract]", "terseLabel": "Acquisitions, Dispositions and Plant Closures [Abstract]" } } }, "localname": "AcquisitionsDispositionsandPlantClosuresAbstract", "nsuri": "http://www.celanese.com/20230331", "xbrltype": "stringItemType" }, "ce_AcquisitionsDispositionsandPlantClosuresTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisitions, Dispositions and Plant Closures [Text Block].", "label": "Acquisitions, Dispositions and Plant Closures [Text Block]", "terseLabel": "Acquisitions, Dispositions and Plant Closures" } } }, "localname": "AcquisitionsDispositionsandPlantClosuresTextBlock", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosures" ], "xbrltype": "textBlockItemType" }, "ce_ActiveSites": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 3.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Active sites.", "label": "Active sites", "terseLabel": "Active sites" } } }, "localname": "ActiveSites", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_AmendedRestatedReceivableSecuritizationFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An accounts receivable securitization facility which allows a wholly owned, bankruptcy-remote subsidiary to sell an undivided interest in a pool of trade receivables (received through contribution from certain subsidiaries that retain the responsibility of servicing the receivables) to financial institutions participating in the facility.", "label": "Amended Restated Receivable Securitization Facility [Member]", "terseLabel": "Amended restated receivable securitization facility" } } }, "localname": "AmendedRestatedReceivableSecuritizationFacilityMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxesNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Income (Loss) From Continuing Operations Before Income Taxes, Noncontrolling Interest", "terseLabel": "Proforma Earnings (loss) from continuing operations before tax" } } }, "localname": "BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxesNoncontrollingInterest", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresBusinessAcquisitionProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "ce_BusinessCombinationProFormaInformationInterestExpenseAndDebtIssuanceCostAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of pro forma interest expense and debt issuance cost amortization related to borrowings under the Term Loan Facility and the issuance of Acquisition notes as if the business combination had been completed at the beginning of a period.", "label": "Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization", "terseLabel": "Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization" } } }, "localname": "BusinessCombinationProFormaInformationInterestExpenseAndDebtIssuanceCostAmortization", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_BusinessCombinationProFormaInformationInventoryStepUpAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of pro forma inventory step-up amortization as if the business combination had been completed at the beginning of a period.", "label": "Business Combination, Pro Forma Information, Inventory Step Up Amortization", "terseLabel": "Business Combination, Pro Forma Information, Inventory Step Up Amortization" } } }, "localname": "BusinessCombinationProFormaInformationInventoryStepUpAmortization", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_CelaneseCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Celanese Corporation", "label": "Celanese Corporation [Member]", "terseLabel": "Celanese Corporation" } } }, "localname": "CelaneseCorporationMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_ChinaRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "China Revolving Credit Facility [Member]", "terseLabel": "China Revolving Credit Facility" } } }, "localname": "ChinaRevolvingCreditFacilityMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_ChinaWorkingCapitalTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CSIT senior unsecured working capital loan contract for CNY 800 million payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates.", "label": "China Working Capital Term Loan [Member]", "terseLabel": "China Working Capital Term Loan" } } }, "localname": "ChinaWorkingCapitalTermLoanMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_ConsolidatedVenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consolidated Ventures", "label": "Consolidated Ventures [Member]", "terseLabel": "Consolidated Ventures" } } }, "localname": "ConsolidatedVenturesMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_CurrentOtherLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current Other Liabilities [Line Items]", "label": "Current Other Liabilities [Line Items]", "terseLabel": "Current Other Liabilities [Line Items]" } } }, "localname": "CurrentOtherLiabilitiesLineItems", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ce_CurrentOtherLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current Other Liabilities [Table]", "label": "Current Other Liabilities [Table]", "terseLabel": "Current Other Liabilities [Table]" } } }, "localname": "CurrentOtherLiabilitiesTable", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ce_DemergerObligations": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 1.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Demerger obligations.", "label": "Demerger obligations", "verboseLabel": "Demerger obligations (Note\u00a014)" } } }, "localname": "DemergerObligations", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_DerivativeFinancialInstrumentsScheduleofIntersetRateSwapNarrativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract]", "label": "Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract]", "terseLabel": "Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract]" } } }, "localname": "DerivativeFinancialInstrumentsScheduleofIntersetRateSwapNarrativeAbstract", "nsuri": "http://www.celanese.com/20230331", "xbrltype": "stringItemType" }, "ce_DivestitureAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divestiture Agreements [Member].", "label": "Divestiture Agreements [Member]", "terseLabel": "Divestiture Agreements" } } }, "localname": "DivestitureAgreementsMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_DivestitureObligations": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 2.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Divestiture obligations.", "label": "Divestiture obligations", "terseLabel": "Divestiture obligations (Note\u00a014)" } } }, "localname": "DivestitureObligations", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_EURSeniorUnsecuredNotesDue2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes Due 2023 [Member]", "label": "EUR Senior Unsecured Notes Due 2023 [Member]", "terseLabel": "Senior Unsecured Notes Due 2023" } } }, "localname": "EURSeniorUnsecuredNotesDue2023Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes Due 2025 [Member]", "label": "EUR Senior Unsecured Notes Due 2025 [Member]", "terseLabel": "Senior Unsecured Notes Due 2025" } } }, "localname": "EURSeniorUnsecuredNotesDue2025Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EUR 1 Billion 4.777% Senior Unsecured Notes Due 2026", "label": "EUR Senior Unsecured Notes Due 2026 [Member]", "terseLabel": "EUR Senior Unsecured Notes Due 2026" } } }, "localname": "EURSeniorUnsecuredNotesDue2026Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EUR Senior Unsecured Notes Due 2027 [Member]", "label": "EUR Senior Unsecured Notes Due 2027 [Member]", "terseLabel": "Senior Unsecured Notes Due 2027" } } }, "localname": "EURSeniorUnsecuredNotesDue2027Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EUR Senior Unsecured Notes Due 2028", "label": "EUR Senior Unsecured Notes Due 2028 [Member]", "terseLabel": "Senior Unsecured Notes Due 2028" } } }, "localname": "EURSeniorUnsecuredNotesDue2028Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EUR 500 Million 5.337% Senior Unsecured Notes Due 2029 [Member]", "label": "EUR Senior Unsecured Notes Due 2029 [Member]", "terseLabel": "EUR Senior Unsecured Notes Due 2029" } } }, "localname": "EURSeniorUnsecuredNotesDue2029Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EngineeredMaterialsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Engineered Materials", "label": "Engineered Materials [Member]", "terseLabel": "Engineered Materials" } } }, "localname": "EngineeredMaterialsMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "ce_Environmental": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss exposure for environmental contingencies at an individual site for which no accrual has been recorded based upon EPA determination.", "label": "environmental", "terseLabel": "Cost of EPA's plan estimate" } } }, "localname": "Environmental", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_EnvironmentalLiabilityPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Estimated ultimate allocable share of cleanup costs.", "label": "Environmental Liability Percentage", "terseLabel": "Environmental liability percentage" } } }, "localname": "EnvironmentalLiabilityPercentage", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_EquityMethodInvestmentIncrease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase in an equity method investment, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Equity Method Investment, Increase", "terseLabel": "Equity method investment, increase" } } }, "localname": "EquityMethodInvestmentIncrease", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_EquityMethodInvestmentLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity Method Investment Liability, Current", "label": "Equity Method Investment Liability, Current", "terseLabel": "Investment in affiliates" } } }, "localname": "EquityMethodInvestmentLiabilityCurrent", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ce_EuropeAndSingaporeFactoringAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Europe and Singapore Factoring Agreements", "label": "Europe and Singapore Factoring Agreements [Member]", "terseLabel": "Europe and Singapore Factoring Agreement" } } }, "localname": "EuropeAndSingaporeFactoringAgreementsMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_EuropeFactoringAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Europe Factoring Agreements", "label": "Europe Factoring Agreements [Member]", "terseLabel": "Europe Factoring Agreements" } } }, "localname": "EuropeFactoringAgreementsMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Denominated Debt [Member]", "label": "Foreign Currency Denominated Debt [Member]", "terseLabel": "Foreign Currency Denominated Debt [Member]" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "domainItemType" }, "ce_GainLossOnNonDerivativeUsedInNetInvestmentHedge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment in other comprehensive income reflecting gains or losses on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect.", "label": "Gain (Loss) On Non-Derivative Used In Net Investment Hedge", "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "GainLossOnNonDerivativeUsedInNetInvestmentHedge", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "ce_GainLossOnNonDerivativesandDerivativesUsedInNetInvestmentHedge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment in other comprehensive income reflecting gains (losses) on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect.", "label": "Gain (Loss) On Non-Derivatives and Derivatives Used In Net Investment Hedge", "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "GainLossOnNonDerivativesandDerivativesUsedInNetInvestmentHedge", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "ce_IncreaseDecreaseOfAccruedCapitalExpenditures": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) of Accrued Capital Expenditures.", "label": "Increase (Decrease) of Accrued Capital Expenditures", "terseLabel": "Increase (decrease) in accrued capital expenditures" } } }, "localname": "IncreaseDecreaseOfAccruedCapitalExpenditures", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "ce_IndemnificationAgreementsHoechstMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indemnification Agreements Hoechst [Member].", "label": "Indemnification Agreements Hoechst [Member]", "terseLabel": "Indemnification Agreements Hoechst" } } }, "localname": "IndemnificationAgreementsHoechstMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_IndemnificationCeilingAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Ceiling amount above which the Company will indemnify Hoechst for.", "label": "Indemnification ceiling amount", "terseLabel": "Indemnification ceiling amount" } } }, "localname": "IndemnificationCeilingAmount", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_IndemnificationFloorAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount that the Company will indemnify Hoechst for in full.", "label": "Indemnification floor amount", "terseLabel": "Indemnification amount" } } }, "localname": "IndemnificationFloorAmount", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_IndemnificationPercentageExceedingCeilingAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of the amount above the ceiling that the Company will indemnify Hoechst for.", "label": "Indemnification percentage exceeding ceiling amount", "terseLabel": "Indemnification percentage exceeding ceiling amount" } } }, "localname": "IndemnificationPercentageExceedingCeilingAmount", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_IndemnificationPercentageOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of other liabilities the Company has agreed to indemnify Hoechst for as part of the Demerger Agreement.", "label": "Indemnification percentage, other", "terseLabel": "Indemnification percentage, other" } } }, "localname": "IndemnificationPercentageOther", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_KoreaEngineeringPlasticsCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Korea Engineering Plastics Co., Ltd. [Member].", "label": "Korea Engineering Plastics Co., Ltd. [Member]", "terseLabel": "Korea Engineering Plastics Co., Ltd." } } }, "localname": "KoreaEngineeringPlasticsCoLtdMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_MitsubishiGasChemicalCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mitsubishi Gas Chemical Company", "label": "Mitsubishi Gas Chemical Company [Member]", "terseLabel": "Mitsubishi Gas Chemical Company" } } }, "localname": "MitsubishiGasChemicalCompanyMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_MobilityMaterialsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mobility & Materials", "label": "Mobility & Materials [Member]", "terseLabel": "Mobility & Materials" } } }, "localname": "MobilityMaterialsMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ce_NoncontrollingInterestDecreaseFromDividendsToNoncontrollingInterestHolders": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Dividends to Noncontrolling Interest Holders", "negatedTerseLabel": "Dividends to noncontrolling interests" } } }, "localname": "NoncontrollingInterestDecreaseFromDividendsToNoncontrollingInterestHolders", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "ce_Nonoperatingpensionandotherpostretirementemployeebenefitexpenseincome": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non-operating pension and other postretirement employee benefit (expense) income", "label": "Non-operating pension and other postretirement employee benefit (expense) income", "terseLabel": "Non-operating pension and other postretirement employee benefit (expense) income" } } }, "localname": "Nonoperatingpensionandotherpostretirementemployeebenefitexpenseincome", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "ce_NotesOfferingRelatedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fees and expenses related to the notes offering, inclusive of underwriting discounts.", "label": "Notes Offering Related Costs", "terseLabel": "Notes offering related costs" } } }, "localname": "NotesOfferingRelatedCosts", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_NumberOfDivestitureAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of divestiture agreements.", "label": "Number of divestiture agreements", "terseLabel": "Number of divestiture agreements" } } }, "localname": "NumberOfDivestitureAgreements", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_NumberOfFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of facilities.", "label": "Number Of Facilities", "terseLabel": "Number of facilities" } } }, "localname": "NumberOfFacilities", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_NumberOfPartiesIncludedInUsepaOrder": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Parties included in USEPA order.", "label": "Number of Parties included in USEPA order", "terseLabel": "Number of parties included in USEPA order" } } }, "localname": "NumberOfPartiesIncludedInUsepaOrder", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_NumberOfPatents": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of patents.", "label": "Number Of Patents", "terseLabel": "Number of patents" } } }, "localname": "NumberOfPatents", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_NumberOfPaymentsToEquityMethodInvestments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Payments to Equity Method Investments", "label": "Number of Payments to Equity Method Investments", "terseLabel": "Number of equal annual investments restructuring payment" } } }, "localname": "NumberOfPaymentsToEquityMethodInvestments", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_OtherChargesGainsNetTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other (Charges) Gains, Net [Text Block].", "label": "Other (Charges) Gains, Net [Text Block]", "terseLabel": "Other (Charges) Gains, Net" } } }, "localname": "OtherChargesGainsNetTextBlock", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNet" ], "xbrltype": "textBlockItemType" }, "ce_OtherEnvironmentalRemediationReserves": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 5.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other environmental remediation reserves.", "label": "Other environmental remediation reserves", "terseLabel": "Other environmental remediation liabilities" } } }, "localname": "OtherEnvironmentalRemediationReserves", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_PassaicRiverNewJerseyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Passaic River, New Jersey [Member].", "label": "Passaic River, New Jersey [Member]", "terseLabel": "Passaic River, New Jersey" } } }, "localname": "PassaicRiverNewJerseyMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_PaymentsToEquityMethodInvestment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with payments to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Equity Method Investment", "terseLabel": "Payments to equity method investment" } } }, "localname": "PaymentsToEquityMethodInvestment", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_PercentageOfFairValueOfSalesReceivables": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of fair value of sales receivables.", "label": "Percentage of Fair Value of Sales Receivables", "terseLabel": "Percentage of fair value of sales receivables" } } }, "localname": "PercentageOfFairValueOfSalesReceivables", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_PlantClosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plant Closures [Abstract]", "label": "Plant Closures [Abstract]", "terseLabel": "Plant Closures [Abstract]" } } }, "localname": "PlantClosuresAbstract", "nsuri": "http://www.celanese.com/20230331", "xbrltype": "stringItemType" }, "ce_ProceedsCollectedOnAccountsReceivableSoldUnderFactoringFacilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds Collected on Accounts Receivable Sold under Factoring Facilities", "label": "Proceeds Collected on Accounts Receivable Sold under Factoring Facilities", "terseLabel": "Proceeds collected on accounts receivable sold under factoring facilities" } } }, "localname": "ProceedsCollectedOnAccountsReceivableSoldUnderFactoringFacilities", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_RecentAccountingPronouncementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recent Accounting Pronouncements [Abstract]", "label": "Recent Accounting Pronouncements [Abstract]", "terseLabel": "Recent Accounting Pronouncements [Abstract]" } } }, "localname": "RecentAccountingPronouncementsAbstract", "nsuri": "http://www.celanese.com/20230331", "xbrltype": "stringItemType" }, "ce_RefundingloanforpollutioncontrolandindustrialrevenuebondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refunding loan for pollution control and industrial revenue bonds [Member]", "label": "Refunding loan for pollution control and industrial revenue bonds [Member]", "terseLabel": "Refunding loan for pollution control and industrial revenue bonds" } } }, "localname": "RefundingloanforpollutioncontrolandindustrialrevenuebondsMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block].", "label": "Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block]", "terseLabel": "Schedule of Company Commitments to Fund Benefit Obligations" } } }, "localname": "ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/BenefitObligationsTables" ], "xbrltype": "textBlockItemType" }, "ce_ScheduleOfOtherChargesGainsNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Other (Charges) Gains, Net [Table Text Block].", "label": "Schedule of Other (Charges) Gains, Net [Table Text Block]", "terseLabel": "Schedule of Other (Charges) Gains, Net" } } }, "localname": "ScheduleOfOtherChargesGainsNetTableTextBlock", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetTables" ], "xbrltype": "textBlockItemType" }, "ce_SeniorUnsecuredNotesDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD Senior Unsecured Notes Due May 8, 2024", "label": "Senior Unsecured Notes Due 2024 [Member]", "terseLabel": "Senior Unsecured Notes Due 2024" } } }, "localname": "SeniorUnsecuredNotesDue2024Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_SeniorUnsecuredTermLoanDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior unsecured term loan due 2025", "label": "Senior Unsecured Term Loan Due 2025 [Member]", "terseLabel": "Senior Unsecured Term Loan Due 2025" } } }, "localname": "SeniorUnsecuredTermLoanDue2025Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_SeniorUnsecuredTermLoanDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Term Loan Due 2027", "label": "Senior Unsecured Term Loan Due 2027 [Member]", "terseLabel": "Senior Unsecured Term Loan Due 2027" } } }, "localname": "SeniorUnsecuredTermLoanDue2027Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_SingaporeFactoringAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Singapore Factoring Agreements", "label": "Singapore Factoring Agreements [Member]", "terseLabel": "Singapore Factoring Agreements" } } }, "localname": "SingaporeFactoringAgreementsMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_StockRepurchaseProgramAuthorizedAmountInPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized in the period.", "label": "StockRepurchaseProgramAuthorizedAmountInPeriod", "terseLabel": "Aggregate Board of Directors repurchase authorizations during the period (in $ millions)" } } }, "localname": "StockRepurchaseProgramAuthorizedAmountInPeriod", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails" ], "xbrltype": "monetaryItemType" }, "ce_TermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan Facility", "label": "Term Loan Facility [Member]", "terseLabel": "Term Loan Facility" } } }, "localname": "TermLoanFacilityMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_TradeReceivablesPledgedAsCollateral": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of trade receivables pledged as collateral.", "label": "Trade Receivables Pledged As Collateral", "terseLabel": "Cash flows between transferor and transferee, proceeds from new transfers" } } }, "localname": "TradeReceivablesPledgedAsCollateral", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_TransferOfFinancialAssetsAccountedForAsSalesNonRecourseBasisAccountReceivablePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfer Of Financial Assets Accounted For As Sales, Non-recourse Basis, Account Receivable Percentage", "label": "Transfer Of Financial Assets Accounted For As Sales, Non-recourse Basis, Account Receivable Percentage", "terseLabel": "Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage" } } }, "localname": "TransferOfFinancialAssetsAccountedForAsSalesNonRecourseBasisAccountReceivablePercentage", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_USDSeniorUnsecuredNotesDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 2 Billion 5.900% Senior Unsecured Notes Due 2024", "label": "USD Senior Unsecured Notes Due 2024 [Member]", "terseLabel": "Acquisition Notes Due July 2024" } } }, "localname": "USDSeniorUnsecuredNotesDue2024Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 1.75 Billion 6.050% Senior Unsecured Notes Due 2025", "label": "USD Senior Unsecured Notes Due 2025 [Member]", "terseLabel": "Acquisition Notes Due March 2025" } } }, "localname": "USDSeniorUnsecuredNotesDue2025Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD Senior Unsecured Notes Due 2026 [Member]", "label": "USD Senior Unsecured Notes Due 2026 [Member]", "terseLabel": "Senior Unsecured Notes Due 2026" } } }, "localname": "USDSeniorUnsecuredNotesDue2026Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 2 Billion 6.165% Senior Unsecured Notes Due 2027", "label": "USD Senior Unsecured Notes Due 2027 [Member]", "terseLabel": "USD Senior Unsecured Notes Due 2027" } } }, "localname": "USDSeniorUnsecuredNotesDue2027Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 750 Million 6.330% Senior Unsecured Notes Due 2029", "label": "USD Senior Unsecured Notes Due 2029 [Member]", "terseLabel": "Acquisition Notes Due July 2029" } } }, "localname": "USDSeniorUnsecuredNotesDue2029Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2032Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 1 Billion 6.379% Senior Unsecured Notes Due 2032", "label": "USD Senior Unsecured Notes Due 2032 [Member]", "terseLabel": "USD Senior Unsecured Notes Due 2032" } } }, "localname": "USDSeniorUnsecuredNotesDue2032Member", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "ce_UsSuperfundSites": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 4.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "US Superfund sites.", "label": "US Superfund sites", "terseLabel": "U.S. Superfund sites" } } }, "localname": "UsSuperfundSites", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_VariableInterbankInterestRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Certain interbank rates at current Company credit ratings", "label": "Variable Interbank Interest Rate [Member]", "terseLabel": "Variable Interbank Interest Rate" } } }, "localname": "VariableInterbankInterestRateMember", "nsuri": "http://www.celanese.com/20230331", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r772" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r773" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityNumberOfEmployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of persons employed by the Entity", "label": "Entity Number of Employees", "terseLabel": "Entity number of employees" } } }, "localname": "EntityNumberOfEmployees", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "decimalItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Small Reporting Company" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia-Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r304", "r352", "r364", "r365", "r366", "r367", "r368", "r370", "r374", "r431", "r432", "r433", "r434", "r436", "r437", "r439", "r441", "r442", "r840", "r841" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r304", "r352", "r364", "r365", "r366", "r367", "r368", "r370", "r374", "r431", "r432", "r433", "r434", "r436", "r437", "r439", "r441", "r442", "r840", "r841" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r426", "r427", "r429", "r430", "r575", "r685", "r707", "r727", "r728", "r747", "r759", "r767", "r842", "r858", "r859", "r860", "r861", "r862", "r863" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r426", "r427", "r429", "r430", "r575", "r685", "r707", "r727", "r728", "r747", "r759", "r767", "r842", "r858", "r859", "r860", "r861", "r862", "r863" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r426", "r427", "r429", "r430", "r527", "r575", "r580", "r581", "r582", "r681", "r685", "r707", "r727", "r728", "r747", "r759", "r767", "r829", "r842", "r859", "r860", "r861", "r862", "r863" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r426", "r427", "r429", "r430", "r527", "r575", "r580", "r581", "r582", "r681", "r685", "r707", "r727", "r728", "r747", "r759", "r767", "r829", "r842", "r859", "r860", "r861", "r862", "r863" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r377", "r378", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r748", "r766", "r844" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "srt_SouthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South America [Member]", "terseLabel": "South America" } } }, "localname": "SouthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r377", "r378", "r716", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r748", "r766", "r844" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Current Other Liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r25", "r765" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Trade payables\u00a0- third party and affiliates" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r382", "r383" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "verboseLabel": "Trade receivables\u00a0- third party and affiliates" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForEnvironmentalLossContingencies": { "auth_ref": [ "r428", "r740", "r778", "r780", "r830", "r834" ], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.", "label": "Accrual for Environmental Loss Contingencies", "totalLabel": "Total" } } }, "localname": "AccrualForEnvironmentalLossContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r11", "r221", "r239" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Customer rebates" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r48", "r54", "r173", "r791", "r792", "r793" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Pension and Postretirement Benefits" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r115", "r261" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Accumulated depreciation, depletion and amortization, property, plant, and equipment" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r282", "r289", "r290", "r621", "r735", "r791" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), net [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r51", "r53", "r54", "r271", "r700", "r712", "r715" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "As of March 31, 2023", "periodStartLabel": "As of December 31, 2022", "terseLabel": "Accumulated other comprehensive income (loss), net" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r288", "r289", "r658", "r659", "r660", "r661", "r662", "r665" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r50", "r54", "r173", "r675", "r708", "r709", "r791", "r792", "r793", "r808", "r809", "r810" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r47", "r54", "r173", "r289", "r290", "r659", "r660", "r661", "r662", "r665", "r791" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Gain (Loss)" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r16", "r765" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r583", "r584", "r585", "r808", "r809", "r810", "r852" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r153", "r154", "r578" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation, net of tax" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r81", "r103", "r109" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "negatedLabel": "Amortization of intangible assets", "negatedTerseLabel": "Amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmountOfIneffectivenessOnNetInvestmentHedges": { "auth_ref": [ "r198" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) on hedging derivative instrument or the foreign currency transaction gain (loss) on the nonderivative hedging instrument designated as a hedge of a net investment in foreign operations related to hedge ineffectiveness, which is included in earnings in the period.", "label": "Amount of Ineffectiveness on Net Investment Hedges", "terseLabel": "Gain (Loss) Recognized in Earnings (Loss)" } } }, "localname": "AmountOfIneffectivenessOnNetInvestmentHedges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r219", "r238", "r265", "r301", "r360", "r366", "r372", "r388", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r617", "r622", "r648", "r765", "r840", "r841", "r856" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r259", "r274", "r301", "r388", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r617", "r622", "r648", "r765", "r840", "r841", "r856" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r207" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r192", "r196" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r614", "r753", "r756" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r160", "r161", "r614", "r753", "r756" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r847", "r848" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Business Acquisition, Pro Forma Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r612", "r613" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Proforma Net sales" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresBusinessAcquisitionProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r8", "r85", "r90" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Description of the Company and Basis of Presentation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r77", "r83", "r84" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents as of end of period", "periodStartLabel": "Cash and cash equivalents as of beginning of period", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r77", "r210" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Derivatives Designated as Cash Flow Hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "auth_ref": [ "r6", "r77" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "terseLabel": "Operating cash provided by (used in) discontinued operations" } } }, "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashSurrenderValueFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Cash Surrender Value, Fair Value Disclosure", "terseLabel": "Insurance contracts in nonqualified trusts, fair value" } } }, "localname": "CashSurrenderValueFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashSurrenderValueOfLifeInsurance": { "auth_ref": [ "r786" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.", "label": "Cash Surrender Value of Life Insurance", "terseLabel": "Insurance contracts in nonqualified trusts, carrying amount" } } }, "localname": "CashSurrenderValueOfLifeInsurance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r268", "r269", "r270", "r301", "r327", "r331", "r333", "r335", "r342", "r343", "r388", "r431", "r434", "r435", "r436", "r442", "r443", "r472", "r473", "r476", "r480", "r487", "r648", "r729", "r774", "r803", "r811" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r34", "r226", "r246" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r119", "r422", "r424", "r717", "r839" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommodityContractMember": { "auth_ref": [ "r749", "r764" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.", "label": "Commodity Contract [Member]", "terseLabel": "Commodity swaps" } } }, "localname": "CommodityContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Common stock, dividends, declared (in dollar per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r808", "r809", "r852" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r129" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15", "r765" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001\u00a0par value, 400,000,000\u00a0shares authorized (2023: 170,448,231 issued and 108,786,738 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r55", "r285", "r287", "r295", "r696", "r704" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income (loss) attributable to Celanese Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r170", "r171", "r181", "r285", "r287", "r294", "r695", "r703" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Comprehensive (income) loss attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r169", "r181", "r285", "r287", "r293", "r694", "r702" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total comprehensive income (loss), net of tax" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateAndOtherMember": { "auth_ref": [ "r813" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.", "label": "Corporate and Other [Member]", "terseLabel": "Other Activities" } } }, "localname": "CorporateAndOtherMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r94", "r365", "r366", "r367", "r368", "r374", "r814" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate, Non-Segment" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r64", "r686" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Currency Swap" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer- Related Intangible Assets" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r266" ], "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of debt and lease obligation, classified as current.", "label": "Debt, Current", "totalLabel": "Total", "verboseLabel": "Short-term borrowings and current installments of long-term debt -\u00a0third party and affiliates" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt, Current [Abstract]", "terseLabel": "Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates" } } }, "localname": "DebtCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r125", "r299", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r460", "r467", "r468", "r470" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r10", "r11", "r12", "r220", "r223", "r236", "r304", "r444", "r445", "r446", "r447", "r448", "r450", "r456", "r457", "r458", "r459", "r461", "r462", "r463", "r464", "r465", "r466", "r668", "r742", "r743", "r744", "r745", "r746", "r804" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument, basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r212", "r214", "r444", "r668", "r743", "r744" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r31", "r445" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r32", "r304", "r444", "r445", "r446", "r447", "r448", "r450", "r456", "r457", "r458", "r459", "r461", "r462", "r463", "r464", "r465", "r466", "r668", "r742", "r743", "r744", "r745", "r746", "r804" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Debt instrument, redemption price, percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r32", "r130", "r133", "r134", "r135", "r211", "r212", "r214", "r235", "r304", "r444", "r445", "r446", "r447", "r448", "r450", "r456", "r457", "r458", "r459", "r461", "r462", "r463", "r464", "r465", "r466", "r469", "r668", "r742", "r743", "r744", "r745", "r746", "r804" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r213", "r843" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Unamortized debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r586", "r587" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r81", "r157", "r593", "r601", "r602", "r806" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income taxes, net" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r586", "r587" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": { "auth_ref": [ "r218", "r237", "r503", "r504", "r526", "r751" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.", "label": "Assets for Plan Benefits, Defined Benefit Plan", "terseLabel": "Noncurrent Other assets" } } }, "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r520", "r530", "r568", "r749", "r750", "r751", "r752" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Total contributions year-to-date" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear": { "auth_ref": [ "r752", "r846" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year", "terseLabel": "Total expected contributions in current fiscal year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r505", "r542", "r563", "r751", "r752" ], "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r503", "r526", "r751" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "terseLabel": "Net amount recognized" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r505", "r509", "r541", "r562", "r751", "r752" ], "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r539", "r560", "r751", "r752" ], "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Total" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r507", "r540", "r561", "r751", "r752" ], "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAmortizationAndAccretionNet": { "auth_ref": [ "r81" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Depreciation, Amortization and Accretion, Net", "terseLabel": "Depreciation, amortization and accretion" } } }, "localname": "DepreciationAmortizationAndAccretionNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r81", "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetCollateralObligationToReturnCashOffset": { "auth_ref": [ "r38", "r183" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to return cash collateral under master netting arrangements offset against derivative assets.", "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash, Offset Against Derivative Asset", "terseLabel": "Gross amount not offset in the consolidated balance sheets" } } }, "localname": "DerivativeAssetCollateralObligationToReturnCashOffset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as current.", "label": "Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "auth_ref": [ "r38", "r43", "r194" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset", "terseLabel": "Gross amount offset in the consolidated balance sheets" } } }, "localname": "DerivativeAssetFairValueGrossLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as noncurrent.", "label": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative asset.", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r276", "r278", "r647", "r734" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative Asset", "totalLabel": "Net amount" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Asset [Abstract]", "terseLabel": "Derivative Assets [Abstract]" } } }, "localname": "DerivativeAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r42", "r194", "r216", "r275", "r734" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Gross amount recognized" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r39", "r41", "r44", "r202" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral", "totalLabel": "Net amount presented in the consolidated balance sheets" } } }, "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r42", "r194", "r216", "r275", "r734" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Gross amount recognized" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r39", "r41", "r44", "r202" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral", "totalLabel": "Net amount presented in the consolidated balance sheets" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r851" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Gain (Loss) Recognized in Earnings (Loss)" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "auth_ref": [ "r851" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.", "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r193", "r195", "r199", "r200", "r734" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]", "verboseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r206", "r630" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r190", "r193", "r199" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r276", "r278", "r647", "r734" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedTerseLabel": "Commodity swaps", "totalLabel": "Net amount" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability [Abstract]", "terseLabel": "Derivative Liabilities [Abstract]" } } }, "localname": "DerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r276" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivatives (Note 12)" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset": { "auth_ref": [ "r38", "r183" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right to receive cash collateral under master netting arrangements offset against derivative liabilities.", "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Offset", "terseLabel": "Gross amount not offset in the consolidated balance sheets" } } }, "localname": "DerivativeLiabilityCollateralRightToReclaimCashOffset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as current.", "label": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative liability, statement of financial position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "auth_ref": [ "r38", "r43", "r194", "r733" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset", "terseLabel": "Gross amount offset in the consolidated balance sheets" } } }, "localname": "DerivativeLiabilityFairValueGrossAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability.", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative liability, statement of financial position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r849", "r850" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r184", "r186", "r187", "r190", "r191", "r197", "r199", "r201", "r203", "r205", "r630" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed Technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r844" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Revenue by Major Customers by Reporting Segments" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": { "auth_ref": [ "r0", "r1", "r5" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax", "terseLabel": "Earnings (loss) from operation of discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "auth_ref": [ "r1", "r2", "r3", "r4", "r5", "r7", "r588", "r600", "r606" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "negatedLabel": "Income tax (provision) benefit from discontinued operations" } } }, "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r136", "r233" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedLabel": "Common stock dividends" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "terseLabel": "Dividends, common stock, cash" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "Europe and Africa" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r296", "r314", "r315", "r316", "r317", "r318", "r325", "r327", "r333", "r334", "r335", "r339", "r634", "r635", "r697", "r705", "r736" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "totalLabel": "Net earnings (loss)\u00a0- basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings (loss) per common share\u00a0- basic" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r296", "r314", "r315", "r316", "r317", "r318", "r327", "r333", "r334", "r335", "r339", "r634", "r635", "r697", "r705", "r736" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "totalLabel": "Net earnings (loss)\u00a0- diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Earnings (loss) per common share\u00a0- diluted" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r336", "r337", "r338", "r340" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r657" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Exchange rate effects on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r589" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/IncomeTaxesScheduleofEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Salaries and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Severance" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Share-Based Payment Arrangement, Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideRevenueMajorCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Major Customer [Line Items]", "terseLabel": "Revenue, Major Customer [Line Items]" } } }, "localname": "EntityWideRevenueMajorCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EnvironmentalExitCostsByCostTextBlock": { "auth_ref": [ "r838" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of material liabilities for remediation, site restoration, postclosure, monitoring commitments, or other exit costs that may occur on the sale, disposal or abandonment of a property as a result of unanticipated contamination of the assets.", "label": "Environmental Exit Costs by Cost [Table Text Block]", "terseLabel": "Schedule of Environmental Remediation Reserves" } } }, "localname": "EnvironmentalExitCostsByCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EnvironmentalTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EnvironmentalLossContingencyDisclosureTextBlock": { "auth_ref": [ "r412", "r739", "r740", "r741", "r775", "r776", "r777", "r779", "r780", "r781", "r782", "r783", "r784", "r785" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for environmental loss contingencies, such as presence of hazardous waste, relevant information from reports issued by regulators, and estimated costs to achieve compliance with regulatory requirements. This element may be used for all of an entity's disclosures about environmental loss contingencies.", "label": "Environmental Loss Contingency Disclosure [Text Block]", "terseLabel": "Environmental" } } }, "localname": "EnvironmentalLossContingencyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/Environmental" ], "xbrltype": "textBlockItemType" }, "us-gaap_EnvironmentalRemediationObligationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Environmental Remediation Obligations [Abstract]", "terseLabel": "Environmental Remediation Obligations [Abstract]" } } }, "localname": "EnvironmentalRemediationObligationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EnvironmentalRemediationSiteAxis": { "auth_ref": [ "r739", "r740", "r778", "r779", "r780", "r837", "r838" ], "lang": { "en-us": { "role": { "documentation": "Information by location or named area designated for environmental remediation.", "label": "Environmental Remediation Site [Axis]", "terseLabel": "Environmental Remediation Site [Axis]" } } }, "localname": "EnvironmentalRemediationSiteAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EnvironmentalRemediationSiteDomain": { "auth_ref": [ "r739", "r740", "r778", "r779", "r780", "r837", "r838" ], "lang": { "en-us": { "role": { "documentation": "Location or named area designated for environmental remediation.", "label": "Environmental Remediation Site [Domain]", "terseLabel": "Environmental Remediation Site [Domain]" } } }, "localname": "EnvironmentalRemediationSiteDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r129", "r254", "r288", "r289", "r290", "r305", "r306", "r307", "r311", "r319", "r321", "r341", "r389", "r488", "r583", "r584", "r585", "r594", "r595", "r633", "r658", "r659", "r660", "r661", "r662", "r665", "r675", "r708", "r709", "r710" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": { "auth_ref": [ "r646" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.", "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value", "terseLabel": "Equity investments without readily determinable fair values, fair value" } } }, "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r386" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "terseLabel": "Equity investments without readily determinable fair values, carrying amount" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r639", "r640", "r644" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r207", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r207", "r208" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Schedule of Carrying Values and Fair Values of Financial Instruments" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r458", "r530", "r531", "r532", "r533", "r534", "r535", "r640", "r678", "r679", "r680", "r743", "r744", "r749", "r750", "r751" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r639", "r640", "r641", "r642", "r645" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r643" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r458", "r530", "r535", "r640", "r678", "r749", "r750", "r751" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r458", "r530", "r535", "r640", "r679", "r743", "r744", "r749", "r750", "r751" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant Other Observable Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r458", "r530", "r531", "r532", "r533", "r534", "r535", "r640", "r680", "r743", "r744", "r749", "r750", "r751" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r458", "r530", "r531", "r532", "r533", "r534", "r535", "r678", "r679", "r680", "r743", "r744", "r749", "r750", "r751" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r643", "r645" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r672", "r673" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Total debt" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r263", "r408" ], "calculation": { "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedPeriodEndLabel": "As of March 31, 2023", "negatedPeriodStartLabel": "As of December 31, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r110" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r110" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2028" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r110" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r110" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r110" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r405", "r407", "r408", "r410", "r687", "r691" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend": { "auth_ref": [ "r112" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of capitalized costs incurred in the period to renew or extend the term of a recognized finite-lived (amortizing and amortizable) intangible asset.", "label": "Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend", "terseLabel": "Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend" } } }, "localname": "FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Exchange rate changes" } } }, "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r108", "r691" ], "calculation": { "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "periodEndLabel": "As of March 31, 2023", "periodStartLabel": "As of December 31, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r104", "r107" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r108", "r687" ], "calculation": { "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net book value" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for foreign currency translation adjustments and purchase accounting adjustments.", "label": "Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments", "negatedTerseLabel": "Exchange rate changes" } } }, "localname": "FiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.", "label": "Foreign Currency Contract, Asset, Fair Value Disclosure", "terseLabel": "Foreign currency forwards and swaps" } } }, "localname": "ForeignCurrencyContractAssetFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.", "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure", "negatedLabel": "Foreign currency forwards and swaps" } } }, "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r652", "r653", "r654", "r656" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Foreign exchange gain (loss), net" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r734", "r749", "r763" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Exchange Contract [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r801", "r827", "r828" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "terseLabel": "Gain (loss) on disposition of businesses and assets, net" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r81" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "(Gain) loss on disposition of businesses and assets, net" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r262", "r393", "r692", "r738", "r765", "r816", "r823" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "As of March\u00a031, 2023(1)", "periodStartLabel": "As of December 31, 2022", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets, Net" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsnet" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [ "r394", "r401", "r738" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "negatedTerseLabel": "Goodwill, impaired, accumulated impairment loss" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r158", "r822" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Acquisitions (Note 3)" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": { "auth_ref": [ "r158", "r824" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Translation and Purchase Accounting Adjustments", "terseLabel": "Exchange rate changes" } } }, "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r62", "r301", "r360", "r365", "r371", "r374", "r388", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r648", "r737", "r840" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteeObligationsMaximumExposure": { "auth_ref": [ "r122" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.", "label": "Guarantor Obligations, Maximum Exposure, Undiscounted", "terseLabel": "Guarantor obligations, maximum exposure" } } }, "localname": "GuaranteeObligationsMaximumExposure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r190", "r628" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]", "terseLabel": "Amounts attributable to Celanese Corporation" } } }, "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r63", "r82", "r168", "r314", "r315", "r316", "r317", "r332", "r335" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Earnings (loss) from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r58", "r217", "r229", "r252", "r360", "r365", "r371", "r374", "r698", "r737" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings (loss) from continuing operations before tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r169", "r301", "r310", "r360", "r365", "r371", "r374", "r388", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r635", "r648", "r737", "r840" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Earnings (loss) from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r57", "r227", "r230", "r248", "r296", "r310", "r314", "r315", "r316", "r317", "r327", "r333", "r334", "r635", "r697" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Continuing operations - basic (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r57", "r248", "r251", "r296", "r310", "r314", "r315", "r316", "r317", "r327", "r333", "r334", "r335", "r635", "r697", "r705" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Continuing operations - diluted (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r7", "r249", "r258", "r608" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Earnings (loss) from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r5", "r7", "r169" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "terseLabel": "Earnings (loss) from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "auth_ref": [ "r60", "r249", "r251", "r296", "r331", "r333", "r334", "r865", "r866" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share", "terseLabel": "Discontinued operations - basic (in dollars per share)" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "auth_ref": [ "r182", "r331", "r333", "r334" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share", "terseLabel": "Discontinued operations - diluted (in dollars per share)" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r59", "r81", "r97", "r228", "r247", "r357" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Equity in net earnings (loss) of affiliates" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r81" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions", "negatedTerseLabel": "Undistributed earnings in unconsolidated affiliates" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r302", "r590", "r591", "r592", "r599", "r603", "r609", "r610", "r611" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r303", "r320", "r321", "r358", "r588", "r600", "r605", "r706" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax (provision) benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r80" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Trade payables\u00a0- third party and affiliates" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r80" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r80" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r80" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r80" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Receivables", "negatedLabel": "Trade receivables\u00a0- third party and affiliates, net" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r328", "r329", "r330", "r335", "r579" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Incremental shares attributable to equity awards(1)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r406", "r409" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-Lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "periodEndLabel": "As of March 31, 2023", "periodStartLabel": "As of December 31, 2022" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Exchange rate changes" } } }, "localname": "IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r105", "r111" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r102", "r106" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets, Net (Including Goodwill)", "terseLabel": "Goodwill and intangible assets, net" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r213", "r232", "r291", "r354", "r667" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Interest (Note 7)" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r762" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap [Member]" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r352", "r364", "r365", "r366", "r367", "r368", "r370", "r374" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Intersegment Eliminations", "verboseLabel": "Eliminations" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r100", "r731" ], "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r272", "r730", "r765" ], "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r100", "r790" ], "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "terseLabel": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r100", "r732" ], "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeDividend": { "auth_ref": [ "r66" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend income on nonoperating securities.", "label": "Investment Income, Dividend", "terseLabel": "Dividend income - equity investments" } } }, "localname": "InvestmentIncomeDividend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r67", "r353" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r787" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Investments in affiliates" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r20", "r225", "r244", "r765", "r805", "r815", "r853" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r30", "r260", "r301", "r388", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r618", "r622", "r623", "r648", "r765", "r840", "r856", "r857" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r207" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure", "negatedLabel": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r33" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "terseLabel": "Uncertain tax positions" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]", "terseLabel": "Licenses" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r27" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing base" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r27" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Available for borrowing" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r27", "r804" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r10", "r220" ], "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_DebtCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line of Credit, Current", "terseLabel": "Revolving credit facilities(2)" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Borrowing supported by a written promise to pay an obligation.", "label": "Loans Payable [Member]", "terseLabel": "Loans Payable" } } }, "localname": "LoansPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r12", "r223", "r241", "r457", "r471", "r743", "r744" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "terseLabel": "Long-term debt, including current installments of long-term debt, carrying amount" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r12" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-Term Debt and Lease Obligation", "terseLabel": "Total" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_DebtCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as current.", "label": "Long-Term Debt and Lease Obligation, Current", "negatedTerseLabel": "Long-Term Debt and Lease Obligation, Current", "terseLabel": "Current installments of long-term debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.", "label": "Long-Term Debt and Lease Obligation, Including Current Maturities", "terseLabel": "Subtotal" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-Term Debt, Fair Value", "verboseLabel": "Long-term debt, including current installments of long-term debt, fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r267" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, net of unamortized deferred financing costs" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r32", "r124" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Long-term debt, weighted average interest rate, at point in time" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r120", "r121", "r425", "r426", "r427", "r835", "r836" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingencies by Nature of Contingency [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r120", "r121", "r425", "r426", "r427", "r835", "r836" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r425" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 10.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Legal (Note 14)" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualPayments": { "auth_ref": [ "r834" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow reducing loss contingency liability.", "label": "Loss Contingency Accrual, Payments", "terseLabel": "Loss contingency accrual, carrying value, payments" } } }, "localname": "LossContingencyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r120", "r121", "r425", "r426", "r427", "r835", "r836" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r37", "r224", "r243", "r301", "r388", "r431", "r434", "r435", "r436", "r442", "r443", "r648" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "periodEndLabel": "Balance as of the end of the period, noncontrolling interest", "periodStartLabel": "Balance as of the beginning of the period, noncontrolling interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedTerseLabel": "Distributions to noncontrolling interests" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Noncontrolling interest, ownership percentage by parent" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r298" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r298" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r77", "r79", "r82" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r61", "r82", "r231", "r250", "r258", "r283", "r286", "r290", "r301", "r310", "r314", "r315", "r316", "r317", "r320", "r321", "r332", "r360", "r365", "r371", "r374", "r388", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r635", "r648", "r737", "r840" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net earnings (loss) attributable to Celanese Corporation", "totalLabel": "Net earnings (loss)", "verboseLabel": "Net earnings (loss) attributable to Celanese Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r172", "r180", "r283", "r286", "r320", "r321", "r793" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net (earnings) loss attributable to noncontrolling interests", "terseLabel": "Net earnings (loss) attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedging [Member]" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r256", "r308", "r309", "r312", "r313", "r322", "r323", "r324", "r384", "r385", "r390", "r391", "r596", "r597", "r598", "r632", "r636", "r637", "r638", "r649", "r650", "r651", "r669", "r670", "r674", "r676", "r688", "r689", "r690", "r711", "r712", "r713", "r714", "r715" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Pronouncements, Policy" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r166", "r488", "r808", "r809", "r810" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NontradeReceivablesCurrent": { "auth_ref": [ "r789" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Nontrade Receivables, Current", "terseLabel": "Non-trade receivables, net" } } }, "localname": "NontradeReceivablesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotionalAmountOfNonderivativeInstruments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on a nonderivative instrument.", "label": "Notional Amount of Nonderivative Instruments", "terseLabel": "Notional Amount of Nonderivative Instruments" } } }, "localname": "NotionalAmountOfNonderivativeInstruments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsTableTextBlock": { "auth_ref": [ "r40", "r277" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Assets [Table Text Block]", "terseLabel": "Offsetting Assets" } } }, "localname": "OffsettingAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "auth_ref": [ "r40", "r277" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Liabilities [Table Text Block]", "terseLabel": "Offsetting Liabilities" } } }, "localname": "OffsettingLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r360", "r365", "r371", "r374", "r737" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating profit (loss)", "totalLabel": "Operating profit (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r672" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r672" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r671" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating Lease, Right-of-Use Asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r364", "r365", "r366", "r367", "r368", "r374" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r273", "r765" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r264" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r54", "r289", "r658", "r660", "r665", "r791" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Other comprehensive income (loss) before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r98", "r292", "r658", "r663", "r665", "r693", "r701", "r791", "r792" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Tax", "totalLabel": "Total other comprehensive income (loss), before tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r279", "r280" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Gain (loss) on cash flow hedges", "verboseLabel": "Gain (loss) on cash flow hedges, net amount" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": { "auth_ref": [ "r279", "r280" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax", "terseLabel": "Gain (loss) on cash flow hedges, gross amount" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": { "auth_ref": [ "r281" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax", "negatedTerseLabel": "Gain (loss) on cash flow hedges, income tax (provision) benefit" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r279", "r280", "r625", "r626", "r629" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "auth_ref": [ "r46", "r51" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax", "terseLabel": "Foreign currency translation gain (loss), gross amount" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r46" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation gain (loss)" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r46", "r52", "r655", "r664" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "negatedTerseLabel": "Foreign currency translation gain (loss), income tax (provision) benefit" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r627" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r56", "r129", "r284", "r287", "r292", "r658", "r663", "r665", "r693", "r701", "r791", "r792" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Total other comprehensive income (loss), net of tax", "totalLabel": "Total other comprehensive income (loss), net of tax", "verboseLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": { "auth_ref": [ "r49", "r51", "r751", "r845" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax", "negatedTerseLabel": "Pension and postretirement benefits gain (loss), gross amount" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r49", "r51" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Pension and postretirement benefits" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": { "auth_ref": [ "r49", "r52", "r169" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax", "terseLabel": "Pension and postretirement benefits gain (loss), income tax (provision) benefit" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r52", "r288", "r292", "r588", "r604", "r607", "r658", "r661", "r665", "r693", "r701" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "negatedTerseLabel": "Income tax (provision) benefit", "totalLabel": "Total other comprehensive income (loss), tax" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r192", "r204" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Current Other assets", "verboseLabel": "Current Other assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Current Other liabilities" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other current liabilities.", "label": "Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of Current Other Liabilities" } } }, "localname": "OtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Covenants Not to Compete and Other" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r29", "r765" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current [Abstract]", "terseLabel": "Other Liabilities, Current [Abstract]" } } }, "localname": "OtherLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r33" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r12", "r223", "r241" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long-Term Debt", "terseLabel": "Other long-term debt" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Noncurrent Other assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Noncurrent Liabilities [Member]" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r68" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonrecurringIncomeExpense": { "auth_ref": [ "r69" ], "calculation": { "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature.", "label": "Other Nonrecurring (Income) Expense", "negatedLabel": "Other (charges) gains, net (Note 14)", "negatedTerseLabel": "Other (charges) gains, net", "negatedTotalLabel": "Total" } } }, "localname": "OtherNonrecurringIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Other, net" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPensionPlansDefinedBenefitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide retirement benefits, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Other Pension Plan [Member]", "terseLabel": "Benefit payments to nonqualified pension plans" } } }, "localname": "OtherPensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r143", "r503", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r530", "r531", "r532", "r533", "r534", "r535", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r553", "r556", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r572", "r573", "r574", "r751", "r752", "r753", "r754", "r755" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Post-retirement Benefits", "verboseLabel": "Benefit payments to other postretirement benefit plans" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherShortTermBorrowings": { "auth_ref": [ "r24" ], "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "order": 3.0, "parentTag": "us-gaap_DebtCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.", "label": "Other Short-Term Borrowings", "terseLabel": "Short-term borrowings, including amounts due to affiliates(1)" } } }, "localname": "OtherShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesCurrent": { "auth_ref": [ "r29", "r123" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.", "label": "Other Sundry Liabilities, Current", "terseLabel": "Other Sundry Liabilities, Current" } } }, "localname": "OtherSundryLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r794", "r795" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r74" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury stock, including related fees" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r414", "r800" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Cash payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r74" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Common stock dividends" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r76" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedTerseLabel": "Issuance cost of bridge facility" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r71", "r615" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire businesses, gross" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r72" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures on property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": { "auth_ref": [ "r11", "r144", "r145", "r146" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 11.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Current", "terseLabel": "Benefit obligations (Note 8)" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r13", "r144", "r145", "r146" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "terseLabel": "Benefit obligations" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "auth_ref": [ "r78" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.", "label": "Payment for Pension and Other Postretirement Benefits", "negatedLabel": "Pension and postretirement contributions" } } }, "localname": "PensionAndOtherPostretirementBenefitContributions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)", "terseLabel": "Pension and postretirement net periodic benefit cost" } } }, "localname": "PensionAndOtherPostretirementBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r527", "r529", "r535", "r552", "r554", "r555", "r556", "r557", "r558", "r570", "r571", "r572", "r577", "r751" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "Benefit Obligations" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "auth_ref": [ "r11", "r503", "r504", "r526", "r751" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.", "label": "Liability, Defined Benefit Plan, Current", "negatedTerseLabel": "Current Other liabilities" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r222", "r240", "r504", "r526" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.", "label": "Liability, Defined Benefit Plan", "negatedTerseLabel": "Benefit obligations" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r142", "r503", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r553", "r556", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r572", "r573", "r576", "r751", "r752", "r756", "r757", "r758" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Benefits", "verboseLabel": "Cash contributions to defined benefit pension plans" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PositionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by position taken for a security.", "label": "Position [Axis]", "terseLabel": "Position [Axis]" } } }, "localname": "PositionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_PositionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicates position taken for a security.", "label": "Position [Domain]", "terseLabel": "Position [Domain]" } } }, "localname": "PositionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_PostemploymentBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Postemployment Benefits [Abstract]" } } }, "localname": "PostemploymentBenefitsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r14", "r472" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r14", "r472" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r14", "r765" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.01\u00a0par value, 100,000,000\u00a0shares authorized (2023 and 2022: 0 issued and outstanding)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r797", "r799" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other, net" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsToMinorityShareholders": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.", "label": "Proceeds from (Payments to) Noncontrolling Interests", "terseLabel": "Distributions to noncontrolling interests" } } }, "localname": "ProceedsFromPaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r796", "r798", "r802" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.", "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less", "terseLabel": "Net change in short-term borrowings with maturities of 3 months or less" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r70" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds from Sale of Productive Assets", "terseLabel": "Proceeds from sale of businesses and assets, net" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r73" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from Short-Term Debt", "terseLabel": "Proceeds from short-term borrowings" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r258", "r283", "r286", "r297", "r301", "r310", "r320", "r321", "r360", "r365", "r371", "r374", "r388", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r616", "r619", "r620", "r635", "r648", "r698", "r737", "r760", "r761", "r793", "r840" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings (loss)", "totalLabel": "Net earnings (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Additions", "terseLabel": "Capital expenditures" } } }, "localname": "PropertyPlantAndEquipmentAdditions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r116", "r245", "r699", "r765" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment (net of accumulated depreciation\u00a0- 2023: $3,791; 2022: $3,687)" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r54", "r289", "r658", "r662", "r665", "r791" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "terseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r75" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Repayments of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r155", "r253", "r864" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "negatedLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r81", "r417", "r419", "r831" ], "calculation": { "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherNonrecurringIncomeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "negatedLabel": "Restructuring", "negatedTerseLabel": "Restructuring Charges", "terseLabel": "Additions" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetNarrativeDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r413", "r414", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r414", "r418" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r788", "r832", "r833" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Restructuring (Note 18)" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r17", "r136", "r242", "r711", "r715", "r765" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r254", "r305", "r306", "r307", "r311", "r319", "r321", "r389", "r583", "r584", "r585", "r594", "r595", "r633", "r708", "r710" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r142", "r143", "r503", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r553", "r556", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r572", "r573", "r574", "r576", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r142", "r143", "r503", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r553", "r556", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r572", "r573", "r574", "r576", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r351", "r352", "r364", "r369", "r370", "r376", "r377", "r380", "r499", "r500", "r686" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r489", "r490", "r491", "r492", "r493", "r494", "r497", "r498", "r501", "r502" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Recognition and Deferred Revenue [Abstract]", "terseLabel": "Revenue Recognition and Deferred Revenue [Abstract]" } } }, "localname": "RevenueRecognitionAndDeferredRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r495" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, remaining performance obligation, amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Sales and use tax/foreign withholding tax payable" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r54", "r854", "r855" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r160", "r161", "r614" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.", "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Components of Other Comprehensive Income (Loss), Net" } } }, "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r32", "r130", "r133", "r134", "r135", "r211", "r212", "r214", "r235", "r743", "r745", "r807" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r148", "r149", "r150", "r151", "r152" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "auth_ref": [ "r148", "r149", "r150", "r151", "r152" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.", "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r193", "r199", "r628" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of Changes in Fair Value of Derivatives" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings (Loss) Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.", "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]", "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]" } } }, "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r639", "r640" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r104", "r107", "r687" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r104", "r107" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r738" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r738", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r111", "r113" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r111", "r113" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r9", "r21", "r22", "r23" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Schedule of Line of Credit Facilities [Table Text Block]", "terseLabel": "Schedule of Balances Available for Borrowing" } } }, "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Periodic Benefit Costs Recognized" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/BenefitObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Derivative and Nonderivative Instruments" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r413", "r414", "r415", "r416", "r419", "r420", "r421" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r91", "r92", "r93", "r101" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r91", "r92", "r93", "r101" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Business Segments" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]", "terseLabel": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table Text Block]", "terseLabel": "Schedule of Short-term Debt" } } }, "localname": "ScheduleOfShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r126", "r127", "r128", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r268", "r269", "r270", "r342", "r472", "r473", "r474", "r476", "r480", "r485", "r487", "r747", "r774", "r803" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "auth_ref": [ "r137", "r138", "r139", "r140" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table Text Block]", "terseLabel": "Schedule of Treasury Stock" } } }, "localname": "ScheduleOfTreasuryStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "auth_ref": [ "r174", "r175", "r176", "r177", "r178", "r617", "r618", "r622", "r623", "r682", "r683", "r684" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "Schedule of Variable Interest Entities [Table]", "terseLabel": "Schedule of Variable Interest Entities [Table]" } } }, "localname": "ScheduleOfVariableInterestEntitiesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r348", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r374", "r380", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r416", "r421", "r738", "r867" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r348", "r349", "r350", "r360", "r363", "r368", "r372", "r373", "r374", "r375", "r376", "r379", "r380", "r381" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r65" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Notes [Abstract]", "terseLabel": "Senior Notes [Abstract]" } } }, "localname": "SeniorLongtermNotesCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r80" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance as of the end of the period (in shares)", "periodStartLabel": "Balance as of the beginning of the period (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]", "terseLabel": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term within one year or the normal operating cycle, if longer.", "label": "Short-Term Debt [Member]", "terseLabel": "Loans Payable" } } }, "localname": "ShortTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]", "terseLabel": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-Term Debt, Type [Domain]", "terseLabel": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermDebtWeightedAverageInterestRate": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.", "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted average interest rate, short-term borrowings" } } }, "localname": "ShortTermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SiteContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Site Contingency [Line Items]", "terseLabel": "Site Contingency [Line Items]" } } }, "localname": "SiteContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SiteContingencyTable": { "auth_ref": [ "r429", "r739", "r740", "r778", "r779", "r780", "r829", "r838" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from an environmental remediation obligation.", "label": "Site Contingency [Table]", "terseLabel": "Site Contingency [Table]" } } }, "localname": "SiteContingencyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r257", "r348", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r374", "r380", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r411", "r416", "r421", "r738", "r867" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r268", "r269", "r270", "r301", "r327", "r331", "r333", "r335", "r342", "r343", "r388", "r431", "r434", "r435", "r436", "r442", "r443", "r472", "r473", "r476", "r480", "r487", "r648", "r729", "r774", "r803", "r811" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r36", "r129", "r254", "r288", "r289", "r290", "r305", "r306", "r307", "r311", "r319", "r321", "r341", "r389", "r488", "r583", "r584", "r585", "r594", "r595", "r633", "r658", "r659", "r660", "r661", "r662", "r665", "r675", "r708", "r709", "r710" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r305", "r306", "r307", "r341", "r686" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r14", "r15", "r129", "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Stock awards (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r129", "r136" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Stock awards" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r18", "r19", "r96", "r765", "r805", "r815", "r853" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "terseLabel": "Celanese Corporation stockholders' equity", "totalLabel": "Total Celanese Corporation shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r166", "r167", "r179", "r254", "r255", "r289", "r305", "r306", "r307", "r311", "r319", "r389", "r488", "r583", "r584", "r585", "r594", "r595", "r633", "r658", "r659", "r665", "r675", "r709", "r710", "r805", "r815", "r853" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance as of the end of the period", "periodStartLabel": "Balance as of the beginning of the period", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r141", "r300", "r473", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r486", "r488", "r631" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r666", "r677" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r666", "r677" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r666", "r677" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trademarks and Trade Names" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": { "auth_ref": [ "r215" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.", "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized", "terseLabel": "Transfer of financial assets accounted for as sales, amount derecognized" } } }, "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Average purchase price (in dollar per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r35", "r137" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r35", "r137" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury stock, shares (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r15", "r129", "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "negatedTerseLabel": "Purchases of treasury stock (in shares)", "verboseLabel": "Shares repurchased (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r35", "r137", "r140" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost (2023: 61,661,493 shares; 2022: 61,661,493 shares)" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r129", "r136", "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Purchases of treasury stock, including related fees", "terseLabel": "Shares repurchased (in $ millions)" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r413", "r414", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": { "auth_ref": [ "r423" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary": { "auth_ref": [ "r423" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary": { "auth_ref": [ "r423" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary": { "auth_ref": [ "r423" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": { "auth_ref": [ "r423" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).", "label": "Unrecorded Unconditional Purchase Obligation", "terseLabel": "Unrecorded unconditional purchase obligations" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in remainder of current fiscal year.", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r12", "r223", "r241" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Senior unsecured debt" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r87", "r88", "r89", "r344", "r345", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Estimates and Assumptions" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/RecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Variable Interest Entity [Line Items]", "terseLabel": "Variable Interest Entity [Line Items]" } } }, "localname": "VariableInterestEntityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r326", "r335" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares\u00a0- diluted (in shares)", "totalLabel": "Weighted average shares\u00a0- diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r325", "r335" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares\u00a0- basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.E)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(21))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org/subtopic&trid=2175709", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q1)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226038-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13644-110860", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13703-110860", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13718-110860", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r768": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r769": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r771": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r772": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r773": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(1)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(2)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(3)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(4)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(5)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13283-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13319-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13328-110859", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 111 0001306830-23-000086-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001306830-23-000086-xbrl.zip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�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ͩ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�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